QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
Securities registered pursuant to Section 12(b) of the Act: | |||||||||||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | |||||||||
☑ | Accelerated filer | ☐ | |||||||||||||||
Non-accelerated filer | ☐ | Smaller reporting company | |||||||||||||||
Emerging growth company |
Part I. | FINANCIAL INFORMATION | Page | |||||||||
Item 1. | |||||||||||
Note 1. | |||||||||||
Note 2. | |||||||||||
Note 3. | |||||||||||
Note 4. | |||||||||||
Note 5. | |||||||||||
Note 6. | |||||||||||
Note 7. | |||||||||||
Note 8. | |||||||||||
Note 9. | |||||||||||
Note 10. | |||||||||||
Note 11. | |||||||||||
Note 12. | |||||||||||
Note 13. | |||||||||||
Note 14. | |||||||||||
Note 15. | |||||||||||
Note 16. | |||||||||||
Note 17. | |||||||||||
Note 18. | |||||||||||
Note 19. | |||||||||||
Item 2. | |||||||||||
Item 3. | |||||||||||
Item 4. | |||||||||||
Part II. | OTHER INFORMATION | ||||||||||
Item 1. | |||||||||||
Item 1A. | |||||||||||
Item 2. | |||||||||||
Item 5. | |||||||||||
Item 6. |
ITEM 1. Financial Statements |
September 30, 2023 | December 31, 2022 | ||||||||||
(in millions of U.S. dollars, except share and per share data) | As Adjusted | ||||||||||
Assets | |||||||||||
Investments | |||||||||||
Short-term investments, at fair value (amortized cost – $ | $ | $ | |||||||||
Fixed maturities available for sale, at fair value, net of valuation allowance - $ (amortized cost – $ | |||||||||||
Fixed maturities held to maturity, at amortized cost, net of valuation allowance - (fair value – | |||||||||||
Private debt held-for-investment, at amortized cost | |||||||||||
Equity securities, at fair value | |||||||||||
Private equities | |||||||||||
Other investments | |||||||||||
Total investments (refer to Note 3 for balances associated with variable interest entities (VIEs)) | |||||||||||
Cash, including restricted cash $ | |||||||||||
Securities lending collateral | |||||||||||
Accrued investment income | |||||||||||
Insurance and reinsurance balances receivable, net of valuation allowance - $ | |||||||||||
Reinsurance recoverable on losses and loss expenses, net of valuation allowance - $ | |||||||||||
Reinsurance recoverable on policy benefits | |||||||||||
Deferred policy acquisition costs | |||||||||||
Value of business acquired | |||||||||||
Goodwill | |||||||||||
Other intangible assets | |||||||||||
Prepaid reinsurance premiums | |||||||||||
Investments in partially-owned insurance companies | |||||||||||
Separate account assets | |||||||||||
Other assets | |||||||||||
Total assets | $ | $ | |||||||||
Liabilities | |||||||||||
Unpaid losses and loss expenses | $ | $ | |||||||||
Unearned premiums | |||||||||||
Future policy benefits | |||||||||||
Market risk benefits | |||||||||||
Policyholders' account balances | |||||||||||
Separate account liabilities | |||||||||||
Insurance and reinsurance balances payable | |||||||||||
Securities lending payable | |||||||||||
Accounts payable, accrued expenses, and other liabilities | |||||||||||
Deferred tax liabilities | |||||||||||
Repurchase agreements (refer to Note 3 for balances associated with VIEs) | |||||||||||
Short-term debt | |||||||||||
Long-term debt | |||||||||||
Trust preferred securities | |||||||||||
Total liabilities | |||||||||||
Commitments and contingencies (refer to Note 13) | |||||||||||
Shareholders’ equity | |||||||||||
Common Shares (CHF | |||||||||||
Common Shares in treasury ( | ( | ( | |||||||||
Additional paid-in capital | |||||||||||
Retained earnings | |||||||||||
Accumulated other comprehensive income (loss) (AOCI) | ( | ( | |||||||||
Total Chubb shareholders’ equity | |||||||||||
Noncontrolling interests (refer to Note 3 for balances associated with VIEs) | |||||||||||
Total shareholders' equity | |||||||||||
Total liabilities and shareholders’ equity | $ | $ |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
September 30 | September 30 | ||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
(in millions of U.S. dollars, except per share data) | As Adjusted | As Adjusted | |||||||||||||||||||||
Revenues | |||||||||||||||||||||||
Net premiums written | $ | $ | $ | $ | |||||||||||||||||||
Increase in unearned premiums | ( | ( | ( | ( | |||||||||||||||||||
Net premiums earned | |||||||||||||||||||||||
Net investment income | |||||||||||||||||||||||
Net realized gains (losses) | ( | ( | ( | ( | |||||||||||||||||||
Market risk benefits gains (losses) | ( | ( | |||||||||||||||||||||
Total revenues | |||||||||||||||||||||||
Expenses | |||||||||||||||||||||||
Losses and loss expenses | |||||||||||||||||||||||
Policy benefits (includes remeasurement gains of $ | |||||||||||||||||||||||
Policy acquisition costs | |||||||||||||||||||||||
Administrative expenses | |||||||||||||||||||||||
Interest expense | |||||||||||||||||||||||
Other (income) expense | ( | ( | ( | ||||||||||||||||||||
Amortization of purchased intangibles | |||||||||||||||||||||||
Cigna integration expenses | |||||||||||||||||||||||
Total expenses | |||||||||||||||||||||||
Income before income tax | |||||||||||||||||||||||
Income tax expense | |||||||||||||||||||||||
Net income | $ | $ | $ | $ | |||||||||||||||||||
Net loss attributable to noncontrolling interests | ( | ( | |||||||||||||||||||||
Net income attributable to Chubb | $ | $ | $ | $ | |||||||||||||||||||
Other comprehensive income (loss) | |||||||||||||||||||||||
Change in: | |||||||||||||||||||||||
Unrealized depreciation | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
Current discount rate on future policy benefits | |||||||||||||||||||||||
Instrument-specific credit risk on market risk benefits | ( | ||||||||||||||||||||||
Cumulative foreign currency translation adjustment | ( | ( | ( | ( | |||||||||||||||||||
Other, including postretirement benefit liability adjustment | ( | ( | |||||||||||||||||||||
Other comprehensive loss, before income tax | ( | ( | ( | ( | |||||||||||||||||||
Income tax (expense) benefit related to OCI items | ( | ||||||||||||||||||||||
Other comprehensive loss | ( | ( | ( | ( | |||||||||||||||||||
Comprehensive income (loss) | ( | ( | |||||||||||||||||||||
Comprehensive loss attributable to noncontrolling interests | ( | ( | |||||||||||||||||||||
Comprehensive income (loss) attributable to Chubb | $ | $ | ( | $ | $ | ( | |||||||||||||||||
Earnings per share | |||||||||||||||||||||||
Basic earnings per share attributable to Chubb | $ | $ | $ | $ | |||||||||||||||||||
Diluted earnings per share attributable to Chubb | $ | $ | $ | $ |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
September 30 | September 30 | ||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
(in millions of U.S. dollars) | As Adjusted | As Adjusted | |||||||||||||||||||||
Common Shares | |||||||||||||||||||||||
Balance – beginning of period | $ | $ | $ | $ | |||||||||||||||||||
Par value reduction | ( | ||||||||||||||||||||||
Cancellation of treasury shares | ( | ( | ( | ||||||||||||||||||||
Balance – end of period | |||||||||||||||||||||||
Common Shares in treasury | |||||||||||||||||||||||
Balance – beginning of period | ( | ( | ( | ( | |||||||||||||||||||
Common Shares repurchased | ( | ( | ( | ( | |||||||||||||||||||
Cancellation of treasury shares | |||||||||||||||||||||||
Net shares issued under employee share-based compensation plans | |||||||||||||||||||||||
Balance – end of period | ( | ( | ( | ( | |||||||||||||||||||
Additional paid-in capital | |||||||||||||||||||||||
Balance – beginning of period | |||||||||||||||||||||||
Net shares redeemed (issued) under employee share-based compensation plans | ( | ( | |||||||||||||||||||||
Exercise of stock options | ( | ( | ( | ( | |||||||||||||||||||
Share-based compensation expense | |||||||||||||||||||||||
Par value reduction | |||||||||||||||||||||||
Funding of dividends declared to Retained earnings | ( | ( | ( | ( | |||||||||||||||||||
Balance – end of period | |||||||||||||||||||||||
Retained earnings | |||||||||||||||||||||||
Balance – beginning of period | |||||||||||||||||||||||
Net income attributable to Chubb | |||||||||||||||||||||||
Cancellation of treasury shares | ( | ( | ( | ||||||||||||||||||||
Funding of dividends declared from Additional paid-in capital | |||||||||||||||||||||||
Dividends declared on Common Shares | ( | ( | ( | ( | |||||||||||||||||||
Balance – end of period | |||||||||||||||||||||||
Accumulated other comprehensive income (loss) (AOCI) | |||||||||||||||||||||||
Balance – beginning of period | ( | ( | ( | ( | |||||||||||||||||||
Other comprehensive loss | ( | ( | ( | ( | |||||||||||||||||||
Balance – end of period | ( | ( | ( | ( | |||||||||||||||||||
Total Chubb shareholders’ equity | $ | $ | $ | $ | |||||||||||||||||||
Noncontrolling interests | |||||||||||||||||||||||
Balance – beginning of period | $ | $ | $ | $ | |||||||||||||||||||
Consolidation of Huatai Group | |||||||||||||||||||||||
Net loss attributable to noncontrolling interests | ( | ( | |||||||||||||||||||||
Other comprehensive loss attributable to noncontrolling interests | ( | ( | |||||||||||||||||||||
Balance – end of period | $ | $ | $ | $ | |||||||||||||||||||
Total shareholders' equity | $ | $ | $ | $ |
Nine Months Ended | |||||||||||
September 30 | |||||||||||
2023 | 2022 | ||||||||||
(in millions of U.S. dollars) | As Adjusted | ||||||||||
Cash flows from operating activities | |||||||||||
Net income | $ | $ | |||||||||
Adjustments to reconcile net income to net cash flows from operating activities | |||||||||||
Net realized (gains) losses | |||||||||||
Market risk benefits (gains) losses | ( | ||||||||||
Amortization of premiums/discounts on fixed maturities | ( | ||||||||||
Amortization of purchased intangibles | |||||||||||
Equity in net income of partially-owned entities | ( | ( | |||||||||
Deferred income taxes | |||||||||||
Unpaid losses and loss expenses | |||||||||||
Unearned premiums | |||||||||||
Future policy benefits | |||||||||||
Insurance and reinsurance balances payable | |||||||||||
Accounts payable, accrued expenses, and other liabilities | ( | ||||||||||
Income taxes payable | ( | ( | |||||||||
Insurance and reinsurance balances receivable | ( | ( | |||||||||
Reinsurance recoverable | ( | ( | |||||||||
Deferred policy acquisition costs | ( | ( | |||||||||
Other | ( | ||||||||||
Net cash flows from operating activities | |||||||||||
Cash flows from investing activities | |||||||||||
Purchases of fixed maturities available for sale | ( | ( | |||||||||
Purchases of fixed maturities held to maturity | ( | ( | |||||||||
Purchases of equity securities | ( | ( | |||||||||
Sales of fixed maturities available for sale | |||||||||||
Sales of equity securities | |||||||||||
Maturities and redemptions of fixed maturities available for sale | |||||||||||
Maturities and redemptions of fixed maturities held to maturity | |||||||||||
Net change in short-term investments | ( | ||||||||||
Net derivative instruments settlements | ( | ( | |||||||||
Private equity contributions | ( | ( | |||||||||
Private equity distributions | |||||||||||
Acquisition of subsidiaries (net of cash acquired) | ( | ||||||||||
Other | ( | ( | |||||||||
Net cash flows used for investing activities | ( | ( | |||||||||
Cash flows from financing activities | |||||||||||
Dividends paid on Common Shares | ( | ( | |||||||||
Common Shares repurchased | ( | ( | |||||||||
Proceeds from issuance of repurchase agreements | |||||||||||
Repayment of long-term debt | ( | ||||||||||
Repayment of repurchase agreements | ( | ( | |||||||||
Proceeds from share-based compensation plans | |||||||||||
Policyholder contract deposits | |||||||||||
Policyholder contract withdrawals | ( | ( | |||||||||
Tax withholding payments for share-based compensation plans | ( | ( | |||||||||
Other | ( | ( | |||||||||
Net cash flows used for financing activities | ( | ( | |||||||||
Effect of foreign currency rate changes on cash and restricted cash | ( | ( | |||||||||
Net increase in cash and restricted cash | |||||||||||
Cash and restricted cash – beginning of period | |||||||||||
Cash and restricted cash – end of period | $ | $ | |||||||||
Supplemental cash flow information | |||||||||||
Taxes paid | $ | $ | |||||||||
Interest paid | $ | $ |
December 31, 2022 | |||||||||||||||||
(in millions of U.S. dollars) | As Previously Reported | LDTI Adoption Adjustment | As Adjusted | ||||||||||||||
Consolidated balance sheet | |||||||||||||||||
Reinsurance recoverable on losses and loss expenses | $ | $ | ( | $ | |||||||||||||
Reinsurance recoverable on policy benefits | ( | ||||||||||||||||
Deferred policy acquisition costs | |||||||||||||||||
Value of business acquired | |||||||||||||||||
Prepaid reinsurance premiums | ( | ||||||||||||||||
Investments in partially-owned insurance companies | ( | ||||||||||||||||
Unpaid losses and loss expenses | ( | ||||||||||||||||
Unearned premiums | ( | ||||||||||||||||
Future policy benefits | |||||||||||||||||
Market risk benefits | |||||||||||||||||
Insurance and reinsurance balances payable | ( | ||||||||||||||||
Deferred tax liabilities | |||||||||||||||||
Retained Earnings | ( | ||||||||||||||||
Accumulated other comprehensive income (loss) | ( | ( |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||
September 30, 2022 | September 30, 2022 | ||||||||||||||||||||||||||||||||||
(in millions of U.S. dollars) | As Previously Reported | LDTI Adoption Adjustment | As Adjusted | As Previously Reported | LDTI Adoption Adjustment | As Adjusted | |||||||||||||||||||||||||||||
Consolidated statements of operations and comprehensive income | |||||||||||||||||||||||||||||||||||
Net premiums written | $ | $ | ( | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||
Net premiums earned | ( | ( | |||||||||||||||||||||||||||||||||
Net realized gains (losses) | ( | ( | ( | ( | ( | ( | |||||||||||||||||||||||||||||
Market risk benefits gains (losses) | |||||||||||||||||||||||||||||||||||
Losses and loss expenses | ( | ( | |||||||||||||||||||||||||||||||||
Policy benefits | |||||||||||||||||||||||||||||||||||
Policy acquisition costs | ( | ( | |||||||||||||||||||||||||||||||||
Other (income) expense | ( | ( | |||||||||||||||||||||||||||||||||
Income tax expense | ( | ( | |||||||||||||||||||||||||||||||||
Net Income | ( | ( | |||||||||||||||||||||||||||||||||
Other comprehensive income | |||||||||||||||||||||||||||||||||||
Change in current discount rate on future policy benefits | |||||||||||||||||||||||||||||||||||
Change in instrument-specific credit risk on market risk benefits | |||||||||||||||||||||||||||||||||||
Income tax benefit related to OCI items | ( | ( | |||||||||||||||||||||||||||||||||
Comprehensive income (loss) | ( | ( | ( | ( |
Nine Months Ended | |||||||||||||||||
September 30,2022 | |||||||||||||||||
(in millions of U.S. dollars) | As Previously Reported | LDTI Adoption Adjustment | As Adjusted | ||||||||||||||
Consolidated statement of cash flows | |||||||||||||||||
Net cash flows from operating activities | $ | $ | $ | ||||||||||||||
Net cash flows used for financing activities | ( | ( | ( |
Life Insurance | Overseas General Insurance | Offsetting Equity Line Classification | |||||||||||||||||||||||||||||||||||||||
(in millions of U.S. dollars) | Term Life | Whole Life | A&H | Other | A&H | Total | |||||||||||||||||||||||||||||||||||
Future policy benefits | |||||||||||||||||||||||||||||||||||||||||
Balance – December 31, 2020 (1) | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||
Effect of change in current discount rate | AOCI | ||||||||||||||||||||||||||||||||||||||||
Balance – January 1, 2021 | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||
(in millions of U.S. dollars) | Offsetting Equity Line Classification | ||||||||||
Market risk benefits | |||||||||||
Balance – December 31, 2020 | $ | ||||||||||
Cumulative effect of changes in instrument-specific credit risk between original contract issuance date and transition date (1) | AOCI | ||||||||||
Other fair value adjustments | ( | Retained Earnings | |||||||||
Balance – January 1, 2021 | $ |
Preliminary estimate of Huatai Group assets and liabilities consolidated | July 1 | ||||
(in millions of U.S. dollars) | 2023 | ||||
Assets | |||||
Investments and Cash | $ | ||||
Accrued investment income | |||||
Insurance and reinsurance balances receivable | |||||
Reinsurance recoverable on losses and loss expenses | |||||
Reinsurance recoverable on future policy benefits | |||||
Value of business acquired | |||||
Goodwill and intangible assets | |||||
Other assets | |||||
Total assets | $ | ||||
Liabilities | |||||
Unpaid losses and loss expenses | $ | ||||
Unearned premiums | |||||
Future policy benefits | |||||
Policyholders' account balances | |||||
Insurance and reinsurance balances payable | |||||
Accounts payable, accrued expenses, and other liabilities | |||||
Deferred tax liabilities | |||||
Repurchase agreements | |||||
Total liabilities | $ | ||||
Net acquired assets, including goodwill, attributable to Chubb | |||||
Net acquired assets, attributable to noncontrolling interests | |||||
Net acquired assets, including goodwill | $ |
(in millions of U.S. dollars) | |||||
Total revenues | $ | ||||
Net loss | $ | ( | |||
Net loss attributable to Chubb | $ | ( | |||
(in millions of U.S. dollars) | Amount | Weighted-average useful life | |||||||||
Definite life | |||||||||||
Agency distribution relationships | $ | ||||||||||
Asset management customer contracts | |||||||||||
Unearned premium reserves (UPR) intangible asset | |||||||||||
Land use rights | |||||||||||
Technology | |||||||||||
Indefinite life | |||||||||||
Trademarks | Indefinite | ||||||||||
Asset management mutual funds | Indefinite | ||||||||||
Total identified intangible assets | $ |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
Pro forma: | September 30 | September 30 | |||||||||||||||||||||
(in millions of U.S. dollars) | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
Net premiums earned | $ | $ | $ | $ | |||||||||||||||||||
Total revenues | $ | $ | $ | $ | |||||||||||||||||||
Net income | $ | $ | $ | $ | |||||||||||||||||||
Net income attributable to Chubb | $ | $ | $ | $ |
Assets acquired and liabilities assumed from Cigna's business in Asia | July 1 | ||||
(in millions of U.S. dollars) | 2022 | ||||
Assets | |||||
Investments and Cash | $ | ||||
Accrued investment income | |||||
Insurance and reinsurance balances receivable | |||||
Reinsurance recoverable on losses and loss expenses | |||||
Reinsurance recoverable on future policy benefits | |||||
Value of business acquired | |||||
Goodwill and intangible assets | |||||
Other assets | |||||
Total assets | $ | ||||
Liabilities | |||||
Unpaid losses and loss expenses | $ | ||||
Unearned premiums | |||||
Future policy benefits | |||||
Insurance and reinsurance balances payable | |||||
Accounts payable, accrued expenses, and other liabilities | |||||
Deferred tax liabilities | |||||
Total liabilities | $ | ||||
Net acquired assets, including goodwill | |||||
Total | $ |
(in millions of U.S. dollars) | |||||
Total revenues | $ | ||||
Net income | $ |
Three Months Ended | Nine Months Ended | ||||||||||
Pro forma: | September 30 | September 30 | |||||||||
(in millions of U.S. dollars) | 2022 | 2022 | |||||||||
Net premiums earned | $ | $ | |||||||||
Total revenues | $ | $ | |||||||||
Net income | $ | $ | |||||||||
September 30, 2023 | Amortized Cost | Valuation Allowance | Gross Unrealized Appreciation | Gross Unrealized Depreciation | Fair Value | ||||||||||||||||||||||||||||||
(in millions of U.S. dollars) | |||||||||||||||||||||||||||||||||||
Available for sale | |||||||||||||||||||||||||||||||||||
U.S. Treasury / Agency | $ | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||||
Non-U.S. | ( | ( | |||||||||||||||||||||||||||||||||
Corporate and asset-backed securities | ( | ( | |||||||||||||||||||||||||||||||||
Mortgage-backed securities | ( | ( | |||||||||||||||||||||||||||||||||
Municipal | ( | ||||||||||||||||||||||||||||||||||
$ | $ | ( | $ | $ | ( | $ |
December 31, 2022 | Amortized Cost | Valuation Allowance | Gross Unrealized Appreciation | Gross Unrealized Depreciation | Fair Value | ||||||||||||||||||||||||||||||
(in millions of U.S. dollars) | |||||||||||||||||||||||||||||||||||
Available for sale | |||||||||||||||||||||||||||||||||||
U.S. Treasury / Agency | $ | $ | $ | $ | ( | $ | |||||||||||||||||||||||||||||
Non-U.S. | ( | ( | |||||||||||||||||||||||||||||||||
Corporate and asset-backed securities | ( | ( | |||||||||||||||||||||||||||||||||
Mortgage-backed securities | ( | ( | |||||||||||||||||||||||||||||||||
Municipal | ( | ||||||||||||||||||||||||||||||||||
$ | $ | ( | $ | $ | ( | $ |
December 31, 2022 | Amortized Cost | Valuation Allowance | Net Carrying Value | Gross Unrealized Appreciation | Gross Unrealized Depreciation | Fair Value | |||||||||||||||||||||||||||||
(in millions of U.S. dollars) | |||||||||||||||||||||||||||||||||||
Held to maturity | |||||||||||||||||||||||||||||||||||
U.S. Treasury / Agency | $ | $ | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||
Non-U.S. | ( | ( | |||||||||||||||||||||||||||||||||
Corporate and asset-backed securities | ( | ( | |||||||||||||||||||||||||||||||||
Mortgage-backed securities | ( | ( | |||||||||||||||||||||||||||||||||
Municipal | ( | ( | |||||||||||||||||||||||||||||||||
$ | $ | ( | $ | $ | $ | ( | $ |
December 31, 2022 | |||||||||||
(in millions of U.S. dollars, except for percentages) | Amortized cost | % of Total | |||||||||
AAA | $ | % | |||||||||
AA | % | ||||||||||
A | % | ||||||||||
BBB | % | ||||||||||
BB | % | ||||||||||
Total | $ | % |
September 30, 2023 | December 31, 2022 | ||||||||||||||||||||||
(in millions of U.S. dollars) | Net Carrying Value | Fair Value | Net Carrying Value | Fair Value | |||||||||||||||||||
Available for sale | |||||||||||||||||||||||
Due in 1 year or less | $ | $ | $ | $ | |||||||||||||||||||
Due after 1 year through 5 years | |||||||||||||||||||||||
Due after 5 years through 10 years | |||||||||||||||||||||||
Due after 10 years | |||||||||||||||||||||||
Mortgage-backed securities | |||||||||||||||||||||||
$ | $ | $ | $ | ||||||||||||||||||||
Held to maturity | |||||||||||||||||||||||
Due in 1 year or less | $ | $ | $ | $ | |||||||||||||||||||
Due after 1 year through 5 years | |||||||||||||||||||||||
Due after 5 years through 10 years | |||||||||||||||||||||||
Due after 10 years | |||||||||||||||||||||||
Mortgage-backed securities | |||||||||||||||||||||||
$ | $ | $ | $ |
0 – 12 Months | Over 12 Months | Total | |||||||||||||||||||||||||||||||||
September 30, 2023 | Fair Value | Gross Unrealized Loss | Fair Value | Gross Unrealized Loss | Fair Value | Gross Unrealized Loss | |||||||||||||||||||||||||||||
(in millions of U.S. dollars) | |||||||||||||||||||||||||||||||||||
U.S. Treasury / Agency | $ | $ | ( | $ | $ | ( | $ | $ | ( | ||||||||||||||||||||||||||
Non-U.S. | ( | ( | ( | ||||||||||||||||||||||||||||||||
Corporate and asset-backed securities | ( | ( | ( | ||||||||||||||||||||||||||||||||
Mortgage-backed securities | ( | ( | ( | ||||||||||||||||||||||||||||||||
Municipal | ( | ( | ( | ||||||||||||||||||||||||||||||||
Total AFS fixed maturities | $ | $ | ( | $ | $ | ( | $ | $ | ( | ||||||||||||||||||||||||||
0 – 12 Months | Over 12 Months | Total | |||||||||||||||||||||||||||||||||
December 31, 2022 | Fair Value | Gross Unrealized Loss | Fair Value | Gross Unrealized Loss | Fair Value | Gross Unrealized Loss | |||||||||||||||||||||||||||||
(in millions of U.S. dollars) | |||||||||||||||||||||||||||||||||||
U.S. Treasury / Agency | $ | $ | ( | $ | $ | ( | $ | $ | ( | ||||||||||||||||||||||||||
Non-U.S. | ( | ( | ( | ||||||||||||||||||||||||||||||||
Corporate and asset-backed securities | ( | ( | ( | ||||||||||||||||||||||||||||||||
Mortgage-backed securities | ( | ( | ( | ||||||||||||||||||||||||||||||||
Municipal | ( | ( | ( | ||||||||||||||||||||||||||||||||
Total AFS fixed maturities | $ | $ | ( | $ | $ | ( | $ | $ | ( | ||||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
September 30 | September 30 | ||||||||||||||||||||||
(in millions of U.S. dollars) | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
Available for sale | |||||||||||||||||||||||
Valuation allowance for expected credit losses - beginning of period | $ | $ | $ | $ | |||||||||||||||||||
Provision for expected credit loss | |||||||||||||||||||||||
Write-offs charged against the expected credit loss | ( | ( | |||||||||||||||||||||
Foreign currency revaluation | ( | ( | |||||||||||||||||||||
Recovery of expected credit loss | ( | ( | ( | ( | |||||||||||||||||||
Valuation allowance for expected credit losses - end of period | $ | $ | $ | $ | |||||||||||||||||||
Held to maturity | |||||||||||||||||||||||
Valuation allowance for expected credit losses - beginning of period | $ | $ | $ | $ | |||||||||||||||||||
Provision for expected credit loss | |||||||||||||||||||||||
Recovery of expected credit loss | ( | ( | ( | ||||||||||||||||||||
Valuation allowance for expected credit losses - end of period | $ | $ | $ | $ | |||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
September 30 | September 30 | ||||||||||||||||||||||
(in millions of U.S. dollars) | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
Fixed maturities: | |||||||||||||||||||||||
Gross realized gains | $ | $ | $ | $ | |||||||||||||||||||
Gross realized losses | ( | ( | ( | ( | |||||||||||||||||||
Net (provision for) recovery of expected credit losses | ( | ( | |||||||||||||||||||||
Impairment (1) | ( | ( | ( | ( | |||||||||||||||||||
Total fixed maturities | ( | ( | ( | ( | |||||||||||||||||||
Equity securities | ( | ( | ( | ( | |||||||||||||||||||
Private equities | ( | ||||||||||||||||||||||
Foreign exchange | ( | ( | |||||||||||||||||||||
Investment and embedded derivative instruments | ( | ( | ( | ||||||||||||||||||||
Other derivative instruments | ( | ( | ( | ( | |||||||||||||||||||
Other (2) | ( | ( | |||||||||||||||||||||
Net realized gains (losses) (pre-tax) | $ | ( | $ | ( | $ | ( | $ | ( |
Three Months Ended | |||||||||||||||||||||||||||||||||||||||||
September 30 | |||||||||||||||||||||||||||||||||||||||||
2023 | 2022 | ||||||||||||||||||||||||||||||||||||||||
(in millions of U.S. dollars) | Other Investments | Equity Securities | Private Equities | Total | Equity Securities | Private Equities | Total | ||||||||||||||||||||||||||||||||||
Net gains (losses) recognized during the period | $ | ( | $ | ( | $ | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||||||||||||||||||||||
Less: Net gains (losses) recognized from sales of securities | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||
Unrealized gains (losses) recognized for securities still held at reporting date | $ | ( | $ | ( | $ | $ | ( | $ | ( | $ | ( | $ | ( |
Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||
September 30 | |||||||||||||||||||||||||||||||||||||||||
2023 | 2022 | ||||||||||||||||||||||||||||||||||||||||
(in millions of U.S. dollars) | Other Investments | Equity Securities | Private Equities | Total | Equity Securities | Private Equities | Total | ||||||||||||||||||||||||||||||||||
Net gains (losses) recognized during the period | $ | ( | $ | ( | $ | $ | $ | ( | $ | $ | ( | ||||||||||||||||||||||||||||||
Less: Net gains (losses) recognized from sales of securities | ( | ( | |||||||||||||||||||||||||||||||||||||||
Unrealized gains (losses) recognized for securities still held at reporting date | $ | ( | $ | ( | $ | $ | $ | ( | $ | $ | ( |
Expected Liquidation Period of Underlying Assets | September 30, 2023 | December 31, 2022 | |||||||||||||||||||||||||||
(in millions of U.S. dollars) | Fair Value | Maximum Future Funding Commitments | Fair Value | Maximum Future Funding Commitments | |||||||||||||||||||||||||
Financial | $ | $ | $ | $ | |||||||||||||||||||||||||
Real assets | |||||||||||||||||||||||||||||
Distressed | |||||||||||||||||||||||||||||
Private credit | |||||||||||||||||||||||||||||
Traditional | |||||||||||||||||||||||||||||
Vintage | |||||||||||||||||||||||||||||
Investment funds | Not Applicable | ||||||||||||||||||||||||||||
$ | $ | $ | $ |
Investment Category: | Consists of investments in private equity funds: | |||||||
Financial | targeting financial services companies, such as financial institutions and insurance services worldwide | |||||||
Real assets | targeting investments related to hard physical assets, such as real estate, infrastructure and natural resources | |||||||
Distressed | targeting distressed corporate debt/credit and equity opportunities in the U.S. | |||||||
Private credit | targeting privately originated corporate debt investments, including senior secured loans and subordinated bonds | |||||||
Traditional | employing traditional private equity investment strategies, such as buyout and growth equity globally | |||||||
Vintage | funds where the initial fund term has expired |
September 30 | December 31 | ||||||||||
(in millions of U.S. dollars) | 2023 | 2022 | |||||||||
Trust funds | $ | $ | |||||||||
Deposits with U.S. regulatory authorities | |||||||||||
Deposits with non-U.S. regulatory authorities | |||||||||||
Assets pledged under repurchase agreements | |||||||||||
Other pledged assets | |||||||||||
Total | $ | $ |
September 30 | |||||
(in millions of U.S. dollars) | 2023 | ||||
Short-term investments | $ | ||||
Equity securities | |||||
Private equities | |||||
Other investments | |||||
Total investments of consolidated VIEs | |||||
Cash | |||||
Other assets | |||||
Total assets of consolidated VIEs | $ | ||||
Other liabilities | |||||
Repurchase agreements | |||||
Total liabilities of consolidated VIEs | |||||
Noncontrolling interests | |||||
Chubb's net interest in consolidated VIEs | $ |
September 30, 2023 | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||
(in millions of U.S. dollars) | |||||||||||||||||||||||
Assets: | |||||||||||||||||||||||
Fixed maturities available for sale | |||||||||||||||||||||||
U.S. Treasury / Agency | $ | $ | $ | $ | |||||||||||||||||||
Non-U.S. | |||||||||||||||||||||||
Corporate and asset-backed securities | |||||||||||||||||||||||
Mortgage-backed securities | |||||||||||||||||||||||
Municipal | |||||||||||||||||||||||
Equity securities | |||||||||||||||||||||||
Short-term investments | |||||||||||||||||||||||
Other investments (1) | |||||||||||||||||||||||
Securities lending collateral | |||||||||||||||||||||||
Investment derivatives | |||||||||||||||||||||||
Derivatives designated as hedging instruments | |||||||||||||||||||||||
Other derivative instruments | |||||||||||||||||||||||
Separate account assets | |||||||||||||||||||||||
Total assets measured at fair value (1)(2) | $ | $ | $ | $ | |||||||||||||||||||
Liabilities: | |||||||||||||||||||||||
Investment derivatives | $ | $ | $ | $ | |||||||||||||||||||
Derivatives designated as hedging instruments | |||||||||||||||||||||||
Other derivative instruments | |||||||||||||||||||||||
Market risk benefits (3) | |||||||||||||||||||||||
Total liabilities measured at fair value | $ | $ | $ | $ |
December 31, 2022 | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||
(in millions of U.S. dollars) | |||||||||||||||||||||||
Assets: | |||||||||||||||||||||||
Fixed maturities available for sale | |||||||||||||||||||||||
U.S. Treasury / Agency | $ | $ | $ | $ | |||||||||||||||||||
Non-U.S. | |||||||||||||||||||||||
Corporate and asset-backed securities | |||||||||||||||||||||||
Mortgage-backed securities | |||||||||||||||||||||||
Municipal | |||||||||||||||||||||||
Equity securities | |||||||||||||||||||||||
Short-term investments | |||||||||||||||||||||||
Other investments (1) | |||||||||||||||||||||||
Securities lending collateral | |||||||||||||||||||||||
Investment derivative instruments | |||||||||||||||||||||||
Derivatives designated as hedging instruments | |||||||||||||||||||||||
Other derivative instruments | |||||||||||||||||||||||
Separate account assets | |||||||||||||||||||||||
Total assets measured at fair value (1)(2) | $ | $ | $ | $ | |||||||||||||||||||
Liabilities: | |||||||||||||||||||||||
Investment derivatives | $ | $ | $ | $ | |||||||||||||||||||
Derivatives designated as hedging instruments | |||||||||||||||||||||||
Market risk benefits (3) | |||||||||||||||||||||||
Total liabilities measured at fair value | $ | $ | $ | $ |
Three Months Ended September 30, 2023 (in millions of U.S. dollars) | Available-for-Sale Debt Securities | Equity securities | Short-term investments | ||||||||||||||||||||||||||
Non-U.S. | Corporate and asset- backed securities | Mortgage-backed securities | |||||||||||||||||||||||||||
Balance, beginning of period | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Transfers into Level 3 | |||||||||||||||||||||||||||||
Transfers out of Level 3 | ( | ( | |||||||||||||||||||||||||||
( | |||||||||||||||||||||||||||||
( | ( | ||||||||||||||||||||||||||||
Purchases | |||||||||||||||||||||||||||||
Sales | ( | ( | ( | ( | |||||||||||||||||||||||||
Settlements | ( | ( | ( | ||||||||||||||||||||||||||
Balance, end of period | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
$ | ( | $ | ( | $ | $ | $ | |||||||||||||||||||||||
Change in Net Unrealized Gains/Losses included in OCI at the Balance Sheet date | $ | ( | $ | $ | $ | $ |
Three Months Ended September 30, 2022 (in millions of U.S. dollars) | Available-for-Sale Debt Securities | Equity securities | Short-term investments | ||||||||||||||||||||||||||
Non-U.S. | Corporate and asset- backed securities | Mortgage-backed securities | |||||||||||||||||||||||||||
Balance, beginning of period | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Transfers into Level 3 | |||||||||||||||||||||||||||||
Transfers out of Level 3 | ( | ||||||||||||||||||||||||||||
( | ( | ||||||||||||||||||||||||||||
( | ( | ( | |||||||||||||||||||||||||||
Purchases | |||||||||||||||||||||||||||||
Sales | ( | ( | ( | ||||||||||||||||||||||||||
Settlements | ( | ( | ( | ( | |||||||||||||||||||||||||
Balance, end of period | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
$ | ( | $ | ( | $ | $ | $ | ( | ||||||||||||||||||||||
Change in Net Unrealized Gains/Losses included in OCI at the Balance Sheet date | $ | ( | $ | ( | $ | $ | $ | ||||||||||||||||||||||
Nine Months Ended September 30, 2023 (in millions of U.S. dollars) | Available-for-Sale Debt Securities | Equity securities | Short-term investments | ||||||||||||||||||||||||||
Non-U.S. | Corporate and asset- backed securities | Mortgage-backed securities | |||||||||||||||||||||||||||
Balance, beginning of period | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Transfers into Level 3 | |||||||||||||||||||||||||||||
Transfers out of Level 3 | ( | ( | |||||||||||||||||||||||||||
( | |||||||||||||||||||||||||||||
( | ( | ( | |||||||||||||||||||||||||||
Purchases | |||||||||||||||||||||||||||||
Sales | ( | ( | ( | ( | |||||||||||||||||||||||||
Settlements | ( | ( | ( | ||||||||||||||||||||||||||
Balance, end of period | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
$ | ( | $ | ( | $ | $ | ( | $ | ||||||||||||||||||||||
Change in Net Unrealized Gains/Losses included in OCI at the Balance Sheet date | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Nine Months Ended September 30, 2022 (in millions of U.S. dollars) | Available-for-Sale Debt Securities | Equity securities | Short-term investments | ||||||||||||||||||||||||||
Non-U.S. | Corporate and asset- backed securities | Mortgage-backed securities | |||||||||||||||||||||||||||
Balance, beginning of period | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Transfers into Level 3 | |||||||||||||||||||||||||||||
Transfers out of Level 3 | ( | ( | ( | ||||||||||||||||||||||||||
( | ( | ||||||||||||||||||||||||||||
( | ( | ( | |||||||||||||||||||||||||||
Purchases | |||||||||||||||||||||||||||||
Sales | ( | ( | ( | ||||||||||||||||||||||||||
Settlements | ( | ( | ( | ( | |||||||||||||||||||||||||
Balance, end of period | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
$ | ( | $ | ( | $ | $ | $ | ( | ||||||||||||||||||||||
Change in Net Unrealized Gains/Losses included in OCI at the Balance Sheet date | $ | ( | $ | ( | $ | $ | $ | ||||||||||||||||||||||
September 30, 2023 | Fair Value | Net Carrying Value | |||||||||||||||||||||||||||
(in millions of U.S. dollars) | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||||||
Private debt held-for-investment | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Total assets | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Liabilities: | |||||||||||||||||||||||||||||
Repurchase agreements | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Short-term debt | |||||||||||||||||||||||||||||
Long-term debt | |||||||||||||||||||||||||||||
Trust preferred securities | |||||||||||||||||||||||||||||
Total liabilities | $ | $ | $ | $ | $ |
December 31, 2022 | Fair Value | Net Carrying Value | |||||||||||||||||||||||||||
(in millions of U.S. dollars) | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||
Assets: | |||||||||||||||||||||||||||||
Fixed maturities held to maturity | |||||||||||||||||||||||||||||
U.S. Treasury / Agency | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Non-U.S. | |||||||||||||||||||||||||||||
Corporate and asset-backed securities | |||||||||||||||||||||||||||||
Mortgage-backed securities | |||||||||||||||||||||||||||||
Municipal | |||||||||||||||||||||||||||||
Total assets | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Liabilities: | |||||||||||||||||||||||||||||
Repurchase agreements | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Short-term debt | |||||||||||||||||||||||||||||
Long-term debt | |||||||||||||||||||||||||||||
Trust preferred securities | |||||||||||||||||||||||||||||
Total liabilities | $ | $ | $ | $ | $ |
September 30, 2023 | December 31, 2022 | |||||||||||||||||||||||||
(in millions of U.S. dollars) | Net Reinsurance Recoverable (1) | Valuation allowance | Net Reinsurance Recoverable (1) | Valuation allowance | ||||||||||||||||||||||
Reinsurance recoverable on unpaid losses and loss expenses | $ | $ | $ | $ | ||||||||||||||||||||||
Reinsurance recoverable on paid losses and loss expenses | ||||||||||||||||||||||||||
Reinsurance recoverable on losses and loss expenses | $ | $ | $ | $ | ||||||||||||||||||||||
Reinsurance recoverable on policy benefits | $ | $ | $ | $ |
Nine Months Ended | |||||||||||
September 30 | |||||||||||
(in millions of U.S. dollars) | 2023 | 2022 | |||||||||
Valuation allowance for uncollectible reinsurance - beginning of period | $ | $ | |||||||||
Provision for uncollectible reinsurance | |||||||||||
Write-offs charged against the valuation allowance | ( | ( | |||||||||
Foreign exchange revaluation | ( | ||||||||||
Valuation allowance for uncollectible reinsurance - end of period | $ | $ |
Nine Months Ended September 30, 2023 | |||||||||||||||||||||||||||||||||||
(in millions of U.S. dollars) | Term Life | Universal Life | Whole Life | A&H | Other | Total | |||||||||||||||||||||||||||||
Balance – beginning of period | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Capitalizations | |||||||||||||||||||||||||||||||||||
Amortization expense | ( | ( | ( | ( | ( | ( | |||||||||||||||||||||||||||||
Other (including foreign exchange) | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Balance - end of period | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Overseas General Insurance segment excluded from table | |||||||||||||||||||||||||||||||||||
Total deferred acquisition costs on long-duration contracts | $ |
Nine Months Ended September 30, 2022 | |||||||||||||||||||||||||||||||||||
(in millions of U.S. dollars) | Term Life | Universal Life | Whole Life | A&H | Other | Total | |||||||||||||||||||||||||||||
Balance – beginning of period | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Capitalizations | |||||||||||||||||||||||||||||||||||
Amortization expense | ( | ( | ( | ( | ( | ( | |||||||||||||||||||||||||||||
Other (including foreign exchange) | ( | ( | ( | ( | ( | ( | |||||||||||||||||||||||||||||
Balance - end of period | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Overseas General Insurance segment excluded from table | |||||||||||||||||||||||||||||||||||
Total deferred acquisition costs on long-duration contracts | $ |
(in millions of U.S. dollars) | North America Commercial P&C Insurance | North America Personal P&C Insurance | North America Agricultural Insurance | Overseas General Insurance | Global Reinsurance | Life Insurance | Chubb Consolidated | ||||||||||||||||||||||||||||||||||
Balance at December 31, 2022 | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
Consolidation of Huatai Group (1) | |||||||||||||||||||||||||||||||||||||||||
Foreign exchange revaluation and other | ( | ( | |||||||||||||||||||||||||||||||||||||||
Balance at September 30, 2023 | $ | $ | $ | $ | $ | $ | $ |
Nine Months Ended | |||||
September 30 | |||||
(in millions of U.S. dollars) | 2023 | ||||
Balance, beginning of period | $ | ||||
Consolidation of Huatai Group | |||||
Amortization of VOBA (1) | ( | ||||
Foreign exchange revaluation and other | ( | ||||
Balance, end of period | $ |
For the Years Ending December 31 (in millions of U.S. dollars) | Total amortization of VOBA | ||||
Fourth quarter of 2023 | $ | ||||
2024 | |||||
2025 | |||||
2026 | |||||
2027 | |||||
2028 | |||||
Total | $ | ||||
(in millions of U.S. dollars) | September 30 2023 | December 31 2022 | ||||||||||||
Subject to amortization | $ | $ | ||||||||||||
Not subject to amortization | ||||||||||||||
Total | $ | $ |
For the Years Ending December 31 (in millions of U.S. dollars) | Total amortization of purchased intangibles | Amortization of Huatai UPR intangible asset (1) | Amortization of Huatai land use rights (2) | Total amortization | ||||||||||||||||||||||
Fourth quarter of 2023 | $ | $ | $ | $ | ||||||||||||||||||||||
2024 | ||||||||||||||||||||||||||
2025 | ||||||||||||||||||||||||||
2026 | ||||||||||||||||||||||||||
2027 | ||||||||||||||||||||||||||
2028 | ||||||||||||||||||||||||||
Total | $ | $ | $ | $ |
Nine Months Ended | |||||||||||
September 30 | |||||||||||
2023 | 2022 | ||||||||||
(in millions of U.S. dollars) | As Adjusted | ||||||||||
Gross unpaid losses and loss expenses – beginning of period | $ | $ | |||||||||
Reinsurance recoverable on unpaid losses – beginning of period (1) | ( | ( | |||||||||
Net unpaid losses and loss expenses – beginning of period | |||||||||||
Net losses and loss expenses incurred in respect of losses occurring in: | |||||||||||
Current year | |||||||||||
Prior years (2) | ( | ( | |||||||||
Total | |||||||||||
Net losses and loss expenses paid in respect of losses occurring in: | |||||||||||
Current year | |||||||||||
Prior years | |||||||||||
Total | |||||||||||
Consolidation of Huatai Group | |||||||||||
Foreign currency revaluation and other | ( | ( | |||||||||
Net unpaid losses and loss expenses – end of period | |||||||||||
Reinsurance recoverable on unpaid losses (1) | |||||||||||
Gross unpaid losses and loss expenses – end of period | $ | $ |
Three Months Ended September 30 | Nine Months Ended September 30 | ||||||||||||||||||||||||||||||||||
(in millions of U.S. dollars) | Long-tail | Short-tail | Total | Long-tail | Short-tail | Total | |||||||||||||||||||||||||||||
2023 | |||||||||||||||||||||||||||||||||||
North America Commercial P&C Insurance | $ | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||||||||||||||||||
North America Personal P&C Insurance | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
North America Agricultural Insurance | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Overseas General Insurance | ( | ( | ( | ( | ( | ||||||||||||||||||||||||||||||
Global Reinsurance | ( | ( | |||||||||||||||||||||||||||||||||
Corporate | |||||||||||||||||||||||||||||||||||
Total | $ | $ | ( | $ | ( | $ | $ | ( | $ | ( | |||||||||||||||||||||||||
2022 | |||||||||||||||||||||||||||||||||||
North America Commercial P&C Insurance | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||||||||||
North America Personal P&C Insurance | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
North America Agricultural Insurance | ( | ( | |||||||||||||||||||||||||||||||||
Overseas General Insurance | ( | ( | ( | ( | ( | ||||||||||||||||||||||||||||||
Global Reinsurance | ( | ||||||||||||||||||||||||||||||||||
Corporate | |||||||||||||||||||||||||||||||||||
Total | $ | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( |
Present Value of Expected Net Premiums | Nine Months Ended September 30, 2023 | ||||||||||||||||||||||||||||
(in millions of U.S. dollars) | Term Life | Whole Life | A&H | Other | Total | ||||||||||||||||||||||||
Balance – beginning of period | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Beginning balance at original discount rate | |||||||||||||||||||||||||||||
Effect of changes in cash flow assumptions | ( | ( | |||||||||||||||||||||||||||
Effect of actual variances from expected experience | ( | ( | ( | ||||||||||||||||||||||||||
Adjusted beginning of period balance | |||||||||||||||||||||||||||||
Consolidation of Huatai Group | |||||||||||||||||||||||||||||
Issuances | |||||||||||||||||||||||||||||
Interest accrual | |||||||||||||||||||||||||||||
Net premiums collected (1) | ( | ( | ( | ( | ( | ||||||||||||||||||||||||
Other (including foreign exchange) | ( | ( | ( | ( | |||||||||||||||||||||||||
Ending balance at original discount rate | |||||||||||||||||||||||||||||
Effect of changes in discount rate assumptions | ( | ( | ( | ( | ( | ||||||||||||||||||||||||
Balance – end of period | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Present Value of Expected Future Policy Benefits | Nine Months Ended September 30, 2023 | ||||||||||||||||||||||||||||
(in millions of U.S. dollars) | Term Life | Whole Life | A&H | Other | Total | ||||||||||||||||||||||||
Balance – beginning of period | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Beginning balance at original discount rate | |||||||||||||||||||||||||||||
Effect of changes in cash flow assumptions | ( | ( | |||||||||||||||||||||||||||
Effect of actual variances from expected experience | ( | ( | ( | ||||||||||||||||||||||||||
Adjusted beginning of period balance | |||||||||||||||||||||||||||||
Consolidation of Huatai Group | |||||||||||||||||||||||||||||
Issuances | |||||||||||||||||||||||||||||
Interest accrual | |||||||||||||||||||||||||||||
Benefits payments | ( | ( | ( | ( | ( | ||||||||||||||||||||||||
Other (including foreign exchange) | ( | ( | |||||||||||||||||||||||||||
Ending balance at original discount rate | |||||||||||||||||||||||||||||
Effect of changes in discount rate assumptions | ( | ( | ( | ( | ( | ||||||||||||||||||||||||
Balance – end of period | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
September 30, 2023 | |||||||||||||||||||||||||||||||||||
Liability for Future Policy Benefits | Life Insurance | Overseas General Insurance | Chubb Consolidated | ||||||||||||||||||||||||||||||||
(in millions of U.S. dollars, except for years) | Term Life | Whole Life | A&H | Other | A&H | Total | |||||||||||||||||||||||||||||
Net liability for future policy benefits | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Deferred profit liability | |||||||||||||||||||||||||||||||||||
Net liability for future policy benefits, per consolidated balance sheet | |||||||||||||||||||||||||||||||||||
Less: Reinsurance recoverable on future policy benefits | |||||||||||||||||||||||||||||||||||
Net liability for future policy benefits, after reinsurance recoverable | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Weighted-average duration (years) |
Present Value of Expected Net Premiums | Nine Months Ended September 30, 2022 | ||||||||||||||||||||||||||||
(in millions of U.S. dollars) | Term Life | Whole Life | A&H | Other | Total | ||||||||||||||||||||||||
Balance – beginning of period | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Beginning balance at original discount rate | |||||||||||||||||||||||||||||
Effect of changes in cash flow assumptions | ( | ( | ( | ||||||||||||||||||||||||||
Effect of actuarial variances from expected experience | ( | ( | ( | ||||||||||||||||||||||||||
Adjusted beginning of period balance | |||||||||||||||||||||||||||||
Acquisition of Cigna | |||||||||||||||||||||||||||||
Issuances | |||||||||||||||||||||||||||||
Interest accrual | |||||||||||||||||||||||||||||
Net premiums collected (1) | ( | ( | ( | ( | ( | ||||||||||||||||||||||||
Other (including foreign exchange) | ( | ( | ( | ( | ( | ||||||||||||||||||||||||
Ending balance at original discount rate | |||||||||||||||||||||||||||||
Effect of changes in discount rate assumptions | ( | ( | ( | ( | ( | ||||||||||||||||||||||||
Balance – end of period | $ | $ | $ | $ | $ |
Present Value of Expected Future Policy Benefits | Nine Months Ended September 30, 2022 | ||||||||||||||||||||||||||||
(in millions of U.S. dollars) | Term Life | Whole Life | A&H | Other | Total | ||||||||||||||||||||||||
Balance – beginning of period | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Beginning balance at original discount rate | |||||||||||||||||||||||||||||
Effect of changes in cash flow assumptions | ( | ( | ( | ( | |||||||||||||||||||||||||
Effect of actuarial variances from expected experience | ( | ( | ( | ||||||||||||||||||||||||||
Adjusted beginning of period balance | |||||||||||||||||||||||||||||
Acquisition of Cigna | |||||||||||||||||||||||||||||
Issuances | |||||||||||||||||||||||||||||
Interest accrual | |||||||||||||||||||||||||||||
Benefits payments | ( | ( | ( | ( | ( | ||||||||||||||||||||||||
Other (including foreign exchange) | ( | ( | ( | ( | ( | ||||||||||||||||||||||||
Ending balance at original discount rate | |||||||||||||||||||||||||||||
Effect of changes in discount rate assumptions | ( | ( | ( | ( | ( | ||||||||||||||||||||||||
Balance – end of period | $ | $ | $ | $ | $ |
September 30, 2022 | |||||||||||||||||||||||||||||||||||
Liability for Future Policy Benefits | Life Insurance | Overseas General Insurance | Chubb Consolidated | ||||||||||||||||||||||||||||||||
(in millions of U.S. dollars, except for years) | Term Life | Whole Life | A&H | Other | A&H | Total | |||||||||||||||||||||||||||||
Net liability for future policy benefits | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Deferred profit liability | |||||||||||||||||||||||||||||||||||
Net liability for future policy benefits, per consolidated balance sheet | |||||||||||||||||||||||||||||||||||
Less: Reinsurance recoverable on future policy benefits | |||||||||||||||||||||||||||||||||||
Net liability for future policy benefits, after reinsurance recoverable | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Weighted-average duration (years) |
September 30 | September 30 | ||||||||||
(in millions of U.S. dollars) | 2023 | 2022 | |||||||||
Term Life | |||||||||||
Undiscounted expected future benefit payments | $ | $ | |||||||||
Undiscounted expected future gross premiums | $ | $ | |||||||||
Discounted expected future benefit payments | $ | $ | |||||||||
Discounted expected future gross premiums | $ | $ | |||||||||
Whole Life | |||||||||||
Undiscounted expected future benefit payments | $ | $ | |||||||||
Undiscounted expected future gross premiums | $ | $ | |||||||||
Discounted expected future benefit payments | $ | $ | |||||||||
Discounted expected future gross premiums | $ | $ | |||||||||
A&H | |||||||||||
Undiscounted expected future benefit payments | $ | $ | |||||||||
Undiscounted expected future gross premiums | $ | $ | |||||||||
Discounted expected future benefit payments | $ | $ | |||||||||
Discounted expected future gross premiums | $ | $ | |||||||||
Other | |||||||||||
Undiscounted expected future benefit payments | $ | $ | |||||||||
Undiscounted expected future gross premiums | $ | $ | |||||||||
Discounted expected future benefit payments | $ | $ | |||||||||
Discounted expected future gross premiums | $ | $ | |||||||||
Gross Premiums or Assessments | Interest Accretion | ||||||||||||||||||||||
Nine Months Ended | Nine Months Ended | ||||||||||||||||||||||
September 30 | September 30 | ||||||||||||||||||||||
(in millions of U.S. dollars) | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
Life Insurance | |||||||||||||||||||||||
Term Life | $ | $ | $ | $ | |||||||||||||||||||
Whole Life | |||||||||||||||||||||||
A&H | |||||||||||||||||||||||
Other | |||||||||||||||||||||||
Overseas General Insurance | |||||||||||||||||||||||
A&H | |||||||||||||||||||||||
Total | $ | $ | $ | $ |
Interest Accretion Rate | Current Discount Rate | ||||||||||||||||||||||
September 30 | September 30 | ||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
Life Insurance | |||||||||||||||||||||||
Term Life | % | % | % | % | |||||||||||||||||||
Whole Life | % | % | % | % | |||||||||||||||||||
A&H | % | % | % | % | |||||||||||||||||||
Other | % | % | % | % | |||||||||||||||||||
Nine Months Ended September 30, 2023 | |||||||||||||||||
(in millions of U.S. dollars) | Universal Life | Other | Total | ||||||||||||||
Balance – beginning of period | $ | $ | $ | ||||||||||||||
Consolidation of Huatai Group | |||||||||||||||||
Premiums received | |||||||||||||||||
Policy charges (1) | ( | ( | ( | ||||||||||||||
Surrenders and withdrawals | ( | ( | ( | ||||||||||||||
Benefit payments | ( | ( | ( | ||||||||||||||
Interest credited | |||||||||||||||||
Other (including foreign exchange) | ( | ( | ( | ||||||||||||||
Balance, end of period | $ | $ | $ |
Nine Months Ended September 30, 2022 | |||||||||||||||||
(in millions of U.S. dollars) | Universal Life | Other | Total | ||||||||||||||
Balance – beginning of period | $ | $ | $ | ||||||||||||||
Acquisition of Cigna | |||||||||||||||||
Premiums received | |||||||||||||||||
Policy charges (1) | ( | ( | ( | ||||||||||||||
Surrenders and withdrawals | ( | ( | ( | ||||||||||||||
Benefit payments | ( | ( | ( | ||||||||||||||
Interest credited | |||||||||||||||||
Other (including foreign exchange) | ( | ( | ( | ||||||||||||||
Balance, end of period | $ | $ | $ |
September 30 | |||||||||||||||||||||||
2023 | 2022 | ||||||||||||||||||||||
(in millions of U.S. dollars, except for percentages) | Universal Life | Other | Universal Life | Other | |||||||||||||||||||
Weighted-average crediting rate | % | % | % | % | |||||||||||||||||||
Net amount at risk (1) | $ | $ | $ | $ | |||||||||||||||||||
Cash Surrender Value | $ | $ | $ | $ |
September 30, 2023 | |||||||||||||||||||||||||||||
(in millions of U.S. dollars) | At Guaranteed Minimum | 1 Basis Point - 50 Basis Points Above | 51 Basis Points - 150 Basis Points Above | Greater Than 150 Basis Points Above | Total | ||||||||||||||||||||||||
Guaranteed minimum crediting rates | |||||||||||||||||||||||||||||
Up to | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Greater than | |||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ |
September 30, 2022 | |||||||||||||||||||||||||||||
(in millions of U.S. dollars) | At Guaranteed Minimum | 1 Basis Point - 50 Basis Points Above | 51 Basis Points - 150 Basis Points Above | Greater Than 150 Basis Points Above | Total | ||||||||||||||||||||||||
Guaranteed minimum crediting rates | |||||||||||||||||||||||||||||
Up to | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Greater than | |||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ |
September 30, 2023 | |||||||||||||||||||||||||||||
(in millions of U.S. dollars) | At Guaranteed Minimum | 1 Basis Point - 50 Basis Points Above | 51 Basis Points - 150 Basis Points Above | Greater Than 150 Basis Points Above | Total | ||||||||||||||||||||||||
Guaranteed minimum crediting rates | |||||||||||||||||||||||||||||
Up to | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Greater than | |||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ |
September 30, 2022 | |||||||||||||||||||||||||||||
(in millions of U.S. dollars) | At Guaranteed Minimum | 1 Basis Point - 50 Basis Points Above | 51 Basis Points - 150 Basis Points Above | Greater Than 150 Basis Points Above | Total | ||||||||||||||||||||||||
Guaranteed minimum crediting rates | |||||||||||||||||||||||||||||
Up to | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Greater than | |||||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ |
Nine Months Ended September 30 | |||||||||||
(in millions of U.S. dollars) | 2023 | 2022 | |||||||||
Balance – beginning of period | $ | $ | |||||||||
Balance, beginning of period, before effect of changes in the instrument-specific credit risk | |||||||||||
Interest rate changes | ( | ( | |||||||||
Effect of changes in equity markets | ( | ||||||||||
Effect of changes in volatilities | |||||||||||
Effect of changes in future expected policyholder behavior | |||||||||||
Effect of timing and all other | ( | ||||||||||
Balance, end of period, before effect of changes in the instrument-specific credit risk | $ | $ | |||||||||
Effect of changes in the instrument-specific credit risk | |||||||||||
Balance – end of period | $ | $ | |||||||||
Weighted-average age of policyholders (years) | |||||||||||
Net amount at risk | $ | $ |
Valuation Technique | Significant Unobservable Inputs | September 30, 2023 | September 30, 2022 | |||||||||||||||||||||||||||||||||||
Ranges | Weighted Average(1) | Ranges | Weighted Average(1) | |||||||||||||||||||||||||||||||||||
MRB (1) | Actuarial model | Lapse rate | % | % | ||||||||||||||||||||||||||||||||||
Annuitization rate | % | % |
September 30 | December 31 | ||||||||||
(in millions of U.S. dollars) | 2023 | 2022 | |||||||||
Cash and cash equivalents | $ | $ | |||||||||
Mutual funds | |||||||||||
Fixed maturities | |||||||||||
Total | $ | $ |
Nine Months Ended | |||||||||||
September 30 | |||||||||||
(in millions of U.S. dollars) | 2023 | 2022 | |||||||||
Balance – beginning of period | $ | $ | |||||||||
Acquisition of Cigna | |||||||||||
Premiums and deposits | |||||||||||
Policy charges | ( | ( | |||||||||
Surrenders and withdrawals | ( | ( | |||||||||
Benefit payments | ( | ( | |||||||||
Investment performance | ( | ||||||||||
Other (including foreign exchange) | ( | ( | |||||||||
Balance – end of period | $ | $ | |||||||||
Cash surrender value (1) | $ | $ |
September 30, 2023 | December 31, 2022 | ||||||||||||||||||||||||||||||||||||||||
Consolidated Balance Sheet Location | Fair Value | Notional Value/ Payment Provision | Fair Value | Notional Value/ Payment Provision | |||||||||||||||||||||||||||||||||||||
(in millions of U.S. dollars) | Derivative Asset | Derivative (Liability) | Derivative Asset | Derivative (Liability) | |||||||||||||||||||||||||||||||||||||
Investment and embedded derivatives not designated as hedging instruments: | |||||||||||||||||||||||||||||||||||||||||
Foreign currency forward contracts | OA / (AP) | $ | $ | ( | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||||||
Options/Futures contracts on notes and bonds | OA / (AP) | ( | ( | ||||||||||||||||||||||||||||||||||||||
Convertible securities (1) | FM AFS / ES | ||||||||||||||||||||||||||||||||||||||||
$ | $ | ( | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||||||||
Other derivative instruments: | |||||||||||||||||||||||||||||||||||||||||
Futures contracts on equities (2) | OA / (AP) | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
Other | OA / (AP) | ( | |||||||||||||||||||||||||||||||||||||||
$ | $ | ( | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||
Derivatives designated as hedging instruments: | |||||||||||||||||||||||||||||||||||||||||
Cross-currency swaps - fair value hedges | OA / (AP) | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
Cross-currency swaps - net investment hedges | OA / (AP) | ( | ( | ||||||||||||||||||||||||||||||||||||||
$ | $ | ( | $ | $ | $ | ( | $ |
Three Months Ended | Nine Months Ended | ||||||||||||||||
September 30 | September 30 | ||||||||||||||||
(in millions of U.S. dollars) | 2023 | 2022 | 2023 | 2022 | |||||||||||||
Gain/(loss) recognized in OCI | $ | ( | $ | ( | $ | $ | ( | ||||||||||
Net realized gain/(loss) reclassified from OCI | ( | ( | ( | ( | |||||||||||||
Interest expense reclassified from OCI | ( | ( | |||||||||||||||
OCI gain/(loss) after reclassifications | $ | $ | ( | $ | $ | ( |
Three Months Ended | Nine Months Ended | ||||||||||||||||
September 30 | September 30 | ||||||||||||||||
(in millions of U.S. dollars) | 2023 | 2022 | 2023 | 2022 | |||||||||||||
Gain/(loss) recognized in OCI | $ | ( | $ | $ | ( | $ | |||||||||||
Interest income reclassified from OCI | |||||||||||||||||
OCI gain/(loss) after reclassifications | $ | ( | $ | $ | ( | $ | |||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
September 30 | September 30 | ||||||||||||||||||||||
(in millions of U.S. dollars) | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
Investment and embedded derivative instruments: | |||||||||||||||||||||||
Foreign currency forward contracts | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
All other futures contracts, options, and equities | |||||||||||||||||||||||
Convertible securities (1) | ( | ( | ( | ||||||||||||||||||||
Total investment and embedded derivative instruments | $ | $ | ( | $ | ( | $ | ( | ||||||||||||||||
Other derivative instruments: | |||||||||||||||||||||||
Futures contracts on equities (2) | $ | $ | $ | ( | $ | ||||||||||||||||||
Other | ( | ( | ( | ( | |||||||||||||||||||
Total other derivative instruments | $ | $ | $ | ( | $ | ||||||||||||||||||
$ | $ | ( | $ | ( | $ | ( |
Remaining contractual maturity | ||||||||||||||
September 30, 2023 | December 31, 2022 | |||||||||||||
(in millions of U.S. dollars) | Overnight and Continuous | |||||||||||||
Collateral held under securities lending agreements: | ||||||||||||||
Cash | $ | $ | ||||||||||||
U.S. Treasury / Agency | ||||||||||||||
Non-U.S. | ||||||||||||||
Corporate and asset-backed securities | ||||||||||||||
Municipal | ||||||||||||||
Equity securities | ||||||||||||||
$ | $ | |||||||||||||
Gross amount of recognized liability for securities lending payable | $ | $ | ||||||||||||
Remaining contractual maturity | |||||||||||||||||||||||||||||||||||||||||
September 30, 2023 | December 31, 2022 | ||||||||||||||||||||||||||||||||||||||||
Up to 30 Days | 30-90 Days | Greater than 90 Days | Total | Up to 30 Days | 30-90 Days | Total | |||||||||||||||||||||||||||||||||||
(in millions of U.S. dollars) | |||||||||||||||||||||||||||||||||||||||||
Collateral pledged under repurchase agreements: | |||||||||||||||||||||||||||||||||||||||||
Cash | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||
Non-U.S. | $ | $ | |||||||||||||||||||||||||||||||||||||||
U.S. Treasury / Agency | |||||||||||||||||||||||||||||||||||||||||
Mortgage-backed securities | |||||||||||||||||||||||||||||||||||||||||
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||||||||
Gross amount of recognized liabilities for repurchase agreements | $ | $ | |||||||||||||||||||||||||||||||||||||||
Difference (1) | $ | $ |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||
September 30 | September 30 | ||||||||||||||||||||||||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||||||||||||||||||||||||
CHF | USD | CHF | USD | CHF | USD | CHF | USD | ||||||||||||||||||||||||||||||||||||||||
Total dividend distributions per common share | $ | $ | $ | $ |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
September 30 | September 30 | ||||||||||||||||||||||
(in millions of U.S. dollars, except share data) | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
Number of shares repurchased | |||||||||||||||||||||||
Cost of shares repurchased | $ | $ | $ | $ | |||||||||||||||||||
Repurchase authorization remaining at end of period | $ | $ | $ | $ |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
September 30 | September 30 | ||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
(in millions of U.S. dollars) | As Adjusted | As Adjusted | |||||||||||||||||||||
Accumulated other comprehensive income (loss) (AOCI) | |||||||||||||||||||||||
Net unrealized appreciation (depreciation) on investments | |||||||||||||||||||||||
Balance – beginning of period, net of tax | $ | ( | $ | ( | $ | ( | $ | ||||||||||||||||
Change in period, before reclassification from AOCI (before tax) | ( | ( | ( | ( | |||||||||||||||||||
Amounts reclassified from AOCI (before tax) | |||||||||||||||||||||||
Change in period, before tax | ( | ( | ( | ( | |||||||||||||||||||
Income tax (expense) benefit | ( | ||||||||||||||||||||||
Total other comprehensive loss | ( | ( | ( | ( | |||||||||||||||||||
Noncontrolling interests, net of tax | |||||||||||||||||||||||
Balance – end of period, net of tax | ( | ( | ( | ( | |||||||||||||||||||
Current discount rate on liability for future policy benefits | |||||||||||||||||||||||
Balance – beginning of period, net of tax | ( | ( | ( | ( | |||||||||||||||||||
Change in period, before tax | |||||||||||||||||||||||
Income tax expense | ( | ( | ( | ( | |||||||||||||||||||
Total other comprehensive income | |||||||||||||||||||||||
Noncontrolling interests, net of tax | ( | ( | |||||||||||||||||||||
Balance – end of period, net of tax | ( | ( | |||||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
September 30 | September 30 | ||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
(in millions of U.S. dollars) | As Adjusted | As Adjusted | |||||||||||||||||||||
Accumulated other comprehensive income (loss) (AOCI) - continued | |||||||||||||||||||||||
Instrument-specific credit risk on market risk benefits | |||||||||||||||||||||||
Balance – beginning of period, net of tax | ( | ( | ( | ( | |||||||||||||||||||
Change in period, before and net of tax | ( | ||||||||||||||||||||||
Total other comprehensive income (loss) | ( | ||||||||||||||||||||||
Noncontrolling interests, net of tax | |||||||||||||||||||||||
Balance – end of period, net of tax | ( | ( | ( | ( | |||||||||||||||||||
Cumulative foreign currency translation adjustment | |||||||||||||||||||||||
Balance – beginning of period, net of tax | ( | ( | ( | ( | |||||||||||||||||||
Change in period, before reclassification from AOCI (before tax) | ( | ( | ( | ( | |||||||||||||||||||
Amounts reclassified from AOCI (before tax) | ( | ( | |||||||||||||||||||||
Change in period, before tax | ( | ( | ( | ( | |||||||||||||||||||
Income tax benefit | |||||||||||||||||||||||
Total other comprehensive loss | ( | ( | ( | ( | |||||||||||||||||||
Noncontrolling interests, net of tax | ( | ( | |||||||||||||||||||||
Balance – end of period, net of tax | ( | ( | ( | ( | |||||||||||||||||||
Fair value hedging instruments | |||||||||||||||||||||||
Balance – beginning of period, net of tax | ( | ( | |||||||||||||||||||||
Change in period, before reclassification from AOCI (before tax) | ( | ( | ( | ||||||||||||||||||||
Amounts reclassified from AOCI (before tax) | |||||||||||||||||||||||
Change in period, before tax | ( | ( | |||||||||||||||||||||
Income tax (expense) benefit | ( | ( | |||||||||||||||||||||
Total other comprehensive income (loss) | ( | ( | |||||||||||||||||||||
Noncontrolling interests, net of tax | |||||||||||||||||||||||
Balance – end of period, net of tax | ( | ( | ( | ( | |||||||||||||||||||
Postretirement benefit liability adjustment | |||||||||||||||||||||||
Balance – beginning of period, net of tax | |||||||||||||||||||||||
Change in period, before tax | ( | ( | |||||||||||||||||||||
Income tax expense | ( | ( | |||||||||||||||||||||
Total other comprehensive income (loss) | ( | ( | |||||||||||||||||||||
Noncontrolling interests, net of tax | |||||||||||||||||||||||
Balance – end of period, net of tax | |||||||||||||||||||||||
Accumulated other comprehensive income (loss) | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
Three Months Ended | Nine Months Ended | Consolidated Statement of Operations Location | ||||||||||||||||||||||||
September 30 | September 30 | |||||||||||||||||||||||||
(in millions of U.S. dollars) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
Fixed maturities available for sale | $ | ( | $ | ( | $ | ( | $ | ( | Net realized gains (losses) | |||||||||||||||||
Income tax benefit | Income tax expense | |||||||||||||||||||||||||
$ | ( | $ | ( | $ | ( | $ | ( | Net income | ||||||||||||||||||
Cumulative foreign currency translation adjustment | ||||||||||||||||||||||||||
Cross-currency swaps | $ | $ | $ | $ | Interest expense | |||||||||||||||||||||
Income tax expense | ( | ( | Income tax expense | |||||||||||||||||||||||
$ | $ | $ | $ | Net income | ||||||||||||||||||||||
Net gains (losses) of fair value hedging instruments | ||||||||||||||||||||||||||
Cross-currency swaps | $ | ( | $ | ( | $ | ( | $ | ( | Net realized gains (losses) | |||||||||||||||||
Cross-currency swaps | ( | ( | Interest expense | |||||||||||||||||||||||
Income tax benefit | Income tax expense | |||||||||||||||||||||||||
$ | ( | $ | ( | $ | ( | $ | ( | Net income | ||||||||||||||||||
Total amounts reclassified from AOCI | $ | ( | $ | ( | $ | ( | $ | ( |
Pension Benefit Plans | Other Postretirement Benefit Plans | ||||||||||||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||||||||||||
Three Months Ended September 30 | U.S. Plans | Non-U.S. Plans | U.S. Plans | Non-U.S. Plans | |||||||||||||||||||||||||||||||
(in millions of U.S. dollars) | |||||||||||||||||||||||||||||||||||
Service cost | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Non-service cost (benefit): | |||||||||||||||||||||||||||||||||||
Interest cost | |||||||||||||||||||||||||||||||||||
Expected return on plan assets | ( | ( | ( | ( | |||||||||||||||||||||||||||||||
Amortization of net actuarial loss | ( | ||||||||||||||||||||||||||||||||||
Amortization of prior service cost | ( | ||||||||||||||||||||||||||||||||||
Settlements | |||||||||||||||||||||||||||||||||||
Total non-service cost (benefit) | ( | ( | ( | ( | ( | ||||||||||||||||||||||||||||||
Net periodic benefit cost (benefit) | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | $ |
Pension Benefit Plans | Other Postretirement Benefit Plans | ||||||||||||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||||||||||||
Nine Months Ended September 30 | U.S. Plans | Non-U.S. Plans | U.S. Plans | Non-U.S. Plans | |||||||||||||||||||||||||||||||
(in millions of U.S. dollars) | |||||||||||||||||||||||||||||||||||
Service cost: | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Non-service cost (benefit): | |||||||||||||||||||||||||||||||||||
Interest cost | |||||||||||||||||||||||||||||||||||
Expected return on plan assets | ( | ( | ( | ( | ( | ( | |||||||||||||||||||||||||||||
Amortization of net actuarial loss | ( | ||||||||||||||||||||||||||||||||||
Amortization of prior service cost | ( | ||||||||||||||||||||||||||||||||||
Settlements | |||||||||||||||||||||||||||||||||||
Total non-service cost (benefit) | ( | ( | ( | ( | ( | ||||||||||||||||||||||||||||||
Net periodic benefit cost (benefit) | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | $ |
Pension Benefit Plans | Other Postretirement Benefit Plans | ||||||||||||||||||||||
Three Months Ended September 30 | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
(in millions of U.S. dollars) | |||||||||||||||||||||||
Service cost: | |||||||||||||||||||||||
Losses and loss expenses | $ | $ | $ | $ | |||||||||||||||||||
Administrative expenses | |||||||||||||||||||||||
Total service cost | |||||||||||||||||||||||
Non-service cost (benefit): | |||||||||||||||||||||||
Losses and loss expenses | ( | ( | |||||||||||||||||||||
Administrative expenses | ( | ( | ( | ||||||||||||||||||||
Total non-service cost (benefit) | ( | ( | ( | ||||||||||||||||||||
Net periodic benefit cost (benefit) | $ | ( | $ | ( | $ | ( | $ |
Pension Benefit Plans | Other Postretirement Benefit Plans | ||||||||||||||||||||||
Nine Months Ended September 30 | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
(in millions of U.S. dollars) | |||||||||||||||||||||||
Service cost: | |||||||||||||||||||||||
Losses and loss expenses | $ | $ | $ | $ | |||||||||||||||||||
Administrative expenses | |||||||||||||||||||||||
Total service cost | |||||||||||||||||||||||
Non-service cost (benefit): | |||||||||||||||||||||||
Losses and loss expenses | ( | ( | |||||||||||||||||||||
Administrative expenses | ( | ( | ( | ||||||||||||||||||||
Total non-service cost (benefit) | ( | ( | ( | ||||||||||||||||||||
Net periodic benefit cost (benefit) | $ | ( | $ | ( | $ | ( | $ |
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||
September 30 | September 30 | |||||||||||||||||||||||||
(in millions of U.S. dollars) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||
Equity in net income (loss) of partially-owned entities | $ | $ | ( | $ | $ | |||||||||||||||||||||
Gains (losses) from fair value changes in separate account assets (1) | ( | ( | ( | ( | ||||||||||||||||||||||
Asset management and performance fee revenue | ||||||||||||||||||||||||||
Asset management and performance fee expense | ( | ( | ||||||||||||||||||||||||
Federal excise and capital taxes | ( | ( | ( | ( | ||||||||||||||||||||||
Other | ( | ( | ( | |||||||||||||||||||||||
Total | $ | $ | ( | $ | $ |
For the Three Months Ended September 30, 2023 (in millions of U.S. dollars) | North America Commercial P&C Insurance | North America Personal P&C Insurance | North America Agricultural Insurance | Overseas General Insurance | Global Reinsurance | Life Insurance | Corporate | Segment Measure Reclass | Chubb Consolidated | ||||||||||||||||||||||||||||||||||||||||||||
Net premiums written | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||||
Net premiums earned | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Losses and loss expenses | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Policy benefits | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Policy acquisition costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Administrative expenses | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Underwriting income (loss) | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Net investment income | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Other (income) expense | ( | ( | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||
Amortization expense of purchased intangibles | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment income (loss) | $ | $ | $ | $ | $ | $ | $ | ( | $ | $ | |||||||||||||||||||||||||||||||||||||||||||
Net realized gains (losses) | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||
Market risk benefits gains (losses) | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||
Interest expense | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Cigna integration expenses | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Income tax expense | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Net income (loss) | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Net loss attributable to noncontrolling interests | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||
Net income (loss) attributable to Chubb | $ | ( | $ | $ |
For the Three Months Ended September 30, 2022 (As Adjusted) (in millions of U.S. dollars) | North America Commercial P&C Insurance | North America Personal P&C Insurance | North America Agricultural Insurance | Overseas General Insurance | Global Reinsurance | Life Insurance | Corporate | Segment Measure Reclass | Chubb Consolidated | ||||||||||||||||||||||||||||||||||||||||||||
Net premiums written | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||||
Net premiums earned | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Losses and loss expenses | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Policy benefits | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Policy acquisition costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Administrative expenses | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Underwriting income (loss) | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||
Net investment income | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Other (income) expense | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||
Amortization expense of purchased intangibles | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment income (loss) | $ | $ | $ | $ | $ | ( | $ | $ | ( | $ | $ | ||||||||||||||||||||||||||||||||||||||||||
Net realized gains (losses) | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||
Market risk benefits gains (losses) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest expense | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Cigna integration expenses | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Income tax expense | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Net income (loss) | $ | ( | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||||||
For the Nine Months Ended September 30, 2023 (in millions of U.S. dollars) | North America Commercial P&C Insurance | North America Personal P&C Insurance | North America Agricultural Insurance | Overseas General Insurance | Global Reinsurance | Life Insurance | Corporate | Segment Measure Reclass | Chubb Consolidated | ||||||||||||||||||||||||||||||||||||||||||||
Net premiums written | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||||
Net premiums earned | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Losses and loss expenses | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Policy benefits | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Policy acquisition costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Administrative expenses | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Underwriting income (loss) | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Net investment income | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Other (income) expense | ( | ( | ( | ( | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization expense of purchased intangibles | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment income (loss) | $ | $ | $ | $ | $ | $ | $ | ( | $ | $ | |||||||||||||||||||||||||||||||||||||||||||
Net realized gains (losses) | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||
Market risk benefits gains (losses) | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||
Interest expense | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Cigna integration expenses | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Income tax expense | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Net income (loss) | $ | ( | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||||||
Net loss attributable to noncontrolling interests | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||
Net income (loss) attributable to Chubb | $ | ( | $ | $ |
For the Nine Months Ended September 30, 2022 (As Adjusted) (in millions of U.S. dollars) | North America Commercial P&C Insurance | North America Personal P&C Insurance | North America Agricultural Insurance | Overseas General Insurance | Global Reinsurance | Life Insurance | Corporate | Segment Measure Reclass | Chubb Consolidated | ||||||||||||||||||||||||||||||||||||||||||||
Net premiums written | $ | $ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||||||||||||||||||||
Net premiums earned | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Losses and loss expenses | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Policy benefits | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Policy acquisition costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Administrative expenses | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Underwriting income (loss) | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||
Net investment income (loss) | ( | ( | |||||||||||||||||||||||||||||||||||||||||||||||||||
Other (income) expense | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||
Amortization expense of purchased intangibles | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment income (loss) | $ | $ | $ | $ | $ | $ | $ | ( | $ | $ | |||||||||||||||||||||||||||||||||||||||||||
Net realized gains (losses) | ( | ( | ( | ||||||||||||||||||||||||||||||||||||||||||||||||||
Market risk benefits gains (losses) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest expense | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Cigna integration expenses | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Income tax expense | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Net income (loss) | $ | ( | $ | $ | |||||||||||||||||||||||||||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
September 30 | September 30 | ||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
(in millions of U.S. dollars, except share and per share data) | As Adjusted | As Adjusted | |||||||||||||||||||||
Numerator: | |||||||||||||||||||||||
Net income | $ | $ | $ | $ | |||||||||||||||||||
Net loss attributable to noncontrolling interests | ( | ( | |||||||||||||||||||||
Net income attributable to Chubb | $ | $ | $ | $ | |||||||||||||||||||
Denominator: | |||||||||||||||||||||||
Denominator for basic earnings per share attributable to Chubb: | |||||||||||||||||||||||
Weighted-average shares outstanding | |||||||||||||||||||||||
Denominator for diluted earnings per share attributable to Chubb: | |||||||||||||||||||||||
Share-based compensation plans | |||||||||||||||||||||||
Weighted-average shares outstanding and assumed conversions | |||||||||||||||||||||||
Basic earnings per share attributable to Chubb | $ | $ | $ | $ | |||||||||||||||||||
Diluted earnings per share attributable to Chubb | $ | $ | $ | $ | |||||||||||||||||||
Potential anti-dilutive share conversions |
ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations |
MD&A Index | Page | ||||
Forward-Looking Statements |
Overview |
Consolidated Operating Results – Three and Nine Months Ended September 30, 2023 and 2022 |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||
September 30 | % Change | September 30 | % Change | ||||||||||||||||||||||||||||||||
(in millions of U.S. dollars, except for percentages) | 2023 | 2022 | Q-23 vs. Q-22 | 2023 | 2022 | YTD-23 vs. YTD-22 | |||||||||||||||||||||||||||||
Net premiums written | $ | 13,104 | $ | 12,012 | 9.1 | % | $ | 35,765 | $ | 31,494 | 13.6 | % | |||||||||||||||||||||||
Net premiums written - constant dollars (1) | 8.4 | % | 14.0 | % | |||||||||||||||||||||||||||||||
Net premiums earned | 12,674 | 11,530 | 9.9 | % | 33,815 | 29,816 | 13.4 | % | |||||||||||||||||||||||||||
Net investment income | 1,314 | 979 | 34.2 | % | 3,566 | 2,689 | 32.6 | % | |||||||||||||||||||||||||||
Net realized gains (losses) | (103) | (456) | (77.3) | % | (484) | (936) | (48.1) | % | |||||||||||||||||||||||||||
Market risk benefits gains (losses) | (32) | 69 | NM | (154) | 85 | NM | |||||||||||||||||||||||||||||
Total revenues | 13,853 | 12,122 | 14.3 | % | 36,743 | 31,654 | 16.1 | % | |||||||||||||||||||||||||||
Losses and loss expenses | 7,106 | 7,063 | 0.6 | % | 17,937 | 16,833 | 6.6 | % | |||||||||||||||||||||||||||
Policy benefits | 938 | 707 | 32.7 | % | 2,565 | 1,441 | 78.0 | % | |||||||||||||||||||||||||||
Policy acquisition costs | 2,178 | 1,970 | 10.6 | % | 6,142 | 5,415 | 13.4 | % | |||||||||||||||||||||||||||
Administrative expenses | 1,060 | 883 | 20.0 | % | 2,959 | 2,479 | 19.3 | % | |||||||||||||||||||||||||||
Interest expense | 174 | 150 | 15.6 | % | 499 | 416 | 19.8 | % | |||||||||||||||||||||||||||
Other (income) expense | (154) | 202 | NM | (550) | (9) | NM | |||||||||||||||||||||||||||||
Amortization of purchased intangibles | 84 | 69 | 22.0 | % | 226 | 211 | 7.1 | % | |||||||||||||||||||||||||||
Cigna integration expenses | 14 | 23 | (38.8) | % | 51 | 26 | 99.4 | % | |||||||||||||||||||||||||||
Total expenses | 11,400 | 11,067 | 3.0 | % | 29,829 | 26,812 | 11.2 | % | |||||||||||||||||||||||||||
Income before income tax | 2,453 | 1,055 | 132.2 | % | 6,914 | 4,842 | 42.8 | % | |||||||||||||||||||||||||||
Income tax expense | 413 | 263 | 57.2 | % | 1,189 | 907 | 31.1 | % | |||||||||||||||||||||||||||
Net income | $ | 2,040 | $ | 792 | 157.0 | % | $ | 5,725 | $ | 3,935 | 45.4 | % | |||||||||||||||||||||||
Net loss attributable to noncontrolling interests | (3) | — | NM | (3) | — | NM | |||||||||||||||||||||||||||||
Net income attributable to Chubb | $ | 2,043 | $ | 792 | 157.8 | % | $ | 5,728 | $ | 3,935 | 45.5 | % | |||||||||||||||||||||||
Net Premiums Written | Three Months Ended September 30 | % Change | Nine Months Ended September 30 | % Change | |||||||||||||||||||||||||
(in millions of U.S. dollars, except for percentages) | 2023 | 2022 | Q-23 vs. Q-22 | C$ Q-23 vs. Q-22 | 2023 | 2022 | YTD-23 vs. YTD-22 | C$ YTD-23 vs. YTD-22 | |||||||||||||||||||||
Commercial casualty | $ | 2,332 | $ | 2,167 | 7.6 | % | 7.2 | % | $ | 6,259 | $ | 5,777 | 8.3 | % | 9.1 | % | |||||||||||||
Workers' compensation | 538 | 476 | 13.1 | % | 13.1 | % | 1,693 | 1,625 | 4.2 | % | 4.2 | % | |||||||||||||||||
Financial lines | 1,333 | 1,270 | 4.9 | % | 4.5 | % | 3,733 | 3,727 | 0.2 | % | 0.9 | % | |||||||||||||||||
Surety | 172 | 152 | 13.1 | % | 10.0 | % | 506 | 477 | 6.1 | % | 5.0 | % | |||||||||||||||||
Commercial multiple peril (1) | 398 | 341 | 16.9 | % | 16.9 | % | 1,129 | 972 | 16.2 | % | 16.2 | % | |||||||||||||||||
Property and other short-tail lines | 2,082 | 1,756 | 18.5 | % | 17.8 | % | 6,453 | 5,503 | 17.3 | % | 18.3 | % | |||||||||||||||||
Total Commercial P&C lines | 6,855 | 6,162 | 11.2 | % | 10.7 | % | 19,773 | 18,081 | 9.4 | % | 10.0 | % | |||||||||||||||||
Agriculture | 1,521 | 1,723 | (11.7) | % | (11.7) | % | 2,581 | 2,523 | 2.3 | % | 2.3 | % | |||||||||||||||||
Personal automobile | 547 | 404 | 35.3 | % | 26.7 | % | 1,434 | 1,239 | 15.7 | % | 10.8 | % | |||||||||||||||||
Personal homeowners | 1,192 | 1,023 | 16.5 | % | 16.6 | % | 3,268 | 2,910 | 12.3 | % | 12.8 | % | |||||||||||||||||
Personal other | 474 | 451 | 5.3 | % | 2.7 | % | 1,466 | 1,406 | 4.3 | % | 5.3 | % | |||||||||||||||||
Total Personal lines | 2,213 | 1,878 | 17.9 | % | 15.5 | % | 6,168 | 5,555 | 11.0 | % | 10.4 | % | |||||||||||||||||
Global A&H - P&C | 802 | 719 | 11.4 | % | 8.9 | % | 2,397 | 2,152 | 11.4 | % | 12.4 | % | |||||||||||||||||
Reinsurance lines | 261 | 265 | (1.4) | % | (1.8) | % | 831 | 780 | 6.5 | % | 6.9 | % | |||||||||||||||||
Total Property and Casualty lines | 11,652 | 10,747 | 8.4 | % | 7.6 | % | 31,750 | 29,091 | 9.1 | % | 9.5 | % | |||||||||||||||||
Life Insurance | 1,452 | 1,265 | 14.9 | % | 15.2 | % | 4,015 | 2,403 | 67.1 | % | 68.4 | % | |||||||||||||||||
Total consolidated | $ | 13,104 | $ | 12,012 | 9.1 | % | 8.4 | % | $ | 35,765 | $ | 31,494 | 13.6 | % | 14.0 | % |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
September 30 | September 30 | ||||||||||||||||||||||
(in millions of U.S. dollars) | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
Catastrophe losses | $ | 670 | $ | 1,158 | $ | 1,528 | $ | 1,782 | |||||||||||||||
Favorable prior period development | $ | 200 | $ | 222 | $ | 596 | $ | 709 |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
September 30 | September 30 | ||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
Loss and loss expense ratio | |||||||||||||||||||||||
CAY loss ratio excluding catastrophe losses | 60.1 | % | 60.6 | % | 58.0 | % | 58.4 | % | |||||||||||||||
Catastrophe losses | 5.9 | % | 11.4 | % | 5.0 | % | 6.6 | % | |||||||||||||||
Prior period development | (2.0) | % | (2.4) | % | (2.1) | % | (3.0) | % | |||||||||||||||
Loss and loss expense ratio | 64.0 | % | 69.6 | % | 60.9 | % | 62.0 | % | |||||||||||||||
Policy acquisition cost ratio | 16.9 | % | 16.6 | % | 17.8 | % | 17.7 | % | |||||||||||||||
Administrative expense ratio | 7.5 | % | 6.9 | % | 8.1 | % | 7.8 | % | |||||||||||||||
P&C Combined ratio | 88.4 | % | 93.1 | % | 86.8 | % | 87.5 | % |
Segment Operating Results – Three and Nine Months Ended September 30, 2023 and 2022 |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||
September 30 | % Change | September 30 | % Change | ||||||||||||||||||||||||||||||||||||||
(in millions of U.S. dollars, except for percentages) | 2023 | 2022 | Q-23 vs. Q-22 | 2023 | 2022 | YTD-23 vs. YTD-22 | |||||||||||||||||||||||||||||||||||
Net premiums written | $ | 5,132 | $ | 4,722 | 8.7 | % | $ | 14,575 | $ | 13,426 | 8.6 | % | |||||||||||||||||||||||||||||
Net premiums earned | 4,735 | 4,283 | 10.6 | % | 13,710 | 12,645 | 8.4 | % | |||||||||||||||||||||||||||||||||
Losses and loss expenses | 3,025 | 3,036 | (0.4) | % | 8,625 | 7,979 | 8.1 | % | |||||||||||||||||||||||||||||||||
Policy acquisition costs | 640 | 583 | 9.9 | % | 1,867 | 1,701 | 9.8 | % | |||||||||||||||||||||||||||||||||
Administrative expenses | 323 | 272 | 19.3 | % | 934 | 814 | 14.9 | % | |||||||||||||||||||||||||||||||||
Underwriting income | 747 | 392 | 90.7 | % | 2,284 | 2,151 | 6.2 | % | |||||||||||||||||||||||||||||||||
Net investment income | 780 | 589 | 32.5 | % | 2,204 | 1,600 | 37.7 | % | |||||||||||||||||||||||||||||||||
Other (income) expense | 6 | 6 | — | 18 | 12 | 48.3 | % | ||||||||||||||||||||||||||||||||||
Segment income | $ | 1,521 | $ | 975 | 56.0 | % | $ | 4,470 | $ | 3,739 | 19.6 | % | |||||||||||||||||||||||||||||
Loss and loss expense ratio: | |||||||||||||||||||||||||||||||||||||||||
CAY loss ratio excluding catastrophe losses | 61.1 | % | 61.5 | % | (0.4) | pts | 60.8 | % | 61.5 | % | (0.7) | pts | |||||||||||||||||||||||||||||
Catastrophe losses | 5.2 | % | 14.0 | % | (8.8) | pts | 4.7 | % | 6.3 | % | (1.6) | pts | |||||||||||||||||||||||||||||
Prior period development | (2.4) | % | (4.6) | % | 2.2 | pts | (2.6) | % | (4.7) | % | 2.1 | pts | |||||||||||||||||||||||||||||
Loss and loss expense ratio | 63.9 | % | 70.9 | % | (7.0) | pts | 62.9 | % | 63.1 | % | (0.2) | pts | |||||||||||||||||||||||||||||
Policy acquisition cost ratio | 13.5 | % | 13.6 | % | (0.1) | pts | 13.6 | % | 13.5 | % | 0.1 | pts | |||||||||||||||||||||||||||||
Administrative expense ratio | 6.8 | % | 6.4 | % | 0.4 | pts | 6.8 | % | 6.4 | % | 0.4 | pts | |||||||||||||||||||||||||||||
Combined ratio | 84.2 | % | 90.9 | % | (6.7) | pts | 83.3 | % | 83.0 | % | 0.3 | pts |
Catastrophe Losses and Prior Period Development | Three Months Ended | Nine Months Ended | |||||||||||||||||||||
September 30 | September 30 | ||||||||||||||||||||||
(in millions of U.S. dollars) | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
Catastrophe losses | $ | 246 | $ | 598 | $ | 639 | $ | 803 | |||||||||||||||
Favorable prior period development | $ | 84 | $ | 166 | $ | 302 | $ | 561 |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||
September 30 | % Change | September 30 | % Change | ||||||||||||||||||||||||||||||||||||||
(in millions of U.S. dollars, except for percentages) | 2023 | 2022 | Q-23 vs. Q-22 | 2023 | 2022 | YTD-23 vs. YTD-22 | |||||||||||||||||||||||||||||||||||
Net premiums written | $ | 1,527 | $ | 1,392 | 9.6 | % | $ | 4,404 | $ | 3,998 | 10.1 | % | |||||||||||||||||||||||||||||
Net premiums earned | 1,407 | 1,334 | 5.5 | % | 4,084 | 3,852 | 6.0 | % | |||||||||||||||||||||||||||||||||
Losses and loss expenses | 900 | 857 | 5.1 | % | 2,634 | 2,343 | 12.4 | % | |||||||||||||||||||||||||||||||||
Policy acquisition costs | 287 | 274 | 4.6 | % | 836 | 792 | 5.6 | % | |||||||||||||||||||||||||||||||||
Administrative expenses | 84 | 71 | 18.9 | % | 247 | 213 | 15.7 | % | |||||||||||||||||||||||||||||||||
Underwriting income | 136 | 132 | 2.6 | % | 367 | 504 | (27.3) | % | |||||||||||||||||||||||||||||||||
Net investment income | 94 | 76 | 23.5 | % | 262 | 199 | 31.3 | % | |||||||||||||||||||||||||||||||||
Other (income) expense | 2 | 1 | NM | 2 | 3 | NM | |||||||||||||||||||||||||||||||||||
Amortization of purchased intangibles | 3 | 2 | NM | 8 | 7 | NM | |||||||||||||||||||||||||||||||||||
Segment income | $ | 225 | $ | 205 | 10.5 | % | $ | 619 | $ | 693 | (10.6) | % | |||||||||||||||||||||||||||||
Loss and loss expense ratio: | |||||||||||||||||||||||||||||||||||||||||
CAY loss ratio excluding catastrophe losses | 52.4 | % | 53.6 | % | (1.2) | pts | 53.4 | % | 53.5 | % | (0.1) | pts | |||||||||||||||||||||||||||||
Catastrophe losses | 19.8 | % | 20.6 | % | (0.8) | pts | 14.3 | % | 12.2 | % | 2.1 | pts | |||||||||||||||||||||||||||||
Prior period development | (8.3) | % | (10.0) | % | 1.7 | pts | (3.2) | % | (4.9) | % | 1.7 | pts | |||||||||||||||||||||||||||||
Loss and loss expense ratio | 63.9 | % | 64.2 | % | (0.3) | pts | 64.5 | % | 60.8 | % | 3.7 | pts | |||||||||||||||||||||||||||||
Policy acquisition cost ratio | 20.4 | % | 20.6 | % | (0.2) | pts | 20.5 | % | 20.6 | % | (0.1) | pts | |||||||||||||||||||||||||||||
Administrative expense ratio | 6.0 | % | 5.3 | % | 0.7 | pts | 6.0 | % | 5.5 | % | 0.5 | pts | |||||||||||||||||||||||||||||
Combined ratio | 90.3 | % | 90.1 | % | 0.2 | pts | 91.0 | % | 86.9 | % | 4.1 | pts | |||||||||||||||||||||||||||||
Catastrophe Losses and Prior Period Development | Three Months Ended | Nine Months Ended | |||||||||||||||||||||
September 30 | September 30 | ||||||||||||||||||||||
(in millions of U.S. dollars) | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
Catastrophe losses | $ | 280 | $ | 274 | $ | 586 | $ | 469 | |||||||||||||||
Favorable prior period development | $ | 119 | $ | 133 | $ | 135 | $ | 187 |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||
September 30 | % Change | September 30 | % Change | ||||||||||||||||||||||||||||||||||||||
(in millions of U.S. dollars, except for percentages) | 2023 | 2022 | Q-23 vs. Q-22 | 2023 | 2022 | YTD-23 vs. YTD-22 | |||||||||||||||||||||||||||||||||||
Net premiums written | $ | 1,521 | $ | 1,723 | (11.7) | % | $ | 2,581 | $ | 2,523 | 2.3 | % | |||||||||||||||||||||||||||||
Net premiums earned | 1,540 | 1,673 | (8.0) | % | 2,334 | 2,217 | 5.3 | % | |||||||||||||||||||||||||||||||||
Losses and loss expenses | 1,356 | 1,444 | (6.1) | % | 2,003 | 1,830 | 9.5 | % | |||||||||||||||||||||||||||||||||
Policy acquisition costs | 76 | 68 | 11.1 | % | 128 | 111 | 15.0 | % | |||||||||||||||||||||||||||||||||
Administrative expenses | 3 | 3 | — | 9 | 4 | 120.9 | % | ||||||||||||||||||||||||||||||||||
Underwriting income | 105 | 158 | (33.4) | % | 194 | 272 | (28.7) | % | |||||||||||||||||||||||||||||||||
Net investment income | 12 | 9 | 47.3 | % | 43 | 23 | 91.7 | % | |||||||||||||||||||||||||||||||||
Other (income) expense | — | 1 | NM | — | 1 | NM | |||||||||||||||||||||||||||||||||||
Amortization of purchased intangibles | 6 | 7 | (2.4) | % | 19 | 20 | (2.4) | % | |||||||||||||||||||||||||||||||||
Segment income | $ | 111 | $ | 159 | (30.3) | % | $ | 218 | $ | 274 | (20.5) | % | |||||||||||||||||||||||||||||
Loss and loss expense ratio: | |||||||||||||||||||||||||||||||||||||||||
CAY loss ratio excluding catastrophe losses | 87.5 | % | 84.0 | % | 3.5 | pts | 84.7 | % | 82.2 | % | 2.5 | pts | |||||||||||||||||||||||||||||
Catastrophe losses | 1.2 | % | 1.8 | % | (0.6) | pts | 1.6 | % | 2.3 | % | (0.7) | pts | |||||||||||||||||||||||||||||
Prior period development | (0.6) | % | 0.5 | % | (1.1) | pts | (0.5) | % | (2.0) | % | 1.5 | pts | |||||||||||||||||||||||||||||
Loss and loss expense ratio | 88.1 | % | 86.3 | % | 1.8 | pts | 85.8 | % | 82.5 | % | 3.3 | pts | |||||||||||||||||||||||||||||
Policy acquisition cost ratio | 4.9 | % | 4.1 | % | 0.8 | pts | 5.5 | % | 5.1 | % | 0.4 | pts | |||||||||||||||||||||||||||||
Administrative expense ratio | 0.2 | % | 0.2 | % | — | pts | 0.4 | % | 0.2 | % | 0.2 | pts | |||||||||||||||||||||||||||||
Combined ratio | 93.2 | % | 90.6 | % | 2.6 | pts | 91.7 | % | 87.8 | % | 3.9 | pts |
Catastrophe Losses and Prior Period Development | Three Months Ended | Nine Months Ended | |||||||||||||||||||||
September 30 | September 30 | ||||||||||||||||||||||
(in millions of U.S. dollars) | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
Catastrophe losses | $ | 18 | $ | 31 | $ | 37 | $ | 52 | |||||||||||||||
Favorable (unfavorable) prior period development | $ | 9 | $ | (9) | $ | 12 | $ | 17 |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||
September 30 | % Change | September 30 | % Change | ||||||||||||||||||||||||||||||||||||||
(in millions of U.S. dollars, except for percentages) | 2023 | 2022 | Q-23 vs. Q-22 | 2023 | 2022 | YTD-23 vs. YTD-22 | |||||||||||||||||||||||||||||||||||
Net premiums written | $ | 3,211 | $ | 2,645 | 21.4 | % | $ | 9,359 | $ | 8,364 | 11.9 | % | |||||||||||||||||||||||||||||
Net premiums written - constant dollars | 17.3 | % | 12.7 | % | |||||||||||||||||||||||||||||||||||||
Net premiums earned | 3,311 | 2,741 | 20.8 | % | 9,005 | 8,065 | 11.7 | % | |||||||||||||||||||||||||||||||||
Loss and loss expenses | 1,635 | 1,333 | 22.7 | % | 4,139 | 3,772 | 9.7 | % | |||||||||||||||||||||||||||||||||
Policy benefits | 91 | 108 | (15.7) | % | 338 | 282 | 19.9 | % | |||||||||||||||||||||||||||||||||
Policy acquisition costs | 827 | 720 | 14.8 | % | 2,286 | 2,096 | 9.1 | % | |||||||||||||||||||||||||||||||||
Administrative expenses | 327 | 264 | 24.3 | % | 899 | 811 | 10.9 | % | |||||||||||||||||||||||||||||||||
Underwriting income | 431 | 316 | 36.2 | % | 1,343 | 1,104 | 21.7 | % | |||||||||||||||||||||||||||||||||
Net investment income | 248 | 151 | 63.6 | % | 636 | 460 | 38.2 | % | |||||||||||||||||||||||||||||||||
Other (income) expense | (10) | (2) | NM | (29) | 3 | NM | |||||||||||||||||||||||||||||||||||
Amortization of purchased intangibles | 19 | 12 | 52.4 | % | 52 | 40 | 27.6 | % | |||||||||||||||||||||||||||||||||
Segment income | $ | 670 | $ | 457 | 46.7 | % | $ | 1,956 | $ | 1,521 | 28.6 | % | |||||||||||||||||||||||||||||
Loss and loss expense ratio: | |||||||||||||||||||||||||||||||||||||||||
CAY loss ratio excluding catastrophe losses | 50.0 | % | 49.2 | % | 0.8 | pts | 49.7 | % | 49.5 | % | 0.2 | pts | |||||||||||||||||||||||||||||
Catastrophe losses | 3.6 | % | 3.6 | % | — | pts | 2.9 | % | 3.7 | % | (0.8) | pts | |||||||||||||||||||||||||||||
Prior period development | (1.5) | % | (0.2) | % | (1.3) | pts | (2.9) | % | (2.9) | % | — | pts | |||||||||||||||||||||||||||||
Loss and loss expense ratio | 52.1 | % | 52.6 | % | (0.5) | pts | 49.7 | % | 50.3 | % | (0.6) | pts | |||||||||||||||||||||||||||||
Policy acquisition cost ratio | 25.0 | % | 26.3 | % | (1.3) | pts | 25.4 | % | 26.0 | % | (0.6) | pts | |||||||||||||||||||||||||||||
Administrative expense ratio | 9.9 | % | 9.6 | % | 0.3 | pts | 10.0 | % | 10.0 | % | — | pts | |||||||||||||||||||||||||||||
Combined ratio | 87.0 | % | 88.5 | % | (1.5) | pts | 85.1 | % | 86.3 | % | (1.2) | pts |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
September 30 | September 30 | ||||||||||||||||||||||
(in millions of U.S. dollars) | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
Catastrophe losses | $ | 120 | $ | 98 | $ | 259 | $ | 298 | |||||||||||||||
Favorable prior period development | $ | 49 | $ | 5 | $ | 253 | $ | 238 |
Net Premiums Written by Region | Three months ended September 30 | ||||||||||||||||||||||||||||||||||||||||
(in millions of U.S. dollars, except for percentages) | 2023 | 2023 % of Total | 2022 | 2022 % of Total | C$ 2022 | Q-23 vs. Q-22 | C$ Q-23 vs. Q-22 | ||||||||||||||||||||||||||||||||||
Region | |||||||||||||||||||||||||||||||||||||||||
Europe, Middle East, and Africa | $ | 1,264 | 39 | % | $ | 1,133 | 43 | % | $ | 1,176 | 11.5 | % | 7.5 | % | |||||||||||||||||||||||||||
Latin America | 695 | 22 | % | 565 | 21 | % | 628 | 23.0 | % | 10.7 | % | ||||||||||||||||||||||||||||||
Asia Pacific (1) | 1,099 | 34 | % | 816 | 31 | % | 809 | 34.5 | % | 35.9 | % | ||||||||||||||||||||||||||||||
Japan | 102 | 3 | % | 101 | 4 | % | 96 | 0.9 | % | 5.5 | % | ||||||||||||||||||||||||||||||
Other (2) | 51 | 2 | % | 30 | 1 | % | 29 | 77.7 | % | 76.6 | % | ||||||||||||||||||||||||||||||
Net premiums written | $ | 3,211 | 100 | % | $ | 2,645 | 100 | % | $ | 2,738 | 21.4 | % | 17.3 | % |
Nine months ended September 30 | |||||||||||||||||||||||||||||||||||||||||
(in millions of U.S. dollars, except for percentages) | 2023 | 2023 % of Total | 2022 | 2022 % of Total | C$ 2022 | Y-23 vs. Y-22 | C$ Y-23 vs. Y-22 | ||||||||||||||||||||||||||||||||||
Region | |||||||||||||||||||||||||||||||||||||||||
Europe, Middle East, and Africa | $ | 4,292 | 46 | % | $ | 3,990 | 48 | % | $ | 3,921 | 7.6 | % | 9.4 | % | |||||||||||||||||||||||||||
Latin America | 1,969 | 21 | % | 1,719 | 21 | % | 1,827 | 14.5 | % | 7.8 | % | ||||||||||||||||||||||||||||||
Asia Pacific (1) | 2,644 | 28 | % | 2,192 | 26 | % | 2,127 | 20.6 | % | 24.3 | % | ||||||||||||||||||||||||||||||
Japan | 349 | 4 | % | 359 | 4 | % | 328 | (2.8) | % | 6.2 | % | ||||||||||||||||||||||||||||||
Other (2) | 105 | 1 | % | 104 | 1 | % | 101 | 1.8 | % | 3.8 | % | ||||||||||||||||||||||||||||||
Net premiums written | $ | 9,359 | 100 | % | $ | 8,364 | 100 | % | $ | 8,304 | 11.9 | % | 12.7 | % |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||
September 30 | % Change | September 30 | % Change | ||||||||||||||||||||||||||||||||||||||
(in millions of U.S. dollars, except for percentages) | 2023 | 2022 | Q-23 vs. Q-22 | 2023 | 2022 | YTD-23 vs. YTD-22 | |||||||||||||||||||||||||||||||||||
Net premiums written | $ | 261 | $ | 265 | (1.4) | % | $ | 831 | $ | 780 | 6.5 | % | |||||||||||||||||||||||||||||
Net premiums written - constant dollars | (1.8) | % | 6.9 | % | |||||||||||||||||||||||||||||||||||||
Net premiums earned | 239 | 255 | (6.5) | % | 720 | 712 | 1.0 | % | |||||||||||||||||||||||||||||||||
Losses and loss expenses | 116 | 311 | (62.9) | % | 319 | 565 | (43.6) | % | |||||||||||||||||||||||||||||||||
Policy acquisition costs | 69 | 59 | 18.6 | % | 196 | 178 | 10.2 | % | |||||||||||||||||||||||||||||||||
Administrative expenses | 9 | 8 | 4.2 | % | 27 | 27 | — | ||||||||||||||||||||||||||||||||||
Underwriting income | 45 | (123) | NM | 178 | (58) | NM | |||||||||||||||||||||||||||||||||||
Net investment income | 47 | 71 | (34.4) | % | 144 | 232 | (37.9) | % | |||||||||||||||||||||||||||||||||
Other (income) expense | — | — | — | (1) | 1 | NM | |||||||||||||||||||||||||||||||||||
Segment income (loss) | $ | 92 | $ | (52) | NM | $ | 323 | $ | 173 | 86.7 | % | ||||||||||||||||||||||||||||||
Loss and loss expense ratio: | |||||||||||||||||||||||||||||||||||||||||
CAY loss ratio excluding catastrophe losses | 45.9 | % | 49.6 | % | (3.7) | pts | 47.2 | % | 49.8 | % | (2.6) | pts | |||||||||||||||||||||||||||||
Catastrophe losses | 2.6 | % | 72.6 | % | (70.0) | pts | 1.0 | % | 26.1 | % | (25.1) | pts | |||||||||||||||||||||||||||||
Prior period development | (0.1) | % | (0.1) | % | — | pts | (3.9) | % | 3.5 | % | (7.4) | pts | |||||||||||||||||||||||||||||
Loss and loss expense ratio | 48.4 | % | 122.1 | % | (73.7) | pts | 44.3 | % | 79.4 | % | (35.1) | pts | |||||||||||||||||||||||||||||
Policy acquisition cost ratio | 29.1 | % | 22.9 | % | 6.2 | pts | 27.2 | % | 25.0 | % | 2.2 | pts | |||||||||||||||||||||||||||||
Administrative expense ratio | 3.8 | % | 3.4 | % | 0.4 | pts | 3.8 | % | 3.8 | % | — | pts | |||||||||||||||||||||||||||||
Combined ratio | 81.3 | % | 148.4 | % | (67.1) | pts | 75.3 | % | 108.2 | % | (32.9) | pts |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
September 30 | September 30 | ||||||||||||||||||||||
(in millions of U.S dollars) | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
Catastrophe losses | $ | 6 | $ | 157 | $ | 7 | $ | 160 | |||||||||||||||
Favorable (unfavorable) prior period development | $ | — | $ | — | $ | 25 | $ | (22) | |||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||
September 30 | % Change | September 30 | % Change | ||||||||||||||||||||||||||||||||
(in millions of U.S. dollars, except for percentages) | 2023 | 2022 | Q-23 vs. Q-22 | 2023 | 2022 | YTD-23 vs. YTD-22 | |||||||||||||||||||||||||||||
Net premiums written | $ | 1,452 | $ | 1,265 | 14.9 | % | $ | 4,015 | $ | 2,403 | 67.1 | % | |||||||||||||||||||||||
Net premiums written - constant dollars | 15.2 | % | 68.4 | % | |||||||||||||||||||||||||||||||
Net premiums earned | 1,442 | 1,244 | 15.9 | % | 3,962 | 2,325 | 70.4 | % | |||||||||||||||||||||||||||
Losses and loss expenses | 20 | 27 | (29.6) | % | 87 | 78 | 11.5 | % | |||||||||||||||||||||||||||
Policy benefits | 866 | 666 | 30.2 | % | 2,283 | 1,275 | 79.1 | % | |||||||||||||||||||||||||||
Policy acquisition costs | 279 | 266 | 5.1 | % | 829 | 537 | 54.3 | % | |||||||||||||||||||||||||||
Administrative expenses | 216 | 174 | 23.0 | % | 553 | 346 | 59.5 | % | |||||||||||||||||||||||||||
Net investment income | 211 | 147 | 42.5 | % | 525 | 359 | 45.9 | % | |||||||||||||||||||||||||||
Other (income) expense | (28) | 4 | NM | (69) | (38) | 90.3 | % | ||||||||||||||||||||||||||||
Amortization of purchased intangibles | 12 | 2 | NM | 18 | 7 | 170.6 | % | ||||||||||||||||||||||||||||
Segment income | $ | 288 | $ | 252 | 14.8 | % | $ | 786 | $ | 479 | 64.6 | % | |||||||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
September 30 | % Change | September 30 | % Change | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(in millions of U.S. dollars, except for percentages) | 2023 | 2022 | C$ 2022 | Q-23 vs. Q-22 | C$ Q-23 vs. Q-22 | 2023 | 2022 | C$ 2022 | Y-23 vs. Y-22 | C$ Y-23 vs. Y-22 | |||||||||||||||||||||||||||||||||||||||||||||||||
Deposits collected on universal life and investment contracts | $ | 388 | $ | 449 | $ | 433 | (13.4) | % | (10.2) | % | $ | 1,097 | $ | 1,433 | $ | 1,352 | (23.4) | % | (18.8) | % |
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||
September 30 | % Change | September 30 | % Change | ||||||||||||||||||||||||||||||||
(in millions of U.S. dollars, except for percentages) | 2023 | 2022 | Q-23 vs. Q-22 | 2023 | 2022 | YTD-23 vs. YTD-22 | |||||||||||||||||||||||||||||
Losses and loss expenses | $ | 61 | $ | 74 | (16.0) | % | $ | 133 | $ | 275 | (51.5) | % | |||||||||||||||||||||||
Administrative expenses | 98 | 91 | 6.7 | % | 290 | 264 | 9.7 | % | |||||||||||||||||||||||||||
Underwriting loss | 159 | 165 | (3.4) | % | 423 | 539 | (21.5) | % | |||||||||||||||||||||||||||
Net investment income (loss) | 14 | 5 | NM | 28 | (4) | NM | |||||||||||||||||||||||||||||
Other (income) expense | (51) | 194 | NM | (251) | 73 | NM | |||||||||||||||||||||||||||||
Amortization of purchased intangibles | 44 | 46 | (1.7) | % | 129 | 137 | (4.9) | % | |||||||||||||||||||||||||||
Net realized gains (losses) | (96) | (437) | (78.0) | % | (481) | (927) | (48.0) | % | |||||||||||||||||||||||||||
Market risk benefits gains (losses) | (32) | 69 | NM | (154) | 85 | NM | |||||||||||||||||||||||||||||
Interest expense | 174 | 150 | 15.6 | % | 499 | 416 | 19.8 | % | |||||||||||||||||||||||||||
Cigna integration expenses | 14 | 23 | (38.8) | % | 51 | 26 | 99.4 | % | |||||||||||||||||||||||||||
Income tax expense | 413 | 263 | 57.2 | % | 1,189 | 907 | 31.1 | % | |||||||||||||||||||||||||||
Net loss | (867) | (1,204) | (27.8) | % | (2,647) | (2,944) | (10.0) | % | |||||||||||||||||||||||||||
Net loss attributable to noncontrolling interests | (3) | — | NM | (3) | — | NM | |||||||||||||||||||||||||||||
Net loss attributable to Chubb | $ | (864) | $ | (1,204) | (28.0) | % | $ | (2,644) | $ | (2,944) | (10.1) | % |
Net Realized and Unrealized Gains (Losses) |
Three Months Ended September 30 | |||||||||||||||||||||||||||||||||||
2023 | 2022 | ||||||||||||||||||||||||||||||||||
(As Adjusted) | |||||||||||||||||||||||||||||||||||
(in millions of U.S. dollars) | Net Realized Gains (Losses) | Net Unrealized Gains (Losses) | Net Impact | Net Realized Gains (Losses) | Net Unrealized Gains (Losses) | Net Impact | |||||||||||||||||||||||||||||
Fixed maturities | $ | (70) | $ | (2,181) | $ | (2,251) | $ | (279) | $ | (3,045) | $ | (3,324) | |||||||||||||||||||||||
Fixed income and investment derivatives | 9 | — | 9 | (198) | — | (198) | |||||||||||||||||||||||||||||
Public equity | |||||||||||||||||||||||||||||||||||
Sales | (45) | — | (45) | (12) | — | (12) | |||||||||||||||||||||||||||||
Mark-to-market | (55) | — | (55) | (68) | — | (68) | |||||||||||||||||||||||||||||
Private equity (less than 3 percent ownership) | |||||||||||||||||||||||||||||||||||
Mark-to-market | 40 | — | 40 | (42) | — | (42) | |||||||||||||||||||||||||||||
Total investment portfolio | (121) | (2,181) | (2,302) | (599) | (3,045) | (3,644) | |||||||||||||||||||||||||||||
Other derivatives | (7) | — | (7) | (19) | — | (19) | |||||||||||||||||||||||||||||
Foreign exchange | (67) | (317) | (384) | 202 | (942) | (740) | |||||||||||||||||||||||||||||
Current discount rate on future policy benefits | — | 683 | 683 | — | 479 | 479 | |||||||||||||||||||||||||||||
Instrument-specific credit risk on market risk benefits | — | (5) | (5) | — | 8 | 8 | |||||||||||||||||||||||||||||
Other (1) | 92 | 48 | 140 | (40) | (59) | (99) | |||||||||||||||||||||||||||||
Net (losses), pre-tax | $ | (103) | $ | (1,772) | $ | (1,875) | $ | (456) | $ | (3,559) | $ | (4,015) | |||||||||||||||||||||||
Nine Months Ended September 30 | |||||||||||||||||||||||||||||||||||
2023 | 2022 | ||||||||||||||||||||||||||||||||||
(As Adjusted) | |||||||||||||||||||||||||||||||||||
(in millions of U.S. dollars) | Net Realized Gains (Losses) | Net Unrealized Gains (Losses) | Net Impact | Net Realized Gains (Losses) | Net Unrealized Gains (Losses) | Net Impact | |||||||||||||||||||||||||||||
Fixed maturities | $ | (357) | $ | (1,589) | $ | (1,946) | $ | (857) | $ | (12,041) | $ | (12,898) | |||||||||||||||||||||||
Fixed income and investment derivatives | (92) | — | (92) | (232) | — | (232) | |||||||||||||||||||||||||||||
Public equity | |||||||||||||||||||||||||||||||||||
Sales | (48) | — | (48) | 406 | — | 406 | |||||||||||||||||||||||||||||
Mark-to-market | (13) | — | (13) | (693) | — | (693) | |||||||||||||||||||||||||||||
Private equity (less than 3 percent ownership) | |||||||||||||||||||||||||||||||||||
Mark-to-market | 75 | — | 75 | 17 | — | 17 | |||||||||||||||||||||||||||||
Total investment portfolio | (435) | (1,589) | (2,024) | (1,359) | (12,041) | (13,400) | |||||||||||||||||||||||||||||
Other derivatives | (6) | — | (6) | (9) | — | (9) | |||||||||||||||||||||||||||||
Foreign exchange | (122) | (279) | (401) | 546 | (1,631) | (1,085) | |||||||||||||||||||||||||||||
Current discount rate on future policy benefits | — | 497 | 497 | — | 1,546 | 1,546 | |||||||||||||||||||||||||||||
Instrument-specific credit risk on market risk benefits | — | 3 | 3 | — | 48 | 48 | |||||||||||||||||||||||||||||
Other (1) | 79 | 63 | 142 | (114) | (35) | (149) | |||||||||||||||||||||||||||||
Net gains (losses), pre-tax | $ | (484) | $ | (1,305) | $ | (1,789) | $ | (936) | $ | (12,113) | $ | (13,049) | |||||||||||||||||||||||
Effective Income Tax Rate |
Non-GAAP Reconciliation |
North America Commercial P&C Insurance | North America Personal P&C Insurance | North America Agricultural Insurance | Overseas General Insurance | Global Reinsurance | Corporate | Total P&C | ||||||||||||||||||||||||||||||||||||||
Three Months Ended | ||||||||||||||||||||||||||||||||||||||||||||
September 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||
(in millions of U.S. dollars except for ratios) | ||||||||||||||||||||||||||||||||||||||||||||
Numerator | ||||||||||||||||||||||||||||||||||||||||||||
Losses and loss expenses/policy benefits | A | $ | 3,025 | $ | 900 | $ | 1,356 | $ | 1,726 | $ | 116 | $ | 61 | $ | 7,184 | |||||||||||||||||||||||||||||
Catastrophe losses and related adjustments | ||||||||||||||||||||||||||||||||||||||||||||
Catastrophe losses, net of related adjustments | (246) | (280) | (18) | (120) | (6) | — | (670) | |||||||||||||||||||||||||||||||||||||
Reinstatement premiums collected (expensed) on catastrophe losses | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
Catastrophe losses, gross of related adjustments | (246) | (280) | (18) | (120) | (6) | — | (670) | |||||||||||||||||||||||||||||||||||||
PPD and related adjustments | ||||||||||||||||||||||||||||||||||||||||||||
PPD, net of related adjustments - favorable (unfavorable) | 84 | 119 | 9 | 49 | — | (61) | 200 | |||||||||||||||||||||||||||||||||||||
Net premiums earned adjustments on PPD - unfavorable (favorable) | 66 | — | — | — | — | — | 66 | |||||||||||||||||||||||||||||||||||||
Expense adjustments - unfavorable (favorable) | 7 | — | — | — | — | — | 7 | |||||||||||||||||||||||||||||||||||||
PPD reinstatement premiums - unfavorable (favorable) | — | (1) | — | — | (1) | — | (2) | |||||||||||||||||||||||||||||||||||||
PPD, gross of related adjustments - favorable (unfavorable) | 157 | 118 | 9 | 49 | (1) | (61) | 271 | |||||||||||||||||||||||||||||||||||||
CAY loss and loss expense ex CATs | B | $ | 2,936 | $ | 738 | $ | 1,347 | $ | 1,655 | $ | 109 | $ | — | $ | 6,785 | |||||||||||||||||||||||||||||
Policy acquisition costs and administrative expenses | ||||||||||||||||||||||||||||||||||||||||||||
Policy acquisition costs and administrative expenses | C | $ | 963 | $ | 371 | $ | 79 | $ | 1,154 | $ | 78 | $ | 98 | $ | 2,743 | |||||||||||||||||||||||||||||
Expense adjustments - favorable (unfavorable) | (7) | — | — | — | — | — | (7) | |||||||||||||||||||||||||||||||||||||
CAY Policy acquisition costs and administrative expenses, adjusted | D | $ | 956 | $ | 371 | $ | 79 | $ | 1,154 | $ | 78 | $ | 98 | $ | 2,736 | |||||||||||||||||||||||||||||
Denominator | ||||||||||||||||||||||||||||||||||||||||||||
Net premiums earned | E | $ | 4,735 | $ | 1,407 | $ | 1,540 | $ | 3,311 | $ | 239 | $ | 11,232 | |||||||||||||||||||||||||||||||
Net premiums earned adjustments on PPD - unfavorable (favorable) | 66 | — | — | — | — | 66 | ||||||||||||||||||||||||||||||||||||||
PPD reinstatement premiums - unfavorable (favorable) | — | (1) | — | — | (1) | (2) | ||||||||||||||||||||||||||||||||||||||
Net premiums earned excluding adjustments | F | $ | 4,801 | $ | 1,406 | $ | 1,540 | $ | 3,311 | $ | 238 | $ | 11,296 | |||||||||||||||||||||||||||||||
P&C Combined ratio | ||||||||||||||||||||||||||||||||||||||||||||
Loss and loss expense ratio | A/E | 63.9 | % | 63.9 | % | 88.1 | % | 52.1 | % | 48.4 | % | 64.0 | % | |||||||||||||||||||||||||||||||
Policy acquisition cost and administrative expense ratio | C/E | 20.3 | % | 26.4 | % | 5.1 | % | 34.9 | % | 32.9 | % | 24.4 | % | |||||||||||||||||||||||||||||||
P&C Combined ratio | 84.2 | % | 90.3 | % | 93.2 | % | 87.0 | % | 81.3 | % | 88.4 | % | ||||||||||||||||||||||||||||||||
CAY P&C Combined ratio ex CATs | ||||||||||||||||||||||||||||||||||||||||||||
Loss and loss expense ratio, adjusted | B/F | 61.1 | % | 52.4 | % | 87.5 | % | 50.0 | % | 45.9 | % | 60.1 | % | |||||||||||||||||||||||||||||||
Policy acquisition cost and administrative expense ratio, adjusted | D/F | 20.0 | % | 26.5 | % | 5.2 | % | 34.8 | % | 32.9 | % | 24.2 | % | |||||||||||||||||||||||||||||||
CAY P&C Combined ratio ex CATs | 81.1 | % | 78.9 | % | 92.7 | % | 84.8 | % | 78.8 | % | 84.3 | % | ||||||||||||||||||||||||||||||||
Combined ratio | ||||||||||||||||||||||||||||||||||||||||||||
Combined ratio | 88.3 | % | ||||||||||||||||||||||||||||||||||||||||||
Add: impact of gains and losses on crop derivatives | 0.1 | % | ||||||||||||||||||||||||||||||||||||||||||
P&C Combined ratio | 88.4 | % | ||||||||||||||||||||||||||||||||||||||||||
Note: The ratios above are calculated using whole U.S. dollars. Accordingly, calculations using rounded amounts may differ. Letters A, B, C, D, E, and F included in the table are references for calculating the ratios above. |
North America Commercial P&C Insurance | North America Personal P&C Insurance | North America Agricultural Insurance | Overseas General Insurance | Global Reinsurance | Corporate | Total P&C | ||||||||||||||||||||||||||||||||||||||
Three Months Ended | ||||||||||||||||||||||||||||||||||||||||||||
September 30, 2022 | ||||||||||||||||||||||||||||||||||||||||||||
(in millions of U.S. dollars except for ratios) | ||||||||||||||||||||||||||||||||||||||||||||
Numerator | ||||||||||||||||||||||||||||||||||||||||||||
Losses and loss expenses/policy benefits | A | $ | 3,036 | $ | 857 | $ | 1,444 | $ | 1,441 | $ | 311 | $ | 74 | $ | 7,163 | |||||||||||||||||||||||||||||
Catastrophe losses and related adjustments | ||||||||||||||||||||||||||||||||||||||||||||
Catastrophe losses, net of related adjustments | (598) | (274) | (31) | (98) | (157) | — | (1,158) | |||||||||||||||||||||||||||||||||||||
Reinstatement premiums collected (expensed) on catastrophe losses | — | — | — | — | 55 | — | 55 | |||||||||||||||||||||||||||||||||||||
Catastrophe losses, gross of related adjustments | (598) | (274) | (31) | (98) | (212) | — | (1,213) | |||||||||||||||||||||||||||||||||||||
PPD and related adjustments | ||||||||||||||||||||||||||||||||||||||||||||
PPD, net of related adjustments - favorable (unfavorable) | 166 | 133 | (9) | 5 | — | (73) | 222 | |||||||||||||||||||||||||||||||||||||
Net premiums earned adjustments on PPD - unfavorable (favorable) | 80 | — | — | — | — | — | 80 | |||||||||||||||||||||||||||||||||||||
Expense adjustments - unfavorable (favorable) | (1) | — | — | — | — | — | (1) | |||||||||||||||||||||||||||||||||||||
PPD, gross of related adjustments - favorable (unfavorable) | 245 | 133 | (9) | 5 | — | (73) | 301 | |||||||||||||||||||||||||||||||||||||
CAY loss and loss expense ex CATs | B | $ | 2,683 | $ | 716 | $ | 1,404 | $ | 1,348 | $ | 99 | $ | 1 | $ | 6,251 | |||||||||||||||||||||||||||||
Policy acquisition costs and administrative expenses | ||||||||||||||||||||||||||||||||||||||||||||
Policy acquisition costs and administrative expenses | C | $ | 855 | $ | 345 | $ | 71 | $ | 984 | $ | 67 | $ | 91 | $ | 2,413 | |||||||||||||||||||||||||||||
Expense adjustments - favorable (unfavorable) | 1 | — | — | — | — | — | 1 | |||||||||||||||||||||||||||||||||||||
CAY Policy acquisition costs and administrative expenses, adjusted | D | $ | 856 | $ | 345 | $ | 71 | $ | 984 | $ | 67 | $ | 91 | $ | 2,414 | |||||||||||||||||||||||||||||
Denominator | ||||||||||||||||||||||||||||||||||||||||||||
Net premiums earned | E | $ | 4,283 | $ | 1,334 | $ | 1,673 | $ | 2,741 | $ | 255 | $ | 10,286 | |||||||||||||||||||||||||||||||
Reinstatement premiums (collected) expensed on catastrophe losses | — | — | — | — | (55) | (55) | ||||||||||||||||||||||||||||||||||||||
Net premiums earned adjustments on PPD - unfavorable (favorable) | 80 | — | — | — | — | 80 | ||||||||||||||||||||||||||||||||||||||
Net premiums earned excluding adjustments | F | $ | 4,363 | $ | 1,334 | $ | 1,673 | $ | 2,741 | $ | 200 | $ | 10,311 | |||||||||||||||||||||||||||||||
P&C Combined ratio | ||||||||||||||||||||||||||||||||||||||||||||
Loss and loss expense ratio | A/E | 70.9 | % | 64.2 | % | 86.3 | % | 52.6 | % | 122.1 | % | 69.6 | % | |||||||||||||||||||||||||||||||
Policy acquisition cost and administrative expense ratio | C/E | 20.0 | % | 25.9 | % | 4.3 | % | 35.9 | % | 26.3 | % | 23.5 | % | |||||||||||||||||||||||||||||||
P&C Combined ratio | 90.9 | % | 90.1 | % | 90.6 | % | 88.5 | % | 148.4 | % | 93.1 | % | ||||||||||||||||||||||||||||||||
CAY P&C Combined ratio ex CATs | ||||||||||||||||||||||||||||||||||||||||||||
Loss and loss expense ratio, adjusted | B/F | 61.5 | % | 53.6 | % | 84.0 | % | 49.2 | % | 49.6 | % | 60.6 | % | |||||||||||||||||||||||||||||||
Policy acquisition cost and administrative expense ratio, adjusted | D/F | 19.6 | % | 25.9 | % | 4.2 | % | 35.9 | % | 33.4 | % | 23.4 | % | |||||||||||||||||||||||||||||||
CAY P&C Combined ratio ex CATs | 81.1 | % | 79.5 | % | 88.2 | % | 85.1 | % | 83.0 | % | 84.0 | % | ||||||||||||||||||||||||||||||||
Combined ratio | ||||||||||||||||||||||||||||||||||||||||||||
Combined ratio | 92.9 | % | ||||||||||||||||||||||||||||||||||||||||||
Add: impact of gains and losses on crop derivatives | 0.2 | % | ||||||||||||||||||||||||||||||||||||||||||
P&C Combined ratio | 93.1 | % | ||||||||||||||||||||||||||||||||||||||||||
Note: The ratios above are calculated using whole U.S. dollars. Accordingly, calculations using rounded amounts may differ. Letters A, B, C, D, E, and F included in the table are references for calculating the ratios above. |
North America Commercial P&C Insurance | North America Personal P&C Insurance | North America Agricultural Insurance | Overseas General Insurance | Global Reinsurance | Corporate | Total P&C | ||||||||||||||||||||||||||||||||||||||
Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||||||
September 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||
(in millions of U.S. dollars except for ratios) | ||||||||||||||||||||||||||||||||||||||||||||
Numerator | ||||||||||||||||||||||||||||||||||||||||||||
Losses and loss expenses/policy benefits | A | $ | 8,625 | $ | 2,634 | $ | 2,003 | $ | 4,477 | $ | 319 | $ | 133 | $ | 18,191 | |||||||||||||||||||||||||||||
Catastrophe losses and related adjustments | ||||||||||||||||||||||||||||||||||||||||||||
Catastrophe losses, net of related adjustments | (639) | (586) | (37) | (259) | (7) | — | (1,528) | |||||||||||||||||||||||||||||||||||||
Reinstatement premiums collected (expensed) on catastrophe losses | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
Catastrophe losses, gross of related adjustments | (639) | (586) | (37) | (259) | (7) | — | (1,528) | |||||||||||||||||||||||||||||||||||||
PPD and related adjustments | ||||||||||||||||||||||||||||||||||||||||||||
PPD, net of related adjustments - favorable (unfavorable) | 302 | 135 | 12 | 253 | 25 | (131) | 596 | |||||||||||||||||||||||||||||||||||||
Net premiums earned adjustments on PPD - unfavorable (favorable) | 78 | — | (2) | — | — | — | 76 | |||||||||||||||||||||||||||||||||||||
Expense adjustments - unfavorable (favorable) | 14 | — | — | — | — | — | 14 | |||||||||||||||||||||||||||||||||||||
PPD reinstatement premiums - unfavorable (favorable) | — | (2) | — | — | 5 | — | 3 | |||||||||||||||||||||||||||||||||||||
PPD, gross of related adjustments - favorable (unfavorable) | 394 | 133 | 10 | 253 | 30 | (131) | 689 | |||||||||||||||||||||||||||||||||||||
CAY loss and loss expense ex CATs | B | $ | 8,380 | $ | 2,181 | $ | 1,976 | $ | 4,471 | $ | 342 | $ | 2 | $ | 17,352 | |||||||||||||||||||||||||||||
Policy acquisition costs and administrative expenses | ||||||||||||||||||||||||||||||||||||||||||||
Policy acquisition costs and administrative expenses | C | 2,801 | 1,083 | 137 | 3,185 | 223 | 290 | 7,719 | ||||||||||||||||||||||||||||||||||||
Expense adjustments - favorable (unfavorable) | (14) | — | — | — | — | — | (14) | |||||||||||||||||||||||||||||||||||||
CAY Policy acquisition costs and administrative expenses, adjusted | D | $ | 2,787 | $ | 1,083 | $ | 137 | $ | 3,185 | $ | 223 | $ | 290 | $ | 7,705 | |||||||||||||||||||||||||||||
Denominator | ||||||||||||||||||||||||||||||||||||||||||||
Net premiums earned | E | $ | 13,710 | $ | 4,084 | $ | 2,334 | $ | 9,005 | $ | 720 | $ | 29,853 | |||||||||||||||||||||||||||||||
Net premiums earned adjustments on PPD - unfavorable (favorable) | 78 | — | (2) | — | — | 76 | ||||||||||||||||||||||||||||||||||||||
PPD reinstatement premiums - unfavorable (favorable) | — | (2) | — | — | 5 | 3 | ||||||||||||||||||||||||||||||||||||||
Net premiums earned excluding adjustments | F | $ | 13,788 | $ | 4,082 | $ | 2,332 | $ | 9,005 | $ | 725 | $ | 29,932 | |||||||||||||||||||||||||||||||
P&C Combined ratio | ||||||||||||||||||||||||||||||||||||||||||||
Loss and loss expense ratio | A/E | 62.9 | % | 64.5 | % | 85.8 | % | 49.7 | % | 44.3 | % | 60.9 | % | |||||||||||||||||||||||||||||||
Policy acquisition cost and administrative expense ratio | C/E | 20.4 | % | 26.5 | % | 5.9 | % | 35.4 | % | 31.0 | % | 25.9 | % | |||||||||||||||||||||||||||||||
P&C Combined ratio | 83.3 | % | 91.0 | % | 91.7 | % | 85.1 | % | 75.3 | % | 86.8 | % | ||||||||||||||||||||||||||||||||
CAY P&C Combined ratio ex CATs | ||||||||||||||||||||||||||||||||||||||||||||
Loss and loss expense ratio, adjusted | B/F | 60.8 | % | 53.4 | % | 84.7 | % | 49.7 | % | 47.2 | % | 58.0 | % | |||||||||||||||||||||||||||||||
Policy acquisition cost and administrative expense ratio, adjusted | D/F | 20.2 | % | 26.6 | % | 5.9 | % | 35.3 | % | 30.8 | % | 25.7 | % | |||||||||||||||||||||||||||||||
CAY P&C Combined ratio ex CATs | 81.0 | % | 80.0 | % | 90.6 | % | 85.0 | % | 78.0 | % | 83.7 | % | ||||||||||||||||||||||||||||||||
Combined ratio | ||||||||||||||||||||||||||||||||||||||||||||
Combined ratio | 86.8 | % | ||||||||||||||||||||||||||||||||||||||||||
Add: impact of gains and losses on crop derivatives | — | |||||||||||||||||||||||||||||||||||||||||||
P&C Combined ratio | 86.8 | % | ||||||||||||||||||||||||||||||||||||||||||
Note: The ratios above are calculated using whole U.S. dollars. Accordingly, calculations using rounded amounts may differ. Letters A, B, C, D, E, and F included in the table are references for calculating the ratios above. |
North America Commercial P&C Insurance | North America Personal P&C Insurance | North America Agricultural Insurance | Overseas General Insurance | Global Reinsurance | Corporate | Total P&C | ||||||||||||||||||||||||||||||||||||||
Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||||||
September 30, 2022 | ||||||||||||||||||||||||||||||||||||||||||||
(in millions of U.S. dollars except for ratios) | ||||||||||||||||||||||||||||||||||||||||||||
Numerator | ||||||||||||||||||||||||||||||||||||||||||||
Losses and loss expenses/policy benefits | A | $ | 7,979 | $ | 2,343 | $ | 1,830 | $ | 4,054 | $ | 565 | $ | 275 | $ | 17,046 | |||||||||||||||||||||||||||||
Catastrophe losses and related adjustments | ||||||||||||||||||||||||||||||||||||||||||||
Catastrophe losses, net of related adjustments | (803) | (469) | (52) | (298) | (160) | — | (1,782) | |||||||||||||||||||||||||||||||||||||
Reinstatement premiums collected (expensed) on catastrophe losses | — | — | — | — | 55 | — | 55 | |||||||||||||||||||||||||||||||||||||
Catastrophe losses, gross of related adjustments | (803) | (469) | (52) | (298) | (215) | — | (1,837) | |||||||||||||||||||||||||||||||||||||
PPD and related adjustments | ||||||||||||||||||||||||||||||||||||||||||||
PPD, net of related adjustments - favorable (unfavorable) | 561 | 187 | 17 | 238 | (22) | (272) | 709 | |||||||||||||||||||||||||||||||||||||
Net premiums earned adjustments on PPD - unfavorable (favorable) | 83 | — | 159 | — | — | — | 242 | |||||||||||||||||||||||||||||||||||||
Expense adjustments - unfavorable (favorable) | 4 | — | (1) | — | — | — | 3 | |||||||||||||||||||||||||||||||||||||
PPD reinstatement premiums - unfavorable (favorable) | — | — | — | — | (2) | — | (2) | |||||||||||||||||||||||||||||||||||||
PPD, gross of related adjustments - favorable (unfavorable) | 648 | 187 | 175 | 238 | (24) | (272) | 952 | |||||||||||||||||||||||||||||||||||||
CAY loss and loss expense ex CATs | B | $ | 7,824 | $ | 2,061 | $ | 1,953 | $ | 3,994 | $ | 326 | $ | 3 | $ | 16,161 | |||||||||||||||||||||||||||||
Policy acquisition costs and administrative expenses | ||||||||||||||||||||||||||||||||||||||||||||
Policy acquisition costs and administrative expenses | C | $ | 2,515 | $ | 1,005 | $ | 115 | $ | 2,907 | $ | 205 | $ | 264 | $ | 7,011 | |||||||||||||||||||||||||||||
Expense adjustments - favorable (unfavorable) | (4) | — | 1 | — | — | — | (3) | |||||||||||||||||||||||||||||||||||||
CAY Policy acquisition costs and administrative expenses, adjusted | D | $ | 2,511 | $ | 1,005 | $ | 116 | $ | 2,907 | $ | 205 | $ | 264 | $ | 7,008 | |||||||||||||||||||||||||||||
Denominator | ||||||||||||||||||||||||||||||||||||||||||||
Net premiums earned | E | $ | 12,645 | $ | 3,852 | $ | 2,217 | $ | 8,065 | $ | 712 | $ | 27,491 | |||||||||||||||||||||||||||||||
Reinstatement premiums (collected) expensed on catastrophe losses | — | — | — | — | (55) | (55) | ||||||||||||||||||||||||||||||||||||||
Net premiums earned adjustments on PPD - unfavorable (favorable) | 83 | — | 159 | — | — | 242 | ||||||||||||||||||||||||||||||||||||||
PPD reinstatement premiums - unfavorable (favorable) | — | — | — | — | (2) | (2) | ||||||||||||||||||||||||||||||||||||||
Net premiums earned excluding adjustments | F | $ | 12,728 | $ | 3,852 | $ | 2,376 | $ | 8,065 | $ | 655 | $ | 27,676 | |||||||||||||||||||||||||||||||
P&C Combined ratio | ||||||||||||||||||||||||||||||||||||||||||||
Loss and loss expense ratio | A/E | 63.1 | % | 60.8 | % | 82.5 | % | 50.3 | % | 79.4 | % | 62.0 | % | |||||||||||||||||||||||||||||||
Policy acquisition cost and administrative expense ratio | C/E | 19.9 | % | 26.1 | % | 5.3 | % | 36.0 | % | 28.8 | % | 25.5 | % | |||||||||||||||||||||||||||||||
P&C Combined ratio | 83.0 | % | 86.9 | % | 87.8 | % | 86.3 | % | 108.2 | % | 87.5 | % | ||||||||||||||||||||||||||||||||
CAY P&C Combined ratio ex CATs | ||||||||||||||||||||||||||||||||||||||||||||
Loss and loss expense ratio, adjusted | B/F | 61.5 | % | 53.5 | % | 82.2 | % | 49.5 | % | 49.8 | % | 58.4 | % | |||||||||||||||||||||||||||||||
Policy acquisition cost and administrative expense ratio, adjusted | D/F | 19.7 | % | 26.1 | % | 4.9 | % | 36.1 | % | 31.2 | % | 25.3 | % | |||||||||||||||||||||||||||||||
CAY P&C Combined ratio ex CATs | 81.2 | % | 79.6 | % | 87.1 | % | 85.6 | % | 81.0 | % | 83.7 | % | ||||||||||||||||||||||||||||||||
Combined ratio | ||||||||||||||||||||||||||||||||||||||||||||
Combined ratio | 87.5 | % | ||||||||||||||||||||||||||||||||||||||||||
Add: impact of gains and losses on crop derivatives | — | |||||||||||||||||||||||||||||||||||||||||||
P&C Combined ratio | 87.5 | % | ||||||||||||||||||||||||||||||||||||||||||
Note: The ratios above are calculated using whole U.S. dollars. Accordingly, calculations using rounded amounts may differ. Letters A, B, C, D, E, and F included in the table are references for calculating the ratios above. |
Amortization of Purchased Intangibles and Other Amortization |
For the Years Ending December 31 (in millions of U.S. dollars) | Reduction to deferred tax liability associated with intangible assets | ||||
Fourth quarter of 2023 | $ | 24 | |||
2024 | 82 | ||||
2025 | 73 | ||||
2026 | 68 | ||||
2027 | 63 | ||||
2028 | 60 | ||||
Total | $ | 370 |
Amortization (expense) benefit of the fair value adjustment on | ||||||||||||||
For the Years Ending December 31 (in millions of U.S. dollars) | Total acquired invested assets (1) | Assumed long-term debt (2) | ||||||||||||
Fourth quarter of 2023 | $ | (8) | $ | 6 | ||||||||||
2024 | (29) | 21 | ||||||||||||
2025 | (13) | 21 | ||||||||||||
2026 | 2 | 21 | ||||||||||||
2027 | 4 | 21 | ||||||||||||
2028 | 6 | 21 | ||||||||||||
Total | $ | (38) | $ | 111 |
Net Investment Income |
Three Months Ended September 30 | Nine Months Ended September 30 | |||||||||||||||||||
(in millions of U.S. dollars) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||
Fixed maturities (1) | $ | 1,198 | $ | 932 | $ | 3,355 | $ | 2,584 | ||||||||||||
Short-term investments | 60 | 25 | 147 | 49 | ||||||||||||||||
Other interest income | 17 | 14 | 46 | 21 | ||||||||||||||||
Equity securities | 53 | 21 | 68 | 93 | ||||||||||||||||
Private equities | 18 | 24 | 38 | 50 | ||||||||||||||||
Other investments | 16 | 8 | 54 | 28 | ||||||||||||||||
Gross investment income (1) | 1,362 | 1,024 | 3,708 | 2,825 | ||||||||||||||||
Investment expenses | (48) | (45) | (142) | (136) | ||||||||||||||||
Net investment income (1) | $ | 1,314 | $ | 979 | $ | 3,566 | $ | 2,689 | ||||||||||||
(1) Includes amortization expense related to fair value adjustment of acquired invested assets | $ | (9) | $ | (6) | $ | (14) | $ | (36) | ||||||||||||
Three Months Ended September 30 | Nine Months Ended September 30 | |||||||||||||||||||
(in millions of U.S. dollars) | 2023 | 2022 | 2023 | 2022 | ||||||||||||||||
Total mark-to-market gain (loss) on private equity, pre-tax | $ | 90 | $ | (232) | $ | 364 | $ | (52) |
Investments |
September 30, 2023 | December 31, 2022 | ||||||||||||||||||||||
(in millions of U.S. dollars) | Fair Value | Cost/ Amortized Cost, Net | Fair Value | Cost/ Amortized Cost, Net | |||||||||||||||||||
Short-term investments | $ | 5,454 | $ | 5,455 | $ | 4,960 | $ | 4,962 | |||||||||||||||
Fixed maturities available for sale | 99,766 | 109,197 | 85,220 | 93,186 | |||||||||||||||||||
Fixed maturities held to maturity | — | — | 8,439 | 8,848 | |||||||||||||||||||
Fixed income securities | 105,220 | 114,652 | 98,619 | 106,996 | |||||||||||||||||||
Equity securities | 3,395 | 3,395 | 827 | 827 | |||||||||||||||||||
Private debt held-for-investment | 2,389 | 2,401 | — | — | |||||||||||||||||||
Private equities | 13,362 | 13,362 | 12,355 | 12,355 | |||||||||||||||||||
Other investments | 5,583 | 5,583 | 1,341 | 1,341 | |||||||||||||||||||
Total investments | $ | 129,949 | $ | 139,393 | $ | 113,142 | $ | 121,519 |
September 30, 2023 | |||||||||||||||||
(in millions of U.S. dollars) | Consolidated | Noncontrolling Interests | Attributable to Chubb | ||||||||||||||
Short-term investments | $ | 1,015 | $ | 491 | $ | 524 | |||||||||||
Fixed maturities available for sale | 2,748 | 696 | 2,052 | ||||||||||||||
Private debt held-for-investment | 2,401 | 656 | 1,745 | ||||||||||||||
Equity securities | 2,286 | 1,329 | 957 | ||||||||||||||
Private equities | 33 | 15 | 18 | ||||||||||||||
Other investments | 4,187 | 3,031 | 1,156 | ||||||||||||||
Total | $ | 12,670 | $ | 6,218 | $ | 6,452 |
September 30, 2023 | December 31, 2022 | ||||||||||||||||||||||
(in millions of U.S. dollars, except for percentages) | Fair Value | % of Total | Fair Value | % of Total | |||||||||||||||||||
U.S. Treasury / Agency | $ | 3,681 | 3 | % | $ | 3,996 | 4 | % | |||||||||||||||
Corporate and asset-backed securities | 40,855 | 37 | % | 38,535 | 40 | % | |||||||||||||||||
Mortgage-backed securities | 19,605 | 18 | % | 17,202 | 17 | % | |||||||||||||||||
Municipal | 2,908 | 3 | % | 6,964 | 7 | % | |||||||||||||||||
Non-U.S. | 36,654 | 34 | % | 26,962 | 27 | % | |||||||||||||||||
Short-term investments | 5,454 | 5 | % | 4,960 | 5 | % | |||||||||||||||||
Total | $ | 109,157 | 100 | % | $ | 98,619 | 100 | % | |||||||||||||||
AAA | $ | 13,567 | 12 | % | $ | 14,779 | 15 | % | |||||||||||||||
AA | 31,204 | 29 | % | 31,195 | 32 | % | |||||||||||||||||
A | 26,567 | 24 | % | 18,366 | 19 | % | |||||||||||||||||
BBB | 19,102 | 18 | % | 16,802 | 17 | % | |||||||||||||||||
BB | 9,880 | 9 | % | 8,722 | 9 | % | |||||||||||||||||
B | 8,306 | 8 | % | 8,347 | 8 | % | |||||||||||||||||
Other | 531 | — | % | 408 | — | % | |||||||||||||||||
Total | $ | 109,157 | 100 | % | $ | 98,619 | 100 | % |
(in millions of U.S. dollars) | Fair Value | ||||
Bank of America Corp | $ | 739 | |||
Morgan Stanley | 651 | ||||
JP Morgan Chase & Co | 647 | ||||
Wells Fargo & Co | 572 | ||||
Citigroup Inc | 505 | ||||
Goldman Sachs Group Inc | 505 | ||||
UBS Group AG | 391 | ||||
HSBC Holdings Plc | 377 | ||||
Verizon Communications Inc | 360 | ||||
Comcast Corp | 352 |
S&P Credit Rating | Fair Value | Amortized Cost, Net | |||||||||||||||||||||||||||||||||||||||
September 30, 2023 (in millions of U.S. dollars) | AAA | AA | A | BBB | BB and below | Total | Total | ||||||||||||||||||||||||||||||||||
Agency residential mortgage-backed securities (RMBS) | $ | 9 | $ | 16,587 | $ | — | $ | — | $ | — | $ | 16,596 | $ | 19,064 | |||||||||||||||||||||||||||
Non-agency RMBS | 729 | 53 | 45 | 32 | 7 | 866 | 965 | ||||||||||||||||||||||||||||||||||
Commercial mortgage-backed securities | 1,854 | 162 | 116 | 9 | 2 | 2,143 | 2,372 | ||||||||||||||||||||||||||||||||||
Total mortgage-backed securities | $ | 2,592 | $ | 16,802 | $ | 161 | $ | 41 | $ | 9 | $ | 19,605 | $ | 22,401 |
(in millions of U.S. dollars) | Fair Value | Amortized Cost, Net | |||||||||
Republic of Korea | $ | 1,617 | $ | 1,701 | |||||||
People's Republic of China | 1,345 | 1,340 | |||||||||
Taiwan | 955 | 923 | |||||||||
Canada | 883 | 969 | |||||||||
Federative Republic of Brazil | 663 | 669 | |||||||||
United Mexican States | 592 | 629 | |||||||||
Province of Ontario | 534 | 587 | |||||||||
Kingdom of Thailand | 525 | 528 | |||||||||
Socialist Republic of Vietnam | 482 | 364 | |||||||||
Commonwealth of Australia | 439 | 526 | |||||||||
Other Non-U.S. Government Securities | 5,408 | 5,946 | |||||||||
Total | $ | 13,443 | $ | 14,182 |
(in millions of U.S. dollars) | Fair Value | Amortized Cost, Net | |||||||||
China | $ | 5,761 | $ | 5,802 | |||||||
United Kingdom | 2,536 | 2,764 | |||||||||
Canada | 1,941 | 2,079 | |||||||||
South Korea | 1,422 | 1,475 | |||||||||
United States (1) | 1,380 | 1,482 | |||||||||
France | 1,378 | 1,477 | |||||||||
Australia | 1,035 | 1,125 | |||||||||
Japan | 759 | 819 | |||||||||
Germany | 575 | 631 | |||||||||
Netherlands | 563 | 613 | |||||||||
Other Non-U.S. Corporate Securities | 5,861 | 6,347 | |||||||||
Total | $ | 23,211 | $ | 24,614 |
Critical Accounting Estimates |
(in millions of U.S. dollars) | Gross Losses | Reinsurance Recoverable (1) | Net Losses | ||||||||||||||
Balance at December 31, 2022 | $ | 75,747 | $ | 17,086 | $ | 58,661 | |||||||||||
Losses and loss expenses incurred | 23,189 | 5,252 | 17,937 | ||||||||||||||
Losses and loss expenses paid | (19,831) | (4,820) | (15,011) | ||||||||||||||
Other (including foreign exchange translation) | 600 | 290 | 310 | ||||||||||||||
Balance at September 30, 2023 | $ | 79,705 | $ | 17,808 | $ | 61,897 |
Catastrophe Management |
Modeled Net Probable Maximum Loss (PML) Pre-tax | |||||||||||||||||||||||||||||||||||
Worldwide (1) | U.S. Hurricane (2) | California Earthquake (3) | |||||||||||||||||||||||||||||||||
Annual Aggregate | Annual Aggregate | Single Occurrence | |||||||||||||||||||||||||||||||||
(in millions of U.S. dollars, except for percentages) | Chubb | % of Total Chubb Shareholders’ Equity | Chubb | % of Total Chubb Shareholders’ Equity | Chubb | % of Total Chubb Shareholders’ Equity | |||||||||||||||||||||||||||||
1-in-10 | $ | 2,327 | 4.4 | % | $ | 1,182 | 2.3 | % | $ | 147 | 0.3 | % | |||||||||||||||||||||||
1-in-100 | $ | 5,082 | 9.7 | % | $ | 3,238 | 6.2 | % | $ | 1,424 | 2.7 | % | |||||||||||||||||||||||
1-in-250 | $ | 8,489 | 16.2 | % | $ | 6,237 | 11.9 | % | $ | 1,685 | 3.2 | % |
Global Property Catastrophe Reinsurance Program |
Loss Location | Layer of Loss | Comments | Notes | ||||||||||||||
United States (excluding Alaska and Hawaii) | $0 million – $1.1 billion | Losses retained by Chubb | (a) | ||||||||||||||
United States (excluding Alaska and Hawaii) | $1.1 billion – $1.25 billion | All natural perils and terrorism | (b) | ||||||||||||||
United States (excluding Alaska and Hawaii) | $1.25 billion – $2.35 billion | All natural perils and terrorism | (c) | ||||||||||||||
United States (excluding Alaska and Hawaii) | $2.35 billion – $3.5 billion | All natural perils and terrorism | (d) | ||||||||||||||
United States (Northeast States Only) | $3.5 billion – $4.0 billion | Named windstorm and earthquake | (e) | ||||||||||||||
International (including Alaska and Hawaii) | $0 million – $200 million | Losses retained by Chubb | (a) | ||||||||||||||
International (including Alaska and Hawaii) | $200 million – $1.3 billion | All natural perils and terrorism | (c) | ||||||||||||||
Alaska, Hawaii, and Canada | $1.3 billion – $2.45 billion | All natural perils and terrorism | (d) | ||||||||||||||
Capital Resources |
September 30 | December 31 | ||||||||||
2023 | 2022 | ||||||||||
(in millions of U.S. dollars, except for ratios) | As Adjusted | ||||||||||
Short-term debt | $ | 700 | $ | 475 | |||||||
Long-term debt | 13,736 | 14,402 | |||||||||
Total financial debt | 14,436 | 14,877 | |||||||||
Trust preferred securities | 308 | 308 | |||||||||
Total Chubb shareholders’ equity | 52,373 | 50,519 | |||||||||
Total capitalization | $ | 67,117 | $ | 65,704 | |||||||
Ratio of financial debt to total capitalization | 21.5 | % | 22.6 | % | |||||||
Ratio of financial debt plus trust preferred securities to total capitalization | 22.0 | % | 23.1 | % |
Shareholders of record as of: | Dividends paid as of: | |||||||||||||
December 16, 2022 | January 6, 2023 | $0.83 (CHF 0.79) | ||||||||||||
March 17, 2023 | April 10, 2023 | $0.83 (CHF 0.77) | ||||||||||||
June 16, 2023 | July 7, 2023 | $0.86 (CHF 0.77) | ||||||||||||
September 15, 2023 | October 6, 2023 | $0.86 (CHF 0.75) |
Liquidity |
Information provided in connection with outstanding debt of subsidiaries |
Chubb Limited (Parent Guarantor) | Chubb INA Holdings Inc. (Subsidiary Issuer) | ||||||||||||||||||||||
September 30 | December 31 | September 30 | December 31 | ||||||||||||||||||||
(in millions of U.S. dollars) | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
Assets | |||||||||||||||||||||||
Investments | $ | — | $ | — | $ | 100 | $ | 135 | |||||||||||||||
Cash | 38 | 40 | 2 | 2 | |||||||||||||||||||
Due from parent guarantor/subsidiary issuer | 2 | 2 | 1,165 | 586 | |||||||||||||||||||
Due from subsidiaries that are not issuers or guarantors | 1,807 | 1,791 | 598 | 598 | |||||||||||||||||||
Other assets | 1 | 16 | 2,425 | 2,106 | |||||||||||||||||||
Total assets | $ | 1,848 | $ | 1,849 | $ | 4,290 | $ | 3,427 | |||||||||||||||
Liabilities | |||||||||||||||||||||||
Due to parent guarantor/subsidiary issuer | $ | 1,165 | $ | 586 | $ | 2 | $ | 2 | |||||||||||||||
Due to subsidiaries that are not issuers or guarantors | 232 | 248 | 1,645 | 1,710 | |||||||||||||||||||
Affiliated notional cash pooling programs | 1,235 | 252 | 2,300 | 1,496 | |||||||||||||||||||
Short-term debt | — | — | 700 | 475 | |||||||||||||||||||
Long-term debt | — | — | 13,736 | 14,402 | |||||||||||||||||||
Trust preferred securities | — | — | 308 | 308 | |||||||||||||||||||
Other liabilities | 527 | 616 | 1,439 | 1,305 | |||||||||||||||||||
Total liabilities | 3,159 | 1,702 | 20,130 | 19,698 | |||||||||||||||||||
Total shareholders’ equity | (1,311) | 147 | (15,840) | (16,271) | |||||||||||||||||||
Total liabilities and shareholders’ equity | $ | 1,848 | $ | 1,849 | $ | 4,290 | $ | 3,427 |
Nine Months Ended September 30, 2023 | Chubb Limited (Parent Guarantor) | Chubb INA Holdings Inc. (Subsidiary Issuer) | |||||||||
(in millions of U.S. dollars) | |||||||||||
Net investment income (loss) | $ | (13) | $ | (94) | |||||||
Net realized gains (losses) | (1) | (107) | |||||||||
Administrative expenses | 86 | (9) | |||||||||
Interest (income) expense | (8) | 332 | |||||||||
Other (income) expense | (33) | 58 | |||||||||
Cigna integration expenses | — | 3 | |||||||||
Income tax expense (benefit) | 10 | (181) | |||||||||
Net loss | $ | (69) | $ | (404) | |||||||
Comprehensive loss | $ | (69) | $ | (535) |
ITEM 3. Quantitative and Qualitative Disclosures about Market Risk |
Sensitivities to equity and interest rate movements | ||||||||||||||||||||||||||||||||||||||
(in millions of U.S. dollars) | Worldwide Equity Shock | |||||||||||||||||||||||||||||||||||||
Interest Rate Shock | +10% | Flat | -10% | -20% | -30% | -40% | ||||||||||||||||||||||||||||||||
+100 bps | (Increase)/decrease in FVL | $ | 279 | $ | 186 | $ | 72 | $ | (75) | $ | (259) | $ | (489) | |||||||||||||||||||||||||
Increase/(decrease) in hedge value | (107) | — | 107 | 214 | 321 | 429 | ||||||||||||||||||||||||||||||||
Increase/(decrease) in net income | $ | 172 | $ | 186 | $ | 179 | $ | 139 | $ | 62 | $ | (60) | ||||||||||||||||||||||||||
Flat | (Increase)/decrease in FVL | $ | 111 | $ | — | $ | (136) | $ | (313) | $ | (527) | $ | (784) | |||||||||||||||||||||||||
Increase/(decrease) in hedge value | (107) | — | 107 | 214 | 321 | 429 | ||||||||||||||||||||||||||||||||
Increase/(decrease) in net income | $ | 4 | $ | — | $ | (29) | $ | (99) | $ | (206) | $ | (355) | ||||||||||||||||||||||||||
-100 bps | (Increase)/decrease in FVL | $ | (92) | $ | (222) | $ | (392) | $ | (595) | $ | (836) | $ | (1,118) | |||||||||||||||||||||||||
Increase/(decrease) in hedge value | (107) | — | 107 | 214 | 321 | 429 | ||||||||||||||||||||||||||||||||
Increase/(decrease) in net income | $ | (199) | $ | (222) | $ | (285) | $ | (381) | $ | (515) | $ | (689) | ||||||||||||||||||||||||||
Sensitivities to Other Economic Variables | AA-rated Credit Spreads | Interest Rate Volatility | Equity Volatility | |||||||||||||||||||||||||||||||||||
(in millions of U.S. dollars) | +100 bps | -100 bps | +2% | -2% | +2% | -2% | ||||||||||||||||||||||||||||||||
(Increase)/decrease in FVL | $ | 50 | $ | (56) | $ | (1) | $ | 1 | $ | (17) | $ | 17 | ||||||||||||||||||||||||||
Increase/(decrease) in net income | $ | 50 | $ | (56) | $ | (1) | $ | 1 | $ | (17) | $ | 17 | ||||||||||||||||||||||||||
Equity Shock | |||||||||||||||||||||||||||||||||||
(in millions of U.S. dollars) | +20 | % | Flat | -20 | % | -40 | % | -60 | % | -80 | % | ||||||||||||||||||||||||
GMDB net amount at risk | $ | 238 | $ | 350 | $ | 615 | $ | 715 | $ | 663 | $ | 541 | |||||||||||||||||||||||
Claims at 100% immediate mortality | 146 | 150 | 149 | 139 | 126 | 114 |
Equity Shock | |||||||||||||||||||||||||||||||||||
(in millions of U.S. dollars) | +20 | % | Flat | -20 | % | -40 | % | -60 | % | -80 | % | ||||||||||||||||||||||||
GLB net amount at risk | $ | 938 | $ | 1,251 | $ | 1,752 | $ | 2,228 | $ | 2,573 | $ | 2,832 |
Equity Shock | |||||||||||||||||||||||||||||||||||
(in millions of U.S. dollars) | +20 | % | Flat | -20 | % | -40 | % | -60 | % | -80 | % | ||||||||||||||||||||||||
GMDB net amount at risk | $ | 46 | $ | 55 | $ | 65 | $ | 75 | $ | 82 | $ | 88 | |||||||||||||||||||||||
GLB net amount at risk | 392 | 482 | 592 | 706 | 819 | 835 | |||||||||||||||||||||||||||||
Claims at 100% immediate mortality | 30 | 30 | 30 | 30 | 30 | 30 |
ITEM 4. Controls and Procedures |
ITEM 1. Legal Proceedings |
ITEM 1A. Risk Factors |
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds and Issuer Repurchases of Equity Securities |
Period | Total Number of Shares Purchased (1) | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plan (2) | Approximate Dollar Value of Shares that May Yet be Purchased Under the Plan | |||||||||||||||||||
July 1 through July 31 | 178,922 | $ | 205.91 | 166,000 | $ | 4.97 | billion | ||||||||||||||||
August 1 through August 31 | 1,700,074 | $ | 202.38 | 1,698,400 | $ | 4.62 | billion | ||||||||||||||||
September 1 through September 30 | 1,088,598 | $ | 209.99 | 1,085,500 | $ | 4.40 | billion | ||||||||||||||||
Total | 2,967,594 | $ | 205.38 | 2,949,900 |
ITEM 5. Other Information |
ITEM 6. Exhibits |
Incorporated by Reference | ||||||||||||||||||||||||||||||||
Exhibit Number | Exhibit Description | Form | Original Number | Date Filed | Filed Herewith | |||||||||||||||||||||||||||
8-K | 3.1 | May 17, 2023 | ||||||||||||||||||||||||||||||
10-K | 3.2 | February 24, 2023 | ||||||||||||||||||||||||||||||
8-K | 4.1 | May 17, 2023 | ||||||||||||||||||||||||||||||
10-K | 4.2 | February 24, 2023 | ||||||||||||||||||||||||||||||
10-Q | 22.1 | May 2, 2023 | ||||||||||||||||||||||||||||||
X | ||||||||||||||||||||||||||||||||
X | ||||||||||||||||||||||||||||||||
X | ||||||||||||||||||||||||||||||||
X | ||||||||||||||||||||||||||||||||
101.1 | The following financial information from Chubb Limited’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2023, formatted in Inline XBRL: (i) Consolidated Balance Sheets at September 30, 2023, and December 31, 2022; (ii) Consolidated Statements of Operations and Comprehensive Income for the three and nine months ended September 30, 2023 and 2022; (iii) Consolidated Statements of Shareholders’ Equity for the three and nine months ended September 30, 2023 and 2022; (iv) Consolidated Statements of Cash Flows for the nine months ended September 30, 2023 and 2022; and (v) Notes to Consolidated Financial Statements | X | ||||||||||||||||||||||||||||||
104.1 | The Cover Page Interactive Data File formatted in Inline XBRL (The cover page XBRL tags are embedded in the Inline XBRL document and included in Exhibit 101.1) | |||||||||||||||||||||||||||||||
SIGNATURES |
CHUBB LIMITED | |||||
(Registrant) | |||||
November 1, 2023 | /s/ Evan G. Greenberg | ||||
Evan G. Greenberg | |||||
Chairman and Chief Executive Officer | |||||
November 1, 2023 | /s/ Peter C. Enns | ||||
Peter C. Enns | |||||
Executive Vice President and Chief Financial Officer |
/s/ Evan G. Greenberg | ||
Evan G. Greenberg | ||
Chairman and Chief Executive Officer |
/s/ Peter C. Enns | ||
Peter C. Enns | ||
Executive Vice President and Chief Financial Officer |
Date: November 1, 2023 | /s/ Evan G. Greenberg | ||||
Evan G. Greenberg | |||||
Chairman and Chief Executive Officer |
Date: November 1, 2023 | /s/ Peter C. Enns | ||||
Peter C. Enns | |||||
Executive Vice President and Chief Financial Officer |
Consolidated Balance Sheets (Parentheticals) (Unaudited) $ in Millions |
Sep. 30, 2023
USD ($)
shares
|
Dec. 31, 2022
USD ($)
shares
|
---|---|---|
Statement of Financial Position [Abstract] | ||
Short-term investments amortized cost | $ 5,455 | $ 4,962 |
Fixed maturities, available-for-sale, valuation allowance | 158 | 169 |
Fixed maturities, available-for-sale, at amortized cost | 109,355 | 93,355 |
Fixed maturities, held-to-maturity, valuation allowance | 0 | 34 |
Fixed maturities, held-to-maturity, fair value | 0 | 8,439 |
Restricted cash | 192 | 115 |
Premium Receivable, Allowance for Credit Loss | 53 | 52 |
Valuation allowance for uncollectible reinsurance | $ 370 | $ 351 |
Common Shares, shares issued | shares | 431,451,586 | 446,376,614 |
Common Shares, shares outstanding | shares | 407,984,339 | 414,594,856 |
Treasury Stock, Common, Shares | shares | 23,467,247 | 31,781,758 |
Consolidated Statements Of Operations and Comprehensive Income (Unaudited) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
|
Revenues | ||||
Net premiums written | $ 13,104 | $ 12,012 | $ 35,765 | $ 31,494 |
Increase in unearned premiums | (430) | (482) | (1,950) | (1,678) |
Net premiums earned | 12,674 | 11,530 | 33,815 | 29,816 |
Net investment income | 1,314 | 979 | 3,566 | 2,689 |
Net realized gains (losses) | (103) | (456) | (484) | (936) |
Market risk benefits gains (losses) | (32) | 69 | (154) | 85 |
Total revenues | 13,853 | 12,122 | 36,743 | 31,654 |
Expenses | ||||
Losses and loss expenses | 7,106 | 7,063 | 17,937 | 16,833 |
Policy benefits (includes remeasurement gains of $25, $17, $21, and $11) | 938 | 707 | 2,565 | 1,441 |
Policy acquisition costs | 2,178 | 1,970 | 6,142 | 5,415 |
Administrative expenses | 1,060 | 883 | 2,959 | 2,479 |
Interest expense | 174 | 150 | 499 | 416 |
Other (income) expense | (154) | 202 | (550) | (9) |
Amortization of purchased intangibles | 84 | 69 | 226 | 211 |
Cigna integration expenses | 14 | 23 | 51 | 26 |
Total expenses | 11,400 | 11,067 | 29,829 | 26,812 |
Income before income tax | 2,453 | 1,055 | 6,914 | 4,842 |
Income tax expense | 413 | 263 | 1,189 | 907 |
Net Income | 2,040 | 792 | 5,725 | 3,935 |
Net loss attributable to noncontrolling interests | (3) | 0 | (3) | 0 |
Net income attributable to Chubb | 2,043 | 792 | 5,728 | 3,935 |
Other comprehensive income (loss): | ||||
Change in unrealized depreciation | (2,170) | (3,045) | (1,578) | (12,041) |
Current discount rate on future policy benefits | 683 | 479 | 497 | 1,546 |
Instrument-specific credit risk on market risk benefits | (5) | 8 | 3 | 48 |
Cumulative foreign currency translation adjustment | (317) | (942) | (279) | (1,631) |
Other, including postretirement benefit liability adjustment | 37 | (59) | 52 | (35) |
Other comprehensive loss, before income tax | (1,772) | (3,559) | (1,305) | (12,113) |
Income tax (expense) benefit related to OCI items | 0 | 109 | (104) | 1,071 |
Other comprehensive loss | (1,772) | (3,450) | (1,409) | (11,042) |
Comprehensive income (loss) | 268 | (2,658) | 4,316 | (7,107) |
Comprehensive loss attributable to noncontrolling interests | (79) | 0 | (79) | 0 |
Comprehensive income (loss) attributable to Chubb | $ 347 | $ (2,658) | $ 4,395 | $ (7,107) |
Earnings per share | ||||
Basic earnings per share attributable to Chubb | $ 4.99 | $ 1.90 | $ 13.90 | $ 9.34 |
Diluted earnings per share attributable to Chubb | $ 4.95 | $ 1.89 | $ 13.79 | $ 9.26 |
Consolidated Statements Of Shareholders' Equity (Unaudited) - USD ($) $ in Millions |
Total |
Common Stock [Member] |
Treasury Stock, Common |
Additional Paid-in Capital [Member] |
Retained Earnings [Member] |
Accumulated Other Comprehensive Income (Loss) [Member] |
Noncontrolling Interest |
---|---|---|---|---|---|---|---|
Noncontrolling interests (refer to Note 3 for balances associated with VIEs) | $ 0 | ||||||
Balance – beginning of period, net of tax at Dec. 31, 2021 | $ 10,985 | $ (7,464) | $ 8,478 | $ 47,403 | $ (1,074) | ||
CB_Par value reduction | 0 | 0 | |||||
Treasury Stock, Retired, Cost Method, Amount | (639) | 4,983 | (4,344) | ||||
Common Shares repurchased | (2,815) | ||||||
Net shares issued under employee share-based compensation plans | 318 | (185) | |||||
Exercise of stock options | (35) | ||||||
Share-based compensation expense | 205 | ||||||
Funding of dividends declared to Retained earnings | (1,034) | ||||||
Net loss attributable to Chubb | $ 3,935 | 3,935 | |||||
Funding of dividends declared from Additional paid-in capital | 1,034 | ||||||
Dividends declared on Common Shares | (1,034) | ||||||
Other Comprehensive Income (Loss), Net of Tax | (11,042) | (11,042) | |||||
Balance – end of period, net of tax at Sep. 30, 2022 | 47,675 | 10,346 | (4,978) | 7,429 | 46,994 | (12,116) | |
Net loss attributable to noncontrolling interests | 0 | 0 | |||||
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest | 0 | ||||||
Noncontrolling interests (refer to Note 3 for balances associated with VIEs) | 0 | ||||||
Balance – beginning of period, net of tax at Jun. 30, 2022 | 10,666 | (6,794) | 7,707 | 48,355 | (8,666) | ||
CB_Par value reduction | 0 | 0 | |||||
Treasury Stock, Retired, Cost Method, Amount | (320) | 2,473 | (2,153) | ||||
Common Shares repurchased | (685) | ||||||
Net shares issued under employee share-based compensation plans | 28 | 10 | |||||
Exercise of stock options | (8) | ||||||
Share-based compensation expense | 66 | ||||||
Funding of dividends declared to Retained earnings | (346) | ||||||
Net loss attributable to Chubb | 792 | 792 | |||||
Funding of dividends declared from Additional paid-in capital | 346 | ||||||
Dividends declared on Common Shares | (346) | ||||||
Other Comprehensive Income (Loss), Net of Tax | (3,450) | (3,450) | |||||
Balance – end of period, net of tax at Sep. 30, 2022 | 47,675 | 10,346 | (4,978) | 7,429 | 46,994 | (12,116) | |
Net loss attributable to noncontrolling interests | 0 | 0 | |||||
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest | 0 | ||||||
Noncontrolling interests (refer to Note 3 for balances associated with VIEs) | 0 | ||||||
Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value | 0 | ||||||
Total shareholders' equity | 47,675 | ||||||
Noncontrolling interests (refer to Note 3 for balances associated with VIEs) | 0 | 0 | |||||
Total shareholders' equity | 50,519 | ||||||
Balance – beginning of period, net of tax at Dec. 31, 2022 | 50,519 | 10,346 | (5,113) | 7,166 | 48,305 | (10,185) | |
CB_Par value reduction | (9,759) | 9,759 | |||||
Treasury Stock, Retired, Cost Method, Amount | (346) | 2,869 | (2,523) | ||||
Common Shares repurchased | (1,758) | ||||||
Net shares issued under employee share-based compensation plans | 255 | (203) | |||||
Exercise of stock options | (15) | ||||||
Share-based compensation expense | 230 | ||||||
Funding of dividends declared to Retained earnings | (1,050) | ||||||
Net loss attributable to Chubb | 5,728 | 5,728 | |||||
Funding of dividends declared from Additional paid-in capital | 1,050 | ||||||
Dividends declared on Common Shares | (1,050) | ||||||
Other Comprehensive Income (Loss), Net of Tax | (1,409) | (1,333) | |||||
Balance – end of period, net of tax at Sep. 30, 2023 | 52,373 | 241 | (3,747) | 15,887 | 51,510 | (11,518) | |
Net loss attributable to noncontrolling interests | (3) | (3) | |||||
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest | (76) | ||||||
Noncontrolling interests (refer to Note 3 for balances associated with VIEs) | 0 | ||||||
Balance – beginning of period, net of tax at Jun. 30, 2023 | 241 | (3,174) | 16,163 | 49,467 | (9,822) | ||
CB_Par value reduction | 0 | 0 | |||||
Treasury Stock, Retired, Cost Method, Amount | 0 | 0 | 0 | ||||
Common Shares repurchased | (606) | ||||||
Net shares issued under employee share-based compensation plans | 33 | 3 | |||||
Exercise of stock options | (2) | ||||||
Share-based compensation expense | 75 | ||||||
Funding of dividends declared to Retained earnings | (352) | ||||||
Net loss attributable to Chubb | 2,043 | 2,043 | |||||
Funding of dividends declared from Additional paid-in capital | 352 | ||||||
Dividends declared on Common Shares | (352) | ||||||
Other Comprehensive Income (Loss), Net of Tax | (1,772) | (1,696) | |||||
Balance – end of period, net of tax at Sep. 30, 2023 | 52,373 | $ 241 | $ (3,747) | $ 15,887 | $ 51,510 | $ (11,518) | |
Net loss attributable to noncontrolling interests | (3) | (3) | |||||
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest | (76) | ||||||
Noncontrolling interests (refer to Note 3 for balances associated with VIEs) | 5,131 | 5,131 | |||||
Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value | $ 5,210 | ||||||
Total shareholders' equity | $ 57,504 |
Consolidated Statements Of Cash Flows (Unaudited) - USD ($) $ in Millions |
9 Months Ended | |
---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
|
Adjustments to reconcile net income to net cash flows from operating activities | ||
Net realized (gains) losses | $ 484 | $ 936 |
Market risk benefits gains (losses) | 154 | (85) |
Amortization of premiums/discounts on fixed maturities | (80) | 185 |
Amortization of purchased intangibles | 226 | 211 |
Equity in net income of partially-owned entities | (610) | (180) |
Deferred income taxes | 39 | 55 |
Unpaid losses and loss expenses | 3,270 | 4,805 |
Unearned premiums | 2,085 | 1,904 |
Future policy benefits | 570 | 117 |
Insurance and reinsurance balances payable | 23 | 544 |
Accounts payable, accrued expenses, and other liabilities | (392) | 337 |
Income taxes payable | (6) | (108) |
Insurance and reinsurance balances receivable | (1,618) | (1,756) |
Reinsurance recoverable | (388) | (1,850) |
Deferred policy acquisition costs | (832) | (355) |
Other | 796 | (95) |
Net cash flows from operating activities | 9,446 | 8,600 |
Cash flows from investing activities | ||
Purchases of fixed maturities available for sale | (21,613) | (23,533) |
Purchases of fixed maturities held to maturity | (208) | (454) |
Purchases of equity securities | (968) | (837) |
Sales of fixed maturities available for sale | 11,293 | 14,142 |
Sales of equity securities | 531 | 4,453 |
Maturities and redemptions of fixed maturities available for sale | 5,107 | 7,882 |
Maturities and redemptions of fixed maturities held to maturity | 708 | 1,357 |
Net change in short-term investments | 484 | (1,106) |
Net derivative instruments settlements | (56) | (52) |
Private equity contribution | (1,313) | (2,194) |
Private equity distribution | 938 | 649 |
Payments to Acquire Businesses, Net of Cash Acquired | 216 | (5,095) |
Other | (553) | (414) |
Net cash flows used for investing activities | (5,434) | (5,202) |
Cash flows from financing activities | ||
Dividends paid on Common Shares | (1,044) | (1,030) |
Common Shares repurchased | (1,848) | (2,783) |
Proceeds from issuance of repurchase agreements | 3,778 | 3,552 |
Repayment of long-term debt | (475) | 0 |
Repayment of repurchase agreements | (3,832) | (2,554) |
Proceeds from share-based compensation plans | 140 | 198 |
Policyholder contract deposits | 415 | 321 |
Policyholder contract withdrawals | (269) | (285) |
Payment, Tax Withholding, Share-based Payment Arrangement | (100) | (100) |
Proceeds from (Payments for) Other Financing Activities | (90) | (49) |
Net cash flows used for financing activities | (3,325) | (2,730) |
Effect of foreign currency rate changes on cash and restricted cash | (36) | (215) |
Net increase (decrease) in cash and restricted cash | 651 | 453 |
Cash and restricted cash - beginning of period | 2,127 | 1,811 |
Cash and restricted cash - end of period | 2,778 | 2,264 |
Supplemental cash flow information | ||
Taxes paid | 1,101 | 964 |
Interest paid | 345 | 339 |
Net income | $ 5,725 | $ 3,935 |
Consolidated Statements of Operations and Comprehensive Income (Parentheticals) (Unaudited) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
|
Income Statement [Abstract] | ||||
Liability for Future Policy Benefit, Remeasurement Gain (Loss) | $ 25 | $ 17 | $ 21 | $ 11 |
General and significant accounting policies |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
General | General and significant accounting policies a) Basis of presentation Chubb Limited is a holding company incorporated in Zurich, Switzerland. Chubb Limited, through its subsidiaries, provides a broad range of insurance and reinsurance products to insureds worldwide. Our results are reported through the following business segments: North America Commercial P&C Insurance, North America Personal P&C Insurance, North America Agricultural Insurance, Overseas General Insurance, Global Reinsurance, and Life Insurance. Refer to Note 18 for additional information. The interim unaudited consolidated financial statements include the accounts of Chubb Limited and its subsidiaries (collectively, Chubb, we, us, or our), over which Chubb exercises control, including Huatai Group, our majority-owned subsidiary, and minority-owned entities such as variable interest entities (VIEs) in which Chubb is considered the primary beneficiary. Noncontrolling interests on the consolidated financial statements represent the portion of majority-owned subsidiaries and VIEs in which we do not have direct equity ownership. These interim unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) and, in the opinion of management, reflect all adjustments necessary for a fair statement of the results and financial position for such periods. All significant intercompany accounts and transactions, including internal reinsurance transactions, have been eliminated. On July 1, 2023, Chubb increased its investment in Huatai Group from approximately 64.2 percent to approximately 69.6 percent. Accordingly, Chubb discontinued the equity method of accounting for its investment in Huatai Group and applied consolidation accounting. Business activity for, and the financial position of, Huatai Group is reported at 100 percent on the Consolidated Financial Statements starting when Chubb obtained control of Huatai Group on July 1, 2023. The relevant amounts attributable to shareholders other than Chubb (representing approximately 30.4 percent of Huatai Group) are reflected under Noncontrolling interests, Net income (loss) attributable to noncontrolling interests, and Comprehensive income (loss) attributable to noncontrolling interests in the Consolidated Financial Statements. Refer to Note 2 for additional information. Huatai Group's life and asset management businesses are included in the Life Insurance segment, and Huatai Group's P&C business is included in the Overseas General Insurance segment. Results for Huatai Group's non-insurance operations, comprising real estate and holding company activity, are included in Corporate. The results of operations and cash flows for any interim period are not necessarily indicative of the results for the full year. These consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in our 2022 Form 10-K. b) Accounting policies adopted upon consolidation of Huatai Group The following accounting policies have been adopted or updated upon the consolidation of Huatai Group and its subsidiaries (collectively, Huatai) in the third quarter of 2023: Asset management and performance fee revenue and expenses Huatai's asset management companies recognize revenue and expenses unrelated to Chubb's core insurance operations from the management of third-party assets. These revenues include fixed-rate management fees, which are recognized in the period in which the services are performed, and asset performance fees, which are recognized to the extent it is probable that a significant reversal will not occur. These fees and expenses are included in Other (income) expense on the Consolidated statements of operations. Refer to Note 17 for additional information. Private debt held-for-investment, at amortized cost Private debt held-for-investment are investments related principally to the funding of public and private projects that are mostly infrastructure related, and were acquired as part of Huatai’s investment portfolio upon consolidation. They have stated interest rates and maturity dates with fixed or determinable payments. Private debt held-for-investment are carried at amortized cost, net of a valuation allowance for credit losses. Interest income is recorded when earned. Other investments Chubb consolidates entities in which it has a controlling interest or is a primary beneficiary of a VIE. Huatai’s asset management businesses create investment entities known as sponsored investment products which include mutual funds with primary holdings in fixed maturities. Other investments principally comprised these fixed maturities. These securities are reported at fair value with changes in fair value reported through the Consolidated statements of operations within Net realized gains (losses) as required under investment company accounting standards. Consolidation of variable interest entities (VIEs) Chubb consolidates entities in which it has a controlling interest or is a primary beneficiary of a VIE. Huatai's asset management businesses create investment entities known as sponsored investment products which include mutual funds with primary holdings in fixed maturities. These entities are created for varied purposes during the ordinary course of business, such as to obtain returns from investments, and to collect management fees for the assets managed on behalf of the third party investors. While many investors may not be related parties, Huatai invests in these funds at various ownership percentages. We determined that we are the primary beneficiary of these VIEs and generally consolidate when we hold an economic interest of 10 percent or more. The consolidation of VIEs records 100 percent of the underlying assets and liabilities of the mutual funds within the Consolidated balance sheets. The relevant amounts attributable to investors other than Chubb are reflected as Noncontrolling interests. Where Huatai's ownership in these sponsored investment products is less than 10 percent, we generally would not expect to be the primary beneficiary of these VIEs. Refer to Note 3 g) for additional information. c) Accounting guidance adopted in 2023 Targeted Improvements to the Accounting for Long-Duration Contracts Effective January 1, 2023, we adopted new guidance on the accounting for long-duration contracts (LDTI). The new accounting guidance requires more frequent updating of assumptions and a standardized discount rate for the future policy benefit liability, a requirement to use the fair value measurement model for policies with market risk benefits, simplified amortization of deferred acquisition costs, and enhanced disclosures. With the exception of market risk benefits, we adopted this guidance on a modified retrospective basis. Under the modified retrospective basis, the liability for future policy benefits is updated to remove any amounts related to changes to the original discount rate at January 1, 2021 (the transition date) in AOCI and future cash flow assumptions are applied to contracts in force. The liability for future policy benefits prior to the transition date continues to use the original discount rate (interest accretion rate). The guidance for long-duration contracts applicable to market risk benefits, primarily assumed reinsurance programs involving minimum benefit guarantees under variable annuity contracts, was adopted on a retrospective transition approach. Under the retrospective transition approach, we calculated the fair value of market risk benefits which were previously accounted for under an insurance accounting model and recognized an adjustment to retained earnings as of January 1, 2021. On January 1, 2021, we recognized a cumulative effect adjustment and increased beginning retained earnings by $52 million, and decreased AOCI by $1.8 billion. Results for the prior reporting periods in this report are presented in accordance with the new guidance. We also adopted the required disclosures in Note 6 Deferred acquisition costs, Note 9 Future policy benefits, Note 10 Policyholders’ account balances, Note 11 Market risk benefits, and Note 12 Separate accounts. The impact of adoption of the new guidance on our historical financial statements is as follows:
Excluded from the table above is the reclassification of Separate account assets, Separate account liabilities, and Policyholders' account balances as separate line items on the Consolidated balance sheets. Separate accounts assets were previously classified in Other assets, and Separate account liabilities and Policyholders' account balances were previously classified in Accounts payable, accrued expenses, and other liabilities.
The following table presents a reconciliation of the pre-adoption December 31, 2020, to the post adoption January 1, 2021, balance of future policy benefits:
(1) Includes future policy benefits previously included within Unpaid losses on the pre-adoption Consolidated balance sheets, primarily certain international A&H business, and excludes deferred profit liability and certain guaranteed minimum death benefits reclassified to Market risk benefits on the post adoption period balance sheets. The following table presents a reconciliation of the pre-adoption December 31, 2020, to the post adoption January 1, 2021, balance of market risk benefits:
(1) Includes $77 million of instrument-specific credit risk allocated from retained earnings to AOCI. Significant accounting policies The following accounting policies have been updated to reflect the adoption of LDTI. Refer to Note 1 in the 2022 Form 10-K for a complete description of our accounting policies. Deferred policy acquisition costs (DAC) Policy acquisition costs on long-duration contracts are grouped by contract type and issue year into cohorts consistent with the grouping used in estimating the associated liability. Deferred policy acquisition costs are amortized on a constant level basis over the expected term of the related contracts to approximate straight-line amortization. The constant level basis used for amortization is the face amount in force and is projected using the same assumptions used in estimating the liability for future policy benefits. If those projected assumptions change in future periods, they will be reflected in the cohort level amortization basis at that time. Unexpected changes in the in-force portfolio, due to variances in mortality and lapse experience, are recognized over the contract term. Changes in future mortality and lapse assumptions are also recognized prospectively over the remaining expected contract term. Future policy benefits For traditional and limited-payment contracts, contracts are grouped into cohorts by contract type and issue year to determine a liability for future policy benefits. The future policy benefit liability (FPBL) is the present value of estimated future policy benefits to be paid to or on behalf of policyholders and certain related expenses less the present value of estimated future net premiums to be collected from policyholders, and is accrued as premium revenue is recognized. The valuation of this liability requires management to make estimates and assumptions regarding expenses, mortality, and persistency. Estimates are primarily based on historical experience. Actual results could differ materially from these estimates. The liability is adjusted for differences between actual and expected experience. With the exception of the expense assumption, we review our future cash flow assumptions at least annually to determine if the net premium ratio (NPR), the mechanism used to record the liability as premium is earned, used to calculate the liability should be changed at that time. We have elected to use expense assumptions that are locked in at contract inception and are not subsequently reviewed or updated. Each quarter, we update the cash flows expected over the entire life of each cohort for actual historical experience and projected future cash flows. These updated cash flows are used to calculate the revised NPR, which is used to derive an updated FPBL as of the beginning of the current reporting period, discounted at the original contract issuance discount rate. This amount is then compared to the carrying amount of the liability as of that same date, but before the updating of cash flow assumptions, to determine the current period change in FPBL. This current period change in the liability is the liability remeasurement gain or loss and is recorded in Policy benefits in the Consolidated statements of operations. In subsequent periods, the revised NPR is used to measure the FPBL until future revisions become required. For traditional and limited-payment contracts, the discount rate assumption based on an upper-medium grade fixed-income instrument yield. An equivalent rate is derived based on A-credit-rated fixed-income instruments with similar duration to the liability. The discount rate assumption is updated quarterly and used to remeasure the liability at each reporting date, with the resulting change reflected in Other comprehensive income. For liability cash flows that are projected beyond the duration of market-observable A-credit-rated fixed-income instruments, we use the last market-observable yield level, as the basis for a linear interpolation to determine yield assumptions for durations that do not have market-observable yields. Deferred profit liability For limited-payment products, gross premiums received in excess of net premiums are deferred at initial recognition as a deferred profit liability (DPL) and recorded as a component of Future policy benefits in the Consolidated balance sheets. Net premiums are measured using actual cash flows and future cash flow assumptions consistent with those used in the measurement of the liability for future policy benefits and remeasured quarterly. The DPL is amortized in proportion to the discounted in-force policies. Interest is accreted on the balance of the DPL using the discount rate consistent with the interest accretion on the FPBL. The recalculated DPL, including adjusted amortization through the current period, is compared to the current carrying amount and the difference is recognized as an adjustment to Policy benefits in the Consolidated statements of operations as a remeasurement gain or loss. Market risk benefits Chubb reinsures various death and living benefit guarantees associated with variable annuities issued primarily in the United States, which are referred to as market risk benefits. These reinsurance contracts provide both protection to the ceding entity from other-than-nominal capital market risk and expose us to other-than-nominal capital market risk. Market risk benefits are measured at fair value using a valuation model based on current net exposures, market data, our experience, and other factors. Changes in fair value are recognized in Market risk benefits gains (losses) in the Consolidated statements of operations, except the change in fair value due to a change in the instrument-specific credit risk, which is recognized in other comprehensive income. Refer to Note 11 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting guidance adopted | Accounting guidance adopted in 2023 Targeted Improvements to the Accounting for Long-Duration Contracts Effective January 1, 2023, we adopted new guidance on the accounting for long-duration contracts (LDTI). The new accounting guidance requires more frequent updating of assumptions and a standardized discount rate for the future policy benefit liability, a requirement to use the fair value measurement model for policies with market risk benefits, simplified amortization of deferred acquisition costs, and enhanced disclosures. With the exception of market risk benefits, we adopted this guidance on a modified retrospective basis. Under the modified retrospective basis, the liability for future policy benefits is updated to remove any amounts related to changes to the original discount rate at January 1, 2021 (the transition date) in AOCI and future cash flow assumptions are applied to contracts in force. The liability for future policy benefits prior to the transition date continues to use the original discount rate (interest accretion rate). The guidance for long-duration contracts applicable to market risk benefits, primarily assumed reinsurance programs involving minimum benefit guarantees under variable annuity contracts, was adopted on a retrospective transition approach. Under the retrospective transition approach, we calculated the fair value of market risk benefits which were previously accounted for under an insurance accounting model and recognized an adjustment to retained earnings as of January 1, 2021. On January 1, 2021, we recognized a cumulative effect adjustment and increased beginning retained earnings by $52 million, and decreased AOCI by $1.8 billion. Results for the prior reporting periods in this report are presented in accordance with the new guidance. We also adopted the required disclosures in Note 6 Deferred acquisition costs, Note 9 Future policy benefits, Note 10 Policyholders’ account balances, Note 11 Market risk benefits, and Note 12 Separate accounts. The impact of adoption of the new guidance on our historical financial statements is as follows:
Excluded from the table above is the reclassification of Separate account assets, Separate account liabilities, and Policyholders' account balances as separate line items on the Consolidated balance sheets. Separate accounts assets were previously classified in Other assets, and Separate account liabilities and Policyholders' account balances were previously classified in Accounts payable, accrued expenses, and other liabilities.
The following table presents a reconciliation of the pre-adoption December 31, 2020, to the post adoption January 1, 2021, balance of future policy benefits:
(1) Includes future policy benefits previously included within Unpaid losses on the pre-adoption Consolidated balance sheets, primarily certain international A&H business, and excludes deferred profit liability and certain guaranteed minimum death benefits reclassified to Market risk benefits on the post adoption period balance sheets. The following table presents a reconciliation of the pre-adoption December 31, 2020, to the post adoption January 1, 2021, balance of market risk benefits:
(1) Includes $77 million of instrument-specific credit risk allocated from retained earnings to AOCI.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Basis of presentation | Basis of presentation Chubb Limited is a holding company incorporated in Zurich, Switzerland. Chubb Limited, through its subsidiaries, provides a broad range of insurance and reinsurance products to insureds worldwide. Our results are reported through the following business segments: North America Commercial P&C Insurance, North America Personal P&C Insurance, North America Agricultural Insurance, Overseas General Insurance, Global Reinsurance, and Life Insurance. Refer to Note 18 for additional information. The interim unaudited consolidated financial statements include the accounts of Chubb Limited and its subsidiaries (collectively, Chubb, we, us, or our), over which Chubb exercises control, including Huatai Group, our majority-owned subsidiary, and minority-owned entities such as variable interest entities (VIEs) in which Chubb is considered the primary beneficiary. Noncontrolling interests on the consolidated financial statements represent the portion of majority-owned subsidiaries and VIEs in which we do not have direct equity ownership. These interim unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) and, in the opinion of management, reflect all adjustments necessary for a fair statement of the results and financial position for such periods. All significant intercompany accounts and transactions, including internal reinsurance transactions, have been eliminated. On July 1, 2023, Chubb increased its investment in Huatai Group from approximately 64.2 percent to approximately 69.6 percent. Accordingly, Chubb discontinued the equity method of accounting for its investment in Huatai Group and applied consolidation accounting. Business activity for, and the financial position of, Huatai Group is reported at 100 percent on the Consolidated Financial Statements starting when Chubb obtained control of Huatai Group on July 1, 2023. The relevant amounts attributable to shareholders other than Chubb (representing approximately 30.4 percent of Huatai Group) are reflected under Noncontrolling interests, Net income (loss) attributable to noncontrolling interests, and Comprehensive income (loss) attributable to noncontrolling interests in the Consolidated Financial Statements. Refer to Note 2 for additional information. Huatai Group's life and asset management businesses are included in the Life Insurance segment, and Huatai Group's P&C business is included in the Overseas General Insurance segment. Results for Huatai Group's non-insurance operations, comprising real estate and holding company activity, are included in Corporate. The results of operations and cash flows for any interim period are not necessarily indicative of the results for the full year. These consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in our 2022 Form 10-K.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Investment | Other investments Chubb consolidates entities in which it has a controlling interest or is a primary beneficiary of a VIE. Huatai’s asset management businesses create investment entities known as sponsored investment products which include mutual funds with primary holdings in fixed maturities. Other investments principally comprised these fixed maturities. These securities are reported at fair value with changes in fair value reported through the Consolidated statements of operations within Net realized gains (losses) as required under investment company accounting standards.
|
Acquisitions |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Combinations [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Acquisitions | Acquisitions Huatai Group Huatai Insurance Group Co., Ltd. (Huatai Group) is a Chinese financial services holding company and the parent company of, among others, Huatai Property & Casualty Insurance Co., Ltd. (Huatai P&C), Huatai Life Insurance Co., Ltd. (Huatai Life), Huatai Asset Management Co., Ltd., and Huatai Baoxing Fund Management Co., Ltd., of which Huatai Group owns 100 percent, 80 percent, 82 percent, and 85 percent, respectively (collectively, Huatai). On July 1, 2023, Chubb increased its investment in Huatai Group from approximately 64.2 percent to approximately 69.6 percent. Chubb paid $318 million for the incremental 5.4 percent ownership interest. On October 1, 2023, we closed on an incremental ownership interest of approximately 2.5 percent for $146 million, which was previously paid as a deposit. Chubb has agreements in place to acquire approximately 14.1 percent of incremental ownership interests, pending completion of certain closing conditions, of which approximately 3 percent also requires regulatory approval. We have paid deposits of $416 million for the approximately 14.1 percent of ownership interests, and the remaining aggregate purchase price to be paid upon closing is approximately $433 million, based on current exchange rates. Refer to Note 2 to the Consolidated Financial Statements in our 2022 Form 10-K for additional information. Upon discontinuation of the equity method of accounting, Chubb remeasured the 64.2 percent equity method investment to its fair value of $4.1 billion as of July 1, 2023, resulting in a one-time realized gain of $744 million after-tax, reflecting the remeasurement of the previously held equity interest's historical carrying value to fair value. There was also a net realized and unrealized loss of $17 million after-tax reflecting the write-off of AOCI loss balances accumulated while under the equity method of $611 million with an offset to realized loss of $628 million. The acquisition of a controlling majority interest in Huatai Group generated $3,394 million of Goodwill, attributable to expected growth and profitability, and $1,655 million of Other intangible assets. None of the goodwill is expected to be deductible for income tax purposes. Additionally, the acquisition of a controlling majority interest in Huatai Group generated $309 million of Value of business acquired (VOBA). Chubb financed the transaction through available cash on hand. Direct costs related to the acquisition were expensed as incurred. These include one-time costs that are directly attributable to third-party consulting fees and other professional and legal fees related to the acquisition. The following table summarizes Chubb's best estimate of fair value of the assets acquired and liabilities assumed on July 1, 2023. The fair value of assets and liabilities are preliminary and may change with offsetting adjustments to goodwill. Chubb may make further adjustments to its purchase price allocation and the fair value of noncontrolling interest through the end of the permissible one-year measurement period.
The following table summarizes the results of the acquired Huatai Group operations that have been included within our Consolidated statements of operations for the three and nine months ended September 30, 2023:
The preliminary purchase price allocation to intangible assets recorded in connection with the Huatai Group acquisition and their related useful lives at July 1, 2023, are as follows:
The following table presents supplemental unaudited pro forma consolidated information for the periods indicated as though the acquisition of a controlling majority interest in Huatai Group that occurred on July 1, 2023, had instead occurred on January 1, 2022. The unaudited pro forma consolidated financial information is presented for informational purposes only and is not necessarily indicative of the operating results that would have occurred had the acquisition of a controlling majority interest been consummated on January 1, 2022, nor is it necessarily indicative of future operating results. Significant assumptions used to determine pro forma operating results include amortization of VOBA and other intangible assets.
Cigna’s Accident and Health (A&H) and Life Insurance Business in Asian Markets On July 1, 2022, we completed the acquisition of the life and non-life insurance companies that house the personal accident, supplemental health, and life insurance business of Cigna in several Asian markets. Chubb paid approximately $5.4 billion in cash for the operations, which include Cigna's accident and health (A&H) and life business in Korea, Taiwan, New Zealand, Thailand, Hong Kong, and Indonesia, collectively referred to as Cigna's business in Asia. This complementary strategic acquisition expands our presence and advances our long-term growth opportunity in Asia. Effective July 1, 2022, the results of operations of this acquired business are reported primarily in our Life Insurance segment and, to a lesser extent, our Overseas General Insurance segment. Refer to the 2022 Form 10-K for additional information on this acquisition. The acquisition of Cigna's business in Asia generated $1,177 million of goodwill, attributable to expected growth and profitability, and $309 million of other intangible assets. None of the goodwill is expected to be deductible for income tax purposes. Additionally, the acquisition of Cigna's business in Asia generated $3,633 million of value of business acquired (VOBA). Chubb financed the transaction through a combination of available cash and $2.0 billion in repurchase agreements that expired at the end of 2022. Direct costs related to the acquisition were expensed as incurred. The following table summarizes the fair value of the assets acquired and liabilities assumed at July 1, 2022:
The following table summarizes the results of the acquired Cigna business in Asia that have been included within our Consolidated statements of operations for the three and nine months ended September 30, 2022:
The following table presents supplemental unaudited pro forma consolidated information for the periods indicated as though the acquisition of Cigna's business in Asia that occurred on July 1, 2022, had instead occurred on January 1, 2021. The unaudited pro forma consolidated financial information is presented for informational purposes only and is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated on January 1, 2021, nor is it necessarily indicative of future operating results. Significant assumptions used to determine pro forma operating results include amortization of VOBA and other intangible assets and recognition of interest expense associated with the repurchase agreement transactions used to effect the acquisition.
|
Investments |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments, Debt and Equity Securities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments | Investments a) Transfers of securities In June 2023, we determined that we no longer have the intent to hold securities in our held to maturity (HTM) portfolio until maturity. As a result, our entire HTM securities portfolio was transferred to the available for sale (AFS) portfolio. This decision allowed us to increase our flexibility to execute on our investment strategy and take advantage of the continuing higher reinvestment environment while not making any major change to our current asset allocation. At the time of the transfer on June 30, 2023, these securities had a carrying value of $8.2 billion and a fair value of $7.8 billion, resulting in an increase to Unrealized depreciation in OCI of $428 million, after-tax. This transfer represents a non-cash transaction and does not impact the Consolidated Statements of Cash Flows. b) Fixed maturities
The following table presents the amortized cost of our held to maturity securities according to S&P rating:
The following table presents fixed maturities by contractual maturity:
Expected maturities could differ from contractual maturities because borrowers may have the right to call or prepay obligations, with or without call or prepayment penalties. c) Gross unrealized loss Fixed maturities in an unrealized loss position at September 30, 2023, and December 31, 2022, comprised both investment grade and below investment grade securities for which fair value declined, principally due to rising interest rates since the date of purchase. Refer to Note 1 e) in the 2022 Form 10-K for further information on factors considered in the evaluation of expected credit losses. The following tables present, for AFS fixed maturities in an unrealized loss position (including securities on loan) that are not deemed to have expected credit losses, the aggregate fair value and gross unrealized loss by length of time the security has been in an unrealized loss position:
At September 30, 2023, the tax benefit on certain unrealized losses in our investment portfolio was reduced by a valuation allowance of $1,108 million necessary due to limitations on the utilization of these losses. As part of evaluating whether it was more likely than not that we could realize these losses, we considered realized gains, carryback ability and available tax planning strategies. The following table presents a roll-forward of valuation allowance for expected credit losses on fixed maturities:
d) Net realized gains (losses) The following table presents the components of Net realized gains (losses):
(1)Relates to certain securities we intended to sell and securities written to market entering default. (2)The three and nine months ended September 30, 2023 Includes a one-time realized gain of $116 million as a result of the consolidation of Huatai Group. Realized gains and losses from Other investments, Equity securities and Private equities from the table above include sales of securities and unrealized gains and losses from fair value changes as follows:
e) Alternative investments Alternative investments include partially-owned investment companies, investment funds, and limited partnerships measured at fair value using net asset value (NAV) as a practical expedient. The following table presents, by investment category, the expected liquidation period, fair value, and maximum future funding commitments of alternative investments:
Included in all categories in the above table, except for Investment funds, are investments for which Chubb will never have the contractual option to redeem but receives distributions based on the liquidation of the underlying assets. Further, for all categories except for Investment funds, Chubb does not have the ability to sell or transfer the investments without consent from the general partner of the individual funds.
Investment funds employ various investment strategies, such as long/short equity and arbitrage/distressed. Included in this category are investments for which Chubb has the option to redeem at agreed upon value as described in each investment fund’s subscription agreement. Depending on the terms of the various subscription agreements, investment fund investments may be redeemed monthly, quarterly, semi-annually, or annually. If Chubb wishes to redeem an investment fund investment, it must first determine if the investment fund is still in a lock-up period (a time when Chubb cannot redeem its investment so that the investment fund manager has time to build the portfolio). If the investment fund is no longer in its lock-up period, Chubb must then notify the investment fund manager of its intention to redeem by the notification date prescribed by the subscription agreement. Subsequent to notification, the investment fund can redeem Chubb’s investment within several months of the notification. Notice periods for redemption of the investment funds are up to 270 days. Chubb can redeem its investment funds without consent from the investment fund managers. f) Restricted assets Chubb is required to maintain assets on deposit with various regulatory authorities to support its insurance and reinsurance operations. These requirements are generally promulgated in the statutory regulations of the individual jurisdictions. The assets on deposit are available to settle insurance and reinsurance liabilities. Chubb is also required to restrict assets pledged under repurchase agreements, which represent Chubb's agreement to sell securities and repurchase them at a future date for a predetermined price. We use trust funds in certain large reinsurance transactions where the trust funds are set up for the benefit of the ceding companies and generally take the place of letter of credit (LOC) requirements. We have investments in segregated portfolios primarily to provide collateral or guarantees for LOC and derivative transactions. Included in restricted assets at September 30, 2023, and December 31, 2022, are investments, primarily fixed maturities, totaling $17,505 million and $15,721 million, respectively, and cash of $192 million and $115 million, respectively. The following table presents the components of restricted assets:
g) Variable interest entities (VIEs) Consolidated VIEs Certain subsidiaries of Huatai Group are the investment manager of, and maintain investments in, sponsored investment products that are considered Variable Interest entities (VIEs). Refer to Note 1 for further information on our consolidation criteria. The assets of these VIEs are not available to our creditors, and the investors in these VIEs have no recourse to Chubb in excess of the assets contained within the VIEs. Our economic exposures are limited to our investments based on our ownership interest in these VIEs. Our total exposure to these sponsored investment products represents the value of our economic ownership interest. The following table presents the balances related to these sponsored investment products accounted for as VIEs that were recorded on our Consolidated balance sheets, including our net interest in these sponsored investment products:
The carrying value of assets and liabilities on the Consolidated balance sheets relating to nonconsolidated sponsored investment products where we are not the primary beneficiary is immaterial.
|
Fair value measurements |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair value measurements | Fair value measurements a) Fair value hierarchy Fair value of financial assets and financial liabilities is estimated based on the framework established in the fair value accounting guidance. The guidance defines fair value as the price to sell an asset or transfer a liability (an exit price) in an orderly transaction between market participants and establishes a three-level valuation hierarchy based on the reliability of the inputs. The fair value hierarchy gives the highest priority to quoted prices in active markets and the lowest priority to unobservable data. The three levels of the hierarchy are as follows: •Level 1 – Unadjusted quoted prices for identical assets or liabilities in active markets; •Level 2 – Includes, among other items, inputs other than quoted prices that are observable for the asset or liability such as interest rates and yield curves, quoted prices for similar assets and liabilities in active markets, and quoted prices for identical or similar assets and liabilities in markets that are not active; and •Level 3 – Inputs that are unobservable and reflect management’s judgments about assumptions that market participants would use in pricing an asset or liability. We categorize financial instruments within the valuation hierarchy at the balance sheet date based upon the lowest level of inputs that are significant to the fair value measurement. We use pricing services to obtain fair value measurements for the majority of our investment securities. Based on management’s understanding of the methodologies used, these pricing services only produce an estimate of fair value if there is observable market information that would allow them to make a fair value estimate. Based on our understanding of the market inputs used by the pricing services, all applicable investments have been valued in accordance with GAAP. We do not adjust prices obtained from pricing services. The following is a description of the valuation techniques and inputs used to determine fair values for financial instruments carried at fair value, as well as the general classification of such financial instruments pursuant to the valuation hierarchy. Fixed maturities We use pricing services to estimate fair value measurements for the majority of our fixed maturities. The pricing services use market quotations for fixed maturities that have quoted prices in active markets; such securities are classified within Level 1. For fixed maturities other than U.S. Treasury securities that generally do not trade on a daily basis, the pricing services prepare estimates of fair value measurements using their pricing applications or pricing models, which include available relevant market information, benchmark curves, benchmarking of like securities, sector groupings, and matrix pricing. Additional valuation factors that can be taken into account are nominal spreads, dollar basis, and liquidity adjustments. The pricing services evaluate each asset class based on relevant market and credit information, perceived market movements, and sector news. The market inputs used in the pricing evaluation, listed in the approximate order of priority include: benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, reference data, and industry and economic events. The extent of the use of each input is dependent on the asset class and the market conditions. Given the asset class, the priority of the use of inputs may change, or some market inputs may not be relevant. Additionally, fixed maturities valuation is more subjective when markets are less liquid due to the lack of market based inputs (i.e., stale pricing) and may require the use of models to be priced. The lack of market based inputs may increase the potential that an investment's estimated fair value is not reflective of the price at which an actual transaction would occur. The overwhelming majority of fixed maturities are classified within Level 2 because the most significant inputs used in the pricing techniques are observable. For a small number of fixed maturities, we obtain a single broker quote (typically from a market maker). Due to the disclaimers on the quotes that indicate that the price is indicative only, we include these fair value estimates in Level 3. Equity securities Equity securities with active markets are classified within Level 1 as fair values are based on quoted market prices. For equity securities in markets which are less active, fair values are based on market valuations and are classified within Level 2. Equity securities for which pricing is unobservable are classified within Level 3. Short-term investments Short-term investments, which comprise securities due to mature within one year of the date of purchase that are traded in active markets, are classified within Level 1 as fair values are based on quoted market prices. Securities such as commercial paper and discount notes are classified within Level 2 because these securities are typically not actively traded due to their approaching maturity, and as such, their cost approximates fair value. Short-term investments for which pricing is unobservable are classified within Level 3. Private equities Fair values for the majority of Private equities including investments in partially-owned investment companies, investment funds, and limited partnerships are based on their respective NAV and are excluded from the fair value hierarchy table below. Other investments Certain of our long-duration contracts are supported by assets that do not qualify for separate account reporting under GAAP. These assets comprise mutual funds, classified within Level 1 in the valuation hierarchy on the same basis as other equity securities traded in active markets. Other investments principally include fixed maturities carried at fair value with changes in fair value recorded through the Consolidated statements of operations. These fixed maturities principally relate to the acquired Huatai investment portfolio and are classified within Level 2. Also included are life insurance policies collateralizing investments held in rabbi trusts maintained by Chubb for deferred compensation plans and supplemental retirement plans. These policies are carried at cash surrender value and are classified in the valuation hierarchy within Level 2. Securities lending collateral The underlying assets included in Securities lending collateral in the Consolidated balance sheets are fixed maturities which are classified in the valuation hierarchy on the same basis as other fixed maturities. Excluded from the valuation hierarchy is the corresponding liability related to Chubb’s obligation to return the collateral plus interest as it is reported at contract value and not fair value in the Consolidated balance sheets. Investment derivatives Actively traded investment derivative instruments, including futures, options, and forward contracts are classified within Level 1 as fair values are based on quoted market prices. The fair value of cross-currency swaps and interest rate swaps is based on market valuations and is classified within Level 2. Investment derivative instruments are recorded in either Other assets or Accounts payable, accrued expenses, and other liabilities in the Consolidated balance sheets. Derivatives designated as hedging instruments Certain of our derivatives are cross-currency swaps designated as fair value and net investment hedging instruments. The fair value of cross-currency swaps and interest rate swaps is based on market valuations and is classified within Level 2. Investment derivative instruments are recorded in either Other assets or Accounts payable, accrued expenses, and other liabilities in the Consolidated balance sheets. Other derivative instruments We maintain positions in exchange-traded equity futures contracts designed to limit exposure to a severe equity market decline, which would cause an increase in expected claims and, therefore, an increase in market risk benefits (MRB) reserves and our MRB reinsurance business. Our positions in exchange-traded equity futures contracts are classified within Level 1. The fair value of the majority of the remaining positions in other derivative instruments is based on significant observable inputs including equity security and interest rate indices. Accordingly, these are classified within Level 2. Other derivative instruments based on unobservable inputs are classified within Level 3. Other derivative instruments are recorded in either Other assets or Accounts payable, accrued expenses, and other liabilities in the Consolidated balance sheets. Separate account assets Separate account assets represent segregated funds where investment risks are borne by the customers, except to the extent of certain guarantees made by Chubb. Separate account assets principally comprise mutual funds classified within Level 1 in the valuation hierarchy on the same basis as other equity securities traded in active markets. Separate account assets also include fixed maturities classified within Level 2 because the most significant inputs used in the pricing techniques are observable. Excluded from the valuation hierarchy are the corresponding liabilities as they are reported at contract value and not fair value in the Consolidated balance sheets. Financial instruments measured at fair value on a recurring basis, by valuation hierarchy
(1)Excluded from the table above are policy loans of $603 million, and other investments of $47 million at September 30, 2023, measured using NAV as a practical expedient. (2)Excluded from the table above are partially-owned investments, investment funds, and limited partnerships of $13,362 million at September 30, 2023, measured using NAV as a practical expedient. (3)Refer to Note 11 for additional information on Market risk benefits.
(1)Excluded from the table above are policy loans of $343 million and other investments of $47 million at December 31, 2022, measured using NAV as a practical expedient. (2)Excluded from the table above are partially-owned investments, investment funds, and limited partnerships of $12,355 million at December 31, 2022, measured using NAV as a practical expedient. (3)Refer to Note 11 for additional information on Market risk benefits. Level 3 financial instruments The following tables present a reconciliation of the beginning and ending balances of financial instruments measured at fair value using significant unobservable inputs (Level 3). Excluded from the following tables is the reconciliation of Market risk benefits, refer to Note 11 for additional information:
b) Financial instruments disclosed, but not measured, at fair value Chubb uses various financial instruments in the normal course of its business. Our insurance contracts are excluded from fair value of financial instruments accounting guidance, and therefore, are not included in the amounts discussed below. The carrying values of cash, other assets, other liabilities, and other financial instruments not included below approximated their fair values. Refer to the 2022 Form 10-K for information on the fair value methods and assumptions for investments in partially-owned insurance companies, short-term and long-term debt, repurchase agreements, and trust-preferred securities. The following tables present fair value, by valuation hierarchy, and carrying value of the financial instruments not measured at fair value:
Private debt held-for-investment is related to Huatai and its consolidation. The fair value of Private debt held-for-investment is derived using a discounted cash flow approach, which includes an evaluation of forecasted contractual cash flows and yield curve information, among other loan characteristics and assumptions. These assumptions are derived from internal and third party sources. Since the valuation is derived from model-based techniques, Private debt held-for-investment is classified within Level 3 of the valuation hierarchy.
|
Reinsurance |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reinsurance Disclosures [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reinsurance [Text Block] | Reinsurance Reinsurance recoverable on ceded reinsurance
(1)Net of valuation allowance for uncollectible reinsurance. The increase in reinsurance recoverable on losses and loss expenses was primarily due to the consolidation of Huatai and unfavorable prior period development on ceded reserves. The following table presents a roll-forward of valuation allowance for uncollectible reinsurance related to Reinsurance recoverable on loss and loss expenses:
|
Deferred acquisition costs |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred Policy Acquisition Costs Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred Policy Acquisition Costs | Deferred acquisition costs Deferred acquisition costs comprise capitalized costs on short-duration contracts of $3,283 million and $2,809 million and long-duration contracts of $3,573 million and $2,979 million at September 30, 2023, and September 30, 2022, respectively. The assumptions used to amortize DAC were consistent with the assumptions used to estimate the liability for future policy benefits for nonparticipating traditional and limited-payment contracts. The following tables present a roll-forward of deferred acquisitions costs on long-duration contracts included in the Life Insurance segment:
|
Goodwill and Value of business acquired |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Text Block] | Goodwill, Value of business acquired, and Other intangible assets Goodwill The following table presents a roll-forward of Goodwill by segment:
(1)Includes $1.0 billion attributable to noncontrolling interests. Value of business acquired Value of business acquired (VOBA) represents the fair value of the future profits of in-force long duration contracts from businesses acquired, principally Cigna's Asian business, and is amortized in relation to the profit emergence of the underlying contracts. The VOBA calculation is based on many factors including mortality, morbidity, persistency, investment yields, expenses, and the discount rate, with the discount rate being the most significant factor. The following table presents a roll-forward of VOBA:
(1)Recognized in Policy acquisition costs in the Consolidated statements of operations. The following table presents, as of September 30, 2023, the expected estimated pre-tax amortization expense related to VOBA at current foreign currency rates, for the fourth quarter of 2023 and for the next five years:
Other intangible assets Other intangible assets that are subject to amortization principally relate to agency distribution relationships, renewal rights, and patents. Other intangible assets that are not subject to amortization principally relate to trademarks. For other intangible assets related to the consolidation of Huatai, refer to Note 2.
The following table presents, as of September 30, 2023, the expected pre-tax amortization expense of purchased intangibles, at current foreign currency exchange rates, for the fourth quarter of 2023 and for the next five years:
(1)Recognized in Policy acquisition costs in the Consolidated statements of operations. (2)Recognized in Other (income) expense in the Consolidated statements of operations.
|
Unpaid losses and loss expenses |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Liability for Claims and Claims Adjustment Expense [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block] | Unpaid losses and loss expenses The following table presents a reconciliation of beginning and ending Unpaid losses and loss expenses:
(1) Net of valuation allowance for uncollectible reinsurance. (2) Relates to prior period loss reserve development only and excludes prior period development related to reinstatement premiums, expense adjustments, earned premiums, and development on international A&H lines totaling $71 million and $213 million for the nine months ended September 30, 2023 and 2022, respectively. Gross and net unpaid losses and loss expenses increased $4.0 billion and $3.2 billion for the nine months ended September 30, 2023, respectively, principally reflecting underlying exposure growth and the consolidation of Huatai. The increase in net unpaid losses also reflected seasonality in our crop insurance business. This increase was partially offset by favorable prior period development and by large payments related to the Boy Scouts of America. Prior Period Development Prior period development (PPD) arises from changes to loss estimates recognized in the current year that relate to loss events that occurred in previous calendar years and excludes the effect of losses from the development of earned premium from previous accident years. Long-tail lines include lines such as workers' compensation, general liability, and financial lines; while short-tail lines include lines such as most property lines, energy, personal accident, and agriculture. The following table summarizes (favorable) and adverse PPD by segment:
Significant prior period movements by segment, principally driven by reserve reviews completed during each respective period, are discussed in more detail below. The remaining net development for long-tail lines and short-tail business for each segment and Corporate comprises numerous favorable and adverse movements across a number of lines and accident years, none of which is significant individually or in the aggregate. North America Commercial P&C Insurance. Net favorable development for the three months ended September 30, 2023 included $71 million in workers' compensation lines, mainly due to lower than expected loss experience, and $188 million in commercial property and marine lines, mainly due to net lower than expected development impacting the most recent accident years. The favorable development was partially offset by adverse development of $222 million in commercial excess and umbrella lines, driven by higher than expected loss development, principally related to automobile exposures. Net favorable development for the nine months ended September 30, 2023 included $379 million in workers' compensation lines, $113 million in commercial property and marine lines, and $101 million in surety, all mainly driven by lower than expected development. These favorable movements were partially offset by adverse development of $227 million in commercial excess and umbrella lines and $125 million in commercial auto liability, both driven by higher than expected loss experience. Net favorable development for the three months ended September 30, 2022 included $164 million from lower than expected loss experience in workers’ compensation lines and $66 million, net of premium adjustments, from lower claims activity in large multi-line loss sensitive accounts. The favorable development was partially offset by net adverse development of $58 million from higher than expected claims severity in commercial auto liability, and $71 million in commercial umbrella/excess portfolios. Net favorable development on our short-tail businesses primarily included $132 million in property and marine portfolios, where paid and reported loss activity for the most recent accident years was lower than expected. Net favorable development for the nine months ended September 30, 2022 also included favorable development in workers’ compensation lines due to updates to loss development factors and our annual assessment of multi-claimant events, including industrial accidents. North America Personal P&C Insurance. Net favorable development for the three and nine months ended September 30, 2023 included $263 million and $244 million, respectively, in homeowners and valuables lines, mainly due to lower than expected loss experience in accident year 2022. The favorable development was partially offset by net adverse development of $145 million in the three months ended September 30, 2023 in personal excess liability due to adverse development on reported losses. Net favorable development for the three and nine months ended September 30, 2022 included favorable development in the homeowners and valuables lines of business, driven by lower than expected claims reserve development. Overseas General Insurance. Net favorable development for the three months ended September 30, 2023 included favorable loss emergence in financial lines of $77 million primarily in accident years 2019 and prior of partially offset by net adverse development of $51 million in political risks. Net favorable development for the nine months ended September 30, 2023, also included net favorable development of $147 million in property and marine lines, and $45 million in A&H lines. Net favorable development for the three months ended September 30, 2022, included lower than expected paid and reported loss activity of $82 million in casualty lines, including primary and excess lines in Continental Europe, the U.K., and Asia Pacific, and $34 million in environmental lines. The favorable development was partially offset by net adverse development of $114 million in financial lines, including Directors and Officers (D&O) due to a combination of higher than expected development on specific claims and increased expected future development in the U.K., Continental Europe, Asia Pacific, and London wholesale business. Net favorable development for the nine months ended September 30, 2022, also included net favorable development of $75 million in A&H lines, $67 million in property lines, and $53 million in personal lines. Corporate. Net adverse development for the three months ended September 30, 2023 and 2022, included adverse development for environmental liabilities. Net adverse development for the nine months ended September 30, 2023 and 2022 also included adverse development for molestation claims of $49 million and $155 million, respectively.
|
Future policy benefits |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Liability for Future Policy Benefits Activity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Liability for future policy benefits | Future policy benefits The following tables present a roll-forward of the liability for future policy benefits included in the Life Insurance segment:
(1)Net premiums collected represent the portion of gross premiums collected from policyholders that is used to fund expected benefit.
(1)Net premiums collected represent the portion of gross premiums collected from policyholders that is used to fund expected benefit.
The following table presents the amount of undiscounted expected gross premiums and expected future policy benefit payments included in the Life Insurance segment:
The following table presents the amount of revenue and interest recognized in the statement of operations:
The following table presents the weighted-average interest rates:
|
Policyholders' account balances |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Policyholder Account Balance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Liability for policyholders' account balance | Policyholders' account balances The following tables present a roll-forward of policyholders' account balances:
(1)Contracts included in the policyholder account balances are generally charged a premium and/or monthly assessments on the basis of the account balance.
(1)For those guarantees of benefits that are payable in the event of death, the net amount at risk is defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date. The following tables present the balance of account values by range of guaranteed minimum crediting rates and the related range of difference, in basis points, between rates being credited to policyholders and the respective guaranteed minimum: Universal Life
Other policyholders' account balances
|
Market risk benefits |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Risk Benefit [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market risk benefits | Market risk benefits Our reinsurance programs covering variable annuity guarantees, comprising guaranteed living benefits (GLB) and guaranteed minimum death benefits (GMDB), meet the definition of Market risk benefits (MRB). The following table presents a roll-forward of MRB:
Excluded from the table above are MRB gains (losses) of $(181) million and $186 million for the nine months ended September 30, 2023 and 2022, respectively, reported in the Consolidated statements of operations, relating to the market risk benefits' economic hedge and other net cash flows. There is no reinsurance recoverable associated with our liability for MRB. In the third quarter of 2023, we completed a review of policyholder behavior related to annuitizations, partial withdrawals, lapses, and mortality for our variable annuity reinsurance business. •As annuitization and partial withdrawal experience continued to emerge, we refined our assumptions for an additional year of data. The annuitization assumption updates included treaty-based and age-based behavior, as well as a refresh of our annuitization rates which depend on the value of the guarantees. These refinements resulted in a net increase of approximately $92 million to the MRB fair value, recognized as a Market risk benefits loss. •We also refined our lapse and mortality assumptions based on additional emerging experience. The changes had an insignificant impact on the MRB fair value. For MRB, Chubb estimates fair value using an internal valuation model which includes a number of factors including interest rates, equity markets, credit risk, current account value, market volatility, expected annuitization rates and other policyholder behavior, and changes in policyholder mortality. All reinsurance treaties contain claim limits, which are also factored into the valuation model.
(1)The weighted-average lapse and annuitization rates are determined by weighting each treaty's rates by the MRB contract's fair value. The most significant policyholder behavior assumptions include lapse rates for MRBs, and GLB annuitization rates. Assumptions regarding lapse rates and GLB annuitization rates differ by treaty, but the underlying methodologies to determine rates applied to each treaty are comparable. A lapse rate is the percentage of in-force policies surrendered in a given calendar year. All else equal, as lapse rates increase, ultimate claim payments will decrease. In general, the base lapse function assumes low lapse rates during the surrender charge period, followed by a "spike" lapse rate in the year immediately following the surrender charge period, and then reverting to an ultimate lapse rate, typically over a 2-year period. This base rate is adjusted downward for policies with more valuable guarantees (policies with guaranteed values far in excess of their account values). Partial withdrawals and the impact of older policyholders with tax-qualified contracts (due to required minimum distributions) are also reflected in our modeling. The GLB annuitization rate is the percentage of policies for which the policyholder will elect to annuitize using the guaranteed benefit provided under the GLB. All else equal, as GLB annuitization rates increase, ultimate claim payments will increase, subject to treaty claim limits. All GLB reinsurance treaties include claim limits to protect Chubb in the event that actual annuitization behavior is significantly higher than expected. In general, Chubb assumes that GLB annuitization rates will be higher for policies with more valuable guarantees (policies with guaranteed values far in excess of their account values). Chubb also assumes that GLB annuitization rates increase as policyholders get older. In addition, it is also assumed that GLB annuitization rates are higher in the first year immediately following the waiting period (the first year the policies are eligible to annuitize using the GLB) in comparison to all subsequent years. Chubb does not yet have fully credible annuitization experience for all clients. The effect of changes in key market factors on assumed lapse and annuitization rates reflect emerging trends using data available from cedants. For treaties with limited experience, rates are established by blending the experience with data received from other ceding companies. The model and related assumptions are regularly re-evaluated by management and enhanced, as appropriate, based upon additional experience obtained related to policyholder behavior and availability of updated information such as market conditions, market participant assumptions, and demographics of in-force annuities.
|
Separate accounts |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Separate Accounts Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Separate Accounts | Separate accounts Separate account assets represent segregated funds where investment risks are borne by the customers, except to the extent of certain guarantees made by Chubb. The assets that support variable contracts are measured at fair value and are reported as Separate account assets and corresponding liabilities are reported within Separate account liabilities on the Consolidated balance sheets. Policy charges assessed against the policyholders for mortality, administration, and other services are included in Net premiums earned on the Consolidated statements of operations. The following table presents the aggregate fair value of Separate account assets, by major security type:
The following table presents a roll-forward of separate account liabilities:
(1) Cash surrender value represents the amount of the contract holder's account balances distributable at the balance sheet date less certain surrender charges.
|
Commitments, contingencies, and guarantees |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments, contingencies, and guarantees | Commitments, contingencies, and guarantees a) Derivative instruments Chubb maintains positions in derivative instruments such as futures, options, swaps, and foreign currency forward contracts for which the primary purposes are to manage duration and foreign currency exposure, yield enhancement, or to obtain an exposure to a particular financial market. Chubb also maintains positions in convertible securities that contain embedded derivatives, and exchange-traded equity futures contracts on equity market indices to limit equity exposure in the MRB book of business. Investment derivative instruments and derivatives designated as hedges for accounting purposes are recorded in either Other assets (OA) or Accounts payable, accrued expenses, and other liabilities (AP); convertible bonds are recorded in Fixed maturities available for sale (FM AFS); and convertible equity securities are recorded in Equity securities (ES) in the Consolidated balance sheets. These are the most numerous and frequent derivative transactions. In addition, Chubb, from time to time, purchases to be announced mortgage-backed securities (TBAs) as part of its investing activities. As a global company, Chubb entities transact business in multiple currencies. Our policy is to generally match assets, liabilities, and required capital for each individual jurisdiction in local currency, which would include the use of derivatives discussed below. Some of Chubb's derivatives satisfy hedge accounting requirements, as discussed below. We also consider economic hedging for planned cross border transactions. The following table presents the balance sheet location, fair value of derivative instruments in an asset or (liability) position, and notional value/payment provision of our derivative instruments:
(1)Includes fair value of embedded derivatives. (2)Related to MRB book of business. At September 30, 2023, and December 31, 2022, net derivative liabilities of $97 million and $60 million, respectively, included in the table above were subject to a master netting agreement. The remaining derivatives included in the table above were not subject to a master netting agreement. b) Hedge accounting We designate certain derivatives as fair value hedges and net investment hedges for accounting purposes to hedge for foreign currency exposure associated with portions of our euro denominated debt and the net investment in certain foreign subsidiaries, respectively. These derivatives comprise cross-currency swaps, which are agreements under which two counterparties exchange interest payments and principal denominated in different currencies at a future date. (i) Cross-currency swaps - fair value hedges In September 2022, Chubb entered into certain cross-currency swaps designated as fair value hedges. The objective of these cross-currency swaps is to hedge the foreign currency risk on €1.5 billion, or approximately $1.6 billion at September 30, 2023, of our euro denominated debt, by converting cash flows back into the U.S. dollar. These fair value hedges are carried at fair value. The hedges are expected to be highly effective, with gains or losses on the fair value hedges offsetting the foreign currency remeasurement on the hedged euro denominated senior notes within Net realized gains (losses). The remaining change in fair value is recorded in Other comprehensive income (OCI), with an immaterial amount recorded in Interest expense. The following table presents pre-tax gains (losses) recognized in OCI and reclassified into earnings for fair value hedges:
(ii) Cross-currency swaps - net investment hedges In September 2022, Chubb entered into certain cross-currency swaps designated as net investment hedges. The objective of these cross-currency swaps is to hedge the foreign currency exposure in the net investments of certain foreign subsidiaries by converting cash flows from U.S. dollar to the British pound sterling, Japanese yen, and Swiss franc. The hedged risk is designated as the foreign currency exposure arising between the functional currency of the foreign subsidiary and the functional currency of its parent entity. These net investment hedges are carried at fair value, with changes in fair value recorded in Cumulative translation adjustments (CTA) within OCI, and an immaterial amount recorded to Interest expense. The mark-to-market adjustments for foreign currency changes will remain until the underlying hedge subsidiary is deconsolidated or if hedge accounting is discontinued. The following table presents pre-tax gains (losses) recognized in OCI and reclassified into earnings for net investment hedges:
c) Derivative instruments not designated as hedges Derivative instruments which are not designated as hedges are carried at fair value with changes in fair value recorded in Net realized gains (losses) or, for futures contracts on equities, Market risk benefits gains (losses) in the Consolidated statements of operations. The following table presents net realized gains (losses) related to derivative instrument activity in the Consolidated statements of operations:
(1)Includes embedded derivatives. (2)Related to MRB book of business. (i) Foreign currency exposure management A foreign currency forward contract (forward) is an agreement between participants to exchange specific currencies at a future date. Chubb uses forwards to minimize the effect of fluctuating foreign currencies as discussed above. (ii) Duration management and market exposure Futures Futures contracts give the holder the right and obligation to participate in market movements, determined by the index or underlying security on which the futures contract is based. Settlement is made daily in cash by an amount equal to the change in value of the futures contract times a multiplier that scales the size of the contract. Exchange-traded futures contracts on money market instruments, notes and bonds are used in fixed maturity portfolios to more efficiently manage duration, as substitutes for ownership of the money market instruments, bonds, and notes without significantly increasing the risk in the portfolio. Investments in futures contracts may be made only to the extent that there are assets under management not otherwise committed. Exchange-traded equity futures contracts are used to limit exposure to a severe equity market decline, which would cause an increase in expected claims and, therefore, an increase in market risk benefit reserves. Options An option contract conveys to the holder the right, but not the obligation, to purchase or sell a specified amount or value of an underlying security at a fixed price. Option contracts are used in our investment portfolio as protection against unexpected shifts in interest rates, which would affect the duration of the fixed maturity portfolio. By using options in the portfolio, the overall interest rate sensitivity of the portfolio can be reduced. Option contracts may also be used as an alternative to futures contracts in the synthetic strategy as described above. The price of an option is influenced by the underlying security, level of interest rates, expected volatility, time to expiration, and supply and demand. The credit risk associated with the above derivative financial instruments relates to the potential for non-performance by counterparties. Although non-performance is not anticipated, in order to minimize the risk of loss, management monitors the creditworthiness of its counterparties and obtains collateral. The performance of exchange-traded instruments is guaranteed by the exchange on which they trade. For non-exchange-traded instruments, the counterparties are principally banks which must meet certain criteria according to our investment guidelines. Other Included within Other are derivatives intended to reduce potential losses which may arise from certain exposures in our insurance business. The economic benefit provided by these derivatives is similar to purchased reinsurance. For example, Chubb may, from time to time, enter into crop derivative contracts to protect underwriting results in the event of a significant decline in commodity prices. (iii) Convertible security investments A convertible security is a debt instrument or preferred stock that can be converted into a predetermined amount of the issuer’s equity. The convertible option is an embedded derivative within the host instruments which are classified in the investment portfolio as either available for sale or as an equity security. Chubb purchases convertible securities for their total return and not specifically for the conversion feature. (iv) TBA By acquiring TBAs, we make a commitment to purchase a future issuance of mortgage-backed securities. For the period between purchase of the TBAs and issuance of the underlying security, we account for our position as a derivative in the Consolidated Financial Statements. Chubb purchases TBAs, from time to time, both for their total return and for the flexibility they provide related to our mortgage-backed security strategy. (v) Futures contracts on equities Under the MRB program, as the assuming entity, Chubb is obligated to provide coverage until the expiration or maturity of the underlying deferred annuity contracts or the expiry of the reinsurance treaty. We may recognize a loss for changes in fair value due to adverse changes in the capital markets (e.g., declining interest rates and/or declining U.S. and/or international equity markets). To mitigate adverse changes in the capital markets, we maintain positions in exchange-traded equity futures contracts, as noted under section "(ii) Futures" above. These futures increase in fair value when the S&P 500 index decreases (and decrease in fair value when the S&P 500 index increases). The net impact of gains or losses related to changes in fair value of the MRB liability and the exchange-traded equity futures are included in Market risk benefits gains (losses) in the Consolidated statements of operations. d) Securities lending and secured borrowings Chubb participates in a securities lending program operated by a third-party banking institution whereby certain assets are loaned to qualified borrowers and from which we earn an incremental return. The securities lending collateral can only be drawn down by Chubb in the event that the institution borrowing the securities is in default under the lending agreement. An indemnification agreement with the lending agent protects us in the event a borrower becomes insolvent or fails to return any of the securities on loan. The collateral is recorded in Securities lending collateral and the liability is recorded in Securities lending payable in the Consolidated balance sheets. The following table presents the carrying value of collateral held under securities lending agreements by investment category and remaining contractual maturity of the underlying agreements:
At September 30, 2023, and December 31, 2022, our repurchase agreement obligations of $2,617 million and $1,419 million, respectively, were fully collateralized. In contrast to securities lending programs, the use of cash received is not restricted for the repurchase obligations. The fair value of the underlying securities sold remains in Fixed maturities available for sale, and the repurchase agreement obligation is recorded in Repurchase agreements in the Consolidated balance sheets. The following table presents the carrying value of collateral pledged under repurchase agreements by investment category and remaining contractual maturity of the underlying agreements:
(1)Per the repurchase agreements, the amount of collateral posted is required to exceed the amount of gross liability. Potential risks exist in our secured borrowing transactions due to market conditions and counterparty exposure. With collateral that we pledge, there is a risk that the collateral may not be returned at the expiration of the agreement. If the counterparty fails to return the collateral, Chubb will have free use of the borrowed funds until our collateral is returned. In addition, we may encounter the risk that Chubb may not be able to renew outstanding borrowings with a new term or with an existing counterparty due to market conditions including a decrease in demand as well as more restrictive terms from banks due to increased regulatory and capital constraints. Should this condition occur, Chubb may seek alternative borrowing sources or reduce borrowings. Additionally, increased margins and collateral requirements due to market conditions would increase our restricted assets as we are required to provide additional collateral to support the transaction. e) Fixed maturities At September 30, 2023, and December 31, 2022, commitments to purchase fixed income securities over the next several years were $1,075 million and $770 million, respectively. f) Private equities At September 30, 2023, included in Private equities in the Consolidated balance sheet are investments in limited partnerships and partially-owned investment companies with a carrying value of $13.1 billion. In connection with these investments, we have commitments that may require funding of up to $6.3 billion over the next several years. At December 31, 2022, these investments had a carrying value of $12.0 billion with commitments that may have required funding of up to $7.4 billion. g) Income taxes At September 30, 2023, $67 million of unrecognized tax benefits remain outstanding. It is reasonably possible that, over the next twelve months, the amount of unrecognized tax benefits may change resulting from the re-evaluation of unrecognized tax benefits arising from examinations by taxing authorities, settlements, and the lapses of statutes of limitations. With few exceptions, Chubb is no longer subject to income tax examinations for years before 2012. h) Legal proceedings Our insurance subsidiaries are subject to claims litigation involving disputed interpretations of policy coverages and, in some jurisdictions, direct actions by allegedly-injured persons seeking damages from policyholders. These lawsuits, involving claims on policies issued by our subsidiaries which are typical to the insurance industry in general and in the normal course of business, are considered in our loss and loss expense reserves. In addition to claims litigation, we are subject to lawsuits and regulatory actions in the normal course of business that do not arise from or directly relate to claims on insurance policies. This category of business litigation typically involves, among other things, allegations of underwriting errors or misconduct, employment claims, regulatory activity, or disputes arising from our business ventures. In the opinion of management, our ultimate liability for these matters could be, but we believe is not likely to be, material to our consolidated financial condition and results of operations. i) Lease commitments At September 30, 2023, and December 31, 2022, the right-of-use asset was $549 million and $607 million, respectively, recorded within , and the lease liability was $577 million and $633 million, respectively, recorded within on the Consolidated balance sheets. These leases consist principally of real estate operating leases that are amortized on a straight-line basis over the term of the lease, which expire at various dates.
|
Shareholders' equity |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shareholders' equity | Shareholders’ equity All of Chubb’s Common Shares are authorized under Swiss corporate law. Though the par value of Common Shares is stated in Swiss francs, Chubb continues to use U.S. dollars as its reporting currency for preparing the Consolidated Financial Statements. Under Swiss corporate law, dividends, including distributions from legal reserves or through a reduction in par value (par value reduction), must be stated in Swiss francs though dividend payments are made by Chubb in U.S. dollars. At September 30, 2023, our Common Shares had a par value of CHF 0.50 per share. At our May 2023 annual general meeting, our shareholders approved an annual dividend for the following year of up to $3.44 per share, expected to be paid in four quarterly installments of $0.86 per share after the general meeting by way of distribution from capital contribution reserves, transferred to free reserves for payment. The Board of Directors (Board) will determine the record and payment dates at which the annual dividend may be paid until the date of 2024 annual general meeting, and is authorized to abstain from distributing a dividend at its discretion. At our May 2022 and 2021 annual general meetings, our shareholders approved annual dividends for the following year of up to $3.32 per share and $3.20 per share, respectively, which were paid in four quarterly installments of $0.83 per share and $0.80 per share, respectively, at dates determined by the Board after the annual general meetings by way of a distribution from capital contribution reserves, transferred to free reserves for payment. The following table presents dividend distributions per Common Share in Swiss francs (CHF) and U.S. dollars (USD):
Increases in Common Shares in treasury are due to open market repurchases of Common Shares and the surrender of Common Shares to satisfy tax withholding obligations in connection with the vesting of restricted stock and the forfeiture of unvested restricted stock. Decreases in Common Shares in treasury are principally due to grants of restricted stock, exercises of stock options, purchases under the Employee Stock Purchase Plan (ESPP), and share cancellations. At the Chubb Limited Extraordinary General Meeting of Shareholders, held on November 3, 2021, shareholders approved the cancellation of 14,465,400 shares repurchased under our share repurchase program during the first six months of 2021. The capital reduction by cancellation of shares was subject to publication requirements and a two-month waiting period in accordance with Swiss law and became effective on January 17, 2022. At our May 2022 annual general meeting, held on May 19, 2022, our shareholders approved the cancellation of 13,179,100 shares purchased under our share repurchase program during the last six months of 2021. The capital reduction by cancellation of shares was subject to publication requirements and a two-month waiting period in accordance with Swiss law and became effective on August 4, 2022. At our May 2023 annual general meeting, held on May 17, 2023, our shareholders approved the cancellation of 14,925,028 shares purchased under our share repurchase programs during 2022. The capital reduction was subject to publication requirements and became effective in accordance with Swiss law on May 22, 2023. During the nine months ended September 30, 2023, 8,634,600 shares were repurchased, 14,925,028 shares were canceled, and 2,024,083 net shares were issued under employee share-based compensation plans. At September 30, 2023, 23,467,247 Common Shares remain in treasury. Chubb Limited securities repurchase authorizations The Board has authorized share repurchase programs as follows: •One-time incremental share repurchase program of $5.0 billion of Chubb Common Shares from July 19, 2021 through June 30, 2022; •$2.5 billion of Chubb Common Shares from May 19, 2022 through June 30, 2023; and •$5.0 billion of Chubb Common Shares effective July 1, 2023 with no expiration date. The following table presents repurchases of Chubb's Common Shares conducted in a series of open market transactions under the Board authorizations:
The following table presents changes in accumulated other comprehensive income (loss):
The following table presents reclassifications from accumulated other comprehensive income (loss) to the Consolidated statements of operations:
|
Share-based compensation |
9 Months Ended |
---|---|
Sep. 30, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Share-based compensation | Share-based compensationThe Chubb Limited 2016 Long-Term Incentive Plan, as amended and restated (the Amended 2016 LTIP), permits grants of both incentive and non-qualified stock options principally at an option price per share equal to the grant date fair value of Chubb's Common Shares. Stock options are generally granted with a 3-year vesting period and a 10-year term. Stock options typically vest in equal annual installments over the respective vesting period, which is also the requisite service period. On February 23, 2023, Chubb granted 1,540,002 stock options with a weighted-average grant date fair value of $51.32 each. The fair value of the options issued is estimated on the grant date using the Black-Scholes option pricing model.The Amended 2016 LTIP also permits grants of service-based restricted stock and restricted stock units as well as performance-based restricted stock awards. Chubb generally grants service-based restricted stock and restricted stock units with a 4-year vesting period, based on a graded vesting schedule. The performance-based restricted stock awards granted comprise target awards and premium awards that cliff vest at the end of a 3-year performance period based on both tangible book value (shareholders' equity less goodwill and intangible assets, net of tax) per share growth and P&C combined ratio compared to a defined group of peer companies. Premium awards are subject to an additional vesting provision based on total shareholder return compared to our peer group. The restricted stock is principally granted at market close price on the grant date. On February 23, 2023, Chubb granted 785,319 service-based restricted stock awards, 315,545 service-based restricted stock units, and 407,825 performance-based stock awards to employees and officers with a grant date fair value of $208.60 each. Each restricted stock unit represents our obligation to deliver to the holder one Common Share upon vesting. |
Postretirement benefits |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Retirement Benefits [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compensation and Employee Benefit Plans [Text Block] | Postretirement benefits The components of net pension and other postretirement benefit costs (benefits) reflected in Net income in the Consolidated statements of operations were as follows:
The line items in which the service cost and non-service cost (benefit) components of net periodic cost (benefit) are included in the Consolidated statements of operations were as follows:
|
Other Income and Expense |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Income and Expenses [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Income and Expense Disclosure | Other income and expense
(1) Related to gains (losses) from fair value changes in separate account assets that do not qualify for separate account reporting under GAAP. Equity in net income of partially-owned entities includes our share of net income or loss, both underlying operating income and mark-to-market movement, related to partially-owned investment companies (private equity) where we own more than three percent, and partially-owned insurance companies. This line item includes mark-to-market gains (losses) on private equities of $51 million and $290 million for the three and nine months ended September 30, 2023, respectively, and $(190) million and $(69) million, respectively, for the prior year periods. Other income and expense includes net income attributable to our investment in Huatai under the equity method of accounting comprising income of $36 million through June 30, 2023, and $28 million and $83 million for the three and nine months ended September 30, 2022, respectively. Effective July 1, 2023, we discontinued the equity method of accounting and include the results of operations of Huatai in our consolidated results. Also included in Other income and expense are gains (losses) from fair value changes in separate account assets that do not qualify for separate account reporting under GAAP. The offsetting movement in the separate account liabilities is included in Policy benefits in the Consolidated statements of operations. Asset management and performance fee revenue and expense primarily relate to the management of third-party assets by Huatai's asset management business, which is unrelated to Huatai Group's core insurance operations. These revenues and expenses are recognized in the period in which the services are performed. Certain federal excise and capital taxes incurred as a result of capital management initiatives are included in Other income and expense as these are considered capital transactions and are excluded from underwriting results. Bad debt expense for uncollectible premiums is also included in Other income and expense.
|
Segment information |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment information | Segment information Chubb operates through six business segments: North America Commercial P&C Insurance, North America Personal P&C Insurance, North America Agricultural Insurance, Overseas General Insurance, Global Reinsurance, and Life Insurance. These segments distribute their products through various forms of brokers, agencies, and direct marketing programs. All business segments have established relationships with reinsurance intermediaries. Commencing in the third quarter of 2023, the results of Huatai Group's life and asset management business are included in the Life Insurance segment, and the results of Huatai Group's P&C business are included in the Overseas General Insurance segment. Results for Huatai Group’s non-insurance operations, comprising real estate and holding company activity, are included in Corporate. Commencing in the third quarter of 2022, the results of Cigna's business in Asia are included in our Life Insurance segment and, to a lesser extent, Overseas General Insurance segment according to the nature of the business written. Management uses underwriting income (loss) as the basis for segment performance for its P&C operations. P&C underwriting income (loss) excludes the Life Insurance segment and is calculated by subtracting Losses and loss expenses, Policy benefits, Policy acquisition costs, and Administrative expenses from Net premiums earned. Segment income (loss) includes Underwriting income (loss), Net investment income (loss), and Other operating income and expense items such as each segment's share of the operating income (loss) related to partially-owned entities and miscellaneous income and expense items for which the segments are held accountable. Our main measure of segment performance is Segment income (loss), which also includes Amortization of purchased intangibles acquired by the segment. We determined that this definition of Segment income (loss) is appropriate and aligns with how the business is managed. We continue to evaluate our segments as our business continues to evolve and may further refine our segments and Segment income (loss) measures. Revenue and expenses managed at the corporate level, including Net realized gains (losses), Market risk benefits gains (losses), Interest expense, Cigna integration expenses, Income tax, and Net income (loss) attributable to noncontrolling interests are reported within Corporate. Cigna integration expenses are one-time costs that are directly attributable to third-party consulting fees, employee-related retention costs, and other professional and legal fees primarily related to the acquisition of Cigna's business in Asia. These items are not allocated to the segment level as they are one-time in nature and are not related to the ongoing business activities of the segment. The Chief Executive Officer does not manage segment results or allocate resources to segments when considering these costs, and therefore are excluded from our definition of Segment income (loss). Certain items are presented in a different manner for segment reporting purposes than in the Consolidated Financial Statements. These items are reconciled to the consolidated presentation in the Segment measure reclass column below and include: •Losses and loss expenses include realized gains and losses on crop derivatives. These derivatives were purchased to provide economic benefit, in a manner similar to reinsurance protection, in the event that a significant decline in commodity pricing impacts underwriting results. We view gains and losses on these derivatives as part of the results of our underwriting operations, and therefore realized gains (losses) from these derivatives are reclassified to Losses and loss expenses. •Policy benefits include fair value changes on separate accounts that do not qualify for separate accounting under GAAP. These gains and losses have been reclassified from Other (income) expense. We view gains and losses from fair value changes in both separate account assets and liabilities as part of the results of our underwriting operations, and therefore these gains and losses are reclassified to Policy benefits. •Net investment income includes investment income reclassified from Other (income) expense related to partially-owned investment companies (private equity partnerships) where our ownership interest is in excess of three percent. We view investment income from these equity-method private equity partnerships as Net investment income for segment reporting purposes. The following tables present the Statement of Operations by segment:
Underwriting assets are reviewed in total by management for purposes of decision-making. Other than Unpaid losses and loss expenses, Future policy benefits, Reinsurance recoverables, DAC, VOBA, Goodwill and Other intangible assets, Chubb does not allocate assets to its segments.
|
Earnings per share |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings per share | Earnings per share
|
Pay vs Performance Disclosure - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
|
Pay vs Performance Disclosure | ||||
Net income (loss) | $ 2,043 | $ 792 | $ 5,728 | $ 3,935 |
Insider Trading Arrangements |
3 Months Ended |
---|---|
Sep. 30, 2023
shares
| |
Trading Arrangements, by Individual | |
Non-Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
John J. Lupica [Member] | |
Trading Arrangements, by Individual | |
Material Terms of Trading Arrangement | On July 31, 2023, John J. Lupica, Vice Chairman, Chubb Group, and President, North America Insurance, adopted a "Rule 10b5-1 trading arrangement" as defined under Item 408 of SEC Regulation S-K. The arrangement is scheduled to expire on October 30, 2024, subject to earlier termination in accordance with its terms. The aggregate number of Chubb common shares authorized to be sold pursuant to the trading arrangement is 17,810. |
Name | John J. Lupica |
Title | Vice Chairman, Chubb Group, and President, North America Insurance |
Rule 10b5-1 Arrangement Adopted | true |
Adoption Date | July 31, 2023 |
Aggregate Available | 17,810 |
General and significant accounting policies (Policies) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Basis of presentation | Basis of presentation Chubb Limited is a holding company incorporated in Zurich, Switzerland. Chubb Limited, through its subsidiaries, provides a broad range of insurance and reinsurance products to insureds worldwide. Our results are reported through the following business segments: North America Commercial P&C Insurance, North America Personal P&C Insurance, North America Agricultural Insurance, Overseas General Insurance, Global Reinsurance, and Life Insurance. Refer to Note 18 for additional information. The interim unaudited consolidated financial statements include the accounts of Chubb Limited and its subsidiaries (collectively, Chubb, we, us, or our), over which Chubb exercises control, including Huatai Group, our majority-owned subsidiary, and minority-owned entities such as variable interest entities (VIEs) in which Chubb is considered the primary beneficiary. Noncontrolling interests on the consolidated financial statements represent the portion of majority-owned subsidiaries and VIEs in which we do not have direct equity ownership. These interim unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) and, in the opinion of management, reflect all adjustments necessary for a fair statement of the results and financial position for such periods. All significant intercompany accounts and transactions, including internal reinsurance transactions, have been eliminated. On July 1, 2023, Chubb increased its investment in Huatai Group from approximately 64.2 percent to approximately 69.6 percent. Accordingly, Chubb discontinued the equity method of accounting for its investment in Huatai Group and applied consolidation accounting. Business activity for, and the financial position of, Huatai Group is reported at 100 percent on the Consolidated Financial Statements starting when Chubb obtained control of Huatai Group on July 1, 2023. The relevant amounts attributable to shareholders other than Chubb (representing approximately 30.4 percent of Huatai Group) are reflected under Noncontrolling interests, Net income (loss) attributable to noncontrolling interests, and Comprehensive income (loss) attributable to noncontrolling interests in the Consolidated Financial Statements. Refer to Note 2 for additional information. Huatai Group's life and asset management businesses are included in the Life Insurance segment, and Huatai Group's P&C business is included in the Overseas General Insurance segment. Results for Huatai Group's non-insurance operations, comprising real estate and holding company activity, are included in Corporate. The results of operations and cash flows for any interim period are not necessarily indicative of the results for the full year. These consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes included in our 2022 Form 10-K.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting guidance adopted | Accounting guidance adopted in 2023 Targeted Improvements to the Accounting for Long-Duration Contracts Effective January 1, 2023, we adopted new guidance on the accounting for long-duration contracts (LDTI). The new accounting guidance requires more frequent updating of assumptions and a standardized discount rate for the future policy benefit liability, a requirement to use the fair value measurement model for policies with market risk benefits, simplified amortization of deferred acquisition costs, and enhanced disclosures. With the exception of market risk benefits, we adopted this guidance on a modified retrospective basis. Under the modified retrospective basis, the liability for future policy benefits is updated to remove any amounts related to changes to the original discount rate at January 1, 2021 (the transition date) in AOCI and future cash flow assumptions are applied to contracts in force. The liability for future policy benefits prior to the transition date continues to use the original discount rate (interest accretion rate). The guidance for long-duration contracts applicable to market risk benefits, primarily assumed reinsurance programs involving minimum benefit guarantees under variable annuity contracts, was adopted on a retrospective transition approach. Under the retrospective transition approach, we calculated the fair value of market risk benefits which were previously accounted for under an insurance accounting model and recognized an adjustment to retained earnings as of January 1, 2021. On January 1, 2021, we recognized a cumulative effect adjustment and increased beginning retained earnings by $52 million, and decreased AOCI by $1.8 billion. Results for the prior reporting periods in this report are presented in accordance with the new guidance. We also adopted the required disclosures in Note 6 Deferred acquisition costs, Note 9 Future policy benefits, Note 10 Policyholders’ account balances, Note 11 Market risk benefits, and Note 12 Separate accounts. The impact of adoption of the new guidance on our historical financial statements is as follows:
Excluded from the table above is the reclassification of Separate account assets, Separate account liabilities, and Policyholders' account balances as separate line items on the Consolidated balance sheets. Separate accounts assets were previously classified in Other assets, and Separate account liabilities and Policyholders' account balances were previously classified in Accounts payable, accrued expenses, and other liabilities.
The following table presents a reconciliation of the pre-adoption December 31, 2020, to the post adoption January 1, 2021, balance of future policy benefits:
(1) Includes future policy benefits previously included within Unpaid losses on the pre-adoption Consolidated balance sheets, primarily certain international A&H business, and excludes deferred profit liability and certain guaranteed minimum death benefits reclassified to Market risk benefits on the post adoption period balance sheets. The following table presents a reconciliation of the pre-adoption December 31, 2020, to the post adoption January 1, 2021, balance of market risk benefits:
(1) Includes $77 million of instrument-specific credit risk allocated from retained earnings to AOCI.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred policy acquisition costs and value of business acquired | Deferred policy acquisition costs (DAC) Policy acquisition costs on long-duration contracts are grouped by contract type and issue year into cohorts consistent with the grouping used in estimating the associated liability. Deferred policy acquisition costs are amortized on a constant level basis over the expected term of the related contracts to approximate straight-line amortization. The constant level basis used for amortization is the face amount in force and is projected using the same assumptions used in estimating the liability for future policy benefits. If those projected assumptions change in future periods, they will be reflected in the cohort level amortization basis at that time. Unexpected changes in the in-force portfolio, due to variances in mortality and lapse experience, are recognized over the contract term. Changes in future mortality and lapse assumptions are also recognized prospectively over the remaining expected contract term.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Future policy benefits | Future policy benefits For traditional and limited-payment contracts, contracts are grouped into cohorts by contract type and issue year to determine a liability for future policy benefits. The future policy benefit liability (FPBL) is the present value of estimated future policy benefits to be paid to or on behalf of policyholders and certain related expenses less the present value of estimated future net premiums to be collected from policyholders, and is accrued as premium revenue is recognized. The valuation of this liability requires management to make estimates and assumptions regarding expenses, mortality, and persistency. Estimates are primarily based on historical experience. Actual results could differ materially from these estimates. The liability is adjusted for differences between actual and expected experience. With the exception of the expense assumption, we review our future cash flow assumptions at least annually to determine if the net premium ratio (NPR), the mechanism used to record the liability as premium is earned, used to calculate the liability should be changed at that time. We have elected to use expense assumptions that are locked in at contract inception and are not subsequently reviewed or updated. Each quarter, we update the cash flows expected over the entire life of each cohort for actual historical experience and projected future cash flows. These updated cash flows are used to calculate the revised NPR, which is used to derive an updated FPBL as of the beginning of the current reporting period, discounted at the original contract issuance discount rate. This amount is then compared to the carrying amount of the liability as of that same date, but before the updating of cash flow assumptions, to determine the current period change in FPBL. This current period change in the liability is the liability remeasurement gain or loss and is recorded in Policy benefits in the Consolidated statements of operations. In subsequent periods, the revised NPR is used to measure the FPBL until future revisions become required. For traditional and limited-payment contracts, the discount rate assumption based on an upper-medium grade fixed-income instrument yield. An equivalent rate is derived based on A-credit-rated fixed-income instruments with similar duration to the liability. The discount rate assumption is updated quarterly and used to remeasure the liability at each reporting date, with the resulting change reflected in Other comprehensive income. For liability cash flows that are projected beyond the duration of market-observable A-credit-rated fixed-income instruments, we use the last market-observable yield level, as the basis for a linear interpolation to determine yield assumptions for durations that do not have market-observable yields. Deferred profit liability For limited-payment products, gross premiums received in excess of net premiums are deferred at initial recognition as a deferred profit liability (DPL) and recorded as a component of Future policy benefits in the Consolidated balance sheets. Net premiums are measured using actual cash flows and future cash flow assumptions consistent with those used in the measurement of the liability for future policy benefits and remeasured quarterly. The DPL is amortized in proportion to the discounted in-force policies. Interest is accreted on the balance of the DPL using the discount rate consistent with the interest accretion on the FPBL. The recalculated DPL, including adjusted amortization through the current period, is compared to the current carrying amount and the difference is recognized as an adjustment to Policy benefits in the Consolidated statements of operations as a remeasurement gain or loss.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Risk Benefit | Market risk benefits Chubb reinsures various death and living benefit guarantees associated with variable annuities issued primarily in the United States, which are referred to as market risk benefits. These reinsurance contracts provide both protection to the ceding entity from other-than-nominal capital market risk and expose us to other-than-nominal capital market risk. Market risk benefits are measured at fair value using a valuation model based on current net exposures, market data, our experience, and other factors. Changes in fair value are recognized in Market risk benefits gains (losses) in the Consolidated statements of operations, except the change in fair value due to a change in the instrument-specific credit risk, which is recognized in other comprehensive income. Refer to Note 11 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Huatai asset management non-premium revenue | Asset management and performance fee revenue and expensesHuatai's asset management companies recognize revenue and expenses unrelated to Chubb's core insurance operations from the management of third-party assets. These revenues include fixed-rate management fees, which are recognized in the period in which the services are performed, and asset performance fees, which are recognized to the extent it is probable that a significant reversal will not occur. These fees and expenses are included in Other (income) expense on the Consolidated statements of operations. Refer to Note 17 for additional information. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loans and leases receivable policy | Private debt held-for-investment, at amortized costPrivate debt held-for-investment are investments related principally to the funding of public and private projects that are mostly infrastructure related, and were acquired as part of Huatai’s investment portfolio upon consolidation. They have stated interest rates and maturity dates with fixed or determinable payments. Private debt held-for-investment are carried at amortized cost, net of a valuation allowance for credit losses. Interest income is recorded when earned. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Investment | Other investments Chubb consolidates entities in which it has a controlling interest or is a primary beneficiary of a VIE. Huatai’s asset management businesses create investment entities known as sponsored investment products which include mutual funds with primary holdings in fixed maturities. Other investments principally comprised these fixed maturities. These securities are reported at fair value with changes in fair value reported through the Consolidated statements of operations within Net realized gains (losses) as required under investment company accounting standards.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consolidation, Variable Interest Entity, Policy | Consolidation of variable interest entities (VIEs)Chubb consolidates entities in which it has a controlling interest or is a primary beneficiary of a VIE. Huatai's asset management businesses create investment entities known as sponsored investment products which include mutual funds with primary holdings in fixed maturities. These entities are created for varied purposes during the ordinary course of business, such as to obtain returns from investments, and to collect management fees for the assets managed on behalf of the third party investors. While many investors may not be related parties, Huatai invests in these funds at various ownership percentages. We determined that we are the primary beneficiary of these VIEs and generally consolidate when we hold an economic interest of 10 percent or more. The consolidation of VIEs records 100 percent of the underlying assets and liabilities of the mutual funds within the Consolidated balance sheets. The relevant amounts attributable to investors other than Chubb are reflected as Noncontrolling interests. Where Huatai's ownership in these sponsored investment products is less than 10 percent, we generally would not expect to be the primary beneficiary of these VIEs. Refer to Note 3 g) for additional information. |
Fair value measurements (Fair Value Measurement Policy) (Policies) |
9 Months Ended |
---|---|
Sep. 30, 2023 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurement, Policy | Fair value of financial assets and financial liabilities is estimated based on the framework established in the fair value accounting guidance. The guidance defines fair value as the price to sell an asset or transfer a liability (an exit price) in an orderly transaction between market participants and establishes a three-level valuation hierarchy based on the reliability of the inputs. The fair value hierarchy gives the highest priority to quoted prices in active markets and the lowest priority to unobservable data. The three levels of the hierarchy are as follows: •Level 1 – Unadjusted quoted prices for identical assets or liabilities in active markets; •Level 2 – Includes, among other items, inputs other than quoted prices that are observable for the asset or liability such as interest rates and yield curves, quoted prices for similar assets and liabilities in active markets, and quoted prices for identical or similar assets and liabilities in markets that are not active; and •Level 3 – Inputs that are unobservable and reflect management’s judgments about assumptions that market participants would use in pricing an asset or liability.
|
General and significant accounting policies (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounting Standards Update and Change in Accounting Principle | The impact of adoption of the new guidance on our historical financial statements is as follows:
Excluded from the table above is the reclassification of Separate account assets, Separate account liabilities, and Policyholders' account balances as separate line items on the Consolidated balance sheets. Separate accounts assets were previously classified in Other assets, and Separate account liabilities and Policyholders' account balances were previously classified in Accounts payable, accrued expenses, and other liabilities.
The following table presents a reconciliation of the pre-adoption December 31, 2020, to the post adoption January 1, 2021, balance of future policy benefits:
(1) Includes future policy benefits previously included within Unpaid losses on the pre-adoption Consolidated balance sheets, primarily certain international A&H business, and excludes deferred profit liability and certain guaranteed minimum death benefits reclassified to Market risk benefits on the post adoption period balance sheets. The following table presents a reconciliation of the pre-adoption December 31, 2020, to the post adoption January 1, 2021, balance of market risk benefits:
(1) Includes $77 million of instrument-specific credit risk allocated from retained earnings to AOCI.
|
Acquisitions (Tables) |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Combinations [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed | The following table summarizes Chubb's best estimate of fair value of the assets acquired and liabilities assumed on July 1, 2023. The fair value of assets and liabilities are preliminary and may change with offsetting adjustments to goodwill. Chubb may make further adjustments to its purchase price allocation and the fair value of noncontrolling interest through the end of the permissible one-year measurement period.
The following table summarizes the fair value of the assets acquired and liabilities assumed at July 1, 2022:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Business Acquisitions, by Acquisition | The following table summarizes the results of the acquired Huatai Group operations that have been included within our Consolidated statements of operations for the three and nine months ended September 30, 2023:
|
The following table summarizes the results of the acquired Cigna business in Asia that have been included within our Consolidated statements of operations for the three and nine months ended September 30, 2022:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination | The preliminary purchase price allocation to intangible assets recorded in connection with the Huatai Group acquisition and their related useful lives at July 1, 2023, are as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Acquisition, Pro Forma Information | The following table presents supplemental unaudited pro forma consolidated information for the periods indicated as though the acquisition of a controlling majority interest in Huatai Group that occurred on July 1, 2023, had instead occurred on January 1, 2022. The unaudited pro forma consolidated financial information is presented for informational purposes only and is not necessarily indicative of the operating results that would have occurred had the acquisition of a controlling majority interest been consummated on January 1, 2022, nor is it necessarily indicative of future operating results. Significant assumptions used to determine pro forma operating results include amortization of VOBA and other intangible assets.
The following table presents supplemental unaudited pro forma consolidated information for the periods indicated as though the acquisition of Cigna's business in Asia that occurred on July 1, 2022, had instead occurred on January 1, 2021. The unaudited pro forma consolidated financial information is presented for informational purposes only and is not necessarily indicative of the operating results that would have occurred had the acquisition been consummated on January 1, 2021, nor is it necessarily indicative of future operating results. Significant assumptions used to determine pro forma operating results include amortization of VOBA and other intangible assets and recognition of interest expense associated with the repurchase agreement transactions used to effect the acquisition.
|
Investments (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments, Debt and Equity Securities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule Of Amortized Cost and Fair Value of Available-for-sale Securities |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule Of Amortized Cost And Fair Value Of HTM Fixed Maturities |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Securities, Held-to-maturity, Credit Quality Indicator | The following table presents the amortized cost of our held to maturity securities according to S&P rating:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule Of Fixed Maturities By Contractual Maturity | The following table presents fixed maturities by contractual maturity:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule Of Aggregate Fair Value And Gross Unrealized Loss By Length Of Time The Security Has Continuously Been In An Unrealized Loss Position | The following tables present, for AFS fixed maturities in an unrealized loss position (including securities on loan) that are not deemed to have expected credit losses, the aggregate fair value and gross unrealized loss by length of time the security has been in an unrealized loss position:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Securities, Available-for-sale, Allowance for Credit Loss | The following table presents a roll-forward of valuation allowance for expected credit losses on fixed maturities:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Securities, Held-to-maturity, Allowance for Credit Loss | The following table presents a roll-forward of valuation allowance for expected credit losses on fixed maturities:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Realized Gain (Loss) | The following table presents the components of Net realized gains (losses):
(1)Relates to certain securities we intended to sell and securities written to market entering default. (2)The three and nine months ended September 30, 2023 Includes a one-time realized gain of $116 million as a result of the consolidation of Huatai Group.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gain (Loss) on Securities | Realized gains and losses from Other investments, Equity securities and Private equities from the table above include sales of securities and unrealized gains and losses from fair value changes as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule Of Components Of Restricted Assets | The following table presents the components of restricted assets:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consolidated Variable Interest Entities | The following table presents the balances related to these sponsored investment products accounted for as VIEs that were recorded on our Consolidated balance sheets, including our net interest in these sponsored investment products:
|
Fair value measurements (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Instruments Measured At Fair Value On A Recurring Basis | Financial instruments measured at fair value on a recurring basis, by valuation hierarchy
(1)Excluded from the table above are policy loans of $603 million, and other investments of $47 million at September 30, 2023, measured using NAV as a practical expedient. (2)Excluded from the table above are partially-owned investments, investment funds, and limited partnerships of $13,362 million at September 30, 2023, measured using NAV as a practical expedient. (3)Refer to Note 11 for additional information on Market risk benefits.
(1)Excluded from the table above are policy loans of $343 million and other investments of $47 million at December 31, 2022, measured using NAV as a practical expedient. (2)Excluded from the table above are partially-owned investments, investment funds, and limited partnerships of $12,355 million at December 31, 2022, measured using NAV as a practical expedient. (3)Refer to Note 11 for additional information on Market risk benefits.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation | The following tables present a reconciliation of the beginning and ending balances of financial instruments measured at fair value using significant unobservable inputs (Level 3). Excluded from the following tables is the reconciliation of Market risk benefits, refer to Note 11 for additional information:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carrying Values And Fair Values Of Financial Instruments Not Measured At Fair Value | The following tables present fair value, by valuation hierarchy, and carrying value of the financial instruments not measured at fair value:
Private debt held-for-investment is related to Huatai and its consolidation. The fair value of Private debt held-for-investment is derived using a discounted cash flow approach, which includes an evaluation of forecasted contractual cash flows and yield curve information, among other loan characteristics and assumptions. These assumptions are derived from internal and third party sources. Since the valuation is derived from model-based techniques, Private debt held-for-investment is classified within Level 3 of the valuation hierarchy.
|
Reinsurance (Tables) |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reinsurance Disclosures [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
schedule of reinsurance recoverable on ceded insurance |
(1)Net of valuation allowance for uncollectible reinsurance.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reinsurance Recoverable, Allowance for Credit Loss [Table Text Block] | The following table presents a roll-forward of valuation allowance for uncollectible reinsurance related to Reinsurance recoverable on loss and loss expenses:
|
Deferred acquisition costs (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred Policy Acquisition Costs Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred Policy Acquisition Costs | The following tables present a roll-forward of deferred acquisitions costs on long-duration contracts included in the Life Insurance segment:
|
Goodwill and Value of business acquired (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill roll-forward by business segment | The following table presents a roll-forward of Goodwill by segment:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Changes in VOBA | The following table presents a roll-forward of VOBA:
(1)Recognized in Policy acquisition costs in the Consolidated statements of operations.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Expected Amortization of VOBA | The following table presents, as of September 30, 2023, the expected estimated pre-tax amortization expense related to VOBA at current foreign currency rates, for the fourth quarter of 2023 and for the next five years:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Intangible Assets and Goodwill | Other intangible assets that are subject to amortization principally relate to agency distribution relationships, renewal rights, and patents. Other intangible assets that are not subject to amortization principally relate to trademarks. For other intangible assets related to the consolidation of Huatai, refer to Note 2.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense | The following table presents, as of September 30, 2023, the expected pre-tax amortization expense of purchased intangibles, at current foreign currency exchange rates, for the fourth quarter of 2023 and for the next five years:
(1)Recognized in Policy acquisition costs in the Consolidated statements of operations. (2)Recognized in Other (income) expense in the Consolidated statements of operations.
|
Unpaid losses and loss expenses (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Liability for Claims and Claims Adjustment Expense [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Unpaid Losses And Loss Expenses Roll Forward [Table Text Block] | The following table presents a reconciliation of beginning and ending Unpaid losses and loss expenses:
(1) Net of valuation allowance for uncollectible reinsurance. (2) Relates to prior period loss reserve development only and excludes prior period development related to reinstatement premiums, expense adjustments, earned premiums, and development on international A&H lines totaling $71 million and $213 million for the nine months ended September 30, 2023 and 2022, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Prior Period Development, by Segment [Table Text Block] | The following table summarizes (favorable) and adverse PPD by segment:
|
Future policy benefits (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Liability for Future Policy Benefits Activity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Liability for Future Policy Benefit, Activity | The following tables present a roll-forward of the liability for future policy benefits included in the Life Insurance segment:
(1)Net premiums collected represent the portion of gross premiums collected from policyholders that is used to fund expected benefit.
(1)Net premiums collected represent the portion of gross premiums collected from policyholders that is used to fund expected benefit.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Undiscounted expected gross premiums and expected future policy benefit payments | The following table presents the amount of undiscounted expected gross premiums and expected future policy benefit payments included in the Life Insurance segment:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gross premiums and interest accretion recognized in statement of operations | The following table presents the amount of revenue and interest recognized in the statement of operations:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Weighted-average interests | The following table presents the weighted-average interest rates:
|
Policyholders' account balances (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Policyholder Account Balance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Policyholder Account Balances | The following tables present a roll-forward of policyholders' account balances:
(1)Contracts included in the policyholder account balances are generally charged a premium and/or monthly assessments on the basis of the account balance.
(1)For those guarantees of benefits that are payable in the event of death, the net amount at risk is defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rates | Universal Life
Other policyholders' account balances
|
Market risk benefits (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Risk Benefit [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Risk Benefit, Activity | The following table presents a roll-forward of MRB:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule Of Significant Unobservable Inputs Used In Level 3 Liability Valuations | For MRB, Chubb estimates fair value using an internal valuation model which includes a number of factors including interest rates, equity markets, credit risk, current account value, market volatility, expected annuitization rates and other policyholder behavior, and changes in policyholder mortality. All reinsurance treaties contain claim limits, which are also factored into the valuation model.
(1)The weighted-average lapse and annuitization rates are determined by weighting each treaty's rates by the MRB contract's fair value.
|
Separate accounts (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Separate Accounts Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value, Separate Account Investment | The following table presents the aggregate fair value of Separate account assets, by major security type:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Separate Account, Liability | The following table presents a roll-forward of separate account liabilities:
(1) Cash surrender value represents the amount of the contract holder's account balances distributable at the balance sheet date less certain surrender charges.
|
Commitments, contingencies, and guarantees (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance Sheet Locations, Fair Values In An Asset Or (Liability) Position, And Notional Values/Payment Provisions Of Derivative Instruments | The following table presents the balance sheet location, fair value of derivative instruments in an asset or (liability) position, and notional value/payment provision of our derivative instruments:
(1)Includes fair value of embedded derivatives. (2)Related to MRB book of business.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location | The following table presents pre-tax gains (losses) recognized in OCI and reclassified into earnings for fair value hedges:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Net Investment Hedges, Statements of Financial Performance and Financial Position, Location | The following table presents pre-tax gains (losses) recognized in OCI and reclassified into earnings for net investment hedges:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net Realized Gains (Losses) Of Derivative Instrument Activity In Consolidated Statement Of Operations | The following table presents net realized gains (losses) related to derivative instrument activity in the Consolidated statements of operations:
(1)Includes embedded derivatives. (2)Related to MRB book of business.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings | The following table presents the carrying value of collateral held under securities lending agreements by investment category and remaining contractual maturity of the underlying agreements:
The following table presents the carrying value of collateral pledged under repurchase agreements by investment category and remaining contractual maturity of the underlying agreements:
(1)Per the repurchase agreements, the amount of collateral posted is required to exceed the amount of gross liability.
|
Shareholders' Equity (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity Note [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dividends Declared | The following table presents dividend distributions per Common Share in Swiss francs (CHF) and U.S. dollars (USD):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share Repurchase Program [Table Text Block] | The following table presents repurchases of Chubb's Common Shares conducted in a series of open market transactions under the Board authorizations:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Accumulated Other Comprehensive Income (Loss) | The following table presents changes in accumulated other comprehensive income (loss):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reclassification out of Accumulated Other Comprehensive Income | The following table presents reclassifications from accumulated other comprehensive income (loss) to the Consolidated statements of operations:
|
Postretirement benefits (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Retirement Benefits [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Net Benefit Costs [Table Text Block] | The components of net pension and other postretirement benefit costs (benefits) reflected in Net income in the Consolidated statements of operations were as follows:
The line items in which the service cost and non-service cost (benefit) components of net periodic cost (benefit) are included in the Consolidated statements of operations were as follows:
|
Other Income and Expense (Tables) |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Income and Expenses [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Other Nonoperating Income (Expense) |
(1) Related to gains (losses) from fair value changes in separate account assets that do not qualify for separate account reporting under GAAP.
|
Segment information (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Operations By Segment | The following tables present the Statement of Operations by segment:
|
Earnings per share (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule Of Earnings Per Share, Basic And Diluted |
|
General and significant accounting policies (Narrative) (Details) - USD ($) $ in Millions |
Sep. 30, 2023 |
Jul. 01, 2023 |
Jun. 30, 2023 |
Dec. 31, 2022 |
Jan. 01, 2021 |
---|---|---|---|---|---|
General and significant accounting policies [Line Items] | |||||
Retained earnings | $ 51,510 | $ 48,305 | |||
Accumulated other comprehensive income (loss) (AOCI) | $ (11,518) | (10,185) | |||
Huatai Group | |||||
General and significant accounting policies [Line Items] | |||||
Equity Method Investment, Ownership Percentage | 64.20% | ||||
Huatai Group | |||||
General and significant accounting policies [Line Items] | |||||
Subsidiary, Ownership Percentage, Parent | 69.60% | 69.60% | |||
Subsidiary, Ownership Percentage, Noncontrolling Owner | 30.40% | ||||
Effect of Modified Retrospective Application Accounting Standards Update 2018-12 | |||||
General and significant accounting policies [Line Items] | |||||
Retained earnings | 29 | $ 52 | |||
Accumulated other comprehensive income (loss) (AOCI) | $ 8 | $ 1,800 |
General and significant accounting policies (ASU 2018-12 Transition) (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 01, 2021 |
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
Dec. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|||||||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||||||||||||||
Reinsurance recoverable on losses and loss expenses | $ (19,750) | [1] | $ (19,750) | [1] | $ (18,859) | [2] | ||||||||||||||
Reinsurance recoverable on policy benefits | [1],[2] | (315) | (315) | (302) | ||||||||||||||||
Deferred policy acquisition costs | 6,856 | 6,856 | 6,031 | |||||||||||||||||
Value of business acquired | (3,675) | (3,675) | (3,702) | |||||||||||||||||
Prepaid reinsurance premiums | (3,514) | (3,514) | (3,136) | |||||||||||||||||
Investments in partially-owned insurance companies | (188) | (188) | (2,507) | |||||||||||||||||
Unpaid losses and loss expenses | (79,705) | $ (75,336) | (79,705) | $ (75,336) | (75,747) | $ (72,330) | ||||||||||||||
Unearned premiums | (22,684) | (22,684) | (19,713) | |||||||||||||||||
Future policy benefits | $ 7,652 | 13,109 | 9,906 | 13,109 | 9,906 | 10,476 | ||||||||||||||
Market risk benefits | 770 | 770 | 800 | |||||||||||||||||
Insurance and reinsurance balances payable | (8,481) | (8,481) | (7,780) | |||||||||||||||||
Deferred tax liabilities | (759) | (759) | (377) | |||||||||||||||||
Retained earnings | (51,510) | (51,510) | (48,305) | |||||||||||||||||
Accumulated other comprehensive income (loss) (AOCI) | (11,518) | (11,518) | (10,185) | |||||||||||||||||
Net premiums written | (13,104) | (12,012) | (35,765) | (31,494) | ||||||||||||||||
Net premiums earned | (12,674) | (11,530) | (33,815) | (29,816) | ||||||||||||||||
Net realized (gains) losses | 103 | 456 | 484 | 936 | ||||||||||||||||
Market risk benefits gains (losses) | 32 | (69) | 154 | (85) | ||||||||||||||||
Losses and loss expenses | (7,106) | (7,063) | (17,937) | (16,833) | ||||||||||||||||
Policy benefits | (938) | (707) | (2,565) | (1,441) | ||||||||||||||||
Policy acquisition costs | (2,178) | (1,970) | (6,142) | (5,415) | ||||||||||||||||
Other (income) expense | (154) | 202 | (550) | (9) | ||||||||||||||||
Income Tax (Expense) Benefit | (413) | (263) | (1,189) | (907) | ||||||||||||||||
Net income (loss) | (2,043) | (792) | (5,728) | (3,935) | ||||||||||||||||
Current discount rate on future policy benefits | 683 | 479 | 497 | 1,546 | ||||||||||||||||
Instrument-specific credit risk on market risk benefits | (5) | 8 | 3 | 48 | ||||||||||||||||
Other Comprehensive Income (Loss), Tax | 0 | 109 | (104) | 1,071 | ||||||||||||||||
Comprehensive income (loss) | 268 | (2,658) | 4,316 | (7,107) | ||||||||||||||||
Comprehensive income (loss) | 347 | (2,658) | 4,395 | (7,107) | ||||||||||||||||
Net Cash Provided by (Used in) Operating Activities | 9,446 | 8,600 | ||||||||||||||||||
Net Cash Provided by (Used in) Financing Activities | (3,325) | (2,730) | ||||||||||||||||||
Liability for Future Policy Benefit, Remeasurement Gain (Loss) | 25 | 17 | 21 | 11 | ||||||||||||||||
Equity in net income of partially-owned entities | (150) | 111 | (610) | (180) | ||||||||||||||||
Increase (Decrease) in Deferred Income Taxes | 39 | 55 | ||||||||||||||||||
Unpaid losses and loss expenses | 3,270 | 4,805 | ||||||||||||||||||
Unearned premiums | 2,085 | 1,904 | ||||||||||||||||||
Future policy benefits | 570 | 117 | ||||||||||||||||||
Accounts payable, accrued expenses, and other liabilities | (392) | 337 | ||||||||||||||||||
Reinsurance recoverable | (388) | (1,850) | ||||||||||||||||||
Increase (Decrease) in Deferred Policy Acquisition Costs | (832) | (355) | ||||||||||||||||||
Increase (Decrease) in Other Operating Assets and Liabilities, Net | 796 | (95) | ||||||||||||||||||
Net cash flows used for investing activities | (5,434) | (5,202) | ||||||||||||||||||
Segment Life [Member] | ||||||||||||||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||||||||||||||
Net premiums written | (1,452) | (1,265) | (4,015) | (2,403) | ||||||||||||||||
Net premiums earned | (1,442) | (1,244) | (3,962) | (2,325) | ||||||||||||||||
Losses and loss expenses | (20) | (27) | (87) | (78) | ||||||||||||||||
Policy benefits | (866) | (666) | (2,283) | (1,275) | ||||||||||||||||
Policy acquisition costs | (279) | (266) | (829) | (537) | ||||||||||||||||
Other (income) expense | (28) | 4 | (69) | (38) | ||||||||||||||||
Overseas General Insurance [Member] | ||||||||||||||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||||||||||||||
Net premiums written | (3,211) | (2,645) | (9,359) | (8,364) | ||||||||||||||||
Net premiums earned | (3,311) | (2,741) | (9,005) | (8,065) | ||||||||||||||||
Losses and loss expenses | (1,635) | (1,333) | (4,139) | (3,772) | ||||||||||||||||
Policy benefits | (91) | (108) | (338) | (282) | ||||||||||||||||
Policy acquisition costs | (827) | (720) | (2,286) | (2,096) | ||||||||||||||||
Other (income) expense | (10) | (2) | (29) | 3 | ||||||||||||||||
Term Life Insurance | Segment Life [Member] | ||||||||||||||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||||||||||||||
Deferred policy acquisition costs | 372 | 299 | 372 | 299 | 320 | 246 | ||||||||||||||
Future policy benefits | 454 | 947 | 740 | 947 | 740 | |||||||||||||||
Policy acquisition costs | (74) | (56) | ||||||||||||||||||
Whole Life Insurance | Segment Life [Member] | ||||||||||||||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||||||||||||||
Deferred policy acquisition costs | 488 | 350 | 488 | 350 | 395 | 334 | ||||||||||||||
Future policy benefits | 3,767 | 6,702 | 4,004 | 6,702 | 4,004 | |||||||||||||||
Policy acquisition costs | (16) | (14) | ||||||||||||||||||
Accident and Health Insurance Product Line [Member] | Segment Life [Member] | ||||||||||||||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||||||||||||||
Deferred policy acquisition costs | 1,181 | 819 | 1,181 | 819 | 902 | 745 | ||||||||||||||
Future policy benefits | 2,569 | 4,072 | 4,335 | 4,072 | 4,335 | |||||||||||||||
Policy acquisition costs | (100) | (72) | ||||||||||||||||||
Accident and Health Insurance Product Line [Member] | Overseas General Insurance [Member] | ||||||||||||||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||||||||||||||
Future policy benefits | 773 | 718 | 735 | 718 | 735 | |||||||||||||||
Insurance, Other | Segment Life [Member] | ||||||||||||||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||||||||||||||
Deferred policy acquisition costs | 127 | 117 | 127 | 117 | 121 | $ 108 | ||||||||||||||
Future policy benefits | 89 | $ 670 | 92 | 670 | 92 | |||||||||||||||
Policy acquisition costs | $ (15) | (16) | ||||||||||||||||||
Variable Annuity | ||||||||||||||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||||||||||||||
Market risk benefits | 1,163 | |||||||||||||||||||
Previously Reported | ||||||||||||||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||||||||||||||
Reinsurance recoverable on losses and loss expenses | (18,901) | |||||||||||||||||||
Reinsurance recoverable on policy benefits | (303) | |||||||||||||||||||
Deferred policy acquisition costs | 5,788 | |||||||||||||||||||
Value of business acquired | (3,596) | |||||||||||||||||||
Prepaid reinsurance premiums | (3,140) | |||||||||||||||||||
Investments in partially-owned insurance companies | (2,877) | |||||||||||||||||||
Unpaid losses and loss expenses | (76,323) | |||||||||||||||||||
Unearned premiums | (20,360) | |||||||||||||||||||
Future policy benefits | 10,120 | $ 6,065 | [3] | |||||||||||||||||
Market risk benefits | 0 | |||||||||||||||||||
Insurance and reinsurance balances payable | (7,795) | |||||||||||||||||||
Deferred tax liabilities | (292) | |||||||||||||||||||
Retained earnings | (48,334) | |||||||||||||||||||
Accumulated other comprehensive income (loss) (AOCI) | (10,193) | |||||||||||||||||||
Net premiums written | (12,020) | (31,521) | ||||||||||||||||||
Net premiums earned | (11,535) | (29,838) | ||||||||||||||||||
Net realized (gains) losses | 384 | 787 | ||||||||||||||||||
Market risk benefits gains (losses) | 0 | 0 | ||||||||||||||||||
Losses and loss expenses | (7,279) | (17,474) | ||||||||||||||||||
Policy benefits | (486) | (790) | ||||||||||||||||||
Policy acquisition costs | (1,975) | (5,451) | ||||||||||||||||||
Other (income) expense | 188 | (21) | ||||||||||||||||||
Income Tax (Expense) Benefit | (265) | (913) | ||||||||||||||||||
Net income (loss) | (812) | (4,001) | ||||||||||||||||||
Current discount rate on future policy benefits | 0 | 0 | ||||||||||||||||||
Instrument-specific credit risk on market risk benefits | 0 | 0 | ||||||||||||||||||
Other Comprehensive Income (Loss), Tax | (165) | (1,222) | ||||||||||||||||||
Comprehensive income (loss) | (3,093) | (8,529) | ||||||||||||||||||
Net Cash Provided by (Used in) Operating Activities | 8,592 | |||||||||||||||||||
Net Cash Provided by (Used in) Financing Activities | (2,722) | |||||||||||||||||||
Previously Reported | Term Life Insurance | Segment Life [Member] | ||||||||||||||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||||||||||||||
Future policy benefits | [3] | 391 | ||||||||||||||||||
Previously Reported | Whole Life Insurance | Segment Life [Member] | ||||||||||||||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||||||||||||||
Future policy benefits | [3] | 2,578 | ||||||||||||||||||
Previously Reported | Accident and Health Insurance Product Line [Member] | Segment Life [Member] | ||||||||||||||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||||||||||||||
Future policy benefits | [3] | 2,270 | ||||||||||||||||||
Previously Reported | Accident and Health Insurance Product Line [Member] | Overseas General Insurance [Member] | ||||||||||||||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||||||||||||||
Future policy benefits | [3] | 754 | ||||||||||||||||||
Previously Reported | Insurance, Other | Segment Life [Member] | ||||||||||||||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||||||||||||||
Future policy benefits | [3] | 72 | ||||||||||||||||||
Previously Reported | Variable Annuity | ||||||||||||||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||||||||||||||
Market risk benefits | $ 1,138 | |||||||||||||||||||
Effect of Modified Retrospective Application Accounting Standards Update 2018-12 | ||||||||||||||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||||||||||||||
Reinsurance recoverable on losses and loss expenses | (42) | |||||||||||||||||||
Reinsurance recoverable on policy benefits | (1) | |||||||||||||||||||
Deferred policy acquisition costs | 243 | |||||||||||||||||||
Value of business acquired | (106) | |||||||||||||||||||
Prepaid reinsurance premiums | (4) | |||||||||||||||||||
Investments in partially-owned insurance companies | (370) | |||||||||||||||||||
Unpaid losses and loss expenses | (576) | |||||||||||||||||||
Unearned premiums | (647) | |||||||||||||||||||
Future policy benefits | 356 | |||||||||||||||||||
Market risk benefits | 800 | |||||||||||||||||||
Insurance and reinsurance balances payable | (15) | |||||||||||||||||||
Deferred tax liabilities | (85) | |||||||||||||||||||
Retained earnings | (52) | (29) | ||||||||||||||||||
Accumulated other comprehensive income (loss) (AOCI) | 1,800 | $ 8 | ||||||||||||||||||
Net premiums written | (8) | (27) | ||||||||||||||||||
Net premiums earned | (5) | (22) | ||||||||||||||||||
Net realized (gains) losses | (72) | (149) | ||||||||||||||||||
Market risk benefits gains (losses) | 69 | 85 | ||||||||||||||||||
Losses and loss expenses | (216) | (641) | ||||||||||||||||||
Policy benefits | 221 | 651 | ||||||||||||||||||
Policy acquisition costs | (5) | (36) | ||||||||||||||||||
Other (income) expense | 14 | 12 | ||||||||||||||||||
Income Tax (Expense) Benefit | (2) | (6) | ||||||||||||||||||
Net income (loss) | (20) | (66) | ||||||||||||||||||
Current discount rate on future policy benefits | 479 | 1,546 | ||||||||||||||||||
Instrument-specific credit risk on market risk benefits | 8 | 48 | ||||||||||||||||||
Other Comprehensive Income (Loss), Tax | 56 | 151 | ||||||||||||||||||
Comprehensive income (loss) | $ 435 | 1,422 | ||||||||||||||||||
Net Cash Provided by (Used in) Operating Activities | 8 | |||||||||||||||||||
Net Cash Provided by (Used in) Financing Activities | $ (8) | |||||||||||||||||||
Liability for Future Policy Benefit, Remeasurement Gain (Loss) | 1,587 | |||||||||||||||||||
AOCI, Market Risk Benefit, Instrument-Specific Credit Risk, before Tax | 77 | |||||||||||||||||||
Effect of Modified Retrospective Application Accounting Standards Update 2018-12 | Term Life Insurance | Segment Life [Member] | ||||||||||||||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||||||||||||||
Liability for Future Policy Benefit, Remeasurement Gain (Loss) | 63 | |||||||||||||||||||
Effect of Modified Retrospective Application Accounting Standards Update 2018-12 | Whole Life Insurance | Segment Life [Member] | ||||||||||||||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||||||||||||||
Liability for Future Policy Benefit, Remeasurement Gain (Loss) | 1,189 | |||||||||||||||||||
Effect of Modified Retrospective Application Accounting Standards Update 2018-12 | Accident and Health Insurance Product Line [Member] | Segment Life [Member] | ||||||||||||||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||||||||||||||
Liability for Future Policy Benefit, Remeasurement Gain (Loss) | 299 | |||||||||||||||||||
Effect of Modified Retrospective Application Accounting Standards Update 2018-12 | Accident and Health Insurance Product Line [Member] | Overseas General Insurance [Member] | ||||||||||||||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||||||||||||||
Liability for Future Policy Benefit, Remeasurement Gain (Loss) | 19 | |||||||||||||||||||
Effect of Modified Retrospective Application Accounting Standards Update 2018-12 | Insurance, Other | Segment Life [Member] | ||||||||||||||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||||||||||||||
Liability for Future Policy Benefit, Remeasurement Gain (Loss) | 17 | |||||||||||||||||||
Effect of Modified Retrospective Application Accounting Standards Update 2018-12 | Guaranteed Minimum Death Benefit | ||||||||||||||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||||||||||||||
Market risk benefits gains (losses) | 59 | |||||||||||||||||||
OCI, Market Risk Benefit, Instrument-Specific Credit Risk, Gain (Loss), before Adjustments and Tax | [4] | $ 84 | ||||||||||||||||||
|
Acquisitions (Narrative) (Details) - USD ($) $ in Millions |
9 Months Ended | |||||
---|---|---|---|---|---|---|
Oct. 01, 2023 |
Jul. 01, 2023 |
Jul. 01, 2022 |
Sep. 30, 2023 |
Jun. 30, 2023 |
Dec. 31, 2022 |
|
Business Acquisition [Line Items] | ||||||
Goodwill | $ 19,554 | $ 16,228 | ||||
Other intangible assets | 6,844 | 5,441 | ||||
Value of business acquired | 3,675 | 3,702 | ||||
Repurchase agreements (refer to Note 3 for balances associated with VIEs) | $ 2,617 | $ 1,419 | ||||
Huatai Group | ||||||
Business Acquisition [Line Items] | ||||||
Subsidiary, Ownership Percentage, Parent | 69.60% | 69.60% | ||||
Additional 5.4 percent ownership interest obtained in subsidiary | 5.40% | |||||
Subsidiary, Ownership Percentage, Noncontrolling Owner | 30.40% | |||||
Outstanding 14.1 percent additional ownership interest agreed on | 14.10% | |||||
Outstanding 3.0 percent ownership interest agreed on requiring regulatory approval | 3.00% | |||||
Huatai Group | Subsequent Event [Member] | ||||||
Business Acquisition [Line Items] | ||||||
Additional 2.5 percent ownership interest obtained in subsidiary | 2.50% | |||||
Huatai Group | ||||||
Business Acquisition [Line Items] | ||||||
Equity Method Investment, Ownership Percentage | 64.20% | |||||
Cigna's Life Insurance Business in Asia-Pacific Markets [Member] | ||||||
Business Acquisition [Line Items] | ||||||
Goodwill | $ 1,177 | |||||
Other intangible assets | 309 | |||||
Value of business acquired | $ 3,633 | |||||
Business Acquisition, Effective Date of Acquisition | Jul. 01, 2022 | |||||
Payments to Acquire Businesses, Gross | $ 5,400 | |||||
Repurchase agreements (refer to Note 3 for balances associated with VIEs) | $ 2,000 | |||||
Huatai Group | ||||||
Business Acquisition [Line Items] | ||||||
Payments to Acquire Additional Interest in Subsidiaries | $ 318 | |||||
Deposits previously paid on additional ownership interest agreed on | $ 416 | |||||
Outstanding payment to be made on additional ownership interest agreed on | $ 433 | |||||
Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value | 4,100 | |||||
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain | 744 | |||||
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Loss | 17 | |||||
Write-off of Accumulated AOCI Loss Balance, Equity Method Invesmtent | 611 | |||||
Business combination, Realized Gain (Loss) from Write-off of AOCI | (628) | |||||
Goodwill | 3,394 | |||||
Other intangible assets | 1,655 | |||||
Value of business acquired | 309 | |||||
Repurchase agreements (refer to Note 3 for balances associated with VIEs) | $ 1,269 | |||||
Huatai Group | Subsequent Event [Member] | ||||||
Business Acquisition [Line Items] | ||||||
Deposits previously paid on additional ownership interest obtained | $ 146 |
Acquisitions (Schedule of recognized identifiable assets acquired and liabilities assumed) (Details) - USD ($) $ in Millions |
Sep. 30, 2023 |
Jul. 01, 2023 |
Dec. 31, 2022 |
Sep. 30, 2022 |
Jul. 01, 2022 |
Dec. 31, 2021 |
Jan. 01, 2021 |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Business Acquisition [Line Items] | |||||||||||||
Accrued investment income | $ 1,040 | $ 941 | |||||||||||
Insurance and reinsurance balances receivable | 13,907 | 11,933 | |||||||||||
Reinsurance recoverable on losses and loss expenses | 19,750 | [1] | 18,859 | [2] | |||||||||
Reinsurance recoverable on policy benefits | [1],[2] | 315 | 302 | ||||||||||
Value of business acquired | 3,675 | 3,702 | |||||||||||
Other assets | 7,591 | 7,546 | |||||||||||
Total assets | 222,748 | 199,017 | |||||||||||
Unpaid losses and loss expenses | 79,705 | 75,747 | $ 75,336 | $ 72,330 | |||||||||
Unearned premiums | 22,684 | 19,713 | |||||||||||
Future policy benefits | 13,109 | 10,476 | 9,906 | $ 7,652 | |||||||||
Policyholders' account balances | 7,178 | 3,140 | 3,008 | $ 2,766 | |||||||||
Insurance and reinsurance balances payable | 8,481 | 7,780 | |||||||||||
Accounts payable, accrued expenses, and other liabilities | 8,422 | 7,148 | |||||||||||
Deferred tax liabilities | 759 | 377 | |||||||||||
Repurchase agreements (refer to Note 3 for balances associated with VIEs) | 2,617 | 1,419 | |||||||||||
Total liabilities | 165,244 | 148,498 | |||||||||||
Net acquired assets, including goodwill | 52,373 | 50,519 | 47,675 | ||||||||||
Equity, Attributable to Noncontrolling Interest | 5,131 | 0 | |||||||||||
Total shareholders' equity | 57,504 | 50,519 | $ 47,675 | ||||||||||
Total liabilities and shareholders’ equity | $ 222,748 | $ 199,017 | |||||||||||
Cigna's Life Insurance Business in Asia-Pacific Markets [Member] | |||||||||||||
Business Acquisition [Line Items] | |||||||||||||
Investments and Cash | $ 5,274 | ||||||||||||
Accrued investment income | 33 | ||||||||||||
Insurance and reinsurance balances receivable | 52 | ||||||||||||
Reinsurance recoverable on losses and loss expenses | 3 | ||||||||||||
Reinsurance recoverable on policy benefits | 85 | ||||||||||||
Value of business acquired | 3,633 | ||||||||||||
Goodwill and intangible assets | 1,486 | ||||||||||||
Other assets | 648 | ||||||||||||
Total assets | 11,214 | ||||||||||||
Unpaid losses and loss expenses | 12 | ||||||||||||
Unearned premiums | 60 | ||||||||||||
Future policy benefits | 3,856 | ||||||||||||
Insurance and reinsurance balances payable | 115 | ||||||||||||
Accounts payable, accrued expenses, and other liabilities | 926 | ||||||||||||
Deferred tax liabilities | 886 | ||||||||||||
Repurchase agreements (refer to Note 3 for balances associated with VIEs) | 2,000 | ||||||||||||
Total liabilities | 5,855 | ||||||||||||
Net acquired assets, including goodwill | 5,359 | ||||||||||||
Total liabilities and shareholders’ equity | $ 11,214 | ||||||||||||
Huatai Group | |||||||||||||
Business Acquisition [Line Items] | |||||||||||||
Investments and Cash | $ 13,346 | ||||||||||||
Accrued investment income | 60 | ||||||||||||
Insurance and reinsurance balances receivable | 277 | ||||||||||||
Reinsurance recoverable on losses and loss expenses | 581 | ||||||||||||
Reinsurance recoverable on policy benefits | 27 | ||||||||||||
Value of business acquired | 309 | ||||||||||||
Goodwill and intangible assets | 5,049 | ||||||||||||
Other assets | 748 | ||||||||||||
Total assets | 20,397 | ||||||||||||
Unpaid losses and loss expenses | 831 | ||||||||||||
Unearned premiums | 800 | ||||||||||||
Future policy benefits | 2,287 | ||||||||||||
Policyholders' account balances | 4,014 | ||||||||||||
Insurance and reinsurance balances payable | 644 | ||||||||||||
Accounts payable, accrued expenses, and other liabilities | 702 | ||||||||||||
Deferred tax liabilities | 232 | ||||||||||||
Repurchase agreements (refer to Note 3 for balances associated with VIEs) | 1,269 | ||||||||||||
Total liabilities | 10,779 | ||||||||||||
Net acquired assets, including goodwill | 4,408 | ||||||||||||
Equity, Attributable to Noncontrolling Interest | 5,210 | ||||||||||||
Total shareholders' equity | $ 9,618 | ||||||||||||
|
Acquisitions (Acquisition operations) (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
|
Business Acquisition [Line Items] | ||||
Total revenues | $ 13,853 | $ 12,122 | $ 36,743 | $ 31,654 |
Net income | 2,040 | 792 | 5,725 | 3,935 |
Net loss attributable to Chubb | $ 2,043 | $ 792 | 5,728 | 3,935 |
Huatai Group | ||||
Business Acquisition [Line Items] | ||||
Total revenues | 389 | |||
Net income | (11) | |||
Net loss attributable to Chubb | $ (9) | |||
Cigna's Life Insurance Business in Asia-Pacific Markets [Member] | ||||
Business Acquisition [Line Items] | ||||
Total revenues | 681 | |||
Net loss attributable to Chubb | $ 17 |
Acquisitions (Finite-lived and indefinite-lived intangible assets acquired) (Details) - USD ($) $ in Millions |
Jul. 01, 2023 |
Sep. 30, 2023 |
Dec. 31, 2022 |
---|---|---|---|
Finite-Lived Intangible Assets [Line Items] | |||
Intangible assets not subject to amortization | $ 3,494 | $ 2,982 | |
Total identified intangible assets | $ 6,844 | $ 5,441 | |
Huatai Group | |||
Finite-Lived Intangible Assets [Line Items] | |||
Total identified intangible assets | $ 1,655 | ||
Huatai Group | Trademarks | |||
Finite-Lived Intangible Assets [Line Items] | |||
Intangible assets not subject to amortization | 398 | ||
Huatai Group | Asset management mutual funds | |||
Finite-Lived Intangible Assets [Line Items] | |||
Intangible assets not subject to amortization | 122 | ||
Huatai Group | Distribution Rights [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Finite-Lived Intangible Assets Acquired | $ 332 | ||
Finite-Lived Intangible Asset, Useful Life | 20 years | ||
Huatai Group | Asset management mutual funds | |||
Finite-Lived Intangible Assets [Line Items] | |||
Finite-Lived Intangible Assets Acquired | $ 94 | ||
Finite-Lived Intangible Asset, Useful Life | 16 years | ||
Huatai Group | Unearned Premium Reserves Intangible Asset | |||
Finite-Lived Intangible Assets [Line Items] | |||
Finite-Lived Intangible Assets Acquired | $ 95 | ||
Finite-Lived Intangible Asset, Useful Life | 3 years | ||
Huatai Group | Use Rights [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Finite-Lived Intangible Assets Acquired | $ 569 | ||
Finite-Lived Intangible Asset, Useful Life | 31 years | ||
Huatai Group | Technology-Based Intangible Assets [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Finite-Lived Intangible Assets Acquired | $ 45 | ||
Finite-Lived Intangible Asset, Useful Life | 6 years |
Acquisitions (Pro forma) (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
|
Business Acquisition [Line Items] | ||||
Net premiums earned | $ 12,674 | $ 11,530 | $ 33,815 | $ 29,816 |
Cigna's Life Insurance Business in Asia-Pacific Markets [Member] | Pro Forma | ||||
Business Acquisition [Line Items] | ||||
Net premiums earned | 11,530 | 31,341 | ||
Total revenues | 12,124 | 33,161 | ||
Business Acquisition, Pro Forma Net Income (Loss) | 837 | 4,172 | ||
Huatai Group | Pro Forma | ||||
Business Acquisition [Line Items] | ||||
Net premiums earned | 12,674 | 11,952 | 34,605 | 30,996 |
Total revenues | 13,755 | 12,612 | 37,589 | 33,019 |
Business Acquisition, Pro Forma Net income (loss), Including Portion Attributable to Noncontrolling Interests | 1,905 | 787 | 5,595 | 3,975 |
Business Acquisition, Pro Forma Net Income (Loss) | $ 1,912 | $ 777 | $ 5,587 | $ 3,935 |
Investments (Narrative) (Details) - USD ($) |
9 Months Ended | |
---|---|---|
Sep. 30, 2023 |
Dec. 31, 2022 |
|
Investments [Line Items] | ||
Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Transfer, Amount | $ 8,200,000,000 | |
Debt Securities, Available-for-Sale and Held-to-Maturity, Fair Value | 7,800,000,000 | |
Debt Securities, Held-to-Maturity, Transfer, Unrealized Gain (Loss) | 428,000,000 | |
Restricted assets in fixed maturities and short-term investments | 17,505,000,000 | $ 15,721,000,000 |
Restricted assets in cash | 192,000,000 | $ 115,000,000 |
Investments | ||
Investments [Line Items] | ||
Deferred Tax Assets, Valuation Allowance | $ 1,108,000,000 |
Investments (Schedule Of Amortized Cost and Fair Value of Available-for-Sale Securities) (Details) - USD ($) $ in Millions |
Sep. 30, 2023 |
Jun. 30, 2023 |
Dec. 31, 2022 |
Sep. 30, 2022 |
Jun. 30, 2022 |
Dec. 31, 2021 |
---|---|---|---|---|---|---|
Debt Securities, Available-for-sale [Line Items] | ||||||
Debt Securities, Available-for-sale, Amortized Cost | $ 109,355 | $ 93,355 | ||||
Debt Securities, Available-for-sale, Allowance for Credit Loss | (158) | $ (193) | (169) | $ (147) | $ (78) | $ (14) |
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 310 | 174 | ||||
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before tax | (9,741) | (8,140) | ||||
Available for sale, Fair Value | 99,766 | 85,220 | ||||
U.S. Treasury / Agency | ||||||
Debt Securities, Available-for-sale [Line Items] | ||||||
Debt Securities, Available-for-sale, Amortized Cost | 3,944 | 2,792 | ||||
Debt Securities, Available-for-sale, Allowance for Credit Loss | 0 | 0 | ||||
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 2 | 5 | ||||
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before tax | (265) | (171) | ||||
Available for sale, Fair Value | 3,681 | 2,626 | ||||
Non-U.S. | ||||||
Debt Securities, Available-for-sale [Line Items] | ||||||
Debt Securities, Available-for-sale, Amortized Cost | 34,912 | 28,064 | ||||
Debt Securities, Available-for-sale, Allowance for Credit Loss | (53) | (59) | ||||
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 239 | 108 | ||||
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before tax | (2,381) | (2,205) | ||||
Available for sale, Fair Value | 32,717 | 25,908 | ||||
Corporate and asset-backed securities | ||||||
Debt Securities, Available-for-sale [Line Items] | ||||||
Debt Securities, Available-for-sale, Amortized Cost | 44,932 | 40,547 | ||||
Debt Securities, Available-for-sale, Allowance for Credit Loss | (104) | (107) | ||||
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 61 | 49 | ||||
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before tax | (4,034) | (3,534) | ||||
Available for sale, Fair Value | 40,855 | 36,955 | ||||
Mortgage-backed securities | ||||||
Debt Securities, Available-for-sale [Line Items] | ||||||
Debt Securities, Available-for-sale, Amortized Cost | 22,402 | 17,871 | ||||
Debt Securities, Available-for-sale, Allowance for Credit Loss | (1) | (3) | ||||
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 6 | 4 | ||||
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before tax | (2,802) | (2,021) | ||||
Available for sale, Fair Value | 19,605 | 15,851 | ||||
Municipal | ||||||
Debt Securities, Available-for-sale [Line Items] | ||||||
Debt Securities, Available-for-sale, Amortized Cost | 3,165 | 4,081 | ||||
Debt Securities, Available-for-sale, Allowance for Credit Loss | 0 | 0 | ||||
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | 2 | 8 | ||||
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before tax | (259) | (209) | ||||
Available for sale, Fair Value | $ 2,908 | $ 3,880 |
Investments (Schedule Of Amortized Cost And Fair Value Of Held-to-Maturity Fixed Maturities) (Details) - USD ($) $ in Millions |
Sep. 30, 2023 |
Jun. 30, 2023 |
Dec. 31, 2022 |
Sep. 30, 2022 |
Jun. 30, 2022 |
Dec. 31, 2021 |
---|---|---|---|---|---|---|
Schedule of Held-to-maturity Securities [Line Items] | ||||||
Debt Securities, Held to maturity, Allowance for Credit Loss | $ 0 | $ 0 | $ 34 | $ 33 | $ 34 | $ 35 |
Debt securities, held to maturity, net carrying value | 0 | 8,848 | ||||
Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain | 3 | |||||
Debt Securities, Held-to-Maturity, Accumulated Unrecognized Loss | (412) | |||||
Held to maturity, Fair Value | $ 0 | 8,439 | ||||
U.S. Treasury / Agency | ||||||
Schedule of Held-to-maturity Securities [Line Items] | ||||||
Debt Securities, Held to maturity, Allowance for Credit Loss | 0 | |||||
Debt securities, held to maturity, net carrying value | 1,417 | |||||
Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain | 1 | |||||
Debt Securities, Held-to-Maturity, Accumulated Unrecognized Loss | (48) | |||||
Held to maturity, Fair Value | 1,370 | |||||
Non-U.S. | ||||||
Schedule of Held-to-maturity Securities [Line Items] | ||||||
Debt Securities, Held to maturity, Allowance for Credit Loss | 4 | |||||
Debt securities, held to maturity, net carrying value | 1,136 | |||||
Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain | 0 | |||||
Debt Securities, Held-to-Maturity, Accumulated Unrecognized Loss | (82) | |||||
Held to maturity, Fair Value | 1,054 | |||||
Corporate and asset-backed securities | ||||||
Schedule of Held-to-maturity Securities [Line Items] | ||||||
Debt Securities, Held to maturity, Allowance for Credit Loss | 28 | |||||
Debt securities, held to maturity, net carrying value | 1,705 | |||||
Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain | 1 | |||||
Debt Securities, Held-to-Maturity, Accumulated Unrecognized Loss | (126) | |||||
Held to maturity, Fair Value | 1,580 | |||||
Mortgage-backed securities | ||||||
Schedule of Held-to-maturity Securities [Line Items] | ||||||
Debt Securities, Held to maturity, Allowance for Credit Loss | 1 | |||||
Debt securities, held to maturity, net carrying value | 1,455 | |||||
Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain | 0 | |||||
Debt Securities, Held-to-Maturity, Accumulated Unrecognized Loss | (104) | |||||
Held to maturity, Fair Value | 1,351 | |||||
Municipal | ||||||
Schedule of Held-to-maturity Securities [Line Items] | ||||||
Debt Securities, Held to maturity, Allowance for Credit Loss | 1 | |||||
Debt securities, held to maturity, net carrying value | 3,135 | |||||
Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain | 1 | |||||
Debt Securities, Held-to-Maturity, Accumulated Unrecognized Loss | (52) | |||||
Held to maturity, Fair Value | $ 3,084 |
Investments (Held-to-Maturity Credit Quality Indicator) (Details) $ in Millions |
Dec. 31, 2022
USD ($)
|
---|---|
Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items] | |
Debt Securities, Held-to-maturity | $ 8,882 |
Fixed Maturities Percent of Total Amortized cost | 100.00% |
Standard & Poor's, AAA Rating [Member] | |
Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items] | |
Debt Securities, Held-to-maturity | $ 1,612 |
Fixed Maturities Percent of Total Amortized cost | 18.00% |
Standard & Poor's, AA Rating [Member] | |
Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items] | |
Debt Securities, Held-to-maturity | $ 5,023 |
Fixed Maturities Percent of Total Amortized cost | 57.00% |
Standard & Poor's, A Rating [Member] | |
Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items] | |
Debt Securities, Held-to-maturity | $ 1,634 |
Fixed Maturities Percent of Total Amortized cost | 18.00% |
Standard & Poor's, BBB Rating [Member] | |
Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items] | |
Debt Securities, Held-to-maturity | $ 593 |
Fixed Maturities Percent of Total Amortized cost | 7.00% |
Standard & Poor's, BB Rating [Member] | |
Debt Securities, Held-to-maturity, Credit Quality Indicator [Line Items] | |
Debt Securities, Held-to-maturity | $ 20 |
Fixed Maturities Percent of Total Amortized cost | 0.00% |
Investments (Schedule Of Fixed Maturities By Contractual Maturity) (Details) - USD ($) $ in Millions |
Sep. 30, 2023 |
Dec. 31, 2022 |
---|---|---|
Investments, Debt and Equity Securities [Abstract] | ||
Available for sale, Due in 1 year or less, Fair Value & Net Carrying Value | $ 4,805 | $ 2,962 |
Available for sale, Due after 1 year through 5 years, Fair Value & Net Carrying Value | 31,738 | 24,791 |
Available for sale, Due after 5 years through 10 years, Fair Value & Net Carrying Value | 27,452 | 26,679 |
Available for sale, Due after 10 years, Fair Value & Net Carrying Value | 16,166 | 14,937 |
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value | 80,161 | 69,369 |
Available for sale, Mortgage backed securities, Fair Value & Net Carrying Value | 19,605 | 15,851 |
Available for sale, Fair Value | 99,766 | 85,220 |
Debt securities, Held-to-maturity, maturity, allocated and single maturity date, within one year, net carrying value | 0 | 1,015 |
Held to maturity, Due in 1 year or less, Fair Value | 0 | 1,003 |
Held-to-maturity, after one through five years, net carrying value | 0 | 3,658 |
Held to maturity, Due after 1 year through 5, Fair Value | 0 | 3,531 |
Held-to-maturity, after 5 through 10 years, net carrying value | 0 | 1,460 |
Held to maturity, Due after 5 years through 10 years, Fair Value | 0 | 1,423 |
Held-to-maturity, after 10 years, net carrying value | 0 | 1,260 |
Held to maturity, Due after 10 years, Fair Value | 0 | 1,131 |
Debt securities, Held-to-maturity, maturity, allocated and single maturity date, net carrying value | 0 | 7,393 |
Debt Securities, Held-to-maturity, Maturity, Allocated and Single Maturity Date, Fair Value | 0 | 7,088 |
Held-to-maturity, MBS, net carrying value | 0 | 1,455 |
Held to maturity, Mortgage backed securities, Fair Value | 0 | 1,351 |
Debt securities, held to maturity, net carrying value | 0 | 8,848 |
Held to maturity, Fair Value | $ 0 | $ 8,439 |
Investments (Aggregate Fair Value And Gross Unrealized Loss By Length Of Time Security Has Continuously Been In Unrealized Loss Position) (Details) - Fixed Maturities [Member] - USD ($) $ in Millions |
Sep. 30, 2023 |
Dec. 31, 2022 |
---|---|---|
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items] | ||
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | $ 27,035 | $ 57,189 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | (974) | (4,115) |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | 56,471 | 14,991 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | (7,062) | (2,291) |
Debt Securities, Available-for-sale, Unrealized Loss Position | 83,506 | 72,180 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | (8,036) | (6,406) |
U.S. Treasury / Agency | ||
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items] | ||
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | 1,108 | 2,152 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | (32) | (125) |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | 2,449 | 386 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | (233) | (46) |
Debt Securities, Available-for-sale, Unrealized Loss Position | 3,557 | 2,538 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | (265) | (171) |
Non-U.S. | ||
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items] | ||
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | 8,591 | 15,538 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | (280) | (1,012) |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | 16,631 | 5,490 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | (1,670) | (704) |
Debt Securities, Available-for-sale, Unrealized Loss Position | 25,222 | 21,028 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | (1,950) | (1,716) |
Corporate and asset-backed securities | ||
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items] | ||
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | 10,120 | 25,687 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | (362) | (1,793) |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | 22,672 | 4,190 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | (2,441) | (552) |
Debt Securities, Available-for-sale, Unrealized Loss Position | 32,792 | 29,877 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | (2,803) | (2,345) |
Mortgage-backed securities | ||
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items] | ||
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | 5,827 | 10,561 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | (249) | (1,033) |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | 13,450 | 4,770 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | (2,510) | (941) |
Debt Securities, Available-for-sale, Unrealized Loss Position | 19,277 | 15,331 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | (2,759) | (1,974) |
Municipal | ||
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items] | ||
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | 1,389 | 3,251 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | (51) | (152) |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | 1,269 | 155 |
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | (208) | (48) |
Debt Securities, Available-for-sale, Unrealized Loss Position | 2,658 | 3,406 |
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | $ (259) | $ (200) |
Investments (Rollforward of expected credit-losses, AFS) (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||||||
---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
Jun. 30, 2023 |
Dec. 31, 2022 |
Jun. 30, 2022 |
Dec. 31, 2021 |
|
Debt Securities, Available-for-sale, Allowance for Credit Loss [Line Items] | ||||||||
Debt Securities, Available for sale, Allowance for Credit Loss | $ 158 | $ 147 | $ 158 | $ 147 | $ 193 | $ 169 | $ 78 | $ 14 |
Debt Securities, Available-for-sale, Allowance for Credit Loss, Period Increase (Decrease) | 34 | 91 | 172 | 169 | ||||
Debt Securities, Available-for-sale, Allowance for Credit Loss, Writeoff | (1) | 0 | (5) | 0 | ||||
Debt Securities, Available-for-Sale, Allowance for Credit Loss, Foreign Currency Revaluation | 0 | (2) | 0 | (2) | ||||
Debt Securities, Available-for-sale, Allowance for Credit Loss, Recovery | $ (68) | $ (20) | $ (178) | $ (34) |
Investments (Rollforward of expected credit losses HTM) (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||||||
---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
Jun. 30, 2023 |
Dec. 31, 2022 |
Jun. 30, 2022 |
Dec. 31, 2021 |
|
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items] | ||||||||
Debt Securities, Held to maturity, Allowance for Credit Loss | $ 0 | $ 33 | $ 0 | $ 33 | $ 0 | $ 34 | $ 34 | $ 35 |
Debt Securities, Held-to-maturity, Allowance for Credit Loss, Period Increase (Decrease) | 0 | 0 | 0 | 1 | ||||
Debt Securities, Held-to-maturity, Allowance for Credit Loss, Recovery | $ 0 | $ (1) | $ (34) | $ (3) |
Investments (Net Realized Gains (Losses) And Losses Included In Net Realized Gains (Losses) And Other Comprehensive Income) (Detail) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||||||
---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
|||||
Gain (Loss) on Securities [Line Items] | ||||||||
Debt Securities, Available-for-Sale, Allowance for Credit Loss, Period Increase (Decrease) | $ 34 | $ 91 | $ 172 | $ 169 | ||||
Debt Securities, Available-for-sale, Gain (Loss), Total | (70) | (279) | (357) | (857) | ||||
Net realized gains (losses) | (103) | (456) | (484) | (936) | ||||
Foreign exchange | (67) | 202 | (122) | 546 | ||||
Gain (Loss) on Derivative | 54 | (163) | (178) | (1) | ||||
Other | [1] | 92 | (40) | 79 | (114) | |||
Huatai Group | ||||||||
Gain (Loss) on Securities [Line Items] | ||||||||
Other | 116 | |||||||
Fixed Maturities [Member] | ||||||||
Gain (Loss) on Securities [Line Items] | ||||||||
Debt Securities, Available-for-Sale, Realized Gain (Loss), Excluding Other-than-temporary Impairment | 97 | 144 | 116 | 545 | ||||
Debt Securities, Available-for-Sale, Realized Loss, Excluding Other-than-temporary Impairment | (185) | (331) | (457) | (1,158) | ||||
Debt Securities, Available-for-Sale, Allowance for Credit Loss, Period Increase (Decrease) | 34 | (70) | 44 | (133) | ||||
Debt Securities, Available-For-Sale, Credit Impairment Charges Intent to Sell | [2] | (16) | (22) | (60) | (111) | |||
Equity Securities | ||||||||
Gain (Loss) on Securities [Line Items] | ||||||||
Equity Securities, FV-NI, Realized Gain (Loss) | (100) | (80) | (61) | (287) | ||||
Other Investments | ||||||||
Gain (Loss) on Securities [Line Items] | ||||||||
Net realized gains (losses) | (1) | (1) | ||||||
Alternative Investment | ||||||||
Gain (Loss) on Securities [Line Items] | ||||||||
Net realized gains (losses) | 40 | (42) | 75 | 17 | ||||
Other derivative instruments | ||||||||
Gain (Loss) on Securities [Line Items] | ||||||||
Gain (Loss) on Derivative | (7) | (19) | (6) | (9) | ||||
Investment and embedded derivative instruments | ||||||||
Gain (Loss) on Securities [Line Items] | ||||||||
Gain (Loss) on Derivative | $ 9 | $ (198) | $ (92) | $ (232) | ||||
|
Investments Schedule of Gains and Losses on Equity and Other Investments (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
|
Gain (Loss) on Securities [Line Items] | ||||
Net realized gains (losses) | $ (103) | $ (456) | $ (484) | $ (936) |
Equity Securities | ||||
Gain (Loss) on Securities [Line Items] | ||||
Equity Securities, FV-NI, Realized Gain (Loss) | (100) | (80) | (61) | (287) |
Less: Net gains (losses) recognized from sales of securities | (45) | (12) | (48) | 406 |
Unrealized Gain (Loss) on Investments | (55) | (68) | (13) | (693) |
Other Investments | ||||
Gain (Loss) on Securities [Line Items] | ||||
Net realized gains (losses) | (1) | (1) | ||
Less: Net gains (losses) recognized from sales of securities | 0 | 0 | ||
Unrealized Gain (Loss) on Investments | (1) | (1) | ||
Equity securities and other investments | ||||
Gain (Loss) on Securities [Line Items] | ||||
Net realized gains (losses) | (122) | (270) | ||
Less: Net gains (losses) recognized from sales of securities | (12) | 406 | ||
Unrealized Gain (Loss) on Investments | (110) | (676) | ||
Fixed maturities trading, equity securities and other investments | ||||
Gain (Loss) on Securities [Line Items] | ||||
Net realized gains (losses) | (61) | 13 | ||
Less: Net gains (losses) recognized from sales of securities | (45) | (48) | ||
Unrealized Gain (Loss) on Investments | (16) | 61 | ||
Alternative Investment | ||||
Gain (Loss) on Securities [Line Items] | ||||
Net realized gains (losses) | 40 | (42) | 75 | 17 |
Less: Net gains (losses) recognized from sales of securities | 0 | 0 | 0 | 0 |
Unrealized Gain (Loss) on Investments | $ 40 | $ (42) | $ 75 | $ 17 |
Investments Entities that Calculate Net Asset Value Per Share (Details) - USD ($) $ in Millions |
9 Months Ended | 12 Months Ended |
---|---|---|
Sep. 30, 2023 |
Dec. 31, 2022 |
|
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Unfunded Commitments | $ 6,309 | $ 7,395 |
Alternative Investment | 13,362 | 12,355 |
Financial [Member] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Unfunded Commitments | 384 | 505 |
Alternative Investment | 1,219 | 1,074 |
Real Estate Funds [Member] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Unfunded Commitments | 526 | 681 |
Alternative Investment | 2,136 | 2,166 |
Distressed Alternative Investments [Member] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Unfunded Commitments | 810 | 755 |
Alternative Investment | 1,160 | 1,048 |
Private Credit Alternative Investments [Member] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Unfunded Commitments | 309 | 429 |
Alternative Investment | 319 | 215 |
Private Equity Funds [Member] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Unfunded Commitments | 4,280 | 5,025 |
Alternative Investment | 8,222 | 7,424 |
Vintage Alternative Investments [Member] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Unfunded Commitments | 0 | 0 |
Alternative Investment | 78 | 55 |
Investment Funds Alternative Investments [Member] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Unfunded Commitments | 0 | 0 |
Alternative Investment | $ 228 | $ 373 |
Minimum | Financial [Member] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Liquidating Investment, Remaining Period | 2 years | 2 years |
Minimum | Real Estate Funds [Member] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Liquidating Investment, Remaining Period | 2 years | 2 years |
Minimum | Distressed Alternative Investments [Member] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Liquidating Investment, Remaining Period | 2 years | 2 years |
Minimum | Private Credit Alternative Investments [Member] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Liquidating Investment, Remaining Period | 3 years | 3 years |
Minimum | Private Equity Funds [Member] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Liquidating Investment, Remaining Period | 2 years | 2 years |
Minimum | Vintage Alternative Investments [Member] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Liquidating Investment, Remaining Period | 1 year | 1 year |
Maximum | Financial [Member] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Liquidating Investment, Remaining Period | 10 years | 10 years |
Maximum | Real Estate Funds [Member] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Liquidating Investment, Remaining Period | 13 years | 13 years |
Maximum | Distressed Alternative Investments [Member] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Liquidating Investment, Remaining Period | 8 years | 8 years |
Maximum | Private Credit Alternative Investments [Member] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Liquidating Investment, Remaining Period | 8 years | 8 years |
Maximum | Private Equity Funds [Member] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Liquidating Investment, Remaining Period | 14 years | 14 years |
Maximum | Vintage Alternative Investments [Member] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items] | ||
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Liquidating Investment, Remaining Period | 3 years | 3 years |
Investments (Schedule Of Components Of Restricted Assets) (Detail) - USD ($) $ in Millions |
Sep. 30, 2023 |
Dec. 31, 2022 |
---|---|---|
Investments [Line Items] | ||
Total restricted assets | $ 17,697 | $ 15,836 |
Asset Pledged as Collateral without Right | ||
Investments [Line Items] | ||
Trust funds | 8,462 | 8,120 |
Deposits with U.S. regulatory authorities | 2,290 | 2,345 |
Deposits with non-U.S. regulatory authorities | 3,366 | 2,959 |
Assets pledged under repurchase agreements | 2,753 | 1,527 |
Other pledged assets | $ 826 | $ 885 |
Investments Variable Interest Entities Consolidated (Details) - USD ($) $ in Millions |
Sep. 30, 2023 |
Dec. 31, 2022 |
Sep. 30, 2022 |
Dec. 31, 2021 |
---|---|---|---|---|
Variable Interest Entity [Line Items] | ||||
Other Short-Term Investments | $ 5,454 | $ 4,960 | ||
Debt Securities, Available-for-Sale | 99,766 | 85,220 | ||
Equity securities, at fair value | 3,395 | 827 | ||
Alternative Investment | 13,362 | 12,355 | ||
Other investments | 5,583 | 1,341 | ||
Total investments (refer to Note 3 for balances associated with variable interest entities (VIEs)) | 129,961 | 113,551 | ||
Repurchase agreements (refer to Note 3 for balances associated with VIEs) | 2,617 | 1,419 | ||
Total liabilities (preliminary) | 165,244 | 148,498 | ||
Noncontrolling interests (refer to Note 3 for balances associated with VIEs) | 5,131 | 0 | ||
Total cash and restricted cash shown in the Consolidated statement of cash flows | 2,778 | 2,127 | $ 2,264 | $ 1,811 |
Other assets | 7,591 | 7,546 | ||
Total assets (preliminary) | 222,748 | $ 199,017 | ||
Variable Interest Entity, Primary Beneficiary | ||||
Variable Interest Entity [Line Items] | ||||
Other Short-Term Investments | 466 | |||
Equity securities, at fair value | 986 | |||
Alternative Investment | 21 | |||
Other investments | 3,937 | |||
Total investments (refer to Note 3 for balances associated with variable interest entities (VIEs)) | 5,410 | |||
Other liabilities | 32 | |||
Repurchase agreements (refer to Note 3 for balances associated with VIEs) | 837 | |||
Total liabilities (preliminary) | 869 | |||
Noncontrolling interests (refer to Note 3 for balances associated with VIEs) | 3,176 | |||
Economic Interests in Consolidated Investment Products | 1,551 | |||
Total cash and restricted cash shown in the Consolidated statement of cash flows | 164 | |||
Other assets | 22 | |||
Total assets (preliminary) | $ 5,596 |
Fair value measurements (Financial Instruments Measured At Fair Value On Recurring Basis) (Details) - USD ($) $ in Millions |
Sep. 30, 2023 |
Dec. 31, 2022 |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | $ 99,766 | $ 85,220 | ||||||||||
Equity securities, at fair value | 3,395 | 827 | ||||||||||
Other Short-Term Investments | 5,454 | 4,960 | ||||||||||
Other investments | 5,583 | 1,341 | ||||||||||
Securities lending collateral | 1,469 | 1,523 | ||||||||||
Separate account assets | 5,306 | 5,190 | ||||||||||
Market risk benefits | 770 | 800 | ||||||||||
Alternative Investment | 13,362 | 12,355 | ||||||||||
Investment Funds Limited Partnerships Partially Owned Investment Companies Fair Value | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Alternative Investment | 13,362 | 12,355 | ||||||||||
Policy Loans | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Other investments | 603 | 343 | ||||||||||
Other Investments | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Other investments | 47 | 47 | ||||||||||
U.S. Treasury / Agency | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | 3,681 | 2,626 | ||||||||||
Non-U.S. | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | 32,717 | 25,908 | ||||||||||
Corporate and asset-backed securities | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | 40,855 | 36,955 | ||||||||||
Mortgage-backed securities | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | 19,605 | 15,851 | ||||||||||
Municipal | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | 2,908 | 3,880 | ||||||||||
Level 1 | Fair Value, Recurring | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | 3,084 | 2,100 | ||||||||||
Equity securities, at fair value | 3,310 | 737 | ||||||||||
Other Short-Term Investments | 2,546 | 3,108 | ||||||||||
Other investments | 569 | [1] | 552 | [2] | ||||||||
Securities lending collateral | 0 | 0 | ||||||||||
Investment derivative instruments | 42 | 82 | ||||||||||
Derivatives designated as hedging instruments | 0 | 0 | ||||||||||
Other derivative instruments | 53 | 33 | ||||||||||
Separate account assets | 5,217 | 5,101 | ||||||||||
Total assets measured at fair value | 14,821 | [1] | 11,713 | [2] | ||||||||
Investment derivatives | 168 | 139 | ||||||||||
Derivatives designated as hedging instruments | 0 | 0 | ||||||||||
Other derivative instruments, liability | 0 | |||||||||||
Market risk benefits | 0 | [3] | 0 | [4] | ||||||||
Total liabilities measured at fair value | 168 | 139 | ||||||||||
Level 1 | U.S. Treasury / Agency | Fair Value, Recurring | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | 3,084 | 2,100 | ||||||||||
Level 1 | Non-U.S. | Fair Value, Recurring | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | 0 | 0 | ||||||||||
Level 1 | Corporate and asset-backed securities | Fair Value, Recurring | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | 0 | 0 | ||||||||||
Level 1 | Mortgage-backed securities | Fair Value, Recurring | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | 0 | 0 | ||||||||||
Level 1 | Municipal | Fair Value, Recurring | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | 0 | 0 | ||||||||||
Level 2 | Fair Value, Recurring | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | 93,455 | 80,096 | ||||||||||
Equity securities, at fair value | 0 | 0 | ||||||||||
Other Short-Term Investments | 2,906 | 1,849 | ||||||||||
Other investments | 4,364 | [1] | 399 | [2] | ||||||||
Securities lending collateral | 1,469 | 1,523 | ||||||||||
Investment derivative instruments | 0 | 0 | ||||||||||
Derivatives designated as hedging instruments | 48 | 17 | ||||||||||
Other derivative instruments | 0 | 0 | ||||||||||
Separate account assets | 89 | 89 | ||||||||||
Total assets measured at fair value | 102,331 | [1] | 83,973 | [2] | ||||||||
Investment derivatives | 0 | 0 | ||||||||||
Derivatives designated as hedging instruments | 68 | 53 | ||||||||||
Other derivative instruments, liability | 4 | |||||||||||
Market risk benefits | 0 | [3] | 0 | [4] | ||||||||
Total liabilities measured at fair value | 72 | 53 | ||||||||||
Level 2 | U.S. Treasury / Agency | Fair Value, Recurring | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | 597 | 526 | ||||||||||
Level 2 | Non-U.S. | Fair Value, Recurring | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | 32,084 | 25,344 | ||||||||||
Level 2 | Corporate and asset-backed securities | Fair Value, Recurring | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | 38,286 | 34,506 | ||||||||||
Level 2 | Mortgage-backed securities | Fair Value, Recurring | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | 19,580 | 15,840 | ||||||||||
Level 2 | Municipal | Fair Value, Recurring | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | 2,908 | 3,880 | ||||||||||
Level 3 | Fair Value, Recurring | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | 3,227 | 3,024 | ||||||||||
Equity securities, at fair value | 85 | 90 | ||||||||||
Other Short-Term Investments | 2 | 3 | ||||||||||
Other investments | 0 | [1] | 0 | [2] | ||||||||
Securities lending collateral | 0 | 0 | ||||||||||
Investment derivative instruments | 0 | 0 | ||||||||||
Derivatives designated as hedging instruments | 0 | 0 | ||||||||||
Other derivative instruments | 0 | 0 | ||||||||||
Separate account assets | 0 | 0 | ||||||||||
Total assets measured at fair value | 3,314 | [1] | 3,117 | [2] | ||||||||
Investment derivatives | 0 | 0 | ||||||||||
Derivatives designated as hedging instruments | 0 | 0 | ||||||||||
Other derivative instruments, liability | 0 | |||||||||||
Market risk benefits | 770 | [3] | 800 | [4] | ||||||||
Total liabilities measured at fair value | 770 | 800 | ||||||||||
Level 3 | U.S. Treasury / Agency | Fair Value, Recurring | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | 0 | 0 | ||||||||||
Level 3 | Non-U.S. | Fair Value, Recurring | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | 633 | 564 | ||||||||||
Level 3 | Corporate and asset-backed securities | Fair Value, Recurring | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | 2,569 | 2,449 | ||||||||||
Level 3 | Mortgage-backed securities | Fair Value, Recurring | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | 25 | 11 | ||||||||||
Level 3 | Municipal | Fair Value, Recurring | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | 0 | 0 | ||||||||||
Total Level 1, Level 2, and Level 3 | Fair Value, Recurring | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | 99,766 | 85,220 | ||||||||||
Equity securities, at fair value | 3,395 | 827 | ||||||||||
Other Short-Term Investments | 5,454 | 4,960 | ||||||||||
Other investments | 4,933 | [1] | 951 | [2] | ||||||||
Securities lending collateral | 1,469 | 1,523 | ||||||||||
Investment derivative instruments | 42 | 82 | ||||||||||
Derivatives designated as hedging instruments | 48 | 17 | ||||||||||
Other derivative instruments | 53 | 33 | ||||||||||
Separate account assets | 5,306 | 5,190 | ||||||||||
Total assets measured at fair value | 120,466 | [1] | 98,803 | [2] | ||||||||
Investment derivatives | 168 | 139 | ||||||||||
Derivatives designated as hedging instruments | 68 | 53 | ||||||||||
Other derivative instruments, liability | 4 | |||||||||||
Market risk benefits | 770 | [3] | 800 | [4] | ||||||||
Total liabilities measured at fair value | 1,010 | 992 | ||||||||||
Total Level 1, Level 2, and Level 3 | U.S. Treasury / Agency | Fair Value, Recurring | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | 3,681 | 2,626 | ||||||||||
Total Level 1, Level 2, and Level 3 | Non-U.S. | Fair Value, Recurring | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | 32,717 | 25,908 | ||||||||||
Total Level 1, Level 2, and Level 3 | Corporate and asset-backed securities | Fair Value, Recurring | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | 40,855 | 36,955 | ||||||||||
Total Level 1, Level 2, and Level 3 | Mortgage-backed securities | Fair Value, Recurring | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | 19,605 | 15,851 | ||||||||||
Total Level 1, Level 2, and Level 3 | Municipal | Fair Value, Recurring | ||||||||||||
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items] | ||||||||||||
Debt Securities, Available-for-Sale | $ 2,908 | $ 3,880 | ||||||||||
|
Fair value measurements (Assets, Measured At Fair Value Using Significant Unobservable Inputs) (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
|
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||
Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] | Other comprehensive loss, before income tax | Other comprehensive loss, before income tax | Other comprehensive loss, before income tax | Other comprehensive loss, before income tax |
Fair Value, Asset (Liability), Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] | Total revenues | Total revenues | Total revenues | Total revenues |
Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] | Total revenues | Total revenues | Total revenues | |
Level 3 | Equity Securities | ||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||
Balance- Beginning of Period, Assets | $ 86 | $ 81 | $ 90 | $ 77 |
Transfers Into Level 3, Asset | 0 | 0 | 0 | 1 |
Transfers out of Level 3, Assets | 0 | 0 | 0 | 0 |
Change in Net Unrealized Gains (Losses) included in OCI, Assets | 0 | 0 | 0 | 0 |
Net Realized Gains/ (Losses), Assets | 0 | 3 | (6) | 7 |
Purchases, Assets | 4 | 3 | 15 | 6 |
Sales, Assets | (5) | (4) | (14) | (8) |
Settlements, Assets | 0 | 0 | 0 | 0 |
Balance-End of Period, Assets | 85 | 83 | 85 | 83 |
Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date, Assets | 0 | 3 | (6) | 6 |
Change in Net Unrealized Gains/Losses included in OCI at the Balance Sheet Date, Assets | 0 | 0 | 0 | 0 |
Level 3 | Short-term Investments | ||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||
Balance- Beginning of Period, Assets | 3 | 9 | 3 | 7 |
Transfers Into Level 3, Asset | 0 | 0 | 0 | 0 |
Transfers out of Level 3, Assets | 0 | 0 | 0 | 0 |
Change in Net Unrealized Gains (Losses) included in OCI, Assets | 0 | 0 | (1) | 0 |
Net Realized Gains/ (Losses), Assets | 0 | (1) | 0 | (1) |
Purchases, Assets | 0 | 1 | 3 | 8 |
Sales, Assets | (1) | 0 | (3) | 0 |
Settlements, Assets | 0 | (6) | 0 | (11) |
Balance-End of Period, Assets | 2 | 3 | 2 | 3 |
Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date, Assets | 0 | (1) | 0 | (1) |
Change in Net Unrealized Gains/Losses included in OCI at the Balance Sheet Date, Assets | 0 | 0 | 0 | 0 |
Level 3 | Available-for-Sale Debt Securities | Non-U.S. | ||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||
Balance- Beginning of Period, Assets | 649 | 549 | 564 | 633 |
Transfers Into Level 3, Asset | 0 | 0 | 21 | 23 |
Transfers out of Level 3, Assets | (22) | 0 | (22) | (23) |
Change in Net Unrealized Gains (Losses) included in OCI, Assets | (6) | (34) | 5 | (88) |
Net Realized Gains/ (Losses), Assets | (2) | (4) | (3) | (6) |
Purchases, Assets | 46 | 39 | 151 | 108 |
Sales, Assets | (17) | (19) | (52) | (44) |
Settlements, Assets | (15) | (25) | (31) | (97) |
Balance-End of Period, Assets | 633 | 506 | 633 | 506 |
Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date, Assets | (1) | (1) | (1) | (3) |
Change in Net Unrealized Gains/Losses included in OCI at the Balance Sheet Date, Assets | (8) | (35) | 1 | (89) |
Level 3 | Available-for-Sale Debt Securities | Corporate and asset-backed securities | ||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||
Balance- Beginning of Period, Assets | 2,524 | 2,261 | 2,449 | 2,049 |
Transfers Into Level 3, Asset | 0 | 2 | 3 | 41 |
Transfers out of Level 3, Assets | (10) | (4) | (23) | (97) |
Change in Net Unrealized Gains (Losses) included in OCI, Assets | 6 | (16) | 8 | (68) |
Net Realized Gains/ (Losses), Assets | (4) | (9) | (7) | (9) |
Purchases, Assets | 158 | 164 | 481 | 658 |
Sales, Assets | (40) | (8) | (70) | (59) |
Settlements, Assets | (65) | (94) | (272) | (219) |
Balance-End of Period, Assets | 2,569 | 2,296 | 2,569 | 2,296 |
Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date, Assets | (4) | (3) | (6) | (4) |
Change in Net Unrealized Gains/Losses included in OCI at the Balance Sheet Date, Assets | 4 | (19) | 2 | (71) |
Level 3 | Available-for-Sale Debt Securities | Mortgage-backed securities | ||||
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||
Balance- Beginning of Period, Assets | 10 | 19 | 11 | 26 |
Transfers Into Level 3, Asset | 0 | 0 | 0 | 0 |
Transfers out of Level 3, Assets | 0 | 0 | 0 | (5) |
Change in Net Unrealized Gains (Losses) included in OCI, Assets | 0 | 0 | 0 | 0 |
Net Realized Gains/ (Losses), Assets | 0 | 0 | 0 | 0 |
Purchases, Assets | 16 | 4 | 16 | 4 |
Sales, Assets | 0 | 0 | 0 | 0 |
Settlements, Assets | (1) | (4) | (2) | (6) |
Balance-End of Period, Assets | 25 | 19 | 25 | 19 |
Net Realized Gains/Losses Attributable to Changes in Fair Value at the Balance Sheet Date, Assets | 0 | 0 | 0 | 0 |
Change in Net Unrealized Gains/Losses included in OCI at the Balance Sheet Date, Assets | $ 0 | $ 0 | $ 0 | $ 0 |
Fair value measurements (Carrying Values And Fair Values Of Financial Instruments Not Measured At Fair Value) (Details) - USD ($) $ in Millions |
Sep. 30, 2023 |
Dec. 31, 2022 |
---|---|---|
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | $ 0 | $ 8,439 |
Private debt held-for-investment | 2,401 | 0 |
Total assets (preliminary) | 222,748 | 199,017 |
Debt Securities, Held-to-maturity | 8,882 | |
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract] | ||
Repurchase agreements (refer to Note 3 for balances associated with VIEs) | 2,617 | 1,419 |
Short-term debt | 700 | 475 |
Long-term debt | 13,736 | 14,402 |
Total liabilities | 165,244 | 148,498 |
Portion at Other than Fair Value Measurement | Level 1 | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | 1,299 | |
Private debt held-for-investment | 0 | |
Total assets (preliminary) | 0 | |
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract] | ||
Repurchase agreements (refer to Note 3 for balances associated with VIEs) | 0 | 0 |
Short-Term Debt, Fair Value | 0 | 0 |
Long-term Debt, Fair Value | 0 | 0 |
Trust preferred securities | 0 | 0 |
Total liabilities | 0 | 0 |
Portion at Other than Fair Value Measurement | Level 2 | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | 7,140 | |
Private debt held-for-investment | 0 | |
Total assets (preliminary) | 0 | |
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract] | ||
Repurchase agreements (refer to Note 3 for balances associated with VIEs) | 2,617 | 1,419 |
Short-Term Debt, Fair Value | 688 | 473 |
Long-term Debt, Fair Value | 11,627 | 12,495 |
Trust preferred securities | 362 | 383 |
Total liabilities | 15,294 | 14,770 |
Portion at Other than Fair Value Measurement | Level 3 | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | 0 | |
Private debt held-for-investment | 2,389 | |
Total assets (preliminary) | 2,389 | |
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract] | ||
Repurchase agreements (refer to Note 3 for balances associated with VIEs) | 0 | 0 |
Short-Term Debt, Fair Value | 0 | 0 |
Long-term Debt, Fair Value | 0 | 0 |
Trust preferred securities | 0 | 0 |
Total liabilities | 0 | 0 |
Portion at Other than Fair Value Measurement | Total Level 1, Level 2, and Level 3 | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | 8,439 | |
Private debt held-for-investment | 2,389 | |
Total assets (preliminary) | 2,389 | |
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract] | ||
Repurchase agreements (refer to Note 3 for balances associated with VIEs) | 2,617 | 1,419 |
Short-Term Debt, Fair Value | 688 | 473 |
Long-term Debt, Fair Value | 11,627 | 12,495 |
Trust preferred securities | 362 | 383 |
Total liabilities | 15,294 | 14,770 |
Reported Value Measurement [Member] | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Private debt held-for-investment | 2,401 | |
Total assets (preliminary) | 2,401 | |
Debt Securities, Held-to-maturity | 8,848 | |
Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract] | ||
Repurchase agreements (refer to Note 3 for balances associated with VIEs) | 2,617 | 1,419 |
Short-term debt | 700 | 475 |
Long-term debt | 13,736 | 14,402 |
Trust preferred securities | 308 | 308 |
Total liabilities | $ 17,361 | 16,604 |
U.S. Treasury / Agency | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | 1,370 | |
Debt Securities, Held-to-maturity | 1,417 | |
U.S. Treasury / Agency | Portion at Other than Fair Value Measurement | Level 1 | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | 1,299 | |
U.S. Treasury / Agency | Portion at Other than Fair Value Measurement | Level 2 | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | 71 | |
U.S. Treasury / Agency | Portion at Other than Fair Value Measurement | Level 3 | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | 0 | |
U.S. Treasury / Agency | Portion at Other than Fair Value Measurement | Total Level 1, Level 2, and Level 3 | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | 1,370 | |
U.S. Treasury / Agency | Reported Value Measurement [Member] | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Debt Securities, Held-to-maturity | 1,417 | |
Non-U.S. | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | 1,054 | |
Debt Securities, Held-to-maturity | 1,140 | |
Non-U.S. | Portion at Other than Fair Value Measurement | Level 1 | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | 0 | |
Non-U.S. | Portion at Other than Fair Value Measurement | Level 2 | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | 1,054 | |
Non-U.S. | Portion at Other than Fair Value Measurement | Level 3 | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | 0 | |
Non-U.S. | Portion at Other than Fair Value Measurement | Total Level 1, Level 2, and Level 3 | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | 1,054 | |
Non-U.S. | Reported Value Measurement [Member] | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Debt Securities, Held-to-maturity | 1,136 | |
Corporate and asset-backed securities | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | 1,580 | |
Debt Securities, Held-to-maturity | 1,733 | |
Corporate and asset-backed securities | Portion at Other than Fair Value Measurement | Level 1 | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | 0 | |
Corporate and asset-backed securities | Portion at Other than Fair Value Measurement | Level 2 | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | 1,580 | |
Corporate and asset-backed securities | Portion at Other than Fair Value Measurement | Level 3 | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | 0 | |
Corporate and asset-backed securities | Portion at Other than Fair Value Measurement | Total Level 1, Level 2, and Level 3 | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | 1,580 | |
Corporate and asset-backed securities | Reported Value Measurement [Member] | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Debt Securities, Held-to-maturity | 1,705 | |
Mortgage-backed securities | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | 1,351 | |
Debt Securities, Held-to-maturity | 1,456 | |
Mortgage-backed securities | Portion at Other than Fair Value Measurement | Level 1 | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | 0 | |
Mortgage-backed securities | Portion at Other than Fair Value Measurement | Level 2 | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | 1,351 | |
Mortgage-backed securities | Portion at Other than Fair Value Measurement | Level 3 | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | 0 | |
Mortgage-backed securities | Portion at Other than Fair Value Measurement | Total Level 1, Level 2, and Level 3 | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | 1,351 | |
Mortgage-backed securities | Reported Value Measurement [Member] | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Debt Securities, Held-to-maturity | 1,455 | |
Municipal | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | 3,084 | |
Debt Securities, Held-to-maturity | 3,136 | |
Municipal | Portion at Other than Fair Value Measurement | Level 1 | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | 0 | |
Municipal | Portion at Other than Fair Value Measurement | Level 2 | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | 3,084 | |
Municipal | Portion at Other than Fair Value Measurement | Level 3 | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | 0 | |
Municipal | Portion at Other than Fair Value Measurement | Total Level 1, Level 2, and Level 3 | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Fixed maturities, held-to-maturity, fair value | 3,084 | |
Municipal | Reported Value Measurement [Member] | ||
Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] | ||
Debt Securities, Held-to-maturity | $ 3,135 |
Reinsurance (Reinsurance Recoverable on Ceded Reinsurance) (Details) - USD ($) $ in Millions |
Sep. 30, 2023 |
Dec. 31, 2022 |
Sep. 30, 2022 |
Dec. 31, 2021 |
||||||
---|---|---|---|---|---|---|---|---|---|---|
Reinsurance Disclosures [Abstract] | ||||||||||
Reinsurance recoverable on unpaid losses and loss expenses | [1] | $ 17,808 | $ 17,086 | $ 17,313 | $ 16,132 | |||||
Reinsurance recoverable on paid losses and loss expenses | [1],[2] | 1,942 | 1,773 | |||||||
Reinsurance recoverable on losses and loss expenses | 19,750 | [1] | 18,859 | [2] | ||||||
Reinsurance recoverable on policy benefits | [1],[2] | 315 | 302 | |||||||
Reinsurance Recoverables on Unpaid Losses, Allowance | 318 | 289 | ||||||||
Reinsurance Recoverables on Paid Losses, Allowance | 52 | 62 | ||||||||
Reinsurance Recoverable, Allowance for Credit Loss, Total | 370 | 351 | $ 352 | $ 329 | ||||||
Reinsurance Recoverables on Future Policy Benefits, Allowance | $ 1 | $ 4 | ||||||||
|
Reinsurance, Allowance (Details) - USD ($) $ in Millions |
9 Months Ended | |
---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
|
Reinsurance Disclosures [Abstract] | ||
Valuation allowance for uncollectible reinsurance - beginning of period | $ 351 | $ 329 |
Provision for uncollectible reinsurance | 27 | 30 |
Write-offs charged against the valuation allowance | (8) | (4) |
Foreign exchange revaluation | 0 | (3) |
Valuation allowance for uncollectible reinsurance - end of period | $ 370 | $ 352 |
Deferred acquisition costs (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
|
Deferred Policy Acquisition Cost [Line Items] | ||||
Deferred Policy Acquisition Cost | $ 6,856 | $ 6,856 | ||
Balance – beginning of period | 6,031 | |||
Amortization expense | (2,178) | $ (1,970) | (6,142) | $ (5,415) |
Balance - end of period | 6,856 | 6,856 | ||
Segment Life [Member] | ||||
Deferred Policy Acquisition Cost [Line Items] | ||||
Amortization expense | (279) | (266) | (829) | (537) |
Overseas General Insurance [Member] | ||||
Deferred Policy Acquisition Cost [Line Items] | ||||
Amortization expense | (827) | (720) | (2,286) | (2,096) |
Short-Duration Insurance, Other | ||||
Deferred Policy Acquisition Cost [Line Items] | ||||
Deferred Policy Acquisition Cost | 3,283 | 2,809 | 3,283 | 2,809 |
Balance - end of period | 3,283 | 2,809 | 3,283 | 2,809 |
Long-Duration Insurance, Other | ||||
Deferred Policy Acquisition Cost [Line Items] | ||||
Deferred Policy Acquisition Cost | 3,573 | 2,979 | 3,573 | 2,979 |
Balance - end of period | 3,573 | 2,979 | 3,573 | 2,979 |
Long-Duration Insurance, Other | Segment Life [Member] | ||||
Deferred Policy Acquisition Cost [Line Items] | ||||
Deferred Policy Acquisition Cost | 2,952 | 2,346 | 2,952 | 2,346 |
Balance – beginning of period | 2,514 | 2,204 | ||
Capitalizations | 722 | 457 | ||
Amortization expense | (262) | (213) | ||
Other (including foreign exchange) | (22) | (102) | ||
Balance - end of period | 2,952 | 2,346 | 2,952 | 2,346 |
Long-Duration Insurance, Other | Overseas General Insurance [Member] | ||||
Deferred Policy Acquisition Cost [Line Items] | ||||
Deferred Policy Acquisition Cost | 621 | 633 | 621 | 633 |
Balance - end of period | 621 | 633 | 621 | 633 |
Term Life Insurance | Segment Life [Member] | ||||
Deferred Policy Acquisition Cost [Line Items] | ||||
Deferred Policy Acquisition Cost | 372 | 299 | 372 | 299 |
Balance – beginning of period | 320 | 246 | ||
Capitalizations | 118 | 111 | ||
Amortization expense | (74) | (56) | ||
Other (including foreign exchange) | 8 | (2) | ||
Balance - end of period | 372 | 299 | 372 | 299 |
Universal Life | Segment Life [Member] | ||||
Deferred Policy Acquisition Cost [Line Items] | ||||
Deferred Policy Acquisition Cost | 784 | 761 | 784 | 761 |
Balance – beginning of period | 776 | 771 | ||
Capitalizations | 85 | 95 | ||
Amortization expense | (57) | (55) | ||
Other (including foreign exchange) | (20) | (50) | ||
Balance - end of period | 784 | 761 | 784 | 761 |
Whole Life Insurance | Segment Life [Member] | ||||
Deferred Policy Acquisition Cost [Line Items] | ||||
Deferred Policy Acquisition Cost | 488 | 350 | 488 | 350 |
Balance – beginning of period | 395 | 334 | ||
Capitalizations | 102 | 46 | ||
Amortization expense | (16) | (14) | ||
Other (including foreign exchange) | 7 | (16) | ||
Balance - end of period | 488 | 350 | 488 | 350 |
Accident and Health Insurance Product Line [Member] | Segment Life [Member] | ||||
Deferred Policy Acquisition Cost [Line Items] | ||||
Deferred Policy Acquisition Cost | 1,181 | 819 | 1,181 | 819 |
Balance – beginning of period | 902 | 745 | ||
Capitalizations | 392 | 166 | ||
Amortization expense | (100) | (72) | ||
Other (including foreign exchange) | (13) | (20) | ||
Balance - end of period | 1,181 | 819 | 1,181 | 819 |
Insurance, Other | Segment Life [Member] | ||||
Deferred Policy Acquisition Cost [Line Items] | ||||
Deferred Policy Acquisition Cost | 127 | 117 | 127 | 117 |
Balance – beginning of period | 121 | 108 | ||
Capitalizations | 25 | 39 | ||
Amortization expense | (15) | (16) | ||
Other (including foreign exchange) | (4) | (14) | ||
Balance - end of period | $ 127 | $ 117 | $ 127 | $ 117 |
Goodwill and Value of business acquired (Roll-forward of Goodwill by Business Segment) (Details) $ in Millions |
9 Months Ended | |||
---|---|---|---|---|
Sep. 30, 2023
USD ($)
| ||||
Goodwill [Roll Forward] | ||||
Balance at beginning of period | $ 16,228 | |||
Goodwill, Acquired During Period | 3,394 | [1] | ||
Foreign exchange revaluation and other | (68) | |||
Balance at end of period | 19,554 | |||
goodwill attributable to noncontrolling interests | 1,000 | |||
North America Commercial P&C Insurance [Member] | ||||
Goodwill [Roll Forward] | ||||
Balance at beginning of period | 6,945 | |||
Foreign exchange revaluation and other | 0 | |||
Balance at end of period | 6,945 | |||
North America Personal P&C Insurance [Member] | ||||
Goodwill [Roll Forward] | ||||
Balance at beginning of period | 2,230 | |||
Foreign exchange revaluation and other | 0 | |||
Balance at end of period | 2,230 | |||
North America Agricultural Insurance [Member] | ||||
Goodwill [Roll Forward] | ||||
Balance at beginning of period | 134 | |||
Foreign exchange revaluation and other | 0 | |||
Balance at end of period | 134 | |||
Overseas General Insurance [Member] | ||||
Goodwill [Roll Forward] | ||||
Balance at beginning of period | 4,605 | |||
Foreign exchange revaluation and other | 44 | |||
Balance at end of period | 5,211 | |||
Global Reinsurance [Member] | ||||
Goodwill [Roll Forward] | ||||
Balance at beginning of period | 371 | |||
Foreign exchange revaluation and other | 0 | |||
Balance at end of period | 371 | |||
Segment Life [Member] | ||||
Goodwill [Roll Forward] | ||||
Balance at beginning of period | 1,943 | |||
Foreign exchange revaluation and other | (112) | |||
Balance at end of period | 4,663 | |||
Huatai Group | North America Commercial P&C Insurance [Member] | ||||
Goodwill [Roll Forward] | ||||
Goodwill, Acquired During Period | 0 | [1] | ||
Huatai Group | North America Personal P&C Insurance [Member] | ||||
Goodwill [Roll Forward] | ||||
Goodwill, Acquired During Period | 0 | [1] | ||
Huatai Group | North America Agricultural Insurance [Member] | ||||
Goodwill [Roll Forward] | ||||
Goodwill, Acquired During Period | 0 | [1] | ||
Huatai Group | Overseas General Insurance [Member] | ||||
Goodwill [Roll Forward] | ||||
Goodwill, Acquired During Period | 562 | [1] | ||
Huatai Group | Global Reinsurance [Member] | ||||
Goodwill [Roll Forward] | ||||
Goodwill, Acquired During Period | 0 | [1] | ||
Huatai Group | Segment Life [Member] | ||||
Goodwill [Roll Forward] | ||||
Goodwill, Acquired During Period | $ 2,832 | [1] | ||
|
Goodwill and Value of business acquired (VOBA) (Details) $ in Millions |
9 Months Ended | |||
---|---|---|---|---|
Sep. 30, 2023
USD ($)
| ||||
VOBA Roll Forward | ||||
Balance, beginning of period | $ 3,702 | |||
Present Value of Future Insurance Profits, Addition from Acquisition | 309 | |||
Amortization of Value of Business Acquired (VOBA) | 235 | [1] | ||
Foreign exchange revaluation and other | (101) | |||
Balance, end of period | 3,675 | |||
Acquired Indefinite-Lived Intangible Assets [Line Items] | ||||
Amortization of Value of Business Acquired (VOBA) | $ 235 | [1] | ||
|
Goodwill and Value of business acquired, and Other Intangible Assets (Other Intangible Assets) (Details)) - USD ($) $ in Millions |
Sep. 30, 2023 |
Dec. 31, 2022 |
---|---|---|
Goodwill and Intangible Assets Disclosure [Abstract] | ||
Intangible assets subject to amortization | $ 3,350 | $ 2,459 |
Intangible assets not subject to amortization | 3,494 | 2,982 |
Other intangible assets | 6,844 | $ 5,441 |
Acquired Indefinite-Lived Intangible Assets [Line Items] | ||
2028, Other intangible assets | $ 253 |
Value of Business Acquired, Goodwill, and Other Intangible Assets (Estimated Amortization Expense Over Next Five Years) (Details) $ in Millions |
Sep. 30, 2023
USD ($)
|
|||||
---|---|---|---|---|---|---|
Finite-Lived Intangible Assets [Line Items] | ||||||
Fourth quarter of 2023, VOBA | $ 67 | |||||
Fourth quarter of 2023, Other intangible assets | 103 | |||||
2024, Other intangible assets | 354 | |||||
2025, Other intangible assets | 314 | |||||
2026, Other intangible assets | 288 | |||||
2027, Other intangible assets | 265 | |||||
2028, Other intangible assets | 253 | |||||
Total, other intangible assets | 1,577 | |||||
2024, Other intangible assets | 270 | |||||
2025, Other intangible assets | 202 | |||||
2026, Other intangible assets | 181 | |||||
2027, Other intangible assets | 165 | |||||
Present Value of Future Insurance Profits, Expected Amortization, Total | 1,115 | |||||
2024, Other intangible assets | 230 | |||||
Huatai Group | Unearned Premium Reserves Intangible Asset | ||||||
Finite-Lived Intangible Assets [Line Items] | ||||||
Fourth quarter of 2023, Other intangible assets | 16 | [1] | ||||
2024, Other intangible assets | 30 | [1] | ||||
2025, Other intangible assets | 16 | [1] | ||||
2026, Other intangible assets | 7 | [1] | ||||
2027, Other intangible assets | 3 | [1] | ||||
2028, Other intangible assets | 0 | [1] | ||||
Total, other intangible assets | 72 | [1] | ||||
Huatai Group | Use Rights [Member] | ||||||
Finite-Lived Intangible Assets [Line Items] | ||||||
Fourth quarter of 2023, Other intangible assets | 3 | [2] | ||||
2024, Other intangible assets | 12 | [2] | ||||
2025, Other intangible assets | 12 | [2] | ||||
2026, Other intangible assets | 12 | [2] | ||||
2027, Other intangible assets | 13 | [2] | ||||
2028, Other intangible assets | 13 | [2] | ||||
Total, other intangible assets | 65 | [2] | ||||
Chubb Acquired Purchased Intangible assets | ||||||
Finite-Lived Intangible Assets [Line Items] | ||||||
Fourth quarter of 2023, Other intangible assets | 84 | |||||
2024, Other intangible assets | 312 | |||||
2025, Other intangible assets | 286 | |||||
2026, Other intangible assets | 269 | |||||
2027, Other intangible assets | 249 | |||||
2028, Other intangible assets | 240 | |||||
Total, other intangible assets | $ 1,440 | |||||
|
Unpaid losses and loss expenses (RF) (Details) - USD ($) $ in Millions |
9 Months Ended | |||||
---|---|---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
|||||
Unpaid Losses and Loss Expenses [Roll Forward] | ||||||
Gross unpaid losses and loss expenses – beginning of period | $ 75,747 | $ 72,330 | ||||
Reinsurance recoverable on unpaid losses – beginning of period (1) | [1] | (17,086) | (16,132) | |||
Net unpaid losses and loss expenses – beginning of period | 58,661 | 56,198 | ||||
Current Year Claims and Claims Adjustment Expense | 18,604 | 17,755 | ||||
Prior Year Claims and Claims Adjustment Expense | [2] | (667) | (922) | |||
Total, Incurred | 17,937 | 16,833 | ||||
Net loss and loss expenses paid, Current Year | 4,853 | 4,511 | ||||
Net loss and loss expenses paid, Prior Years | 10,158 | 9,217 | ||||
Total, Paid | 15,011 | 13,728 | ||||
Liability For Unpaid Claims And Claims Adjustment Expense Foreign Currency Revaluation And Other | (95) | (1,280) | ||||
Net unpaid losses and loss expenses – end of period | 61,897 | 58,023 | ||||
Reinsurance recoverable on unpaid losses (1) | [1] | 17,808 | 17,313 | |||
Gross unpaid losses and loss expenses – end of period | 79,705 | 75,336 | ||||
prior period development, net adjustments | 71 | $ 213 | ||||
Liability for Unpaid Claims and Claims Adjustment Expense, Period Increase (Decrease), Gross | 4,000 | |||||
Liability for Unpaid Claims and Claims Adjustment Expense, Period Increase (Decrease) | $ 3,200 | |||||
|
Unpaid losses and loss expenses Unpaid losses and loss expenses (PPD table) (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
|
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | $ (200) | $ (222) | $ (596) | $ (709) |
North America Commercial P&C Insurance [Member] | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | (84) | (166) | (302) | (561) |
North America Commercial P&C Insurance [Member] | Auto Liability [Member] | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | 58 | |||
North America Commercial P&C Insurance [Member] | Workers' Compensation Insurance [Member] | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | 71 | (164) | 379 | |
North America Commercial P&C Insurance [Member] | Commercial Excess and Umbrella [Member] | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | 71 | |||
North America Commercial P&C Insurance [Member] | Property and Inland Marine | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | (132) | |||
North America Commercial P&C Insurance [Member] | Multi-Line Loss Sensitive | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | (66) | |||
North America Personal P&C Insurance [Member] | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | (119) | (133) | (135) | (187) |
North American Agriculture Insurance [Member] | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | (9) | 9 | (12) | (17) |
Overseas General Insurance [Member] | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | (49) | (5) | (253) | (238) |
Overseas General Insurance [Member] | Accident and Health Insurance Product Line [Member] | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | 45 | (75) | ||
Overseas General Insurance [Member] | Property, Liability and Casualty Insurance Product Line | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | (67) | |||
Overseas General Insurance [Member] | Property and Inland Marine | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | 147 | |||
Overseas General Insurance [Member] | Casualty lines | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | (82) | |||
Overseas General Insurance [Member] | Environmental lines | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | (34) | |||
Overseas General Insurance [Member] | Financial [Member] | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | 114 | |||
Overseas General Insurance [Member] | Personal Lines | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | (53) | |||
Global Reinsurance [Member] | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | 0 | 0 | (25) | 22 |
Corporate Segment [Member] | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | 73 | 131 | 272 | |
Short Tail [Member] | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | (316) | (261) | (659) | (654) |
Short Tail [Member] | North America Commercial P&C Insurance [Member] | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | (191) | (137) | (279) | (246) |
Short Tail [Member] | North America Personal P&C Insurance [Member] | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | (119) | (133) | (135) | (187) |
Short Tail [Member] | North American Agriculture Insurance [Member] | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | (9) | 9 | (12) | (17) |
Short Tail [Member] | Overseas General Insurance [Member] | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | 3 | 0 | (201) | (233) |
Short Tail [Member] | Global Reinsurance [Member] | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | 0 | 0 | (32) | 29 |
Short Tail [Member] | Corporate Segment [Member] | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | 0 | 0 | 0 | 0 |
Long Tail [Member] | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | 116 | 39 | 63 | (55) |
Long Tail [Member] | North America Commercial P&C Insurance [Member] | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | 107 | (29) | (23) | (315) |
Long Tail [Member] | North America Personal P&C Insurance [Member] | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | 0 | 0 | 0 | 0 |
Long Tail [Member] | North American Agriculture Insurance [Member] | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | 0 | 0 | 0 | 0 |
Long Tail [Member] | Overseas General Insurance [Member] | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | (52) | (5) | (52) | (5) |
Long Tail [Member] | Global Reinsurance [Member] | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | 0 | 0 | 7 | (7) |
Long Tail [Member] | Corporate Segment [Member] | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | $ 61 | $ 73 | 131 | 272 |
Long Tail [Member] | Corporate Segment [Member] | Other [Member] | ||||
Liability for Claims and Claims Adjustment Expense [Line Items] | ||||
Net Prior Period Development | $ 49 | $ 155 |
Unpaid losses and loss expenses Unpaid losses and loss expenses (Narrative) (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | |||||
---|---|---|---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
Jul. 01, 2023 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | $ (200) | $ (222) | $ (596) | $ (709) | |||
Unpaid losses and loss expenses | 79,705 | 75,336 | 79,705 | 75,336 | $ 75,747 | $ 72,330 | |
Net loss and loss expenses paid, Prior Years | 10,158 | 9,217 | |||||
Liability for Unpaid Claims and Claims Adjustment Expense, Period Increase (Decrease), Gross | 4,000 | ||||||
Liability for Unpaid Claims and Claims Adjustment Expense, Net | 61,897 | 58,023 | 61,897 | 58,023 | $ 58,661 | 56,198 | |
Huatai Group | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Unpaid losses and loss expenses | $ 831 | ||||||
Liability for Unpaid Claims and Claims Adjustment Expense, Net | $ 405 | $ 0 | |||||
Long Tail [Member] | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | 116 | 39 | 63 | (55) | |||
Short Tail [Member] | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | (316) | (261) | (659) | (654) | |||
North America Commercial P&C Insurance [Member] | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | (84) | (166) | (302) | (561) | |||
North America Commercial P&C Insurance [Member] | Long Tail [Member] | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | 107 | (29) | (23) | (315) | |||
North America Commercial P&C Insurance [Member] | Short Tail [Member] | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | (191) | (137) | (279) | (246) | |||
North America Commercial P&C Insurance [Member] | Commercial Excess and Umbrella [Member] | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | 71 | ||||||
North America Commercial P&C Insurance [Member] | Workers' Compensation Insurance [Member] | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | 71 | (164) | 379 | ||||
North America Commercial P&C Insurance [Member] | Property and Inland Marine | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | (132) | ||||||
North America Commercial P&C Insurance [Member] | Auto Liability [Member] | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | 58 | ||||||
North America Agricultural Insurance [Member] | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | (9) | 9 | (12) | (17) | |||
North America Agricultural Insurance [Member] | Long Tail [Member] | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | 0 | 0 | 0 | 0 | |||
North America Agricultural Insurance [Member] | Short Tail [Member] | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | (9) | 9 | (12) | (17) | |||
Corporate Segment [Member] | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | 73 | 131 | 272 | ||||
Corporate Segment [Member] | Long Tail [Member] | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | 61 | 73 | 131 | 272 | |||
Corporate Segment [Member] | Short Tail [Member] | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | 0 | 0 | 0 | 0 | |||
Corporate Segment [Member] | Other [Member] | Long Tail [Member] | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | 49 | 155 | |||||
Overseas General Insurance [Member] | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | (49) | (5) | (253) | (238) | |||
Overseas General Insurance [Member] | Long Tail [Member] | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | (52) | (5) | (52) | (5) | |||
Overseas General Insurance [Member] | Short Tail [Member] | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | 3 | 0 | (201) | (233) | |||
Overseas General Insurance [Member] | Accident and Health Insurance Product Line [Member] | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | 45 | (75) | |||||
Overseas General Insurance [Member] | Property, Liability and Casualty Insurance Product Line | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | (67) | ||||||
Overseas General Insurance [Member] | Property and Inland Marine | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | 147 | ||||||
Overseas General Insurance [Member] | financial lines | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | 77 | ||||||
Overseas General Insurance [Member] | Political Risk | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | 51 | ||||||
North America Personal P&C Insurance [Member] | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | (119) | (133) | (135) | (187) | |||
North America Personal P&C Insurance [Member] | Long Tail [Member] | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | 0 | 0 | 0 | 0 | |||
North America Personal P&C Insurance [Member] | Short Tail [Member] | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | (119) | (133) | (135) | (187) | |||
Global Reinsurance [Member] | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | 0 | 0 | (25) | 22 | |||
Global Reinsurance [Member] | Long Tail [Member] | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | 0 | 0 | 7 | (7) | |||
Global Reinsurance [Member] | Short Tail [Member] | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | 0 | $ 0 | (32) | $ 29 | |||
North America Commercial P&C Insurance [Member] | Commercial Excess and Umbrella [Member] | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | 222 | 227 | |||||
North America Commercial P&C Insurance [Member] | Property and Inland Marine | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | 188 | 113 | |||||
North America Commercial P&C Insurance [Member] | Surety Product Line [Member] | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | 101 | ||||||
North America Commercial P&C Insurance [Member] | Auto Liability [Member] | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | 125 | ||||||
North American Personal P&C Insurance [Member] | Personal Excess Liability | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | 145 | ||||||
North American Personal P&C Insurance [Member] | homeowners and valuables lines | |||||||
Liability for Claims and Claims Adjustment Expense [Line Items] | |||||||
Net Prior Period Development | $ 263 | $ 244 |
Future policy benefits (Rollforward) (Details) - USD ($) $ in Millions |
9 Months Ended | ||||||
---|---|---|---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Dec. 31, 2022 |
Dec. 31, 2021 |
Jan. 01, 2021 |
|||
Liability for Future Policy Benefit, Activity [Line Items] | |||||||
Balance – beginning of period | $ 13,024 | $ 4,313 | |||||
Beginning balance at original discount rate | $ 13,685 | $ 3,991 | |||||
Effect of changes in cash flow assumptions | (734) | (32) | |||||
Effect of actual variances from expected experience | (127) | (139) | |||||
Adjusted beginning of period balance | 12,824 | 3,820 | |||||
Consolidation of Huatai Group | 1,850 | ||||||
Acquisition of Cigna | 9,737 | ||||||
Issuances | 1,435 | 601 | |||||
Interest accrual | 529 | 267 | |||||
Net premiums collected (1) | [1] | (1,515) | (703) | ||||
Other (including foreign exchange) | 259 | (639) | |||||
Ending balance at original discount rate | 14,864 | 13,083 | |||||
Effect of changes in discount rate assumptions | (629) | (686) | |||||
Balance – end of period | 14,235 | 12,397 | |||||
Balance – beginning of period | 21,920 | 10,775 | |||||
Beginning balance at original discount rate | 23,052 | 9,402 | |||||
Effect of changes in cash flow assumptions | (770) | (38) | |||||
Effect of actual variances from expected experience | (112) | (144) | |||||
Adjusted beginning of period balance | 22,170 | 9,220 | |||||
Consolidation of Huatai Group | 4,137 | ||||||
Acquisition of Cigna | 13,583 | ||||||
Issuances | 1,436 | 606 | |||||
Interest accrual | 750 | 420 | |||||
Benefits payments | (1,404) | (704) | |||||
Other (including foreign exchange) | (336) | 1,072 | |||||
Ending balance at original discount rate | 26,753 | 22,053 | |||||
Effect of changes in discount rate assumptions | (1,227) | (1,240) | |||||
Balance – end of period | 25,526 | 20,813 | |||||
Net liability for future policy benefits | 12,009 | 9,151 | |||||
Deferred profit liability | 1,100 | 755 | |||||
Net liability for future policy benefits, per consolidated balance sheet | 13,109 | 9,906 | 10,476 | $ 7,652 | |||
Less: Reinsurance recoverable on future policy benefits | 315 | 312 | |||||
Net liability for future policy benefits, after reinsurance recoverable | $ 12,794 | $ 9,594 | |||||
Weighted-average duration (years) | 18 years 8 months 12 days | 16 years 2 months 12 days | |||||
Term Life Insurance | Segment Life [Member] | |||||||
Liability for Future Policy Benefit, Activity [Line Items] | |||||||
Balance – beginning of period | $ 818 | $ 422 | |||||
Beginning balance at original discount rate | 879 | 397 | |||||
Effect of changes in cash flow assumptions | 35 | 0 | |||||
Effect of actual variances from expected experience | (13) | (31) | |||||
Adjusted beginning of period balance | 901 | 366 | |||||
Consolidation of Huatai Group | 3 | ||||||
Acquisition of Cigna | 445 | ||||||
Issuances | 90 | 95 | |||||
Interest accrual | 45 | 45 | |||||
Net premiums collected (1) | [1] | (127) | (93) | ||||
Other (including foreign exchange) | 9 | (46) | |||||
Ending balance at original discount rate | 903 | 812 | |||||
Effect of changes in discount rate assumptions | (69) | (59) | |||||
Balance – end of period | 834 | 753 | |||||
Balance – beginning of period | 1,427 | 921 | |||||
Beginning balance at original discount rate | 1,555 | 858 | |||||
Effect of changes in cash flow assumptions | 31 | (5) | |||||
Effect of actual variances from expected experience | (10) | (32) | |||||
Adjusted beginning of period balance | 1,576 | 821 | |||||
Consolidation of Huatai Group | 17 | ||||||
Acquisition of Cigna | 668 | ||||||
Issuances | 90 | 100 | |||||
Interest accrual | 54 | 52 | |||||
Benefits payments | (119) | (82) | |||||
Other (including foreign exchange) | 92 | 112 | |||||
Ending balance at original discount rate | 1,710 | 1,447 | |||||
Effect of changes in discount rate assumptions | (152) | (126) | |||||
Balance – end of period | 1,558 | 1,321 | |||||
Net liability for future policy benefits | 724 | 568 | |||||
Deferred profit liability | 223 | 172 | |||||
Net liability for future policy benefits, per consolidated balance sheet | 947 | 740 | 454 | ||||
Less: Reinsurance recoverable on future policy benefits | 111 | 111 | |||||
Net liability for future policy benefits, after reinsurance recoverable | $ 836 | $ 629 | |||||
Weighted-average duration (years) | 10 years 2 months 12 days | 9 years | |||||
Whole Life Insurance | Segment Life [Member] | |||||||
Liability for Future Policy Benefit, Activity [Line Items] | |||||||
Balance – beginning of period | $ 2,301 | $ 1,341 | |||||
Beginning balance at original discount rate | 2,354 | 1,243 | |||||
Effect of changes in cash flow assumptions | 40 | (3) | |||||
Effect of actual variances from expected experience | 6 | 12 | |||||
Adjusted beginning of period balance | 2,400 | 1,252 | |||||
Consolidation of Huatai Group | 1,690 | ||||||
Acquisition of Cigna | 1,078 | ||||||
Issuances | 274 | 155 | |||||
Interest accrual | 62 | 37 | |||||
Net premiums collected (1) | [1] | (375) | (156) | ||||
Other (including foreign exchange) | 56 | (102) | |||||
Ending balance at original discount rate | 3,995 | 2,264 | |||||
Effect of changes in discount rate assumptions | (62) | (95) | |||||
Balance – end of period | 3,933 | 2,169 | |||||
Balance – beginning of period | 6,048 | 4,785 | |||||
Beginning balance at original discount rate | 6,225 | 3,833 | |||||
Effect of changes in cash flow assumptions | 44 | (3) | |||||
Effect of actual variances from expected experience | 12 | 14 | |||||
Adjusted beginning of period balance | 6,281 | 3,844 | |||||
Consolidation of Huatai Group | 3,659 | ||||||
Acquisition of Cigna | 2,267 | ||||||
Issuances | 276 | 155 | |||||
Interest accrual | 176 | 123 | |||||
Benefits payments | (212) | (151) | |||||
Other (including foreign exchange) | 22 | 207 | |||||
Ending balance at original discount rate | 10,202 | 6,031 | |||||
Effect of changes in discount rate assumptions | (274) | (308) | |||||
Balance – end of period | 9,928 | 5,723 | |||||
Net liability for future policy benefits | 5,995 | 3,554 | |||||
Deferred profit liability | 707 | 450 | |||||
Net liability for future policy benefits, per consolidated balance sheet | 6,702 | 4,004 | 3,767 | ||||
Less: Reinsurance recoverable on future policy benefits | 47 | 56 | |||||
Net liability for future policy benefits, after reinsurance recoverable | $ 6,655 | $ 3,948 | |||||
Weighted-average duration (years) | 26 years 6 months | 24 years 8 months 12 days | |||||
Accident and Health Insurance Product Line [Member] | Segment Life [Member] | |||||||
Liability for Future Policy Benefit, Activity [Line Items] | |||||||
Balance – beginning of period | $ 9,863 | $ 2,520 | |||||
Beginning balance at original discount rate | 10,409 | 2,323 | |||||
Effect of changes in cash flow assumptions | (811) | (29) | |||||
Effect of actual variances from expected experience | (120) | (120) | |||||
Adjusted beginning of period balance | 9,478 | 2,174 | |||||
Consolidation of Huatai Group | 145 | ||||||
Acquisition of Cigna | 8,191 | ||||||
Issuances | 1,066 | 348 | |||||
Interest accrual | 421 | 184 | |||||
Net premiums collected (1) | [1] | (998) | (445) | ||||
Other (including foreign exchange) | 212 | (487) | |||||
Ending balance at original discount rate | 9,900 | 9,965 | |||||
Effect of changes in discount rate assumptions | (497) | (531) | |||||
Balance – end of period | 9,403 | 9,434 | |||||
Balance – beginning of period | 14,206 | 4,939 | |||||
Beginning balance at original discount rate | 15,022 | 4,589 | |||||
Effect of changes in cash flow assumptions | (848) | (41) | |||||
Effect of actual variances from expected experience | (114) | (126) | |||||
Adjusted beginning of period balance | 14,060 | 4,422 | |||||
Consolidation of Huatai Group | 163 | ||||||
Acquisition of Cigna | 10,542 | ||||||
Issuances | 1,065 | 348 | |||||
Interest accrual | 514 | 242 | |||||
Benefits payments | (1,065) | (469) | |||||
Other (including foreign exchange) | (628) | 651 | |||||
Ending balance at original discount rate | 14,109 | 14,434 | |||||
Effect of changes in discount rate assumptions | (790) | (790) | |||||
Balance – end of period | 13,319 | 13,644 | |||||
Net liability for future policy benefits | 3,916 | 4,210 | |||||
Deferred profit liability | 156 | 125 | |||||
Net liability for future policy benefits, per consolidated balance sheet | 4,072 | 4,335 | 2,569 | ||||
Less: Reinsurance recoverable on future policy benefits | 103 | 107 | |||||
Net liability for future policy benefits, after reinsurance recoverable | $ 3,969 | $ 4,228 | |||||
Weighted-average duration (years) | 10 years 3 months 18 days | 11 years | |||||
Accident and Health Insurance Product Line [Member] | Overseas General Insurance [Member] | |||||||
Liability for Future Policy Benefit, Activity [Line Items] | |||||||
Net liability for future policy benefits | $ 718 | $ 735 | |||||
Deferred profit liability | 0 | 0 | |||||
Net liability for future policy benefits, per consolidated balance sheet | 718 | 735 | 773 | ||||
Less: Reinsurance recoverable on future policy benefits | 33 | 38 | |||||
Net liability for future policy benefits, after reinsurance recoverable | $ 685 | $ 697 | |||||
Weighted-average duration (years) | 4 years 10 months 24 days | 5 years 1 month 6 days | |||||
Insurance, Other | Segment Life [Member] | |||||||
Liability for Future Policy Benefit, Activity [Line Items] | |||||||
Balance – beginning of period | $ 42 | $ 30 | |||||
Beginning balance at original discount rate | 43 | 28 | |||||
Effect of changes in cash flow assumptions | 2 | 0 | |||||
Effect of actual variances from expected experience | 0 | 0 | |||||
Adjusted beginning of period balance | 45 | 28 | |||||
Consolidation of Huatai Group | 12 | ||||||
Acquisition of Cigna | 23 | ||||||
Issuances | 5 | 3 | |||||
Interest accrual | 1 | 1 | |||||
Net premiums collected (1) | [1] | (15) | (9) | ||||
Other (including foreign exchange) | (18) | (4) | |||||
Ending balance at original discount rate | 66 | 42 | |||||
Effect of changes in discount rate assumptions | (1) | (1) | |||||
Balance – end of period | 65 | 41 | |||||
Balance – beginning of period | 239 | 130 | |||||
Beginning balance at original discount rate | 250 | 122 | |||||
Effect of changes in cash flow assumptions | 3 | 11 | |||||
Effect of actual variances from expected experience | $ 0 | $ 0 | |||||
Adjusted beginning of period balance | 253 | 133 | |||||
Consolidation of Huatai Group | 298 | ||||||
Acquisition of Cigna | 106 | ||||||
Issuances | 5 | 3 | |||||
Interest accrual | 6 | 3 | |||||
Benefits payments | (8) | (2) | |||||
Other (including foreign exchange) | 178 | 102 | |||||
Ending balance at original discount rate | 732 | 141 | |||||
Effect of changes in discount rate assumptions | (11) | (16) | |||||
Balance – end of period | 721 | 125 | |||||
Net liability for future policy benefits | 656 | 84 | |||||
Deferred profit liability | 14 | 8 | |||||
Net liability for future policy benefits, per consolidated balance sheet | 670 | 92 | $ 89 | ||||
Less: Reinsurance recoverable on future policy benefits | 21 | 0 | |||||
Net liability for future policy benefits, after reinsurance recoverable | $ 649 | $ 92 | |||||
Weighted-average duration (years) | 15 years 1 month 6 days | 13 years 6 months | |||||
|
Future policy benefits (Undiscounted & discounted FPB) (Details) - USD ($) $ in Millions |
Sep. 30, 2023 |
Dec. 31, 2022 |
Sep. 30, 2022 |
Dec. 31, 2021 |
---|---|---|---|---|
Liability for Future Policy Benefit, Activity [Line Items] | ||||
Discounted expected future benefit payments | $ 25,526 | $ 21,920 | $ 20,813 | $ 10,775 |
Term Life Insurance | Segment Life [Member] | ||||
Liability for Future Policy Benefit, Activity [Line Items] | ||||
Undiscounted expected future benefit payments | 2,492 | 2,189 | ||
Undiscounted expected future gross premiums | 2,884 | 2,503 | ||
Discounted expected future benefit payments | 1,558 | 1,427 | 1,321 | 921 |
Discounted expected future gross premiums | 1,910 | 1,682 | ||
Whole Life Insurance | Segment Life [Member] | ||||
Liability for Future Policy Benefit, Activity [Line Items] | ||||
Undiscounted expected future benefit payments | 23,457 | 15,631 | ||
Undiscounted expected future gross premiums | 9,478 | 6,654 | ||
Discounted expected future benefit payments | 9,928 | 6,048 | 5,723 | 4,785 |
Discounted expected future gross premiums | 7,654 | 5,173 | ||
Accident and Health Insurance Product Line [Member] | Segment Life [Member] | ||||
Liability for Future Policy Benefit, Activity [Line Items] | ||||
Undiscounted expected future benefit payments | 23,168 | 23,873 | ||
Undiscounted expected future gross premiums | 34,055 | 34,659 | ||
Discounted expected future benefit payments | 13,319 | 14,206 | 13,644 | 4,939 |
Discounted expected future gross premiums | 20,604 | 20,193 | ||
Insurance, Other | Segment Life [Member] | ||||
Liability for Future Policy Benefit, Activity [Line Items] | ||||
Undiscounted expected future benefit payments | 977 | 265 | ||
Undiscounted expected future gross premiums | 103 | 102 | ||
Discounted expected future benefit payments | 721 | $ 239 | 125 | $ 130 |
Discounted expected future gross premiums | $ 92 | $ 92 |
Future policy benefits (Premiums & interest) (Details) - USD ($) $ in Millions |
9 Months Ended | |
---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
|
Liability for Future Policy Benefit, Activity [Line Items] | ||
Gross Premiums or Assessments | $ 4,769 | $ 3,144 |
Interest Accretion | 221 | 153 |
Term Life Insurance | Segment Life [Member] | ||
Liability for Future Policy Benefit, Activity [Line Items] | ||
Gross Premiums or Assessments | 511 | 361 |
Interest Accretion | 9 | 7 |
Whole Life Insurance | Segment Life [Member] | ||
Liability for Future Policy Benefit, Activity [Line Items] | ||
Gross Premiums or Assessments | 858 | 411 |
Interest Accretion | 114 | 86 |
Accident and Health Insurance Product Line [Member] | Segment Life [Member] | ||
Liability for Future Policy Benefit, Activity [Line Items] | ||
Gross Premiums or Assessments | 2,171 | 1,226 |
Interest Accretion | 93 | 58 |
Accident and Health Insurance Product Line [Member] | Overseas General Insurance [Member] | ||
Liability for Future Policy Benefit, Activity [Line Items] | ||
Gross Premiums or Assessments | 1,175 | 1,075 |
Interest Accretion | 0 | 0 |
Insurance, Other | Segment Life [Member] | ||
Liability for Future Policy Benefit, Activity [Line Items] | ||
Gross Premiums or Assessments | 54 | 71 |
Interest Accretion | $ 5 | $ 2 |
Future policy benefits (Weighted average interest rates) (Details) - Segment Life [Member] |
Sep. 30, 2023 |
Sep. 30, 2022 |
---|---|---|
Term Life Insurance | ||
Liability for Future Policy Benefit, Activity [Line Items] | ||
Interest Accretion Rate | 2.90% | 2.60% |
Current Discount Rate | 6.00% | 6.10% |
Whole Life Insurance | ||
Liability for Future Policy Benefit, Activity [Line Items] | ||
Interest Accretion Rate | 3.20% | 3.90% |
Current Discount Rate | 4.70% | 5.50% |
Accident and Health Insurance Product Line [Member] | ||
Liability for Future Policy Benefit, Activity [Line Items] | ||
Interest Accretion Rate | 3.70% | 3.60% |
Current Discount Rate | 6.70% | 6.10% |
Insurance, Other | ||
Liability for Future Policy Benefit, Activity [Line Items] | ||
Interest Accretion Rate | 2.60% | 3.70% |
Current Discount Rate | 4.30% | 6.20% |
Policyholders' account balances (Policyholder Account Balance Rollforward) (Details) - USD ($) $ in Millions |
9 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|
Jul. 01, 2023 |
Jul. 01, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
|||||
Policyholder Account Balance [Line Items] | ||||||||
Policyholder Account Balance, Beginning Balance | $ 3,140 | $ 2,766 | ||||||
Policyholder Account Balance, Consolidation of Huatai Group | $ 4,014 | |||||||
Policyholder Account Balance, Acquisition of Cigna | $ 355 | |||||||
Policyholder Account Balance, Premium Received | 503 | 347 | ||||||
Policyholder Account Balance, Policy Charge | [1] | (143) | (149) | |||||
Policyholder Account Balance, Surrender and Withdrawal | (182) | (94) | ||||||
Policyholder Account Balance, Benefit Payment | (87) | (18) | ||||||
Policyholder Account Balance, Interest Expense | 82 | 55 | ||||||
Policyholder Account Balance, Increase (Decrease) from Other Change | (149) | 254 | ||||||
Policyholder Account Balance, Ending Balance | 7,178 | 3,008 | ||||||
Universal Life | ||||||||
Policyholder Account Balance [Line Items] | ||||||||
Policyholder Account Balance, Beginning Balance | 1,719 | 1,612 | ||||||
Policyholder Account Balance, Consolidation of Huatai Group | 602 | |||||||
Policyholder Account Balance, Acquisition of Cigna | 10 | |||||||
Policyholder Account Balance, Premium Received | 275 | 292 | ||||||
Policyholder Account Balance, Policy Charge | [1] | (135) | (141) | |||||
Policyholder Account Balance, Surrender and Withdrawal | (69) | (55) | ||||||
Policyholder Account Balance, Benefit Payment | (6) | (3) | ||||||
Policyholder Account Balance, Interest Expense | 39 | 30 | ||||||
Policyholder Account Balance, Increase (Decrease) from Other Change | (42) | 69 | ||||||
Policyholder Account Balance, Ending Balance | $ 2,383 | $ 1,676 | ||||||
Policyholder Account Balance, Weighted Average Crediting Rate | 3.80% | 3.70% | ||||||
Policyholder Account Balance, Net Amount at Risk | [2] | $ 10,493 | $ 10,116 | |||||
Policyholder Account Balance, Cash Surrender Value | 1,596 | 934 | ||||||
Insurance, Other | ||||||||
Policyholder Account Balance [Line Items] | ||||||||
Policyholder Account Balance, Beginning Balance | 1,421 | 1,154 | ||||||
Policyholder Account Balance, Consolidation of Huatai Group | $ 3,412 | |||||||
Policyholder Account Balance, Acquisition of Cigna | $ 345 | |||||||
Policyholder Account Balance, Premium Received | 228 | 55 | ||||||
Policyholder Account Balance, Policy Charge | [1] | (8) | (8) | |||||
Policyholder Account Balance, Surrender and Withdrawal | (113) | (39) | ||||||
Policyholder Account Balance, Benefit Payment | (81) | (15) | ||||||
Policyholder Account Balance, Interest Expense | 43 | 25 | ||||||
Policyholder Account Balance, Increase (Decrease) from Other Change | (107) | 185 | ||||||
Policyholder Account Balance, Ending Balance | $ 4,795 | $ 1,332 | ||||||
Policyholder Account Balance, Weighted Average Crediting Rate | 2.10% | 2.60% | ||||||
Policyholder Account Balance, Net Amount at Risk | [2] | $ 1,675 | $ 1,503 | |||||
Policyholder Account Balance, Cash Surrender Value | $ 3,655 | $ 1,280 | ||||||
|
Policyholders' account balances (Guaranteed Minimum Crediting Rates) (Details) - USD ($) $ in Millions |
Sep. 30, 2023 |
Dec. 31, 2022 |
Sep. 30, 2022 |
Dec. 31, 2021 |
---|---|---|---|---|
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | $ 7,178 | $ 3,140 | $ 3,008 | $ 2,766 |
Universal Life | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 2,383 | 1,719 | 1,676 | 1,612 |
Universal Life | Policyholder Account Balance, at Guaranteed Minimum Crediting Rate | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 496 | 490 | ||
Universal Life | Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0001 to 0050 | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 377 | 394 | ||
Universal Life | Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0150 | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 614 | 287 | ||
Universal Life | Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0151 and Greater | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 896 | 505 | ||
Insurance, Other | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 4,795 | 1,421 | 1,332 | $ 1,154 |
Insurance, Other | Policyholder Account Balance, at Guaranteed Minimum Crediting Rate | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 1,763 | 717 | ||
Insurance, Other | Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0001 to 0050 | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 487 | 0 | ||
Insurance, Other | Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0150 | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 1,746 | 191 | ||
Insurance, Other | Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0151 and Greater | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 799 | 424 | ||
Policyholder account balance, guaranteed minimum credit rating, range from 0000 to 0200 | Universal Life | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 622 | 567 | ||
Policyholder account balance, guaranteed minimum credit rating, range from 0000 to 0200 | Universal Life | Policyholder Account Balance, at Guaranteed Minimum Crediting Rate | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 3 | 3 | ||
Policyholder account balance, guaranteed minimum credit rating, range from 0000 to 0200 | Universal Life | Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0001 to 0050 | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 0 | 0 | ||
Policyholder account balance, guaranteed minimum credit rating, range from 0000 to 0200 | Universal Life | Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0150 | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 56 | 59 | ||
Policyholder account balance, guaranteed minimum credit rating, range from 0000 to 0200 | Universal Life | Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0151 and Greater | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 563 | 505 | ||
Policyholder account balance, guaranteed minimum credit rating, range from 0000 to 0200 | Insurance, Other | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 3,846 | 1,026 | ||
Policyholder account balance, guaranteed minimum credit rating, range from 0000 to 0200 | Insurance, Other | Policyholder Account Balance, at Guaranteed Minimum Crediting Rate | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 1,328 | 411 | ||
Policyholder account balance, guaranteed minimum credit rating, range from 0000 to 0200 | Insurance, Other | Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0001 to 0050 | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 0 | 0 | ||
Policyholder account balance, guaranteed minimum credit rating, range from 0000 to 0200 | Insurance, Other | Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0150 | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 1,719 | 191 | ||
Policyholder account balance, guaranteed minimum credit rating, range from 0000 to 0200 | Insurance, Other | Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0151 and Greater | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 799 | 424 | ||
Policyholder account balance, guaranteed minimum credit rating, range from 0201 to 0400 | Universal Life | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 1,740 | 1,078 | ||
Policyholder account balance, guaranteed minimum credit rating, range from 0201 to 0400 | Universal Life | Policyholder Account Balance, at Guaranteed Minimum Crediting Rate | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 472 | 456 | ||
Policyholder account balance, guaranteed minimum credit rating, range from 0201 to 0400 | Universal Life | Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0001 to 0050 | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 377 | 394 | ||
Policyholder account balance, guaranteed minimum credit rating, range from 0201 to 0400 | Universal Life | Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0150 | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 558 | 228 | ||
Policyholder account balance, guaranteed minimum credit rating, range from 0201 to 0400 | Universal Life | Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0151 and Greater | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 333 | $ 0 | ||
Policyholder account balance, guaranteed minimum credit rating, range from 0201 to 0400 | Insurance, Other | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 626 | 0 | ||
Policyholder account balance, guaranteed minimum credit rating, range from 0201 to 0400 | Insurance, Other | Policyholder Account Balance, at Guaranteed Minimum Crediting Rate | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 112 | 0 | ||
Policyholder account balance, guaranteed minimum credit rating, range from 0201 to 0400 | Insurance, Other | Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0001 to 0050 | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 487 | 0 | ||
Policyholder account balance, guaranteed minimum credit rating, range from 0201 to 0400 | Insurance, Other | Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0150 | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 27 | 0 | ||
Policyholder account balance, guaranteed minimum credit rating, range from 0201 to 0400 | Insurance, Other | Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0151 and Greater | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 0 | 0 | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater | Universal Life | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 21 | 31 | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater | Universal Life | Policyholder Account Balance, at Guaranteed Minimum Crediting Rate | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 21 | 31 | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater | Universal Life | Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0001 to 0050 | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 0 | 0 | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater | Universal Life | Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0150 | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 0 | 0 | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater | Universal Life | Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0151 and Greater | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 0 | 0 | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater | Insurance, Other | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 323 | 306 | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater | Insurance, Other | Policyholder Account Balance, at Guaranteed Minimum Crediting Rate | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 323 | 306 | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater | Insurance, Other | Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0001 to 0050 | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 0 | 0 | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater | Insurance, Other | Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0150 | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | 0 | 0 | ||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater | Insurance, Other | Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0151 and Greater | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance | $ 0 | $ 0 | ||
Minimum | Policyholder account balance, guaranteed minimum credit rating, range from 0201 to 0400 | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate | 2.01% | |||
Minimum | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate | 4.00% | |||
Maximum | Policyholder account balance, guaranteed minimum credit rating, range from 0000 to 0200 | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate | 2.00% | |||
Maximum | Policyholder account balance, guaranteed minimum credit rating, range from 0201 to 0400 | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate [Line Items] | ||||
Policyholder Account Balance, Guaranteed Minimum Crediting Rate | 4.00% |
Market risk benefits (MRB Roll-Forward) (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | |||
---|---|---|---|---|---|
Jan. 01, 2021 |
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
|
Market Risk Benefit [Line Items] | |||||
Market Risk Benefit, Liability, beginning of period | $ 800 | ||||
Market Risk Benefit, Liability, end of period | $ 770 | 770 | |||
Market risk benefits gains (losses) | (32) | $ 69 | (154) | $ 85 | |
Variable Annuity | |||||
Market Risk Benefit [Line Items] | |||||
Market Risk Benefit, Liability, end of period | $ 1,163 | ||||
Long-Duration Insurance, Other | Variable Annuity | |||||
Market Risk Benefit [Line Items] | |||||
Market Risk Benefit, Liability, beginning of period | 800 | 812 | |||
Balance, beginning of period, before effect of changes in the instrument-specific credit risk | 776 | 755 | |||
Interest rate changes | (117) | (561) | |||
Effect of changes in equity markets | (69) | 633 | |||
Effect of changes in volatilities | 51 | 14 | |||
Market Risk Benefit, Increase (Decrease) from Future Expected Policyholder Behavior Assumption | 89 | 40 | |||
Effect of timing and all other | 19 | (29) | |||
Balance, end of period, before effect of changes in the instrument-specific credit risk | 749 | 852 | 749 | 852 | |
Effect of changes in the instrument-specific credit risk | 21 | 9 | 21 | 9 | |
Market Risk Benefit, Liability, end of period | 770 | 861 | $ 770 | $ 861 | |
Market risk benefit, weighted-average age of policyholders (age) | 73 years | 73 years | |||
Market Risk Benefit, Net Amount at Risk | 2,138 | $ 2,885 | $ 2,138 | $ 2,885 | |
Market Risk Benefits Other Gains (Losses) | $ (181) | $ 186 | |||
Long-Duration Insurance, Other | Variable Annuity | Measurement Input, Annuitization Rate [Member] | |||||
Market Risk Benefit [Line Items] | |||||
Market Risk Benefit, Increase (Decrease) from Future Expected Policyholder Behavior Assumption | $ 92 |
Market Risk Benefits (MRB Valuation) (Details) |
9 Months Ended | |||
---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
|||
Minimum | ||||
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||
Long-Duration Contracts, Assumptions by Product and Guarantee, Lapse Rate | 0.50% | 0.50% | ||
Significant Unobservable Inputs Annuitization Rate | 0.00% | 0.00% | ||
Maximum | ||||
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||
Long-Duration Contracts, Assumptions by Product and Guarantee, Lapse Rate | 30.00% | 30.40% | ||
Significant Unobservable Inputs Annuitization Rate | 100.00% | 100.00% | ||
Weighted Average | ||||
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||
Long-Duration Contracts, Assumptions by Product and Guarantee, Lapse Rate | [1] | 4.00% | 3.80% | |
Significant Unobservable Inputs Annuitization Rate | [1] | 4.80% | 4.60% | |
|
Separate accounts (Fair Value of Assets) (Details) - USD ($) $ in Millions |
Sep. 30, 2023 |
Dec. 31, 2022 |
---|---|---|
Fair Value, Separate Account Investment [Line Items] | ||
Separate account assets | $ 5,306 | $ 5,190 |
Separate Account, Cash and Cash Equivalents | ||
Fair Value, Separate Account Investment [Line Items] | ||
Separate account assets | 88 | 141 |
Separate Account, equity securities and mutual funds | ||
Fair Value, Separate Account Investment [Line Items] | ||
Separate account assets | 5,129 | 4,960 |
Separate Account, Non-U.S. Government Treasuries | ||
Fair Value, Separate Account Investment [Line Items] | ||
Separate account assets | $ 89 | $ 89 |
Separate accounts (Liabilities) (Details) - USD ($) $ in Millions |
9 Months Ended | |||
---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
|||
Separate Account, Liability, Surrender and Withdrawal [Abstract] | ||||
Separate Account, Liability, Beginning Balance | $ 5,190 | $ 5,560 | ||
Acquisition of Cigna | 0 | 301 | ||
Separate Account, Liability, Premium and Deposit | 724 | 1,147 | ||
Separate Account, Liability, Policy Charge | (103) | (93) | ||
Separate Account, Liability, Surrender and Withdrawal | (407) | (304) | ||
Separate Account, Liability, Benefit Payment | (291) | (289) | ||
Separate Account, Liability, Increase (Decrease) from Invested Performance | 382 | (978) | ||
Separate Account, Liability, Increase (Decrease) from Other Change | (189) | (453) | ||
Separate Account, Liability, Ending Balance | 5,306 | 4,891 | ||
Separate Account, Liability, Cash Surrender Value, Amount | [1] | $ 5,285 | $ 4,771 | |
|
Commitments, Contingencies, And Guarantees (Narrative) (Detail) € in Millions, $ in Millions |
Sep. 30, 2023
USD ($)
|
Sep. 30, 2023
EUR (€)
|
Dec. 31, 2022
USD ($)
|
---|---|---|---|
Financial Instruments Owned and Pledged as Collateral [Line Items] | |||
Derivative liability subject to a master netting agreement | $ 97 | $ 60 | |
Hedged Liability, Fair Value Hedge | 1,600 | € 1,500 | |
Repurchase agreements (refer to Note 3 for balances associated with VIEs) | 2,617 | 1,419 | |
Purchase Commitment, Remaining Minimum Amount Committed | 1,075 | 770 | |
Carrying value of limited partnerships and partially-owned investment companies included in other investments | 13,100 | 12,000 | |
Funding commitments relating to limited partnerships and partially-owned investment companies | 6,300 | 7,400 | |
Unrecognized tax benefits | 67 | ||
Operating Lease, Right-of-Use Asset | 549 | 607 | |
Operating Lease, Liability | $ 577 | $ 633 | |
Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration] | Other liabilities | Other liabilities | Other liabilities |
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] | Other assets | Other assets | Other assets |
Commitments, Contingencies, And Guarantees (Balance Sheet Locations, Fair Values In Asset Or (Liability) Position, And Notional Values/Payment Provisions Of Derivative Instruments) (Detail) - USD ($) $ in Millions |
Sep. 30, 2023 |
Dec. 31, 2022 |
||||
---|---|---|---|---|---|---|
Foreign currency forward contracts | ||||||
Derivatives, Fair Value [Line Items] | ||||||
Derivative, Notional Amount | $ 3,711 | $ 4,134 | ||||
Options/Futures contracts on notes and bonds | ||||||
Derivatives, Fair Value [Line Items] | ||||||
Derivative, Notional Amount | 2,150 | 1,511 | ||||
Convertible securities | ||||||
Derivatives, Fair Value [Line Items] | ||||||
Derivative, Notional Amount | [1] | 61 | 37 | |||
Investment And Embedded Derivative Instruments [Member] | ||||||
Derivatives, Fair Value [Line Items] | ||||||
Derivative Asset, Fair Value, Gross Asset | 95 | 112 | ||||
Fair Value, Liability | (168) | (139) | ||||
Derivative, Notional Amount | 5,922 | 5,682 | ||||
Futures contracts on equities | ||||||
Derivatives, Fair Value [Line Items] | ||||||
Derivative, Notional Amount | [2] | 1,119 | 939 | |||
Other Derivatives [Member] | ||||||
Derivatives, Fair Value [Line Items] | ||||||
Derivative, Notional Amount | 368 | 0 | ||||
Other Derivative Instruments [Member] | ||||||
Derivatives, Fair Value [Line Items] | ||||||
Derivative, Notional Amount | 1,487 | 939 | ||||
Designated as Hedging Instrument | ||||||
Derivatives, Fair Value [Line Items] | ||||||
Derivative Asset, Fair Value, Gross Asset | 48 | 17 | ||||
Fair Value, Liability | (68) | 53 | ||||
Derivative, Notional Amount | 3,203 | 3,199 | ||||
Fair Value Hedging | ||||||
Derivatives, Fair Value [Line Items] | ||||||
Derivative, Notional Amount | 1,609 | 1,595 | ||||
Net Investment Hedging | ||||||
Derivatives, Fair Value [Line Items] | ||||||
Derivative, Notional Amount | 1,594 | 1,604 | ||||
Other Assets [Member] | Foreign currency forward contracts | ||||||
Derivatives, Fair Value [Line Items] | ||||||
Derivative Asset, Fair Value, Gross Asset | 15 | 64 | ||||
Other Assets [Member] | Options/Futures contracts on notes and bonds | ||||||
Derivatives, Fair Value [Line Items] | ||||||
Derivative Asset, Fair Value, Gross Asset | 27 | 18 | ||||
Other Assets [Member] | Futures contracts on equities | ||||||
Derivatives, Fair Value [Line Items] | ||||||
Derivative Asset, Fair Value, Gross Asset | [2] | 48 | 33 | |||
Other Assets [Member] | Other Derivatives [Member] | ||||||
Derivatives, Fair Value [Line Items] | ||||||
Derivative Asset, Fair Value, Gross Asset | 5 | 0 | ||||
Other Assets [Member] | Other Derivative Instruments [Member] | ||||||
Derivatives, Fair Value [Line Items] | ||||||
Derivative Asset, Fair Value, Gross Asset | 53 | 33 | ||||
Other Assets [Member] | Fair Value Hedging | ||||||
Derivatives, Fair Value [Line Items] | ||||||
Derivative Asset, Fair Value, Gross Asset | 48 | 17 | ||||
Other Assets [Member] | Net Investment Hedging | ||||||
Derivatives, Fair Value [Line Items] | ||||||
Derivative Asset, Fair Value, Gross Asset | 0 | 0 | ||||
Fixed Maturities [Member] | Convertible securities | ||||||
Derivatives, Fair Value [Line Items] | ||||||
Derivative Asset, Fair Value, Gross Asset | [1] | 53 | 30 | |||
Accounts Payable, Accrued Expenses, And Other Liabilities [Member] | Foreign currency forward contracts | ||||||
Derivatives, Fair Value [Line Items] | ||||||
Fair Value, Liability | (147) | (115) | ||||
Accounts Payable, Accrued Expenses, And Other Liabilities [Member] | Options/Futures contracts on notes and bonds | ||||||
Derivatives, Fair Value [Line Items] | ||||||
Fair Value, Liability | (21) | (24) | ||||
Accounts Payable, Accrued Expenses, And Other Liabilities [Member] | Futures contracts on equities | ||||||
Derivatives, Fair Value [Line Items] | ||||||
Fair Value, Liability | [2] | 0 | 0 | |||
Accounts Payable, Accrued Expenses, And Other Liabilities [Member] | Other Derivatives [Member] | ||||||
Derivatives, Fair Value [Line Items] | ||||||
Fair Value, Liability | (4) | 0 | ||||
Accounts Payable, Accrued Expenses, And Other Liabilities [Member] | Other Derivative Instruments [Member] | ||||||
Derivatives, Fair Value [Line Items] | ||||||
Fair Value, Liability | (4) | 0 | ||||
Accounts Payable, Accrued Expenses, And Other Liabilities [Member] | Fair Value Hedging | ||||||
Derivatives, Fair Value [Line Items] | ||||||
Fair Value, Liability | 0 | 0 | ||||
Accounts Payable, Accrued Expenses, And Other Liabilities [Member] | Net Investment Hedging | ||||||
Derivatives, Fair Value [Line Items] | ||||||
Fair Value, Liability | (68) | (53) | ||||
Equity Securities | Convertible securities | ||||||
Derivatives, Fair Value [Line Items] | ||||||
Fair Value, Liability | [1] | $ 0 | $ 0 | |||
|
Commitment, Contingencies, And Guarantees (Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position) (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
|
Financial Instruments Owned and Pledged as Collateral [Line Items] | ||||
Interest expense reclassified from OCI | $ 174 | $ 150 | $ 499 | $ 416 |
Fair Value Hedging | ||||
Financial Instruments Owned and Pledged as Collateral [Line Items] | ||||
Gain/(loss) recognized in OCI | (17) | (94) | 23 | (94) |
Net realized gain/(loss) reclassified from OCI | (51) | (32) | (20) | (32) |
Interest expense reclassified from OCI | (4) | 0 | (12) | 0 |
Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent | $ 38 | $ (62) | $ 55 | $ (62) |
Commitments, Contingencies, And Guarantees (Schedule of Net Investment Hedges, Statements of Financial Performance and Financial Position, Location) (Details) - Net Investment Hedging - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
|
Financial Instruments Owned and Pledged as Collateral [Line Items] | ||||
Gain/(loss) recognized in OCI | $ (20) | $ 64 | $ (8) | $ 64 |
Interest income reclassified from OCI | 3 | 0 | 10 | 0 |
Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent | $ (23) | $ 64 | $ (18) | $ 64 |
Commitments, Contingencies, And Guarantees (Net Realized Gains (Losses) Of Derivative Instrument Activity In Consolidated Statement Of Operations) (Detail) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||||||
---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
|||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||||||
Gain (Loss) on Derivative | $ 54 | $ (163) | $ (178) | $ (1) | ||||
Foreign currency forward contracts | ||||||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||||||
Gain (Loss) on Derivative | (17) | (247) | (95) | (515) | ||||
All Other Futures Contracts, Options and equities [Member] | ||||||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||||||
Gain (Loss) on Derivative | 29 | 49 | 5 | 285 | ||||
Convertible securities | ||||||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||||||
Gain (Loss) on Derivative | [1] | (3) | 0 | (2) | (2) | |||
Investment And Embedded Derivative Instruments [Member] | ||||||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||||||
Gain (Loss) on Derivative | 9 | (198) | (92) | (232) | ||||
Futures contracts on equities | ||||||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||||||
Gain (Loss) on Derivative | [2] | 52 | 54 | (80) | 240 | |||
Other Derivatives [Member] | ||||||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||||||
Gain (Loss) on Derivative | (7) | (19) | (6) | (9) | ||||
Guaranteed Living Benefit And Other Derivative Instruments [Member] | ||||||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||||||
Gain (Loss) on Derivative | $ 45 | $ 35 | $ (86) | $ 231 | ||||
|
Commitments, contingencies, and guarantees Commitments, Contingencies, And Guarantees (Transactions accounted for as secured borrowings) (Detail) - USD ($) $ in Millions |
Sep. 30, 2023 |
Dec. 31, 2022 |
---|---|---|
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Securities lending collateral | $ 1,469 | $ 1,523 |
Securities lending payable | 1,469 | 1,523 |
Cash [Member] | Overnight and Continuous [Member] | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Securities lending collateral | 762 | 820 |
U.S. Treasury / Agency | Overnight and Continuous [Member] | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Securities lending collateral | 81 | 72 |
Foreign [Member] | Overnight and Continuous [Member] | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Securities lending collateral | 555 | 604 |
Corporate and asset-backed securities | Overnight and Continuous [Member] | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Securities lending collateral | 47 | 27 |
Equity Securities | Overnight and Continuous [Member] | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Securities lending collateral | 18 | 0 |
Municipal | Overnight and Continuous [Member] | ||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||
Securities lending collateral | $ 6 | $ 0 |
Commitments, contingencies, and guarantees Commitments, Contingencies, And Guarantees (Collateral pledged under repurchase agreements) (Details) - USD ($) $ in Millions |
Sep. 30, 2023 |
Dec. 31, 2022 |
||
---|---|---|---|---|
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||||
Repurchase agreements (refer to Note 3 for balances associated with VIEs) | $ 2,617 | $ 1,419 | ||
Asset Pledged as Collateral without Right | ||||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||||
Assets pledged under repurchase agreements | 2,753 | 1,527 | ||
Cash [Member] | Asset Pledged as Collateral without Right | ||||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||||
Assets pledged under repurchase agreements | 46 | 12 | ||
U.S. Treasury / Agency | Asset Pledged as Collateral without Right | ||||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||||
Assets pledged under repurchase agreements | 103 | 101 | ||
Mortgage-backed securities | Asset Pledged as Collateral without Right | ||||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||||
Assets pledged under repurchase agreements | 1,466 | 1,414 | ||
Repurchase Agreements [Member] | ||||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||||
Secured Borrowings, Gross, Difference, Amount | [1] | 136 | 108 | |
Non-US [Member] | Asset Pledged as Collateral without Right | ||||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||||
Assets pledged under repurchase agreements | 1,138 | 0 | ||
Maturity Less than 30 Days [Member] | Asset Pledged as Collateral without Right | ||||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||||
Assets pledged under repurchase agreements | 1,188 | 933 | ||
Maturity Less than 30 Days [Member] | Cash [Member] | Asset Pledged as Collateral without Right | ||||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||||
Assets pledged under repurchase agreements | 0 | 12 | ||
Maturity Less than 30 Days [Member] | U.S. Treasury / Agency | Asset Pledged as Collateral without Right | ||||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||||
Assets pledged under repurchase agreements | 0 | 0 | ||
Maturity Less than 30 Days [Member] | Mortgage-backed securities | Asset Pledged as Collateral without Right | ||||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||||
Assets pledged under repurchase agreements | 50 | 921 | ||
Maturity Less than 30 Days [Member] | Non-US [Member] | Asset Pledged as Collateral without Right | ||||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||||
Assets pledged under repurchase agreements | 1,138 | 0 | ||
Maturity 30 to 90 Days [Member] | Asset Pledged as Collateral without Right | ||||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||||
Assets pledged under repurchase agreements | 610 | 594 | ||
Maturity 30 to 90 Days [Member] | Cash [Member] | Asset Pledged as Collateral without Right | ||||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||||
Assets pledged under repurchase agreements | 0 | 0 | ||
Maturity 30 to 90 Days [Member] | U.S. Treasury / Agency | Asset Pledged as Collateral without Right | ||||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||||
Assets pledged under repurchase agreements | 103 | 101 | ||
Maturity 30 to 90 Days [Member] | Mortgage-backed securities | Asset Pledged as Collateral without Right | ||||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||||
Assets pledged under repurchase agreements | 507 | 493 | ||
Maturity 30 to 90 Days [Member] | Non-US [Member] | Asset Pledged as Collateral without Right | ||||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||||
Assets pledged under repurchase agreements | 0 | $ 0 | ||
Maturity Greater than 90 Days [Member] | Asset Pledged as Collateral without Right | ||||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||||
Assets pledged under repurchase agreements | 955 | |||
Maturity Greater than 90 Days [Member] | Cash [Member] | Asset Pledged as Collateral without Right | ||||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||||
Assets pledged under repurchase agreements | 46 | |||
Maturity Greater than 90 Days [Member] | U.S. Treasury / Agency | Asset Pledged as Collateral without Right | ||||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||||
Assets pledged under repurchase agreements | 0 | |||
Maturity Greater than 90 Days [Member] | Mortgage-backed securities | Asset Pledged as Collateral without Right | ||||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||||
Assets pledged under repurchase agreements | 909 | |||
Maturity Greater than 90 Days [Member] | Non-US [Member] | Asset Pledged as Collateral without Right | ||||
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | ||||
Assets pledged under repurchase agreements | $ 0 | |||
|
Shareholders' equity (Details) |
9 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|
May 22, 2023
shares
|
Aug. 04, 2022
shares
|
Jan. 17, 2022
shares
|
Sep. 30, 2023
SFr / shares
shares
|
May 17, 2023
$ / shares
|
Dec. 31, 2022
SFr / shares
shares
|
May 19, 2022
$ / shares
|
May 20, 2021
$ / shares
|
|
Stockholders' Equity Note [Abstract] | ||||||||
Common Shares, par value | SFr / shares | SFr 0.50 | SFr 24.15 | ||||||
Treasury Stock, Shares, Retired | 14,925,028 | 13,179,100 | 14,465,400 | 14,925,028 | ||||
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures | 2,024,083 | |||||||
Common Stock, Dividend Rate Approved | $ / shares | $ 0.86 | $ 0.83 | $ 0.80 | |||||
Annual dividend per share approved by shareholders | $ / shares | 3.44 | 3.32 | 3.20 | |||||
Equity, Class of Treasury Stock [Line Items] | ||||||||
Common Stock, Dividend Rate Approved | $ / shares | $ 0.86 | $ 0.83 | $ 0.80 | |||||
Treasury Stock, Shares, Retired | 14,925,028 | 13,179,100 | 14,465,400 | 14,925,028 | ||||
Treasury Stock, Common, Shares | 23,467,247 | 31,781,758 | ||||||
Common Shares, par value | SFr / shares | SFr 0.50 | SFr 24.15 |
Shareholders' equity Dividends Declared (Details) |
3 Months Ended | 9 Months Ended | ||||||
---|---|---|---|---|---|---|---|---|
Sep. 30, 2023
SFr / shares
|
Sep. 30, 2023
$ / shares
|
Sep. 30, 2022
SFr / shares
|
Sep. 30, 2022
$ / shares
|
Sep. 30, 2023
SFr / shares
|
Sep. 30, 2023
$ / shares
|
Sep. 30, 2022
SFr / shares
|
Sep. 30, 2022
$ / shares
|
|
United States of America, Dollars | ||||||||
Equity, Class of Treasury Stock [Line Items] | ||||||||
Common Stock, Dividends, Per Share, Declared | $ / shares | $ 0.86 | $ 0.83 | $ 2.55 | $ 2.46 | ||||
Switzerland, Francs | ||||||||
Equity, Class of Treasury Stock [Line Items] | ||||||||
Common Stock, Dividends, Per Share, Declared | SFr / shares | SFr 0.75 | SFr 0.78 | SFr 2.29 | SFr 2.32 |
Shareholders' equity Share Repurchases (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | |||||
---|---|---|---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
Jul. 01, 2023 |
May 19, 2022 |
Jul. 19, 2021 |
|
July 2021 Stock Repurchase Plan | |||||||
Equity, Class of Treasury Stock [Line Items] | |||||||
Stock Repurchase Program, Authorized Amount | $ 5,000 | ||||||
Number of shares repurchased | 14,022,728 | ||||||
Cost of shares repurchased | $ 2,815 | ||||||
May 2022 Stock Repurchase Plan | |||||||
Equity, Class of Treasury Stock [Line Items] | |||||||
Stock Repurchase Program, Authorized Amount | $ 2,500 | ||||||
Number of shares repurchased | 3,676,528 | 8,634,600 | 14,022,728 | ||||
Cost of shares repurchased | $ 685 | $ 1,758 | $ 2,815 | ||||
Repurchase authorization remaining at end of period | $ 1,816 | $ 1,816 | |||||
July 2023 Stock Repurchase Plan | |||||||
Equity, Class of Treasury Stock [Line Items] | |||||||
Stock Repurchase Program, Authorized Amount | $ 5,000 | ||||||
Number of shares repurchased | 2,949,900 | 8,634,600 | |||||
Cost of shares repurchased | $ 606 | $ 1,758 | |||||
Repurchase authorization remaining at end of period | $ 4,398 | $ 4,398 |
Shareholders' equity AOCI (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
|
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Balance – beginning of period, net of tax | $ 50,519 | |||
Other comprehensive loss, before income tax | $ (1,772) | $ (3,559) | (1,305) | $ (12,113) |
Other Comprehensive Income (Loss), Tax | 0 | (109) | 104 | (1,071) |
Other Comprehensive Income (Loss), Net of Tax | (1,772) | (3,450) | (1,409) | (11,042) |
Balance – end of period, net of tax | 52,373 | 47,675 | 52,373 | 47,675 |
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member] | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Balance – beginning of period, net of tax | (6,809) | (5,713) | (7,279) | 2,256 |
Balance – end of period, net of tax | (8,953) | (8,611) | (8,953) | (8,611) |
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Including Noncontrolling Interest | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Other Comprehensive Income (Loss), before Reclassifications, before Tax | (2,240) | (3,324) | (1,935) | (12,898) |
Net Realized Gains (Losses) Reclassified from AOCI | (70) | (279) | (357) | (857) |
Other comprehensive loss, before income tax | (2,170) | (3,045) | (1,578) | (12,041) |
Other Comprehensive Income (Loss), Tax | (29) | (147) | 93 | (1,174) |
Other Comprehensive Income (Loss), Net of Tax | (2,141) | (2,898) | (1,671) | (10,867) |
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Noncontrolling Interest | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Other Comprehensive Income (Loss), Net of Tax | 3 | 0 | 3 | 0 |
AOCI, Liability for Future Policy Benefit, Parent | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Balance – beginning of period, net of tax | (247) | (427) | (75) | (1,399) |
Balance – end of period, net of tax | 404 | (5) | 404 | (5) |
AOCI, Liability for Future Policy Benefit, Including Noncontrolling Interest | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Other comprehensive loss, before income tax | 683 | 479 | 497 | 1,546 |
Other Comprehensive Income (Loss), Tax | 35 | 57 | 21 | 152 |
Other Comprehensive Income (Loss), Net of Tax | 648 | 422 | 476 | 1,394 |
AOCI, Liability for Future Policy Benefit, Noncontrolling Interest | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Other Comprehensive Income (Loss), Net of Tax | (3) | 0 | (3) | 0 |
AOCI, Market Risk Benefit, Instrument-Specific Credit Risk, Parent | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Balance – beginning of period, net of tax | (16) | (17) | (24) | (57) |
Balance – end of period, net of tax | (21) | (9) | (21) | (9) |
AOCI, Market Risk Benefit, Instrument-Specific Credit Risk, Including Noncontrolling Interest | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Other Comprehensive Income (Loss), Net of Tax | (5) | 8 | 3 | 48 |
AOCI, Market Risk Benefit, Instrument-Specific Credit Risk, Noncontrolling Interest | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Other Comprehensive Income (Loss), Net of Tax | 0 | 0 | 0 | 0 |
Cumulative Foreign Currency Translation Adjustment [Member] | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Balance – beginning of period, net of tax | (2,920) | (2,768) | (2,966) | (2,114) |
Balance – end of period, net of tax | (3,148) | (3,703) | (3,148) | (3,703) |
Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Other Comprehensive Income (Loss), before Reclassifications, before Tax | (314) | (942) | (269) | (1,631) |
Net Realized Gains (Losses) Reclassified from AOCI | 3 | 0 | 10 | 0 |
Other comprehensive loss, before income tax | (317) | (942) | (279) | (1,631) |
Other Comprehensive Income (Loss), Tax | (13) | (7) | (21) | (42) |
Other Comprehensive Income (Loss), Net of Tax | (304) | (935) | (258) | (1,589) |
Accumulated Foreign Currency Adjustment Attributable to Noncontrolling Interest | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Other Comprehensive Income (Loss), Net of Tax | (76) | 0 | (76) | 0 |
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Balance – beginning of period, net of tax | (53) | 0 | (66) | 0 |
Balance – end of period, net of tax | (22) | (49) | (22) | (49) |
Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Other Comprehensive Income (Loss), before Reclassifications, before Tax | (17) | (94) | 23 | (94) |
Net Realized Gains (Losses) Reclassified from AOCI | (55) | (32) | (32) | (32) |
Other comprehensive loss, before income tax | 38 | (62) | 55 | (62) |
Other Comprehensive Income (Loss), Tax | 7 | (13) | 11 | (13) |
Other Comprehensive Income (Loss), Net of Tax | 31 | (49) | 44 | (49) |
Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Noncontrolling Interest | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Other Comprehensive Income (Loss), Net of Tax | 0 | 0 | 0 | 0 |
Postretirement Benefit Liability Adjustment [Member] | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Balance – beginning of period, net of tax | 223 | 259 | 225 | 240 |
Balance – end of period, net of tax | 222 | 261 | 222 | 261 |
Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Other comprehensive loss, before income tax | (1) | 3 | (3) | 27 |
Other Comprehensive Income (Loss), Tax | 0 | 1 | 0 | 6 |
Other Comprehensive Income (Loss), Net of Tax | (1) | 2 | (3) | 21 |
Accumulated Defined Benefit Plans Adjustment Attributable to Noncontrolling Interest | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Other Comprehensive Income (Loss), Net of Tax | 0 | 0 | 0 | 0 |
Accumulated Other Comprehensive Income (Loss) [Member] | ||||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | ||||
Balance – beginning of period, net of tax | (9,822) | (8,666) | (10,185) | (1,074) |
Other Comprehensive Income (Loss), Net of Tax | (1,696) | (3,450) | (1,333) | (11,042) |
Balance – end of period, net of tax | $ (11,518) | $ (12,116) | $ (11,518) | $ (12,116) |
Shareholders' equity AOCI Reclassifications (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
|
Equity, Class of Treasury Stock [Line Items] | ||||
Interest expense | $ 174 | $ 150 | $ 499 | $ 416 |
Income Tax (Expense) Benefit | (413) | (263) | (1,189) | (907) |
Net income (loss) | 2,043 | 792 | 5,728 | 3,935 |
Reclassification out of Accumulated Other Comprehensive Income | ||||
Equity, Class of Treasury Stock [Line Items] | ||||
Net income (loss) | (86) | (265) | (315) | (744) |
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member] | Reclassification out of Accumulated Other Comprehensive Income | ||||
Equity, Class of Treasury Stock [Line Items] | ||||
Debt Securities, Available-for-sale, Realized Gain | (70) | (279) | (357) | (857) |
Income Tax (Expense) Benefit | 25 | 39 | (59) | (138) |
Net income (loss) | (45) | (240) | (298) | (719) |
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent | Reclassification out of Accumulated Other Comprehensive Income | ||||
Equity, Class of Treasury Stock [Line Items] | ||||
Foreign Currency Transaction Gain (Loss), Realized | (51) | (32) | (20) | (32) |
Interest expense | (4) | 0 | (12) | 0 |
Income Tax (Expense) Benefit | 12 | (7) | (7) | (7) |
Net income (loss) | (43) | (25) | (25) | (25) |
Cumulative Foreign Currency Translation Adjustment [Member] | Reclassification out of Accumulated Other Comprehensive Income | ||||
Equity, Class of Treasury Stock [Line Items] | ||||
Interest expense | 3 | 0 | 10 | 0 |
Income Tax (Expense) Benefit | (1) | 0 | 2 | 0 |
Net income (loss) | $ 2 | $ 0 | $ 8 | $ 0 |
Share-Based Compensation (Detail) - $ / shares |
9 Months Ended | |
---|---|---|
Feb. 23, 2023 |
Sep. 30, 2023 |
|
Stock Options [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Award vesting period in years | 3 years | |
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period | 3 years | |
Award term period in years | 10 years | |
Stock options granted | 1,540,002 | |
Weighted-average grant date fair value for stock options granted | $ 51.32 | |
Restricted Stock [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Award vesting period in years | 4 years | |
Restricted stock awards granted to employees and officers of the company | 785,319 | |
Grant date fair value of awards except for options granted to employees and officers of the company | $ 208.60 | |
Performance Shares [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Award vesting period in years | 3 years | |
Restricted stock awards granted to employees and officers of the company | 407,825 | |
Grant date fair value of awards except for options granted to employees and officers of the company | $ 208.60 | |
Restricted Stock Units (RSUs) [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Award vesting period in years | 4 years | |
Restricted stock awards granted to employees and officers of the company | 315,545 | |
Grant date fair value of awards except for options granted to employees and officers of the company | $ 208.60 |
Postretirement benefits Components of net periodic benefit costs (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
|
Pension Plan [Member] | ||||
Defined Benefit Plans and Other Postretirement Benefit Plans | ||||
Service cost | $ 2 | $ 1 | $ 6 | $ 3 |
Non-service (benefit) cost | (22) | (55) | (73) | (164) |
Net periodic benefit cost (benefit) | (20) | (54) | (67) | (161) |
Other Postretirement Benefits Plan [Member] | ||||
Defined Benefit Plans and Other Postretirement Benefit Plans | ||||
Service cost | 0 | 0 | 0 | 0 |
Interest cost | 1 | 0 | 2 | 1 |
Expected return on plan assets | 0 | 0 | (2) | (1) |
Defined Benefit Plan, Amortization of Gain (Loss) | (1) | 0 | (1) | 0 |
Amortization of prior service cost | (1) | 0 | (1) | 0 |
Settlements | 0 | 0 | 0 | 0 |
Non-service (benefit) cost | (1) | 0 | (2) | 0 |
Net periodic benefit cost (benefit) | (1) | 0 | (2) | 0 |
Losses and loss expenses | Pension Plan [Member] | ||||
Defined Benefit Plans and Other Postretirement Benefit Plans | ||||
Service cost | 0 | 0 | 0 | 0 |
Non-service (benefit) cost | (1) | (5) | (6) | (15) |
Losses and loss expenses | Other Postretirement Benefits Plan [Member] | ||||
Defined Benefit Plans and Other Postretirement Benefit Plans | ||||
Service cost | 0 | 0 | 0 | 0 |
Non-service (benefit) cost | 0 | 0 | 0 | 0 |
Administrative Expense | Pension Plan [Member] | ||||
Defined Benefit Plans and Other Postretirement Benefit Plans | ||||
Service cost | 2 | 1 | 6 | 3 |
Non-service (benefit) cost | (21) | (50) | (67) | (149) |
Administrative Expense | Other Postretirement Benefits Plan [Member] | ||||
Defined Benefit Plans and Other Postretirement Benefit Plans | ||||
Service cost | 0 | 0 | 0 | 0 |
Non-service (benefit) cost | (1) | 0 | (2) | 0 |
Foreign Plan [Member] | Pension Plan [Member] | ||||
Defined Benefit Plans and Other Postretirement Benefit Plans | ||||
Service cost | 2 | 1 | 6 | 3 |
Interest cost | 9 | 5 | 27 | 17 |
Expected return on plan assets | (13) | (11) | (38) | (33) |
Defined Benefit Plan, Amortization of Gain (Loss) | 0 | 0 | 0 | 0 |
Amortization of prior service cost | 0 | 0 | 0 | 0 |
Settlements | 0 | 0 | 0 | 0 |
Non-service (benefit) cost | (4) | (6) | (11) | (16) |
Net periodic benefit cost (benefit) | (2) | (5) | (5) | (13) |
UNITED STATES | Pension Plan [Member] | ||||
Defined Benefit Plans and Other Postretirement Benefit Plans | ||||
Service cost | 0 | 0 | 0 | 0 |
Interest cost | 35 | 21 | 103 | 64 |
Expected return on plan assets | (56) | (70) | (168) | (212) |
Defined Benefit Plan, Amortization of Gain (Loss) | 0 | 0 | 0 | 0 |
Amortization of prior service cost | 0 | 0 | 0 | 0 |
Settlements | 3 | 0 | 3 | 0 |
Non-service (benefit) cost | (18) | (49) | (62) | (148) |
Net periodic benefit cost (benefit) | $ (18) | $ (49) | $ (62) | $ (148) |
Other Income and Expense (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||||
---|---|---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
|||
Equity in net income of partially-owned entities | $ 150 | $ (111) | $ 610 | $ 180 | ||
Gains (losses) from fair value changes in separate account assets | [1] | (19) | (67) | (56) | (116) | |
Huatai asset management non-premium revenue | 55 | 0 | 55 | 0 | ||
Huatai asset management non-premium expense | (33) | 0 | (33) | 0 | ||
Federal excise and capital taxes | (6) | (6) | (17) | (15) | ||
Other | 7 | 18 | 9 | 40 | ||
Total | 154 | (202) | 550 | 9 | ||
Partially-owned Investment Companies | ||||||
Unrealized Gain (Loss) on Investments | $ 51 | (190) | 290 | (69) | ||
Huatai Group | ||||||
Equity in net income of partially-owned entities | $ 28 | $ 36 | $ 83 | |||
|
Segment information (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
|
Segment Reporting Information [Line Items] | ||||
Net premiums written | $ 13,104 | $ 12,012 | $ 35,765 | $ 31,494 |
Net premiums earned | 12,674 | 11,530 | 33,815 | 29,816 |
Losses and loss expenses | 7,106 | 7,063 | 17,937 | 16,833 |
Policy benefits (includes remeasurement gains of $25, $17, $21, and $11) | 938 | 707 | 2,565 | 1,441 |
Policy acquisition costs | 2,178 | 1,970 | 6,142 | 5,415 |
Administrative expenses | 1,060 | 883 | 2,959 | 2,479 |
Underwriting income (loss) | 1,392 | 907 | 4,212 | 3,648 |
Net investment income (loss) | 1,314 | 979 | 3,566 | 2,689 |
Other (income) expense | (154) | 202 | (550) | (9) |
Amortization of purchased intangibles | 84 | 69 | 226 | 211 |
Segment Income (loss) | 2,776 | 1,615 | 8,102 | 6,135 |
Net realized gains (losses) | (103) | (456) | (484) | (936) |
Market risk benefits gains (losses) | (32) | 69 | (154) | 85 |
Interest Income (Expense), Net | 174 | 150 | 499 | 416 |
Cigna integration expenses | 14 | 23 | 51 | 26 |
Income tax expense | 413 | 263 | 1,189 | 907 |
Net Income | 2,040 | 792 | 5,725 | 3,935 |
Net loss attributable to noncontrolling interests | (3) | 0 | (3) | 0 |
Net income (loss) | 2,043 | 792 | 5,728 | 3,935 |
North America Commercial P&C Insurance [Member] | ||||
Segment Reporting Information [Line Items] | ||||
Net premiums written | 5,132 | 4,722 | 14,575 | 13,426 |
Net premiums earned | 4,735 | 4,283 | 13,710 | 12,645 |
Losses and loss expenses | 3,025 | 3,036 | 8,625 | 7,979 |
Policy benefits (includes remeasurement gains of $25, $17, $21, and $11) | 0 | 0 | 0 | 0 |
Policy acquisition costs | 640 | 583 | 1,867 | 1,701 |
Administrative expenses | 323 | 272 | 934 | 814 |
Underwriting income (loss) | 747 | 392 | 2,284 | 2,151 |
Net investment income (loss) | 780 | 589 | 2,204 | 1,600 |
Other (income) expense | 6 | 6 | 18 | 12 |
Amortization of purchased intangibles | 0 | 0 | 0 | 0 |
Segment Income (loss) | 1,521 | 975 | 4,470 | 3,739 |
North American Personal P&C Insurance [Member] | ||||
Segment Reporting Information [Line Items] | ||||
Net premiums written | 1,527 | 1,392 | 4,404 | 3,998 |
Net premiums earned | 1,407 | 1,334 | 4,084 | 3,852 |
Losses and loss expenses | 900 | 857 | 2,634 | 2,343 |
Policy benefits (includes remeasurement gains of $25, $17, $21, and $11) | 0 | 0 | 0 | 0 |
Policy acquisition costs | 287 | 274 | 836 | 792 |
Administrative expenses | 84 | 71 | 247 | 213 |
Underwriting income (loss) | 136 | 132 | 367 | 504 |
Net investment income (loss) | 94 | 76 | 262 | 199 |
Other (income) expense | 2 | 1 | 2 | 3 |
Amortization of purchased intangibles | 3 | 2 | 8 | 7 |
Segment Income (loss) | 225 | 205 | 619 | 693 |
North America Agricultural Insurance [Member] | ||||
Segment Reporting Information [Line Items] | ||||
Net premiums written | 1,521 | 1,723 | 2,581 | 2,523 |
Net premiums earned | 1,540 | 1,673 | 2,334 | 2,217 |
Losses and loss expenses | 1,356 | 1,444 | 2,003 | 1,830 |
Policy benefits (includes remeasurement gains of $25, $17, $21, and $11) | 0 | 0 | 0 | 0 |
Policy acquisition costs | 76 | 68 | 128 | 111 |
Administrative expenses | 3 | 3 | 9 | 4 |
Underwriting income (loss) | 105 | 158 | 194 | 272 |
Net investment income (loss) | 12 | 9 | 43 | 23 |
Other (income) expense | 0 | 1 | 0 | 1 |
Amortization of purchased intangibles | 6 | 7 | 19 | 20 |
Segment Income (loss) | 111 | 159 | 218 | 274 |
Overseas General Insurance [Member] | ||||
Segment Reporting Information [Line Items] | ||||
Net premiums written | 3,211 | 2,645 | 9,359 | 8,364 |
Net premiums earned | 3,311 | 2,741 | 9,005 | 8,065 |
Losses and loss expenses | 1,635 | 1,333 | 4,139 | 3,772 |
Policy benefits (includes remeasurement gains of $25, $17, $21, and $11) | 91 | 108 | 338 | 282 |
Policy acquisition costs | 827 | 720 | 2,286 | 2,096 |
Administrative expenses | 327 | 264 | 899 | 811 |
Underwriting income (loss) | 431 | 316 | 1,343 | 1,104 |
Net investment income (loss) | 248 | 151 | 636 | 460 |
Other (income) expense | (10) | (2) | (29) | 3 |
Amortization of purchased intangibles | 19 | 12 | 52 | 40 |
Segment Income (loss) | 670 | 457 | 1,956 | 1,521 |
Global Reinsurance [Member] | ||||
Segment Reporting Information [Line Items] | ||||
Net premiums written | 261 | 265 | 831 | 780 |
Net premiums earned | 239 | 255 | 720 | 712 |
Losses and loss expenses | 116 | 311 | 319 | 565 |
Policy benefits (includes remeasurement gains of $25, $17, $21, and $11) | 0 | 0 | 0 | 0 |
Policy acquisition costs | 69 | 59 | 196 | 178 |
Administrative expenses | 9 | 8 | 27 | 27 |
Underwriting income (loss) | 45 | (123) | 178 | (58) |
Net investment income (loss) | 47 | 71 | 144 | 232 |
Other (income) expense | 0 | 0 | (1) | 1 |
Amortization of purchased intangibles | 0 | 0 | 0 | 0 |
Segment Income (loss) | 92 | (52) | 323 | 173 |
Life Insurance [Member] | ||||
Segment Reporting Information [Line Items] | ||||
Net premiums written | 1,452 | 1,265 | 4,015 | 2,403 |
Net premiums earned | 1,442 | 1,244 | 3,962 | 2,325 |
Losses and loss expenses | 20 | 27 | 87 | 78 |
Policy benefits (includes remeasurement gains of $25, $17, $21, and $11) | 866 | 666 | 2,283 | 1,275 |
Policy acquisition costs | 279 | 266 | 829 | 537 |
Administrative expenses | 216 | 174 | 553 | 346 |
Underwriting income (loss) | 61 | 111 | 210 | 89 |
Net investment income (loss) | 211 | 147 | 525 | 359 |
Other (income) expense | (28) | 4 | (69) | (38) |
Amortization of purchased intangibles | 12 | 2 | 18 | 7 |
Segment Income (loss) | 288 | 252 | 786 | 479 |
Segment Corporate and Other | ||||
Segment Reporting Information [Line Items] | ||||
Net premiums written | 0 | 0 | 0 | 0 |
Net premiums earned | 0 | 0 | 0 | 0 |
Losses and loss expenses | 61 | 74 | 133 | 275 |
Policy benefits (includes remeasurement gains of $25, $17, $21, and $11) | 0 | 0 | 0 | 0 |
Policy acquisition costs | 0 | 0 | 0 | 0 |
Administrative expenses | 98 | 91 | 290 | 264 |
Underwriting income (loss) | (159) | (165) | (423) | (539) |
Net investment income (loss) | 14 | 5 | 28 | (4) |
Other (income) expense | (51) | 194 | (251) | 73 |
Amortization of purchased intangibles | 44 | 46 | 129 | 137 |
Segment Income (loss) | (138) | (400) | (273) | (753) |
Net realized gains (losses) | (96) | (437) | (481) | (927) |
Market risk benefits gains (losses) | (32) | 69 | (154) | 85 |
Interest Income (Expense), Net | 174 | 150 | 499 | 416 |
Cigna integration expenses | 14 | 23 | 51 | 26 |
Income tax expense | 413 | 263 | 1,189 | 907 |
Net Income | (867) | (1,204) | (2,647) | (2,944) |
Net loss attributable to noncontrolling interests | (3) | (3) | ||
Net income (loss) | (864) | (2,644) | ||
Segment Measure Reconciling Items | ||||
Segment Reporting Information [Line Items] | ||||
Net premiums written | 0 | 0 | 0 | 0 |
Net premiums earned | 0 | 0 | 0 | 0 |
Losses and loss expenses | (7) | (19) | (3) | (9) |
Policy benefits (includes remeasurement gains of $25, $17, $21, and $11) | (19) | (67) | (56) | (116) |
Policy acquisition costs | 0 | 0 | 0 | 0 |
Administrative expenses | 0 | 0 | 0 | 0 |
Underwriting income (loss) | 26 | 86 | 59 | 125 |
Net investment income (loss) | (92) | (69) | (276) | (180) |
Other (income) expense | (73) | (2) | (220) | (64) |
Amortization of purchased intangibles | 0 | 0 | 0 | 0 |
Segment Income (loss) | 7 | 19 | 3 | 9 |
Net realized gains (losses) | (7) | (19) | (3) | (9) |
Market risk benefits gains (losses) | 0 | 0 | 0 | 0 |
Interest Income (Expense), Net | 0 | 0 | 0 | 0 |
Cigna integration expenses | 0 | 0 | 0 | 0 |
Income tax expense | 0 | 0 | 0 | 0 |
Net Income | 0 | $ 0 | 0 | $ 0 |
Net loss attributable to noncontrolling interests | 0 | 0 | ||
Net income (loss) | $ 0 | $ 0 |
Earnings Per Share (Detail) - USD ($) $ / shares in Units, $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
|
Earnings Per Share [Abstract] | ||||
Net income | $ 2,040 | $ 792 | $ 5,725 | $ 3,935 |
Net loss attributable to noncontrolling interests | (3) | 0 | (3) | 0 |
Net income (loss) | $ 2,043 | $ 792 | $ 5,728 | $ 3,935 |
Weighted-average shares outstanding | 409,505,454 | 416,542,101 | 412,076,470 | 421,290,032 |
Share-based compensation plans | 3,100,505 | 3,076,855 | 3,288,940 | 3,733,449 |
Weighted-average shares outstanding and assumed conversions | 412,605,959 | 419,618,956 | 415,365,410 | 425,023,481 |
Basic earnings (loss) per share (US$ per share) | $ 4.99 | $ 1.90 | $ 13.90 | $ 9.34 |
Diluted earnings (loss) per share (US$ per share) | $ 4.95 | $ 1.89 | $ 13.79 | $ 9.26 |
Potential anti-dilutive share conversions | 2,562,206 | 1,693,502 | 2,330,821 | 1,377,784 |
N+;'R49@+7)?K+S@HK[
ML-1,8GN&U^VR1UZF&2.WZ_R1"2LG6,0] KQLCDNR:FOW'-N#E%W!X=-:!FS@LN$N+V2T".S@,4=5
M=H*JS7[2IBI,G=76*B9GFKC853JP)6'V"8A]E
MO !1T>EW<@4YKI91E1B
M)/1Q'/2'<\'54+=Z BM&PK^FWEJEF.3]23-RL+I'\N7]VWH^_:*$'HG770\
M;E-E*N'$\*!HSH)WX%,&9]X56HRKF"H:0JX=[5E-"U#0K0PI3#V<]QJU]WLT
MWC^ QO'YN#/'X/@[I$E+(*66,[:8.H#N0 -3I3N!-O$#O!);FK(R=;*!*'32
M3GNC;@TV.T7)5<*VTA\5&>? ;2 [TYCK)HJGX55%])I>J;SJ%R&< S8$MVIF6
MU=8QG1+=MW+&.^]VKWV:Y $IO*)]_CHQ1XRMPV)7?<>!R.8^,OV "1SL\C_U
MZ^'#CL/!R6/]FF_5HEOW4K8>><_AZ5Y1W=GIJL=3[K[0 67^E !_^?VN]E2^
MW*!NL%Y X[.DE_NR/3-JO[U\LN5AOZ0ZO7FK%QAJK6V,'-?#=._CR=1.L(4%
MY,>OVI5.]^Q/]_O;CGY[NIT$R,=O.:99S:YI+_<>(W8$T[?.CJ+Q767RRM3LM:XYT\Z$E/E+?
M'FV P4R=M'K(]-S5[CJ6LGO%A,Z?T9'I=019H3]4I%XOEZIZ?*WS\N%T0B=/)SYF=XO&G)B=G:S4G;[6
MS:?5APJ.9IM9YME2%W56%J32MZ>3
"&,6!HY;Q@>+X'HIK@[@H\[FNZC\V
ME?>I=4'1VOP54:N)1:PX%2Z\ \OQ?4WLB"-R?SGA-E4A1(%9.8F";^V"^PGM
M&:WA2CT:E8]"M]DK%O&81A"K*(I=T >.XWZ.0S8+?%"1CM/>*<"LG#L%?& \
M[F>\\RX3-K&CUSDPE X=3O7SK4
M[=ND+-2YCF
0@D4E3"Z@@_B Q=2.G)!O0LD98.VC$Z%$!2XE[ZB
MU21]RI"VD>C5GDC6^58M;5LX,60;"-I5907S((TT K2D&J_.6]5"->).B*V'
MW/+UW 0+.L17LN-^#0Y*1N:=9K$&W#$6Q$UI"U;"A")AG"(XS*LA(R<,
M$KL+HZVL7J$\(+[.H:55BY)<\X:BU^U4Z92AI*W,;._3SV7&$?HK#R-5#V.(:>-X<(;< PC"(!$QIC#NA:=^QB8
M]=#SSN10.J:H#'E9WA=<_.N]&<4Y2:$HLQH]7;5%5NOB*6=_F$-K%+*J-VJ'
M[(WK!Y)1&IFEEHN;A>R.>>BGLU]NO\RU>=Y1S5FED :*&C*%O